data_1wkt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wkt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 p90 . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tp -132.94 60.19 1.71 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 pt -94.22 175.2 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.123 0.969 . . . . 0.0 110.867 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.7 ptm -138.37 166.89 23.09 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.881 1.273 . . . . 0.0 108.887 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 61.0 m -147.44 162.03 39.85 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.766 1.269 . . . . 0.0 110.707 -158.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -85.76 -29.5 23.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.07 -1.877 . . . . 0.0 110.28 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -126.07 -166.0 1.51 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.9 t -93.0 3.32 55.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -139.94 105.82 6.81 Favored Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 124.365 1.066 . . . . 0.0 112.824 -164.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.45 -20.89 58.85 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.853 1.702 . . . . 0.0 112.659 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -64.22 -44.12 92.88 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.65 1.114 . . . . 0.0 109.886 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 p -113.97 13.5 18.27 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -174.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.63 133.12 6.08 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 124.571 1.082 . . . . 0.0 110.769 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.14 94.25 1.13 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 174.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 70.9 m -77.53 148.19 35.39 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.35 129.74 36.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -111.99 59.84 0.63 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.7 2.8 . . . . 0.0 106.631 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -92.6 165.72 12.85 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 165.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -73.16 143.75 47.14 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 118.199 -1.4 . . . . 0.0 107.525 166.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -130.29 -14.12 3.84 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.726 1.611 . . . . 0.0 109.952 -172.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -79.04 112.82 16.63 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -172.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.6 t30 64.11 44.75 4.39 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.036 0.935 . . . . 0.0 111.36 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.32 141.37 30.94 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.947 0.899 . . . . 0.0 109.093 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.32 77.76 5.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.904 2.081 . . . . 0.0 109.127 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 t -92.64 127.64 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.51 139.68 16.14 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.948 1.261 . . . . 0.0 111.365 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 mm -134.5 165.84 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 126.73 2.012 . . . . 0.0 108.891 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.98 -170.71 40.83 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 163.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.77 80.54 0.2 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.599 1.96 . . . . 0.0 113.643 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 71.2 4.16 4.95 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 126.803 2.041 . . . . 0.0 111.182 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.0 111.44 22.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -146.37 25.75 1.21 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -137.48 114.46 10.69 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 119.729 1.15 . . . . 0.0 111.548 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 21.9 ttt -84.49 113.88 21.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.98 96.92 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -104.19 141.2 36.68 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.674 0.79 . . . . 0.0 109.855 -159.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.358 0 C-N-CA 123.374 0.512 . . . . 0.0 111.83 -169.126 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 mttm . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -46.94 157.61 0.15 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.845 1.658 . . . . 0.0 112.492 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.68 134.41 12.2 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 106.999 -2.44 . . . . 0.0 106.999 166.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.1 m -133.37 155.42 49.5 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.62 149.6 39.17 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.666 0.604 . . . . 0.0 111.36 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.0 m -84.5 126.41 33.26 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 159.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.2 mt -121.2 128.35 75.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -172.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.41 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 9.1 m-90 -111.13 153.68 25.38 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.739 1.615 . . . . 0.0 113.262 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.78 -45.68 74.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.409 2.284 . . . . 0.0 111.181 172.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.81 157.45 48.9 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 m -78.2 122.48 25.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 163.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.52 41.88 9.61 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 124.761 1.172 . . . . 0.0 111.058 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.5 p 45.79 57.04 5.37 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.454 1.902 . . . . 0.0 113.137 166.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 m -124.63 176.03 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 126.203 1.801 . . . . 0.0 106.95 164.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.54 -160.94 28.22 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -72.86 160.69 31.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 8.8 p -145.13 160.55 41.25 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.898 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.1 t -110.27 159.47 17.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 162.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -110.11 111.51 22.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 160.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.03 122.5 41.25 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.876 0.735 . . . . 0.0 110.767 -171.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.5 m -105.74 152.76 22.78 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.937 1.295 . . . . 0.0 111.967 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.7 t -151.93 143.73 16.18 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.258 169.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.81 172.24 7.35 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.837 1.691 . . . . 0.0 113.084 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.99 135.84 33.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.875 1.27 . . . . 0.0 110.97 -172.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 56.25 64.74 1.61 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -165.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 m -145.26 126.67 14.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.34 120.64 28.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.36 1.464 . . . . 0.0 108.725 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.5 m -130.73 105.44 7.8 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -162.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -68.24 112.95 5.45 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.003 0.521 . . . . 0.0 110.785 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.09 107.67 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -136.99 129.75 30.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 162.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -126.48 -169.72 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.677 1.126 . . . . 0.0 110.161 -172.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.71 11.69 67.86 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.34 174.87 10.97 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 125.098 1.359 . . . . 0.0 109.284 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -74.3 148.15 41.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 163.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.62 142.4 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -134.14 -66.75 0.61 Allowed 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.9 m -93.77 173.48 7.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 116.431 -2.108 . . . . 0.0 112.062 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -155.82 168.22 27.9 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.238 165.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.97 136.37 19.0 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 163.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 166.4 16.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.942 -171.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.64 -32.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 116.924 -1.513 . . . . 0.0 113.095 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 N--CA 1.466 0.341 0 C-N-CA 124.869 1.268 . . . . 0.0 108.581 -174.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.6 p90 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.1 tt -144.16 126.23 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 161.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.78 170.95 12.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.3 ptm -117.35 168.49 10.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.876 0.846 . . . . 0.0 110.023 158.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.2 m -156.05 166.25 34.02 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.319 1.448 . . . . 0.0 108.374 -158.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -85.95 -20.52 28.84 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 170.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.2 p30 -136.9 -175.37 4.01 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.849 172.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 40.7 t -89.05 3.82 50.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.347 -170.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -138.02 94.42 11.28 Favored Pre-proline 0 N--CA 1.456 -0.141 0 C-N-CA 123.651 0.78 . . . . 0.0 110.984 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.08 -23.06 2.5 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.52 2.813 . . . . 0.0 114.679 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -63.65 -41.24 98.24 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 119.801 1.182 . . . . 0.0 110.123 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -111.41 14.12 21.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.677 0.791 . . . . 0.0 110.824 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.38 121.02 5.79 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 125.08 1.324 . . . . 0.0 109.85 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.0 m -65.32 123.26 19.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 159.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.4 m -135.93 159.1 42.71 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -172.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.86 92.99 8.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.677 1.227 . . . . 0.0 109.65 169.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -84.51 42.7 0.91 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.243 162.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 167.34 10.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 164.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -64.09 144.08 57.38 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.418 0.627 . . . . 0.0 109.327 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -122.25 -8.3 8.71 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.577 2.351 . . . . 0.0 110.015 167.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -58.78 94.13 0.02 OUTLIER 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.091 0.957 . . . . 0.0 110.093 169.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 41.46 55.79 3.37 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.413 1.485 . . . . 0.0 111.379 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.2 p -138.18 124.35 20.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 102.492 -3.151 . . . . 0.0 102.492 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.4 t -75.3 84.43 2.45 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.681 1.193 . . . . 0.0 109.343 -166.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.7 t -83.63 121.79 36.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -170.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.36 154.51 49.24 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.418 1.009 . . . . 0.0 111.222 174.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -128.27 142.21 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.577 1.951 . . . . 0.0 107.115 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.79 168.81 33.84 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 168.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 61.01 72.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 68.94 2.87 3.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 128.21 2.604 . . . . 0.0 111.259 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -83.71 97.56 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -146.35 34.38 0.97 Allowed 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -135.42 113.98 11.71 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 121.789 -0.569 . . . . 0.0 109.623 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.4 ttp -85.95 132.61 34.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.72 129.38 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.23 128.19 17.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -159.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 172.875 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.4 mttp . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.369 0.128 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -51.75 143.46 12.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.004 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.96 133.17 11.51 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 107.484 -2.247 . . . . 0.0 107.484 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.6 m -119.3 147.33 44.42 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 117.749 0.775 . . . . 0.0 109.164 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.13 140.71 26.89 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 114.711 -1.132 . . . . 0.0 108.86 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.7 m -91.0 113.0 25.14 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.8 mt -95.7 143.79 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.401 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 22.7 m-90 -125.09 152.63 44.11 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.201 1.4 . . . . 0.0 113.076 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -81.15 -38.77 26.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.702 2.401 . . . . 0.0 109.787 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.38 136.66 23.82 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m -60.45 119.89 8.88 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 168.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.15 46.12 7.18 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 124.183 0.897 . . . . 0.0 111.619 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.6 p 44.67 51.69 8.09 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.268 1.827 . . . . 0.0 113.206 169.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 m -125.88 176.86 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 128.588 2.755 . . . . 0.0 106.452 171.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.37 -156.84 34.11 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.3 ttt85 -67.96 153.82 42.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.401 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.2 p -141.47 165.85 26.36 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 174.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.0 t -137.31 138.87 40.46 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -88.43 94.95 10.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 40.6 tpp -86.38 104.7 16.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 98.8 m -93.08 138.14 31.79 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 166.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.5 t -153.52 132.08 6.67 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.176 1.391 . . . . 0.0 109.801 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -63.18 163.6 22.51 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.404 2.069 . . . . 0.0 115.579 -167.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.07 122.97 25.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 83.11 62.72 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 128.011 2.524 . . . . 0.0 107.402 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.72 -176.91 6.2 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.343 1.068 . . . . 0.0 109.778 158.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.29 122.78 25.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 128.907 2.883 . . . . 0.0 106.42 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.23 113.28 24.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.633 1.973 . . . . 0.0 107.061 -171.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -66.47 115.12 6.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 167.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.21 120.62 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 165.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -150.47 66.95 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 170.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 p -78.2 161.56 27.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.581 -167.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -52.84 -30.17 35.82 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.021 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -111.12 159.89 17.41 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 124.575 1.15 . . . . 0.0 109.947 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -72.56 139.26 47.4 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.945 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.32 133.69 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.289 1.036 . . . . 0.0 110.252 -164.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -122.61 -41.05 2.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.906 0.882 . . . . 0.0 111.544 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.94 167.27 22.53 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -154.88 161.44 41.44 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.237 0.615 . . . . 0.0 111.852 163.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -138.29 145.62 41.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.829 2.052 . . . . 0.0 108.395 164.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.98 153.54 34.45 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.875 166.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.35 -17.84 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.811 1.644 . . . . 0.0 110.455 164.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 164.537 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 p90 . . . . . 0 N--CA 1.446 -0.628 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 tt -139.18 103.76 4.84 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 159.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 pt -124.42 171.54 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.0 ptp -136.58 140.11 42.65 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.352 1.061 . . . . 0.0 111.181 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.4 m -125.04 168.8 12.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.108 1.363 . . . . 0.0 109.965 -159.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -79.55 -34.8 40.67 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.928 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -132.47 -168.68 2.1 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 128.033 2.533 . . . . 0.0 107.31 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -94.96 3.46 54.92 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.31 114.55 23.51 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 124.971 1.309 . . . . 0.0 111.229 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.76 -24.4 74.62 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.309 2.006 . . . . 0.0 111.838 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -44.95 91.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.617 1.099 . . . . 0.0 109.44 -177.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.2 p -103.95 13.66 32.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.934 0.894 . . . . 0.0 112.346 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.97 114.65 2.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 124.993 1.282 . . . . 0.0 111.408 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.53 94.21 1.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.0 m -87.72 173.15 9.18 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.563 0.745 . . . . 0.0 109.175 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 162.1 27.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 158.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -151.5 54.87 0.85 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 168.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -114.89 176.27 5.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.839 1.656 . . . . 0.0 108.259 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -63.98 153.4 37.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.215 0.606 . . . . 0.0 109.456 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -146.5 -23.45 0.43 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -103.07 33.67 3.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.565 -1.334 . . . . 0.0 109.67 -173.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -141.72 43.84 1.72 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.599 -167.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 89.98 177.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 173.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.3 t -47.44 109.89 0.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.515 1.526 . . . . 0.0 112.273 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.03 145.02 12.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 127.005 2.122 . . . . 0.0 107.241 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.74 134.94 14.29 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.7 mm -133.15 166.52 29.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 127.093 2.157 . . . . 0.0 108.613 -169.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.62 -166.98 21.65 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 106.598 -2.601 . . . . 0.0 106.598 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 48.72 89.45 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 164.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.4 m120 64.8 22.25 12.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 126.59 1.956 . . . . 0.0 111.517 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.3 t -133.91 101.14 3.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -146.53 25.8 1.19 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.713 1.205 . . . . 0.0 112.335 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -129.81 143.23 50.71 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 166.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 48.5 ttm -107.15 125.3 50.9 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 167.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.98 93.37 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -99.59 155.13 17.76 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.959 1.304 . . . . 0.0 109.002 -167.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.422 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 175.123 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.63 167.58 3.42 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.237 1.015 . . . . 0.0 110.675 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.21 140.57 9.47 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 162.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 m -126.27 166.6 16.81 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.3 147.03 26.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.296 1.438 . . . . 0.0 110.118 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 m -83.5 123.06 29.35 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 161.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 mt -110.12 150.98 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.431 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 24.6 m-90 -129.65 156.77 43.69 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.855 1.662 . . . . 0.0 110.295 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -83.73 -36.01 23.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.35 1.06 . . . . 0.0 111.271 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.88 148.19 50.85 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.119 -0.988 . . . . 0.0 110.746 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m -78.27 53.98 1.32 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.099 0.96 . . . . 0.0 110.35 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.4 55.4 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -171.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 54.42 34.4 20.78 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 162.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 m -125.93 176.55 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 126.932 2.093 . . . . 0.0 109.763 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.52 -152.7 29.39 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -73.66 142.28 46.45 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.431 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.3 p -136.72 168.26 19.86 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.924 0.765 . . . . 0.0 111.411 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.1 t -152.91 140.9 20.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.803 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.8 m -72.67 100.46 2.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 158.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.87 119.39 24.81 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 166.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.7 m -101.46 153.81 19.37 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.7 t -142.61 119.71 7.05 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 123.718 0.807 . . . . 0.0 109.008 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.77 179.89 2.42 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.957 1.771 . . . . 0.0 110.545 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.72 151.54 40.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.831 -161.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.7 m120 50.91 53.34 13.2 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.231 161.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 t -156.08 179.97 8.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.296 0.57 . . . . 0.0 109.804 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 141.75 46.07 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.582 2.753 . . . . 0.0 108.754 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.0 m -143.32 117.69 9.65 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.617 1.167 . . . . 0.0 107.879 -168.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.94 103.96 5.35 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.454 0.57 . . . . 0.0 110.32 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.11 132.96 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t30 141.66 112.82 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 129.111 2.964 . . . . 0.0 104.254 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.45 9.13 19.63 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -174.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.07 -60.91 0.51 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 -159.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -82.73 156.97 23.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -168.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -73.94 133.81 43.09 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.332 -1.304 . . . . 0.0 107.746 172.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.6 128.23 55.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -166.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -136.71 -19.62 1.36 Allowed 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -166.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -142.6 163.24 33.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 119.631 1.105 . . . . 0.0 108.575 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.04 161.48 41.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.958 0.799 . . . . 0.0 112.918 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.37 129.08 12.35 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 171.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.4 mmm-85 -57.41 142.69 42.93 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.17 -3.07 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.193 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 CA--C 1.52 -0.2 0 C-N-CA 126.202 1.801 . . . . 0.0 107.493 177.403 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.3 p90 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.38 119.45 12.03 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.43 151.98 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 126.552 1.941 . . . . 0.0 106.301 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.1 ptp -110.96 159.3 17.85 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.876 0.846 . . . . 0.0 112.187 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.5 m -145.31 154.56 42.47 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 122.753 1.263 . . . . 0.0 110.133 -159.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -86.14 -13.37 47.32 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 112.679 -2.055 . . . . 0.0 110.741 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -150.77 -179.93 7.68 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.849 1.66 . . . . 0.0 107.84 164.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 t -77.28 3.67 12.42 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -128.57 106.11 19.01 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -59.97 -21.12 63.54 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.618 1.545 . . . . 0.0 112.684 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.9 -33.46 75.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.538 0.608 . . . . 0.0 110.64 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 t -142.37 29.5 1.6 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.221 0.464 . . . . 0.0 111.592 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.22 139.19 10.75 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.11 126.58 28.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 164.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.2 m -135.61 137.14 41.62 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -96.28 103.38 15.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 111.559 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -103.71 56.45 0.73 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 129.266 3.027 . . . . 0.0 109.619 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -99.67 -175.76 3.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 159.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -64.01 147.06 52.99 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -143.52 -8.17 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.742 0.817 . . . . 0.0 112.641 -164.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -101.78 143.59 31.51 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 54.94 47.68 21.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.454 1.101 . . . . 0.0 111.991 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 t -144.05 -173.44 4.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.241 1.416 . . . . 0.0 109.322 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.7 t -151.52 66.79 0.88 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.622 1.969 . . . . 0.0 109.405 -173.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.3 t -104.05 120.62 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.47 1.108 . . . . 0.0 109.659 -167.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.8 128.31 8.38 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.147 0.879 . . . . 0.0 112.639 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.31 166.35 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 127.855 2.462 . . . . 0.0 106.09 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.63 -178.92 41.85 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.99 99.38 0.05 Allowed 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 127.537 2.335 . . . . 0.0 110.64 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 73.08 8.36 5.37 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.396 1.878 . . . . 0.0 110.98 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.7 t -84.57 97.62 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -143.25 28.96 1.48 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -143.63 127.41 17.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.6 ttm -104.9 132.93 50.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 162.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 t -125.16 81.29 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -94.66 151.65 19.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -168.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.796 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -175.177 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.295 0.569 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.92 159.66 33.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.844 168.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.32 173.04 31.5 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 164.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.2 m -129.86 159.82 35.42 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -163.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.18 140.53 35.92 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.8 m -83.23 124.45 30.57 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 159.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.2 mt -102.93 146.8 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -123.01 160.98 25.16 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.715 1.606 . . . . 0.0 110.936 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -79.54 -50.16 11.15 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.418 1.487 . . . . 0.0 110.919 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.27 121.05 5.3 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -169.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.71 108.87 0.23 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.05 2.14 . . . . 0.0 108.66 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 129.87 -74.75 0.44 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -172.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.1 p 163.03 55.1 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 129.298 3.039 . . . . 0.0 110.462 165.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.63 176.61 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.566 1.546 . . . . 0.0 107.908 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.78 -158.75 37.31 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -80.4 151.55 29.31 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.73 164.37 30.65 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.11 -169.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.57 128.88 10.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -170.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.0 p -82.3 92.74 7.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 41.2 tpp -83.73 129.78 34.95 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 96.7 m -130.58 134.3 46.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.925 0.784 . . . . 0.0 109.333 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 t -150.16 143.67 16.8 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.653 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -66.98 170.12 13.59 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.539 2.159 . . . . 0.0 113.93 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.61 148.75 42.6 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.1 m120 59.81 41.45 18.09 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.111 1.364 . . . . 0.0 109.007 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.4 m -127.9 131.41 49.39 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.2 t -88.49 124.82 34.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 170.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.4 m -121.18 105.79 10.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -160.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -78.04 104.84 8.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.624 0.647 . . . . 0.0 109.671 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.64 116.0 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -139.84 83.23 1.91 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 p -74.47 -174.87 2.18 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.965 -1.084 . . . . 0.0 108.966 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.65 -20.22 71.85 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.321 -0.862 . . . . 0.0 111.573 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -131.02 177.23 7.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.977 1.311 . . . . 0.0 109.838 -172.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -83.35 135.28 34.77 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.32 146.36 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.461 1.504 . . . . 0.0 110.522 -169.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.1 mtt85 -136.25 -85.78 0.35 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.172 0.989 . . . . 0.0 110.024 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.12 168.33 17.84 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.272 -159.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -157.93 165.15 35.91 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.76 123.65 6.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.393 1.477 . . . . 0.0 107.347 170.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -59.9 129.9 44.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -36.9 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 C-N-CA 126.571 1.948 . . . . 0.0 110.472 -167.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 177.528 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.3 p90 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.4 tt -149.91 91.67 1.81 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 pt -108.29 144.59 16.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.5 ptp -78.16 131.26 37.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 159.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 66.5 m -103.09 156.41 17.71 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -66.46 -39.84 89.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 117.414 -1.715 . . . . 0.0 108.688 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.421 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 39.8 p-10 -131.94 -165.9 1.65 Allowed 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 127.123 2.169 . . . . 0.0 108.53 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.0 t -82.99 3.82 28.55 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.397 -0.815 . . . . 0.0 112.609 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -106.84 114.29 61.82 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 123.267 0.627 . . . . 0.0 110.181 -170.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.39 -32.44 89.21 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.653 1.569 . . . . 0.0 111.504 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -100.56 -51.53 3.58 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.599 1.559 . . . . 0.0 111.757 -161.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -103.92 13.78 32.08 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.679 0.672 . . . . 0.0 112.148 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.45 -69.47 1.39 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 106.855 -2.498 . . . . 0.0 106.855 164.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t 94.22 122.05 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.282 2.633 . . . . 0.0 106.314 -163.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.2 m -136.46 159.75 40.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 126.671 1.989 . . . . 0.0 108.881 -165.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -89.25 94.37 9.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.464 2.078 . . . . 0.0 112.584 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -83.64 51.09 1.93 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.37 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -110.43 -176.65 3.03 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.929 2.492 . . . . 0.0 106.834 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 144.36 49.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 167.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -134.91 2.82 3.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 123.69 0.619 . . . . 0.0 110.016 171.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -93.51 125.66 38.23 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 -172.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 53.74 37.45 26.27 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.78 0.832 . . . . 0.0 111.88 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -133.9 151.44 51.51 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.322 1.849 . . . . 0.0 106.613 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -89.32 85.66 6.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -83.85 124.87 40.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -167.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.69 121.44 5.67 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 118.404 0.547 . . . . 0.0 112.04 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.2 mt -93.46 159.43 2.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 126.577 1.951 . . . . 0.0 108.405 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.91 166.13 28.06 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 169.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.23 74.05 0.21 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.768 2.427 . . . . 0.0 112.342 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 68.21 14.9 9.33 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.886 2.074 . . . . 0.0 110.821 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.1 t -133.53 99.49 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -145.8 39.9 1.15 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.725 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.421 ' CD1' ' HA ' ' A' ' 10' ' ' ASN . 60.2 m95 -135.16 132.11 37.6 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 19.5 ttp -106.58 123.23 47.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 165.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -124.03 117.09 49.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -99.47 -177.03 3.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -168.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.96 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 173.712 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.2 mttp . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 122.322 1.058 . . . . 0.0 108.522 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -66.78 150.99 48.33 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.329 165.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.76 147.91 18.68 Favored Glycine 0 C--O 1.238 0.402 0 N-CA-C 105.791 -2.924 . . . . 0.0 105.791 166.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.9 m -132.96 151.33 52.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.147 1.474 . . . . 0.0 108.721 -172.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.79 144.47 49.03 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.924 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.2 m -83.3 115.53 22.03 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 162.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.84 148.47 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -127.94 151.8 48.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.109 1.364 . . . . 0.0 111.504 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -87.91 -33.67 18.41 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.476 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.87 138.44 31.44 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 173.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.6 m -61.83 135.28 57.52 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 159.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.11 32.45 39.4 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 124.727 1.156 . . . . 0.0 111.006 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 12.1 p 45.39 52.29 9.03 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.643 2.377 . . . . 0.0 112.174 169.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.76 175.73 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 125.703 1.601 . . . . 0.0 107.711 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.71 -151.35 26.29 Favored Glycine 0 CA--C 1.523 0.549 0 O-C-N 121.368 -0.832 . . . . 0.0 111.992 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.2 142.85 49.02 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -170.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.99 147.58 28.03 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -167.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p -128.19 115.84 18.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.4 1.48 . . . . 0.0 108.204 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.8 88.33 0.25 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.054 1.342 . . . . 0.0 108.892 171.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -90.52 132.48 35.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.955 1.302 . . . . 0.0 107.984 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 64.5 m -118.51 143.19 46.9 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.1 t -134.2 114.26 12.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 123.729 0.812 . . . . 0.0 109.362 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -72.01 166.48 29.49 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.354 1.369 . . . . 0.0 113.516 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.3 154.25 40.21 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 45.9 53.5 8.89 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.223 1.009 . . . . 0.0 108.718 -164.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 m -144.4 106.64 4.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -73.93 126.08 29.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 169.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 86.4 m -121.57 139.73 53.14 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.942 1.297 . . . . 0.0 108.592 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -108.46 113.84 27.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 109.546 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 1.5 mp -93.4 71.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -168.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -123.98 84.04 2.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 p -73.97 170.83 14.6 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.01 -36.86 93.49 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -85.07 162.67 19.21 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 122.121 -0.635 . . . . 0.0 109.395 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -84.44 133.7 34.48 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.079 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.75 132.29 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.025 1.33 . . . . 0.0 109.769 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -118.58 -37.39 3.3 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 118.511 -0.757 . . . . 0.0 111.982 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 p -152.72 167.33 29.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -139.18 167.13 22.74 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.32 1.048 . . . . 0.0 112.036 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.8 139.68 40.15 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.013 1.725 . . . . 0.0 109.035 162.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.42 HH21 ' C ' ' A' ' 88' ' ' GLU . 49.3 mmm-85 -54.54 154.62 4.64 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.649 0.659 . . . . 0.0 112.095 170.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.67 -31.19 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 123.215 0.606 . . . . 0.0 110.985 165.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.42 ' C ' HH21 ' A' ' 86' ' ' ARG . 10.0 pt-20 . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.3 p90 . . . . . 0 N--CA 1.443 -0.78 0 CA-C-O 122.163 0.982 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 tt -141.25 110.57 6.31 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 159.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.52 111.23 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -169.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptm -72.38 148.6 45.11 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.686 -1.206 . . . . 0.0 108.478 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 71.4 m -129.78 157.05 43.27 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -172.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -72.65 -30.78 64.58 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 117.544 -1.662 . . . . 0.0 112.359 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -125.59 -166.55 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.589 1.955 . . . . 0.0 109.528 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 t -99.8 25.66 7.04 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.275 1.03 . . . . 0.0 111.909 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -119.63 101.74 48.17 Favored Pre-proline 0 C--N 1.327 -0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 111.81 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -58.27 -24.07 65.72 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 120.858 1.039 . . . . 0.0 113.028 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -66.61 -73.68 0.13 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.112 0.869 . . . . 0.0 111.052 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 t -122.28 37.56 4.36 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.159 0.983 . . . . 0.0 110.413 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.2 -37.37 71.85 Favored Glycine 0 N--CA 1.448 -0.557 0 O-C-N 120.925 -1.109 . . . . 0.0 110.928 161.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.98 114.37 0.05 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -159.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.2 m -136.04 137.26 40.97 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 112.46 -2.155 . . . . 0.0 106.663 -166.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -80.61 93.37 6.1 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 122.707 1.241 . . . . 0.0 109.974 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -83.25 41.95 0.79 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.473 1.909 . . . . 0.0 108.309 165.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -96.67 168.43 10.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 166.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -63.74 143.81 57.54 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 118.429 -1.309 . . . . 0.0 109.014 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -129.82 -44.37 1.2 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 126.807 2.043 . . . . 0.0 108.162 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . 0.3 6.4 t-105 -86.19 59.09 5.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.834 1.254 . . . . 0.0 108.212 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.13 -0.01 0.01 OUTLIER 'General case' 0 N--CA 1.46 0.067 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 173.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 t -167.15 142.06 3.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 120.292 1.405 . . . . 0.0 110.382 -158.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.9 t -65.75 75.42 0.07 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.995 2.518 . . . . 0.0 111.625 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 t -83.64 148.33 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 O-C-N 120.882 -1.136 . . . . 0.0 108.646 -167.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.88 144.7 19.62 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 124.337 0.97 . . . . 0.0 111.013 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -101.22 156.63 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 166.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.81 154.58 10.84 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 66.85 83.07 0.17 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.052 1.741 . . . . 0.0 114.323 165.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 67.67 3.76 3.57 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.395 1.478 . . . . 0.0 111.723 171.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.29 126.48 36.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 122.486 0.314 . . . . 0.0 110.256 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 30.25 1.02 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 169.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.516 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 68.0 m95 -138.35 127.3 23.95 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.986 0.812 . . . . 0.0 112.728 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.1 ttp -90.63 135.58 33.61 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 161.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.9 137.55 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 t -146.07 153.4 40.68 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 121.691 -0.63 . . . . 0.0 110.378 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.547 0 CA-C-N 118.373 0.533 . . . . 0.0 112.143 -177.061 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.2 mttm . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 122.851 1.31 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -44.13 143.63 1.13 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 126.538 1.935 . . . . 0.0 110.665 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.79 137.38 12.38 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.7 m -125.24 153.74 42.7 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.46 143.69 46.01 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.855 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -88.25 130.88 34.97 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 159.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 mt -116.76 144.43 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -130.43 143.72 50.94 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.1 1.36 . . . . 0.0 110.475 -171.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -61.39 -51.96 66.62 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.32 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.46 145.99 36.68 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 124.392 0.996 . . . . 0.0 113.296 -163.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 m -55.13 116.98 3.1 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 162.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.13 51.14 5.9 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.4 p 43.29 53.17 5.56 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.73 1.612 . . . . 0.0 113.342 163.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -125.76 176.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 128.129 2.572 . . . . 0.0 106.35 167.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.91 -168.24 39.07 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 119.421 1.01 . . . . 0.0 110.814 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -69.41 128.36 36.28 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -170.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.92 165.06 15.74 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.811 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -150.66 151.29 32.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 m -87.02 111.07 20.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 164.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 34.9 tpp -87.02 144.06 27.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 167.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 55.4 m -147.37 136.14 22.05 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.3 t -135.03 137.71 27.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 124.78 1.232 . . . . 0.0 108.406 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.05 168.31 7.63 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.185 1.257 . . . . 0.0 110.759 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.8 150.33 41.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.308 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 54.51 48.47 20.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.942 1.297 . . . . 0.0 107.918 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.9 m -145.32 148.07 33.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.462 1.105 . . . . 0.0 108.181 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.516 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -101.17 137.17 39.88 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 128.559 2.744 . . . . 0.0 108.338 172.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 54.3 m -140.84 128.17 21.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.968 0.804 . . . . 0.0 110.398 -175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -73.36 135.84 44.33 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.186 0.994 . . . . 0.0 111.599 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.403 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 1.3 mp -102.23 112.86 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 126.573 1.949 . . . . 0.0 106.233 173.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -150.71 77.35 1.28 Allowed 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.843 -0.535 . . . . 0.0 109.944 169.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.32 165.67 24.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.829 0.851 . . . . 0.0 109.28 172.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.99 -51.5 56.92 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -77.33 154.33 32.93 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.551 0.691 . . . . 0.0 110.096 171.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -86.2 137.12 32.87 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.384 -1.734 . . . . 0.0 109.918 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.48 127.76 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 124.665 1.186 . . . . 0.0 109.892 -170.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -109.01 -17.82 13.82 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.982 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -139.13 166.63 24.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -153.65 162.3 41.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.615 1.166 . . . . 0.0 111.651 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -137.59 143.96 41.76 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.108 1.763 . . . . 0.0 107.837 159.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 154.37 34.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 163.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 m -131.62 -22.99 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 165.855 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.2 p90 . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -147.55 121.17 9.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.3 pt -132.01 168.89 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 126.851 2.06 . . . . 0.0 106.537 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.2 ptp -120.57 144.34 48.14 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 158.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 70.9 m -117.29 156.06 28.44 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.5 pttt -60.87 -44.45 97.04 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 116.827 -1.949 . . . . 0.0 109.029 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -126.82 167.73 15.4 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.812 1.645 . . . . 0.0 109.191 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.9 t -72.72 3.88 4.63 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -101.87 100.65 15.26 Favored Pre-proline 0 N--CA 1.467 0.397 0 O-C-N 121.061 -1.024 . . . . 0.0 110.121 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.45 -27.91 83.5 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.958 1.772 . . . . 0.0 112.256 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -63.47 -60.11 3.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.378 0.535 . . . . 0.0 109.688 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.4 p -103.81 13.36 33.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.75 132.75 11.34 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 p -64.42 114.97 4.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 158.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -126.37 138.23 53.54 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -76.07 92.69 3.21 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.218 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.23 59.57 4.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 128.56 2.744 . . . . 0.0 104.489 166.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -127.53 168.92 14.28 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 170.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -64.3 143.86 57.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -134.22 -39.88 0.83 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.022 0.529 . . . . 0.0 109.813 -170.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.418 ' O ' ' CG ' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -77.62 33.57 0.17 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.443 1.116 . . . . 0.0 111.805 -175.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.83 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 119.182 -2.199 . . . . 0.0 111.838 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.26 146.83 23.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.958 0.409 . . . . 0.0 111.191 -170.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.7 t -77.78 81.87 4.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.614 1.166 . . . . 0.0 108.579 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.43 145.62 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 O-C-N 121.223 -0.923 . . . . 0.0 109.968 -173.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.75 169.24 44.5 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.597 1.094 . . . . 0.0 112.998 -175.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.22 135.72 56.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 126.321 1.848 . . . . 0.0 106.123 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.59 178.1 35.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 167.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 57.82 79.35 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.075 1.75 . . . . 0.0 113.349 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.7 m120 70.3 4.49 4.91 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.25 1.42 . . . . 0.0 111.669 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.23 117.25 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 119.111 0.869 . . . . 0.0 110.87 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -145.96 29.39 1.1 Allowed 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.46 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 79.9 m95 -137.6 121.71 17.93 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 119.377 0.989 . . . . 0.0 112.213 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.2 tpp -84.3 135.4 34.33 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 163.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.78 128.79 54.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -137.77 155.72 48.75 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.193 -0.942 . . . . 0.0 109.409 -171.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.02 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 178.803 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -48.91 152.03 1.12 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.164 1.386 . . . . 0.0 111.628 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.95 153.11 17.3 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.3 m -139.33 153.81 47.78 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.16 149.84 51.68 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 124.076 0.86 . . . . 0.0 110.695 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 m -83.62 126.3 32.71 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 158.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.6 mm -101.35 146.67 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -129.02 156.92 43.05 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.017 0.913 . . . . 0.0 111.859 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -97.9 -33.79 11.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 127.441 2.296 . . . . 0.0 108.829 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 143.61 47.41 Favored Glycine 0 CA--C 1.521 0.421 0 O-C-N 120.991 -1.068 . . . . 0.0 110.904 170.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.1 m -77.35 59.09 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.062 0.931 . . . . 0.0 111.688 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.42 50.75 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.1 p 44.07 42.77 5.09 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.825 1.25 . . . . 0.0 112.925 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.2 176.41 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 171.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.68 -154.25 37.72 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -73.63 154.36 39.77 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.99 168.37 23.3 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.4 144.84 30.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.55 1.54 . . . . 0.0 107.85 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.76 123.35 28.69 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.06 108.35 15.62 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.595 1.558 . . . . 0.0 108.794 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.5 m -110.02 144.75 38.13 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.085 0.954 . . . . 0.0 111.274 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.7 t -152.47 136.86 10.45 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -67.49 159.52 52.1 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.9 2.4 . . . . 0.0 113.088 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.17 53.39 2.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.443 -159.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 156.73 50.49 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -163.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -156.04 167.38 30.59 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 165.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.46 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 13.0 t -103.08 127.28 50.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.261 1.825 . . . . 0.0 107.482 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.18 119.23 31.75 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.173 1.789 . . . . 0.0 107.25 -164.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -82.05 122.55 27.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.118 0.872 . . . . 0.0 110.685 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 75' ' ' ILE . 1.7 mp -92.28 86.46 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.26 83.84 2.16 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 166.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 p -73.66 179.36 4.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.678 1.191 . . . . 0.0 108.785 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.21 -30.12 63.77 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 121.65 -0.656 . . . . 0.0 112.419 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -119.28 171.23 8.45 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 127.1 2.16 . . . . 0.0 109.525 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -74.64 133.34 42.16 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.93 157.98 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.527 0.731 . . . . 0.0 110.734 -173.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.91 -40.65 0.6 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 167.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 p -147.69 170.09 18.28 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -156.68 158.01 36.2 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.311 0.959 . . . . 0.0 112.816 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.84 135.55 11.63 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 166.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -60.74 146.84 44.5 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.307 0.503 . . . . 0.0 112.228 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 m -107.76 -9.97 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.815 1.246 . . . . 0.0 111.915 171.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.175 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 tt -127.76 122.65 33.34 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 103.9 -2.63 . . . . 0.0 103.9 164.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 pt -140.74 168.21 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.21 169.0 9.02 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 122.729 1.252 . . . . 0.0 112.092 159.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 88.1 m -155.7 157.91 37.38 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.958 -159.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -64.02 -32.25 73.72 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.017 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -159.43 175.84 12.82 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.365 0.666 . . . . 0.0 109.742 -165.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.0 t -79.92 20.52 0.62 Allowed 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.024 1.73 . . . . 0.0 113.082 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -141.82 118.58 7.31 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.877 1.271 . . . . 0.0 110.714 171.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.19 -25.34 10.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.109 2.539 . . . . 0.0 111.463 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -63.94 -42.64 97.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.9 p -108.04 13.88 25.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.933 1.293 . . . . 0.0 112.124 177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.0 118.51 3.71 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 125.355 1.455 . . . . 0.0 109.901 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.21 120.82 15.64 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.2 m -122.18 158.96 28.23 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.708 0.803 . . . . 0.0 109.35 -169.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -95.76 93.77 7.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 125.394 2.521 . . . . 0.0 112.729 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -83.98 47.35 1.3 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.052 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.46 -178.03 1.04 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.135 1.774 . . . . 0.0 108.938 173.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -69.73 143.4 53.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 158.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -125.27 -24.44 3.97 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.226 0.61 . . . . 0.0 110.464 -166.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.23 -162.95 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 131.068 3.747 . . . . 0.0 115.948 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -45.57 62.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 130.886 3.675 . . . . 0.0 110.547 158.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 t -140.02 175.35 9.66 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 128.113 2.565 . . . . 0.0 109.555 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.4 t -139.65 67.19 1.38 Allowed 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.249 1.82 . . . . 0.0 107.701 -165.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.4 t -83.64 144.84 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 124.528 1.131 . . . . 0.0 108.323 -163.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.04 133.68 12.14 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mm -136.61 162.33 35.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 123.817 0.847 . . . . 0.0 110.825 -165.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.22 -148.8 19.73 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 52.19 88.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.774 2.03 . . . . 0.0 116.229 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.279 0.0 OUTLIER 53.68 16.31 0.96 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.156 2.183 . . . . 0.0 113.41 175.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.1 t -115.46 120.16 63.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.948 1.299 . . . . 0.0 107.895 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.4 24.28 1.27 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.771 0.828 . . . . 0.0 112.705 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.405 ' CZ3' ' HB2' ' A' ' 74' ' ' ASN . 60.7 m95 -130.75 117.11 18.92 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.0 ttm -83.54 146.57 28.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 165.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 t -141.12 135.02 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -146.32 154.35 41.58 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 C-N-CA 128.363 2.887 . . . . 0.0 112.737 173.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? . . . . . 0 N--CA 1.441 -0.915 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -60.66 144.01 52.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -164.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.72 143.56 16.31 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 106.186 -2.765 . . . . 0.0 106.186 167.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.2 m -133.23 156.07 48.21 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 118.355 1.077 . . . . 0.0 108.335 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.06 147.6 47.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.126 0.97 . . . . 0.0 109.379 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.3 m -83.93 111.1 18.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 158.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.6 mt -83.04 151.8 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 166.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.454 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 13.7 m-90 -126.41 150.36 48.68 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.06 0.933 . . . . 0.0 110.567 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -63.21 -60.9 2.79 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.238 -1.346 . . . . 0.0 107.535 163.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.74 148.81 47.2 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-O 122.408 1.004 . . . . 0.0 112.74 -159.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.33 72.0 8.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.173 0.989 . . . . 0.0 109.747 -168.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.48 46.61 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 125.259 1.409 . . . . 0.0 110.908 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.3 p 44.09 49.97 7.45 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 125.973 1.709 . . . . 0.0 111.376 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.16 176.85 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 126.716 2.006 . . . . 0.0 107.708 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.87 -155.24 38.64 Favored Glycine 0 CA--C 1.518 0.233 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -75.34 159.62 31.24 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.454 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.6 p -127.87 156.23 42.9 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 124.725 1.266 . . . . 0.0 111.663 173.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.46 110.36 8.77 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.153 1.781 . . . . 0.0 106.92 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.3 t -68.25 108.45 3.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 174.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.2 tpt -113.65 106.48 14.56 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.019 0.927 . . . . 0.0 110.134 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.0 m -93.19 154.65 17.93 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.779 0.832 . . . . 0.0 109.353 171.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.5 t -155.13 132.36 6.29 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.453 0.701 . . . . 0.0 110.505 167.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.27 169.11 16.01 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.3 2.0 . . . . 0.0 113.212 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.67 147.4 43.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 59.07 51.65 6.93 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.492 1.117 . . . . 0.0 108.578 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -140.23 130.94 25.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.243 0.544 . . . . 0.0 110.102 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.5 137.04 32.69 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.874 1.67 . . . . 0.0 109.451 165.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 m -138.9 93.57 2.72 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.957 1.303 . . . . 0.0 109.238 -159.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.405 ' HB2' ' CZ3' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -70.23 122.7 20.0 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 119.906 -1.746 . . . . 0.0 110.268 -178.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.06 114.84 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.72 1.208 . . . . 0.0 109.644 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.16 108.52 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.58 -5.81 3.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.899 0.88 . . . . 0.0 110.439 -171.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.3 13.14 82.3 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 121.242 -0.911 . . . . 0.0 112.538 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -139.9 156.42 46.7 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 119.33 1.565 . . . . 0.0 108.411 159.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.82 133.24 43.19 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.33 131.71 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 125.225 1.41 . . . . 0.0 108.412 -169.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.47 -1.52 8.06 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.5 p -156.43 168.98 25.66 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 166.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -153.73 166.84 31.57 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.989 1.316 . . . . 0.0 111.102 165.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -137.01 124.51 22.14 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 128.082 2.553 . . . . 0.0 106.467 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -69.89 130.63 42.76 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 120.746 1.612 . . . . 0.0 107.522 169.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 m -98.26 -33.64 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.106 0.962 . . . . 0.0 111.098 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -177.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.2 p90 . . . . . 0 C--O 1.236 0.376 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 tt -156.61 82.28 0.96 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.612 2.365 . . . . 0.0 108.081 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 pt -108.64 175.98 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 125.477 1.511 . . . . 0.0 107.642 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.3 ptm -124.37 169.53 11.72 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.521 0.677 . . . . 0.0 111.01 158.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.6 m -155.49 163.43 40.03 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.146 1.378 . . . . 0.0 109.14 -158.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.06 -28.97 29.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -121.37 177.95 4.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 169.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.47 3.46 11.2 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.218 1.007 . . . . 0.0 112.904 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -129.83 96.11 27.16 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.017 0.527 . . . . 0.0 110.687 -161.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -68.94 -12.37 34.21 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.56 1.507 . . . . 0.0 113.455 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -70.28 -50.69 36.88 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.196 -0.94 . . . . 0.0 109.678 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.9 p -111.72 22.81 14.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.194 0.998 . . . . 0.0 111.928 -170.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.03 137.24 9.15 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 124.394 0.997 . . . . 0.0 110.7 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.16 129.77 41.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 168.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.0 m -135.8 151.08 49.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.239 1.015 . . . . 0.0 108.672 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -86.16 95.46 9.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.562 1.172 . . . . 0.0 110.879 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -83.53 58.01 4.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.184 2.193 . . . . 0.0 106.877 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -124.36 161.29 26.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.042 1.337 . . . . 0.0 108.271 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -64.09 146.41 54.25 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.693 0.759 . . . . 0.0 109.049 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -145.98 7.76 1.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.763 1.625 . . . . 0.0 111.007 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -88.33 121.83 31.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 54.45 38.0 28.81 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.384 1.073 . . . . 0.0 111.452 167.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 t -135.82 148.3 48.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.99 1.716 . . . . 0.0 107.457 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.2 t -84.38 100.98 11.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.03 126.65 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 120.101 1.319 . . . . 0.0 109.765 -171.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.59 140.72 15.2 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 127.061 2.267 . . . . 0.0 111.632 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.2 152.52 20.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 128.43 2.692 . . . . 0.0 108.943 -163.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.02 -167.01 34.28 Favored Glycine 0 CA--C 1.525 0.656 0 O-C-N 121.468 -0.77 . . . . 0.0 111.329 168.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.263 . . 59.28 64.8 1.29 Allowed 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 126.884 2.074 . . . . 0.0 115.235 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 m120 64.7 3.58 2.04 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.581 2.352 . . . . 0.0 110.886 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.6 t -77.02 106.31 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.629 0.649 . . . . 0.0 109.696 -173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -146.13 29.86 1.06 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -136.43 113.51 10.54 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 121.766 -0.584 . . . . 0.0 109.962 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 59.9 ttp -84.43 142.46 30.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 172.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.09 118.41 21.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.3 118.28 36.23 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.474 0 CA-C-O 123.157 1.421 . . . . 0.0 115.743 169.792 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.6 pttt . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -60.85 162.21 7.12 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 120.923 -1.111 . . . . 0.0 110.364 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.06 159.01 25.46 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 166.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.5 m -143.21 164.62 29.69 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 119.577 1.689 . . . . 0.0 111.293 -167.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.71 159.47 42.03 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 124.324 1.05 . . . . 0.0 109.998 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -84.47 130.46 34.76 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 158.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.62 150.3 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.453 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 20.8 m-90 -125.98 156.09 40.38 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 173.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -84.13 -34.01 24.16 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.728 1.611 . . . . 0.0 109.87 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.18 145.35 24.3 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 121.503 0.502 . . . . 0.0 112.312 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -76.17 85.41 3.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.783 1.633 . . . . 0.0 112.627 -161.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.59 -50.44 0.54 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.6 p 159.34 45.53 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 131.613 3.965 . . . . 0.0 107.622 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.52 176.32 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -171.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.37 -147.74 37.91 Favored Glycine 0 CA--C 1.521 0.466 0 O-C-N 121.328 -0.857 . . . . 0.0 111.053 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -71.28 151.74 43.94 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.681 1.192 . . . . 0.0 108.132 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.453 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.7 p -146.71 159.2 43.78 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.573 1.17 . . . . 0.0 112.22 171.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -139.26 155.58 47.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 170.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 m -83.99 121.4 27.34 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 38.7 tpp -104.06 118.86 37.66 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 20.3 m -108.84 152.91 24.25 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.866 0.866 . . . . 0.0 108.859 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.6 t -151.86 143.24 15.78 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 117.688 -1.148 . . . . 0.0 109.684 171.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.6 168.02 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.196 2.597 . . . . 0.0 111.689 169.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.5 166.76 16.04 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 56.7 47.19 18.74 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.727 0.811 . . . . 0.0 109.215 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -156.28 173.01 17.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.874 0.845 . . . . 0.0 111.438 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -109.14 144.21 37.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.962 2.905 . . . . 0.0 107.942 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.2 m -141.94 99.13 3.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.597 1.159 . . . . 0.0 107.917 -162.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -60.45 105.3 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.167 -0.958 . . . . 0.0 110.22 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.07 121.72 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 164.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -168.05 79.12 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 p -73.53 166.99 22.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.5 -37.02 91.52 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -81.18 158.71 24.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 123.452 0.701 . . . . 0.0 110.831 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.74 134.0 43.41 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.85 140.99 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 123.668 0.787 . . . . 0.0 109.531 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -129.65 -23.22 2.89 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 117.216 -1.374 . . . . 0.0 114.126 168.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -150.52 166.12 31.18 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 120.976 1.716 . . . . 0.0 111.877 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -157.79 157.68 33.82 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.399 0.545 . . . . 0.0 111.857 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -146.29 124.23 12.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.022 1.729 . . . . 0.0 108.407 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 153.69 18.01 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.508 0.595 . . . . 0.0 110.842 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.2 m -124.89 -37.51 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.32 0.648 . . . . 0.0 110.87 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.03 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.4 p90 . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.22 114.95 12.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 170.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.0 pt -129.72 174.9 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.771 1.628 . . . . 0.0 107.129 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.5 ptp -129.32 164.53 23.35 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 160.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.4 m -144.44 160.91 40.28 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.836 1.654 . . . . 0.0 107.777 -161.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -52.99 -53.57 47.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.637 0.732 . . . . 0.0 111.031 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -132.56 -173.36 3.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.413 1.885 . . . . 0.0 107.777 -169.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 t -72.99 4.03 4.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -100.02 105.22 33.94 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 123.201 0.601 . . . . 0.0 111.84 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.25 -34.51 55.78 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 120.864 1.043 . . . . 0.0 112.091 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -74.21 -47.8 33.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.932 -0.48 . . . . 0.0 110.77 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.8 t -125.89 17.9 7.92 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.37 -36.26 45.21 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 120.475 -1.39 . . . . 0.0 111.642 170.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m 73.25 115.53 0.06 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.906 1.683 . . . . 0.0 106.793 -158.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -136.26 152.72 51.02 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.072 0.949 . . . . 0.0 108.584 -166.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.93 93.21 9.27 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.849 1.309 . . . . 0.0 109.725 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -84.03 56.84 3.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.943 2.497 . . . . 0.0 105.591 162.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' CD ' ' H ' ' A' ' 22' ' ' GLN . 5.9 tmtt? -117.31 -175.06 2.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.376 1.871 . . . . 0.0 107.734 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 21' ' ' LYS . 16.6 tt0 -64.39 143.05 58.18 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 171.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -146.62 -15.52 0.43 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.327 1.851 . . . . 0.0 111.296 -159.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -119.15 163.43 17.06 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 129.139 2.976 . . . . 0.0 104.629 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 m120 33.93 58.68 0.58 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.32 1.848 . . . . 0.0 114.285 170.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.35 -173.89 2.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.511 1.924 . . . . 0.0 107.261 166.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.5 t -121.72 136.19 54.94 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.571 1.948 . . . . 0.0 108.335 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -147.46 142.49 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.99 1.268 . . . . 0.0 107.842 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.51 137.96 13.66 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.779 2.133 . . . . 0.0 112.235 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.646 ' CD1' ' HA ' ' A' ' 83' ' ' SER . 4.7 mp -126.71 165.73 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 128.201 2.6 . . . . 0.0 107.135 -166.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.03 -178.98 34.06 Favored Glycine 0 N--CA 1.451 -0.353 0 O-C-N 121.25 -0.906 . . . . 0.0 111.518 159.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 60.31 94.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.894 2.078 . . . . 0.0 112.35 169.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.28 0.0 OUTLIER 56.28 26.12 10.11 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.593 1.557 . . . . 0.0 111.922 -176.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.53 103.71 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -146.32 38.16 1.04 Allowed 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 170.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -138.25 114.24 10.02 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 118.801 0.728 . . . . 0.0 110.245 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.7 ttm -84.01 142.63 30.33 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 170.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.44 130.88 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 t -146.35 146.49 30.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -173.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.1 mttm . . . . . 0 N--CA 1.444 -0.757 0 CA-C-O 121.134 0.492 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.492 ' CB ' ' HA ' ' A' ' 68' ' ' PRO . 28.0 pt20 -64.23 143.43 57.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.182 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.46 152.11 17.19 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.5 m -127.5 154.56 44.97 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.36 133.58 24.49 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.525 1.13 . . . . 0.0 109.08 -174.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -83.63 117.74 23.37 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 mt -95.0 146.55 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -124.11 148.24 47.3 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.521 1.529 . . . . 0.0 110.648 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -74.61 -46.08 40.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.179 1.392 . . . . 0.0 108.193 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.1 144.54 42.08 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 121.619 0.566 . . . . 0.0 112.434 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.2 m -66.43 108.64 2.45 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 165.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.55 52.18 2.9 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 19.2 p 46.98 44.23 14.57 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.251 1.82 . . . . 0.0 113.34 165.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.57 176.41 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.053 1.341 . . . . 0.0 107.385 171.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.73 -146.02 25.38 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 173.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -79.89 147.58 31.63 Favored 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 125.905 1.682 . . . . 0.0 107.792 -170.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -138.76 166.94 23.09 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 123.882 0.739 . . . . 0.0 112.017 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -160.56 119.03 2.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -71.45 117.49 13.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.9 ttp -106.18 137.84 43.41 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 167.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 93.2 m -113.39 149.74 33.67 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.469 1.107 . . . . 0.0 108.75 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.2 t -153.06 123.53 3.46 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.15 0.58 . . . . 0.0 112.288 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.492 ' HA ' ' CB ' ' A' ' 47' ' ' GLN . 12.1 Cg_endo -71.82 149.18 53.58 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 N-CA-C 116.951 1.866 . . . . 0.0 116.951 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.73 108.47 6.58 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 107.47 44.06 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 130.13 3.372 . . . . 0.0 109.112 -174.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -150.57 156.88 42.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.647 1.213 . . . . 0.0 110.511 165.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -92.7 138.11 31.78 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.352 160.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 m -131.59 99.31 4.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 126.514 1.926 . . . . 0.0 108.369 -170.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -56.67 120.83 8.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 119.098 -0.477 . . . . 0.0 109.846 168.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.57 128.7 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 164.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -176.93 98.63 0.05 OUTLIER 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 164.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 p -89.16 -174.57 4.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.456 1.102 . . . . 0.0 108.915 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.69 -4.1 30.95 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.688 -0.633 . . . . 0.0 113.338 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -143.17 159.1 42.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.841 1.656 . . . . 0.0 107.159 174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -69.52 142.4 53.68 Favored 'General case' 0 N--CA 1.441 -0.885 0 O-C-N 124.765 1.291 . . . . 0.0 108.204 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.61 142.79 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 124.126 0.97 . . . . 0.0 109.249 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -129.51 -19.18 3.44 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.646 ' HA ' ' CD1' ' A' ' 30' ' ' ILE . 1.7 m -134.12 168.76 18.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.458 1.481 . . . . 0.0 109.862 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -163.07 167.84 21.78 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.579 0.627 . . . . 0.0 109.887 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -157.27 144.46 18.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 123.91 0.756 . . . . 0.0 109.579 158.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.09 137.43 57.05 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 m -106.47 -13.51 9.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.053 1.341 . . . . 0.0 111.752 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 158.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.6 p90 . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.701 0.286 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 tt -125.46 111.11 14.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 162.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.5 pt -119.8 168.63 11.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.9 ptp -118.91 152.88 35.51 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.022 0.439 . . . . 0.0 110.273 165.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.6 m -138.29 154.04 49.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.538 -158.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -72.26 -6.36 42.49 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.25 1.42 . . . . 0.0 112.6 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.7 p30 -164.15 -177.54 5.05 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.048 1.739 . . . . 0.0 107.297 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.6 t -81.8 4.0 23.8 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.087 0.955 . . . . 0.0 112.576 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -125.95 90.53 50.1 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.686 1.194 . . . . 0.0 110.081 -162.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.55 -20.29 69.26 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.901 1.734 . . . . 0.0 112.264 -172.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -66.9 -24.14 66.07 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.369 -0.832 . . . . 0.0 111.204 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.9 t -144.48 13.89 1.58 Allowed 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -167.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.43 138.54 14.85 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 165.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 p -75.19 93.44 2.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.948 1.374 . . . . 0.0 107.576 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.3 m -94.66 152.59 18.36 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -170.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.84 107.3 19.53 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.924 1.345 . . . . 0.0 111.112 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -83.8 35.78 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.358 2.263 . . . . 0.0 108.806 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -87.23 157.98 19.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.837 1.255 . . . . 0.0 107.994 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -63.38 144.72 56.72 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 166.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -145.88 20.78 1.45 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.007 0.523 . . . . 0.0 112.27 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -115.91 141.75 47.69 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.86 20.4 10.63 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.066 0.546 . . . . 0.0 112.399 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.6 p -141.35 133.08 27.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -171.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.9 t -85.53 75.91 10.1 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.81 144.62 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -166.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.38 160.86 42.42 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.569 1.081 . . . . 0.0 111.15 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 mt -122.14 135.44 62.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 171.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.89 143.69 9.9 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 119.571 1.078 . . . . 0.0 113.175 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 69.46 73.77 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.957 2.103 . . . . 0.0 114.881 161.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.8 9.86 6.36 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.564 1.546 . . . . 0.0 110.355 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.75 97.32 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 170.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -135.07 39.73 2.93 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.765 0.826 . . . . 0.0 110.722 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -145.42 134.84 23.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.0 ttm -114.96 132.88 56.43 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 165.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.94 111.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -170.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.94 72.67 3.0 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.335 1.064 . . . . 0.0 109.526 -170.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.873 0 CA-C-O 123.028 1.349 . . . . 0.0 112.438 167.142 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -53.92 143.26 22.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 160.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.66 131.6 10.73 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 107.007 -2.437 . . . . 0.0 107.007 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 47.2 m -130.62 149.36 52.31 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -162.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.17 140.06 27.69 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.548 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.3 m -83.84 114.74 21.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 162.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 mt -100.99 136.98 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 4.9 m-90 -119.96 158.87 25.84 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.032 0.933 . . . . 0.0 110.029 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.86 -47.51 70.95 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.218 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.5 -179.4 48.86 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 114.119 -3.896 . . . . 0.0 121.365 175.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m 33.61 82.42 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.63 2.772 . . . . 0.0 114.372 161.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.41 25.32 59.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.425 ' HB2' ' CD2' ' A' ' 53' ' ' TRP . 2.9 p 44.73 65.11 1.15 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.729 1.212 . . . . 0.0 111.609 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.1 176.03 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 126.406 1.882 . . . . 0.0 107.638 172.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.04 -152.73 23.97 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.1 ttm-85 -74.5 159.51 32.14 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.434 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 5.9 p -145.66 167.96 21.84 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.208 0.528 . . . . 0.0 111.235 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -154.75 135.97 13.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 m -85.15 105.72 16.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.0 tpp -83.58 144.81 29.23 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.8 m -124.36 145.53 49.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 159.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.7 t -131.6 109.61 14.66 Favored Pre-proline 0 C--N 1.325 -0.461 0 C-N-CA 124.384 1.074 . . . . 0.0 108.253 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -50.01 146.93 15.92 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.979 2.452 . . . . 0.0 112.223 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.0 160.68 30.98 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.306 0.574 . . . . 0.0 110.571 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.16 39.79 9.51 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.31 160.18 39.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.923 0.868 . . . . 0.0 111.201 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.56 134.69 52.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 128.647 2.779 . . . . 0.0 108.079 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 99.3 m -127.06 136.65 52.47 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.456 1.102 . . . . 0.0 109.827 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -82.61 126.73 32.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.581 0.752 . . . . 0.0 111.569 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.1 88.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 127.297 2.239 . . . . 0.0 106.721 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -154.0 67.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 p -73.61 176.27 6.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.194 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -46.96 -50.34 15.62 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -90.85 161.34 15.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 125.057 1.343 . . . . 0.0 110.891 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -75.06 138.9 42.45 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.731 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.44 135.66 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.193 0.997 . . . . 0.0 109.714 -170.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.9 ttt85 -136.36 -20.19 1.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.3 m -132.46 174.05 10.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 121.068 1.758 . . . . 0.0 112.456 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -167.08 172.87 9.68 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 124.903 1.281 . . . . 0.0 110.884 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -149.33 124.07 9.86 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -67.12 138.74 57.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.801 1.182 . . . . 0.0 108.674 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 m -121.1 -28.23 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 175.721 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.5 p90 . . . . . 0 C--O 1.235 0.303 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.8 136.56 52.86 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.933 1.693 . . . . 0.0 106.736 166.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 pt -144.39 148.65 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.4 ptp -96.8 138.25 34.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.5 m -129.43 164.71 23.08 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.659 0.784 . . . . 0.0 109.533 -170.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -75.49 -32.08 60.43 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.469 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -143.18 -177.24 5.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.6 t -84.1 7.62 18.14 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.312 1.045 . . . . 0.0 111.442 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -126.84 93.37 42.34 Favored Pre-proline 0 N--CA 1.447 -0.581 0 C-N-CA 125.317 1.447 . . . . 0.0 111.164 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.18 -14.25 40.67 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.629 1.553 . . . . 0.0 113.271 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -68.2 -40.57 82.15 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 119.146 0.885 . . . . 0.0 110.612 172.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -120.47 13.96 11.87 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.63 129.28 9.47 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 163.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.64 93.15 5.45 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 176.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.1 m -80.21 157.68 26.45 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.339 0.7 OUTLIER -96.16 102.6 14.42 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 122.99 1.376 . . . . 0.0 111.683 170.192 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -83.7 50.27 1.77 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 129.688 3.195 . . . . 0.0 107.329 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -117.45 176.52 5.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -166.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -63.8 143.71 57.63 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -164.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -131.04 -29.45 1.86 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.873 2.869 . . . . 0.0 111.38 -162.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -99.62 -163.95 1.08 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -172.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t30 85.27 -57.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.207 1.803 . . . . 0.0 113.669 161.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.65 156.63 4.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.238 0.472 . . . . 0.0 111.433 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -31.44 116.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 129.002 2.921 . . . . 0.0 113.849 169.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.46 150.29 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 126.354 1.861 . . . . 0.0 108.378 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.32 145.0 20.22 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.882 1.706 . . . . 0.0 111.498 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -131.81 157.26 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.662 1.585 . . . . 0.0 109.047 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.53 -166.73 39.92 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 165.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 72.0 78.37 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.078 2.151 . . . . 0.0 115.104 164.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 68.26 4.49 4.2 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.439 1.896 . . . . 0.0 110.671 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.8 t -82.42 115.54 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -146.66 38.62 1.03 Allowed 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 122.857 0.463 . . . . 0.0 111.805 163.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -144.81 138.68 27.25 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -116.83 130.12 56.51 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 168.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.78 120.08 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.16 148.72 31.26 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.385 1.074 . . . . 0.0 108.745 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.532 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.626 162.053 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 mttp . . . . . 0 C--O 1.235 0.309 0 CA-C-O 123.119 1.438 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -50.18 155.87 0.9 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.497 170.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.97 -178.51 30.23 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 106.727 -2.549 . . . . 0.0 106.727 165.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.6 m -137.76 147.99 45.19 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.259 1.023 . . . . 0.0 110.404 -171.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.54 135.79 51.62 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.681 168.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.4 m -83.51 109.2 17.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 162.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.8 mt -95.06 143.78 11.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 22.0 m-90 -126.11 156.33 40.23 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.529 1.132 . . . . 0.0 112.799 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.98 -47.69 28.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.907 1.683 . . . . 0.0 111.281 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.54 159.48 30.26 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -82.05 54.45 2.5 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.288 -1.125 . . . . 0.0 111.174 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.46 75.35 0.22 Allowed Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -167.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.409 ' HA ' ' CG ' ' A' ' 53' ' ' TRP . 26.0 p 50.46 38.54 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 159.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.13 176.21 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 125.067 1.347 . . . . 0.0 107.588 163.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.48 -156.7 32.2 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -68.24 153.25 44.12 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.478 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 10.5 p -129.87 166.49 19.87 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 124.468 1.105 . . . . 0.0 111.52 161.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.45 156.77 47.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 159.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.8 p -103.35 80.37 1.81 Allowed 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 135.09 34.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -169.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.4 m -128.1 134.27 49.12 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -173.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.79 114.26 11.03 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.626 -170.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -62.86 165.28 16.64 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.661 2.241 . . . . 0.0 114.748 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.74 53.67 1.67 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.933 1.293 . . . . 0.0 113.713 -162.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 p30 157.54 14.24 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.606 2.762 . . . . 0.0 110.434 -167.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.1 m -104.98 136.45 44.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.04 127.14 37.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 160.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.7 m -121.63 136.68 54.94 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.918 1.687 . . . . 0.0 107.59 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -90.29 113.89 25.83 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.793 0.837 . . . . 0.0 111.408 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.3 mp -84.84 66.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 124.609 1.163 . . . . 0.0 108.535 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -130.86 73.82 1.56 Allowed 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 163.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.43 177.48 5.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 176.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.26 -30.66 71.55 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -80.68 155.74 26.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 163.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.29 158.45 34.0 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.66 123.98 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -169.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -136.89 -13.14 1.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 p -154.55 171.14 19.91 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.512 -0.742 . . . . 0.0 110.459 166.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -164.52 170.27 16.08 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -153.23 144.64 23.23 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 158.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -67.94 134.1 50.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 123.623 0.577 . . . . 0.0 109.772 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.39 -30.97 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.052 0.941 . . . . 0.0 111.668 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 p90 . . . . . 0 C--O 1.234 0.258 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.6 tt -158.41 111.6 2.38 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.199 0.999 . . . . 0.0 109.046 168.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.9 pt -120.3 163.08 18.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 124.207 1.003 . . . . 0.0 111.248 -173.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.09 152.3 18.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.238 1.415 . . . . 0.0 107.803 164.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.0 m -143.23 165.49 27.32 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.256 0.622 . . . . 0.0 109.757 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -79.07 -21.84 46.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.787 0.835 . . . . 0.0 112.476 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.49 172.25 18.87 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.34 3.86 1.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.882 1.273 . . . . 0.0 113.123 -175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -104.86 99.77 20.58 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.504 1.522 . . . . 0.0 109.961 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.12 -19.36 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.551 2.167 . . . . 0.0 112.275 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -70.72 -49.21 49.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.189 0.595 . . . . 0.0 109.566 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -127.69 16.4 6.95 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.7 -28.17 72.16 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 119.219 -2.176 . . . . 0.0 112.368 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 m 55.12 93.21 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -159.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.0 m -126.53 141.65 51.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -160.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.255 1.3 p-10 -85.15 102.71 13.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.475 1.131 . . . . 0.0 110.577 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -83.04 47.68 1.26 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.816 2.446 . . . . 0.0 107.375 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -96.71 172.14 8.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.96 1.704 . . . . 0.0 109.031 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.01 144.34 34.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -146.58 27.25 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.555 0.742 . . . . 0.0 112.345 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -100.16 114.5 27.95 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.098 0.959 . . . . 0.0 109.544 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 50.31 53.92 12.04 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.726 0.774 . . . . 0.0 110.127 174.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.9 t -148.23 138.67 22.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.0 t -67.23 99.49 0.7 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.315 1.446 . . . . 0.0 108.205 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.9 t -128.99 118.96 48.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.417 0.687 . . . . 0.0 109.456 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.2 135.19 23.8 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 125.683 1.611 . . . . 0.0 111.235 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.2 mt -84.14 159.82 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.796 2.038 . . . . 0.0 106.903 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 179.2 164.59 32.06 Favored Glycine 0 N--CA 1.449 -0.451 0 O-C-N 121.403 -0.811 . . . . 0.0 113.35 164.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.1 74.7 0.22 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.161 2.185 . . . . 0.0 113.983 166.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 67.71 3.58 3.51 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.631 2.372 . . . . 0.0 110.902 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.5 t -79.21 99.58 3.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 O-C-N 121.153 -0.967 . . . . 0.0 109.681 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -143.87 43.01 1.46 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.797 1.639 . . . . 0.0 109.226 170.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -139.34 139.26 37.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.05 136.99 45.98 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 164.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.34 117.51 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.2 p -94.74 160.98 14.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.687 0 C-N-CA 124.483 1.04 . . . . 0.0 113.597 -178.497 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.1 mttt . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -63.24 143.61 57.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.297 159.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.05 157.12 15.24 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-O 117.167 -1.907 . . . . 0.0 108.685 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 38.2 m -139.47 151.33 46.11 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 121.136 2.468 . . . . 0.0 108.561 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.26 140.16 52.04 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 124.642 1.177 . . . . 0.0 108.479 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.2 m -83.9 119.9 25.43 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 159.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 mt -97.19 147.87 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 126.398 1.879 . . . . 0.0 106.082 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.405 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 3.1 m-90 -125.27 158.2 34.72 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.105 1.762 . . . . 0.0 111.096 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -93.43 -34.02 13.6 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 125.086 1.354 . . . . 0.0 111.581 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.07 138.77 37.33 Favored Glycine 0 CA--C 1.523 0.57 0 O-C-N 120.454 -1.404 . . . . 0.0 110.074 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -70.57 75.44 0.58 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.746 1.219 . . . . 0.0 110.325 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.57 -65.14 0.16 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 21.2 p 156.66 41.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 129.824 3.249 . . . . 0.0 110.792 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 m -125.8 176.4 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.967 1.307 . . . . 0.0 108.023 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.87 -151.53 27.65 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -77.01 152.37 35.19 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.988 1.315 . . . . 0.0 108.011 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.405 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -152.84 151.45 30.43 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.622 0.576 . . . . 0.0 112.47 -167.166 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -145.06 138.69 26.87 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -85.02 99.85 11.29 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.333 0.653 . . . . 0.0 110.273 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -88.37 124.95 34.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 99.3 m -110.02 139.47 45.1 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.9 t -132.47 136.22 27.58 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.15 -0.929 . . . . 0.0 109.768 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.53 -179.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.334 2.689 . . . . 0.0 114.484 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.23 155.84 37.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.22 167.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 33.95 57.6 0.6 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.783 2.033 . . . . 0.0 114.134 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 t -154.71 165.73 35.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.883 0.849 . . . . 0.0 110.75 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.84 139.22 34.83 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.814 2.446 . . . . 0.0 109.478 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.9 m -131.77 135.96 47.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.613 1.565 . . . . 0.0 107.127 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -85.62 114.8 22.89 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.254 0.934 . . . . 0.0 110.731 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.77 72.74 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 108.817 -174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -110.57 152.43 26.44 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 158.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.2 p -144.66 -159.73 1.04 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.074 0.852 . . . . 0.0 108.822 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.49 -15.56 79.1 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.434 -0.648 . . . . 0.0 112.882 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -136.39 163.22 30.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 118.859 1.33 . . . . 0.0 108.687 173.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -69.21 133.82 48.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.37 129.78 54.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.04 0.936 . . . . 0.0 109.471 -162.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -123.96 -29.01 3.7 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -162.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.1 169.71 20.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 117.789 -1.1 . . . . 0.0 110.439 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -157.61 163.62 38.1 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 120.132 1.333 . . . . 0.0 112.906 169.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -125.25 128.65 48.62 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.608 1.963 . . . . 0.0 108.158 161.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.9 mmm-85 -58.86 134.23 56.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 161.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.42 -50.6 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -170.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . 0.357 15.9 pt-20 . . . . . 0 N--CA 1.429 -1.475 1 C-N-CA 132.926 4.491 . . . . 0.0 111.433 158.297 . . . . . . . . 2 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.0 p90 . . . . . 0 CA--C 1.516 -0.344 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 tt -140.34 131.49 26.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.59 146.46 18.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.393 1.077 . . . . 0.0 109.426 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -95.02 141.85 28.19 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.24 0.616 . . . . 0.0 110.005 167.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.9 m -134.56 152.45 51.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.599 1.16 . . . . 0.0 108.555 -172.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -78.66 -16.65 57.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -143.82 -167.93 2.72 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.622 1.169 . . . . 0.0 109.331 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 40.2 t -90.27 4.01 51.93 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.666 0.786 . . . . 0.0 112.887 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -105.0 106.79 56.87 Favored Pre-proline 0 C--N 1.331 -0.217 0 C-N-CA 123.989 0.916 . . . . 0.0 109.319 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.38 -23.86 75.37 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 CA-C-N 120.009 1.039 . . . . 0.0 111.946 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -71.2 -63.93 1.01 Allowed 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 122.045 -0.409 . . . . 0.0 110.343 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -109.99 13.22 23.44 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.94 -30.5 59.26 Favored Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m 70.15 110.75 0.05 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -159.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.5 m -122.5 146.04 47.76 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.35 107.82 20.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.614 1.197 . . . . 0.0 110.806 169.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -83.72 48.32 1.42 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.669 2.388 . . . . 0.0 107.276 174.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -92.83 153.91 18.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.81 142.94 57.18 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 173.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -146.88 19.49 1.28 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.376 1.071 . . . . 0.0 112.307 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -95.13 129.43 42.23 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -166.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 53.31 43.94 30.78 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.129 0.572 . . . . 0.0 110.099 172.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 t -159.87 163.69 34.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.171 -0.956 . . . . 0.0 110.631 -170.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 54.1 t -92.79 96.0 9.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.97 2.108 . . . . 0.0 110.07 -166.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -111.99 104.12 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 119.373 0.988 . . . . 0.0 111.072 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.48 127.76 37.61 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 167.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.2 mt -84.05 156.86 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.327 2.251 . . . . 0.0 106.013 166.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.66 -166.29 22.27 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.281 . . 34.02 75.13 0.05 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 47.41 22.5 0.28 Allowed 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 125.099 1.359 . . . . 0.0 112.282 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.76 118.06 18.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 119.391 -0.924 . . . . 0.0 108.963 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.28 37.45 1.25 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.743 0.817 . . . . 0.0 111.025 171.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -142.88 134.24 26.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 45.4 ttm -113.47 127.34 56.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 165.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -123.64 91.11 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 t -108.3 155.46 20.48 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.603 0.716 . . . . 0.0 111.473 -158.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 C-N-CA 125.845 1.688 . . . . 0.0 112.764 -175.3 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -57.28 169.69 0.57 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.018 1.327 . . . . 0.0 113.018 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -129.88 158.67 22.37 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 62.2 m -143.69 155.67 44.29 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 117.88 0.84 . . . . 0.0 109.118 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.43 148.14 40.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.875 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -84.03 144.54 29.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 162.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -127.19 152.11 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.441 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 21.8 m-90 -133.6 149.98 51.61 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.218 1.372 . . . . 0.0 112.916 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.69 -54.39 23.61 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.658 1.183 . . . . 0.0 109.067 164.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.38 124.63 11.15 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -168.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.54 67.49 0.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.448 3.099 . . . . 0.0 112.552 -162.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.69 -55.12 0.08 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 127.391 2.424 . . . . 0.0 107.919 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 20.0 p 163.65 50.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 130.544 3.538 . . . . 0.0 108.641 166.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.99 176.65 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.979 1.712 . . . . 0.0 108.281 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.79 -157.41 51.54 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.69 132.37 34.87 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 117.691 0.745 . . . . 0.0 109.017 -166.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.441 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 10.1 p -113.64 157.23 22.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 123.598 0.561 . . . . 0.0 112.428 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.83 -177.76 4.58 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 127.352 2.261 . . . . 0.0 106.856 174.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 t -135.15 136.86 42.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -142.32 114.78 8.44 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.044 0.538 . . . . 0.0 110.013 -173.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.7 m -96.05 143.22 27.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.819 1.248 . . . . 0.0 109.557 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.7 t -141.9 123.97 9.1 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.259 1.423 . . . . 0.0 110.511 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.87 145.6 72.15 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.225 1.95 . . . . 0.0 111.506 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.31 140.04 46.48 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 161.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 74.11 45.21 0.22 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -170.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -154.62 144.38 21.6 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 171.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.89 125.19 36.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.424 1.49 . . . . 0.0 108.086 164.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 55.6 m -116.21 136.8 52.69 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 124.905 1.282 . . . . 0.0 109.179 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -98.69 110.83 23.36 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.156 0.982 . . . . 0.0 109.55 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -82.75 96.29 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 122.167 0.984 . . . . 0.0 108.767 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.52 158.08 44.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 163.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.3 p -132.77 -150.1 0.4 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 167.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.31 -28.73 67.48 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 164.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -125.89 165.05 19.44 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.297 1.039 . . . . 0.0 110.082 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -80.58 137.39 36.38 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.64 148.89 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.107 0.963 . . . . 0.0 109.957 -170.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -134.97 -3.67 2.49 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 124.364 1.065 . . . . 0.0 113.333 -170.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.85 164.1 31.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 164.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -144.32 171.79 13.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.104 0.961 . . . . 0.0 112.267 166.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.46 123.88 10.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.52 1.928 . . . . 0.0 106.027 169.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -70.28 138.74 51.83 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 119.199 0.909 . . . . 0.0 109.01 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -104.69 -42.08 7.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 125.04 1.336 . . . . 0.0 110.873 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -177.615 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.52 -0.194 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tt -141.57 103.14 4.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.71 161.13 39.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.4 ptp -125.61 154.46 42.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 122.619 1.2 . . . . 0.0 111.284 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -135.78 169.56 17.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.108 1.763 . . . . 0.0 107.261 -163.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -24.61 42.31 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 166.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -139.19 -176.63 4.58 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 172.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.8 t -83.28 3.61 30.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.869 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -113.11 113.95 48.92 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.942 0.897 . . . . 0.0 109.304 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.73 -39.23 21.17 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 120.997 1.392 . . . . 0.0 110.806 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -69.96 -34.01 72.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.482 1.913 . . . . 0.0 111.09 -165.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.8 t -135.46 15.03 3.45 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.37 -46.65 5.18 Favored Glycine 0 CA--C 1.519 0.309 0 O-C-N 120.463 -1.398 . . . . 0.0 110.755 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t 82.04 124.79 0.04 OUTLIER 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.605 1.562 . . . . 0.0 108.552 -166.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.85 170.75 11.32 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.059 1.743 . . . . 0.0 110.448 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -90.31 94.02 9.57 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 123.164 1.459 . . . . 0.0 113.122 165.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -83.43 45.68 1.07 Allowed 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.724 -1.235 . . . . 0.0 108.428 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -85.77 163.96 17.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.74 1.616 . . . . 0.0 109.592 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -70.98 143.34 50.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 161.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -137.3 -44.44 0.55 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -167.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -48.21 113.94 0.84 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.592 1.557 . . . . 0.0 109.614 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 55.85 19.51 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.403 1.481 . . . . 0.0 112.667 174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.34 179.76 3.86 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.0 t -149.36 74.85 1.26 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 121.183 1.811 . . . . 0.0 109.96 -166.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 t -83.81 163.94 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -166.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.73 115.81 5.21 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 124.631 1.11 . . . . 0.0 111.103 163.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.11 152.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 126.36 1.864 . . . . 0.0 107.551 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.92 -165.52 38.98 Favored Glycine 0 N--CA 1.444 -0.801 0 O-C-N 121.649 -0.657 . . . . 0.0 111.84 167.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 71.09 73.15 0.19 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.687 2.395 . . . . 0.0 113.548 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 61.11 11.27 3.35 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.568 1.547 . . . . 0.0 110.777 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.6 t -73.6 108.84 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -146.63 34.61 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 170.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -140.71 113.62 8.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.309 0.959 . . . . 0.0 111.756 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.3 ttp -84.07 138.92 32.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.06 101.54 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.2 p -93.6 49.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.429 -0.794 . . . . 0.0 111.595 -159.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.391 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -171.209 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -59.51 164.78 3.24 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.0 132.68 8.73 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 170.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 86.0 m -132.99 149.14 52.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.9 140.5 16.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.67 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.8 m -86.66 117.3 25.33 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 166.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 mm -99.47 149.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -130.57 160.34 34.47 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.315 1.446 . . . . 0.0 112.002 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -89.49 -35.34 16.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.087 2.155 . . . . 0.0 111.322 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.75 144.48 38.49 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -76.75 64.02 2.26 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.93 33.73 0.02 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.26 27.9 p 44.65 42.4 5.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.557 1.543 . . . . 0.0 112.226 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -126.18 176.34 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 126.729 2.012 . . . . 0.0 107.695 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.17 -156.93 32.93 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -69.46 153.16 43.95 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.53 168.81 22.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.21 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.93 149.73 26.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.45 106.54 17.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -91.34 83.92 5.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.0 m -84.0 139.42 32.55 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 18.9 t -145.16 142.11 17.99 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 125.122 1.369 . . . . 0.0 109.446 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.33 177.27 2.16 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.974 1.782 . . . . 0.0 111.384 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.55 149.11 42.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.168 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 50.67 38.53 19.37 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.038 1.335 . . . . 0.0 110.094 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.4 m -115.52 137.3 52.21 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -98.17 114.09 26.2 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.26 106.01 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.84 2.056 . . . . 0.0 107.823 -162.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -64.42 136.15 56.81 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.887 0.851 . . . . 0.0 110.637 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 mm -101.86 117.45 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.79 65.57 1.05 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.5 p -73.94 161.79 29.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.269 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -54.14 -52.88 40.78 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -80.64 157.55 25.93 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.527 0.68 . . . . 0.0 110.62 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -76.15 134.43 39.95 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.893 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.09 132.79 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -168.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -135.93 -27.81 1.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -173.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 p -152.69 171.87 17.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.563 0.619 . . . . 0.0 111.251 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -156.32 170.06 23.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.633 0.651 . . . . 0.0 111.157 176.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -140.2 147.1 39.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.496 1.918 . . . . 0.0 109.31 159.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -63.58 163.53 11.04 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.624 0.769 . . . . 0.0 110.607 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.09 -36.51 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 117.809 0.277 . . . . 0.0 110.458 159.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 163.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.9 p90 . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.94 88.59 2.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 159.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pt -108.3 162.47 6.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 169.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 ptm -108.24 167.94 9.66 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.493 1.139 . . . . 0.0 110.118 161.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.2 m -153.58 163.22 40.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 124.5 1.12 . . . . 0.0 108.496 -158.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -85.58 -21.37 28.54 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -133.58 -175.15 3.73 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.811 0.444 . . . . 0.0 111.267 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.1 t -92.13 3.46 55.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.307 1.043 . . . . 0.0 111.811 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -132.98 88.71 36.2 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 126.011 1.725 . . . . 0.0 110.088 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -48.76 -26.77 10.06 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.203 3.268 . . . . 0.0 113.293 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -64.3 -44.32 91.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.46 -0.775 . . . . 0.0 111.495 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.7 p -104.13 13.83 31.65 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.65 135.3 7.48 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 123.966 0.793 . . . . 0.0 112.898 172.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -63.75 137.78 58.21 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.086 -0.655 . . . . 0.0 109.821 169.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -130.39 157.21 43.22 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 125.372 1.469 . . . . 0.0 107.317 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -85.07 93.43 8.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 123.677 1.704 . . . . 0.0 110.821 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -83.87 50.93 1.92 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.658 1.983 . . . . 0.0 107.122 169.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -119.23 -174.1 2.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.88 1.672 . . . . 0.0 108.255 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.11 143.12 50.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 167.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -146.5 5.69 0.93 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.693 -166.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.411 ' CG ' ' N ' ' A' ' 25' ' ' ASN . 19.8 t-105 -78.07 -163.63 0.45 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -165.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' N ' ' CG ' ' A' ' 24' ' ' TRP . 15.0 t-20 -68.31 61.55 0.09 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.526 2.731 . . . . 0.0 110.411 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 t -141.93 149.79 40.61 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 127.477 2.311 . . . . 0.0 105.692 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.2 t -72.56 69.8 0.89 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.433 1.493 . . . . 0.0 111.706 -164.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.3 t -93.42 124.84 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.125 0.97 . . . . 0.0 109.53 -165.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.77 132.39 11.34 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -83.71 153.3 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 169.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.13 158.52 29.86 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 68.87 69.38 0.28 Allowed 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 127.343 2.257 . . . . 0.0 115.835 169.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 49.84 19.26 0.42 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.596 1.159 . . . . 0.0 112.304 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.45 110.86 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -146.26 26.42 1.19 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.939 0.895 . . . . 0.0 112.771 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -138.56 121.45 16.58 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.295 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.1 tpp -83.62 134.7 34.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -131.05 120.21 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.1 p -104.14 45.37 0.96 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.184 0.993 . . . . 0.0 109.975 -159.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -175.465 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.274 0.559 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -53.96 146.19 14.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.564 1.146 . . . . 0.0 111.739 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.43 136.21 10.3 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 59.0 m -122.8 149.76 43.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.01 136.83 21.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.633 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.6 m -89.45 117.38 28.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 170.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.1 mt -106.53 137.92 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.028 1.731 . . . . 0.0 107.049 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 5.0 m-90 -122.14 160.63 24.69 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.54 1.536 . . . . 0.0 112.7 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -91.79 -33.89 14.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.494 2.318 . . . . 0.0 111.236 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.41 128.02 9.44 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 124.668 1.128 . . . . 0.0 111.736 -169.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -44.29 121.31 2.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.814 2.046 . . . . 0.0 112.087 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.38 -60.56 0.59 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 126.574 2.035 . . . . 0.0 109.593 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 30.6 p 168.94 43.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.385 1.874 . . . . 0.0 111.472 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 m -120.41 176.75 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.36 -157.93 28.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -73.59 158.57 34.55 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 126.246 1.818 . . . . 0.0 108.161 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.4 p -159.18 160.68 35.75 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.987 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.0 p -142.67 149.9 39.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.1 t -91.17 128.24 36.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -119.95 116.04 24.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.924 1.69 . . . . 0.0 108.491 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 11.5 m -98.09 146.73 25.26 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.516 0.726 . . . . 0.0 109.77 173.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.2 t -149.41 136.85 11.24 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.405 1.082 . . . . 0.0 111.01 173.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.88 177.75 3.32 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.912 1.741 . . . . 0.0 112.213 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.4 175.24 7.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 37.73 54.1 1.51 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 126.071 1.748 . . . . 0.0 112.265 171.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.24 168.44 25.98 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.923 0.868 . . . . 0.0 108.948 175.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.18 134.34 52.85 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.705 2.002 . . . . 0.0 107.244 172.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.83 118.16 20.38 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -169.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -78.55 122.94 26.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.951 -0.468 . . . . 0.0 110.013 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -102.42 104.19 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 169.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.05 69.86 1.26 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 169.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 p -74.01 176.01 6.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.238 1.815 . . . . 0.0 110.58 -162.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.99 -41.59 92.42 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -93.72 164.18 13.24 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.768 0.827 . . . . 0.0 110.545 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -80.93 133.82 35.61 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.85 129.89 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.086 0.554 . . . . 0.0 110.039 -169.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ttt85 -136.54 -13.2 1.76 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -172.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.84 169.32 16.76 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.454 -0.779 . . . . 0.0 111.708 -173.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -166.9 171.79 10.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.463 0.649 . . . . 0.0 112.46 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . 0.295 0.0 OUTLIER -137.56 135.83 37.04 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 129.281 3.033 . . . . 0.0 105.227 170.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -64.5 159.19 22.09 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 158.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.09 -41.54 3.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 119.351 0.978 . . . . 0.0 111.171 163.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 172.988 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.8 p90 . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -150.01 103.98 3.25 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 pt -153.1 159.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.335 1.854 . . . . 0.0 107.843 -167.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.7 ptm -106.55 147.2 29.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.946 0.898 . . . . 0.0 110.088 166.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.87 162.31 18.32 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -62.86 -37.47 86.97 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 116.347 -2.141 . . . . 0.0 109.936 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -122.15 -171.25 2.21 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 126.831 2.053 . . . . 0.0 109.143 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 50.8 t -78.47 3.23 16.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -118.3 114.52 36.54 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 121.269 -0.894 . . . . 0.0 113.166 -164.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.67 -23.48 56.36 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 120.932 1.088 . . . . 0.0 111.834 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -64.54 -63.11 1.21 Allowed 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.448 1.022 . . . . 0.0 110.221 -176.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -118.92 13.76 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.9 -19.38 78.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.456 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.9 m 58.33 93.22 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -160.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -98.04 145.31 26.65 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -91.61 98.88 11.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.536 1.16 . . . . 0.0 109.474 172.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -83.38 45.56 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.801 2.04 . . . . 0.0 107.995 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.54 -177.68 6.79 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.373 1.469 . . . . 0.0 110.198 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -63.71 150.36 44.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 163.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -139.86 -15.7 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.029 0.932 . . . . 0.0 111.894 176.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -91.08 112.98 25.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 48.72 64.52 1.67 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.709 1.203 . . . . 0.0 110.044 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.21 -178.61 4.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.81 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.3 t -154.41 54.61 0.69 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -94.7 129.98 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 125.395 1.478 . . . . 0.0 109.384 -170.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.15 126.58 7.77 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.783 0.706 . . . . 0.0 112.41 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 mm -107.14 166.24 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 130.406 3.482 . . . . 0.0 108.426 -174.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.85 175.88 25.62 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 165.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 91.32 79.89 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 129.763 3.225 . . . . 0.0 112.343 174.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 80.61 6.96 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 129.34 3.056 . . . . 0.0 110.819 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.99 118.49 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 CA-C-N 118.912 0.778 . . . . 0.0 112.467 -164.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.476 ' CE1' ' HE1' ' A' ' 36' ' ' TRP . 4.4 p80 -146.55 35.53 0.96 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 163.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.476 ' HE1' ' CE1' ' A' ' 35' ' ' HIS . 74.6 m95 -140.67 124.47 17.16 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.148 1.34 . . . . 0.0 112.224 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.1 tpt -84.89 131.14 34.54 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 161.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.47 85.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -172.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 t -93.95 143.89 25.94 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 C-N-CA 124.493 1.044 . . . . 0.0 111.286 -178.016 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -53.03 144.46 15.12 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.56 153.6 16.9 Favored Glycine 0 C--O 1.239 0.442 0 N-CA-C 107.078 -2.409 . . . . 0.0 107.078 167.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.6 m -126.52 144.23 50.94 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.93 126.68 49.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.0 m -83.59 118.88 24.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 168.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 mt -96.65 150.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 -129.08 157.85 40.59 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.984 1.714 . . . . 0.0 111.549 -175.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -82.42 -44.28 16.26 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.09 2.156 . . . . 0.0 111.636 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.81 135.15 21.33 Favored Glycine 0 N--CA 1.449 -0.494 0 O-C-N 120.999 -1.063 . . . . 0.0 111.098 -173.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.1 m -54.48 102.54 0.06 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.587 0.755 . . . . 0.0 109.979 171.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.53 -75.92 0.4 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 24.0 p 158.69 42.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 128.692 2.797 . . . . 0.0 110.397 -174.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.38 176.28 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.33 -167.19 44.81 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 119.615 1.098 . . . . 0.0 110.592 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -73.84 149.57 41.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.497 -1.002 . . . . 0.0 108.874 -170.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.9 161.34 40.94 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.103 -163.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.53 117.05 4.66 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -167.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.5 m -71.55 100.25 2.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.317 0.647 . . . . 0.0 109.51 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.8 tpp -84.04 103.56 13.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.655 1.182 . . . . 0.0 107.836 172.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 50.7 m -84.7 146.45 27.43 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.3 t -155.53 108.31 2.2 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.447 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.2 162.13 14.82 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.844 2.363 . . . . 0.0 113.297 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.53 137.94 44.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 58.76 48.56 11.23 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.348 1.859 . . . . 0.0 110.853 -166.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m -124.44 116.81 23.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.314 0.578 . . . . 0.0 109.99 170.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.406 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -74.35 114.11 12.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 158.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.2 m -116.2 123.84 48.78 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.286 1.834 . . . . 0.0 107.922 -172.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -78.24 132.49 37.56 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 118.454 0.57 . . . . 0.0 110.364 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.407 ' N ' ' CD1' ' A' ' 75' ' ' ILE . 1.2 mp -98.35 107.54 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -123.52 144.63 49.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 p -142.35 -161.93 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 175.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.39 15.58 57.41 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.073 168.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.7 169.97 17.42 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 119.075 1.437 . . . . 0.0 109.425 -173.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -70.51 133.98 47.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 170.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.61 128.75 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.19 -46.97 0.64 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.559 -158.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -133.06 175.89 8.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 119.758 1.163 . . . . 0.0 110.424 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -160.64 163.86 32.25 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 119.779 1.172 . . . . 0.0 113.34 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.06 127.77 10.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 169.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -66.1 115.87 6.59 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.53 -39.33 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 C-N-CA 124.612 1.165 . . . . 0.0 110.047 -168.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.92 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 p90 . . . . . 0 C--O 1.235 0.297 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 tt -140.98 117.71 11.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.211 1.404 . . . . 0.0 108.266 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.27 165.95 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 123.783 0.833 . . . . 0.0 110.077 174.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.6 ptm -105.51 142.39 35.34 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 108.541 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -138.46 158.53 44.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.651 1.181 . . . . 0.0 108.935 -165.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -82.57 -5.88 59.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.63 -172.44 3.12 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.219 1.408 . . . . 0.0 108.149 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.7 t -86.43 3.57 43.26 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.594 0.757 . . . . 0.0 112.081 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -128.43 105.71 19.35 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 118.754 -0.641 . . . . 0.0 111.574 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -58.14 -24.89 68.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.513 1.476 . . . . 0.0 111.581 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -63.83 -27.69 69.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.223 -0.923 . . . . 0.0 110.953 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.0 t -138.79 23.23 2.65 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.352 0.661 . . . . 0.0 111.338 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.05 123.7 5.98 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 164.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.14 94.59 4.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 171.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.5 m -92.44 149.77 21.19 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -171.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -96.29 98.9 10.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.798 0.808 . . . . 0.0 111.462 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -83.77 44.83 1.02 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 130.028 3.331 . . . . 0.0 111.304 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -101.28 174.13 6.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.748 1.219 . . . . 0.0 110.057 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -65.04 143.82 57.68 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.496 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.27 -27.35 8.71 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.931 1.292 . . . . 0.0 109.913 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -84.52 143.28 29.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.785 1.634 . . . . 0.0 106.812 -177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 44.92 43.57 7.23 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.818 1.647 . . . . 0.0 111.527 171.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 t -162.98 149.31 12.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 167.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.4 t -115.97 84.17 2.07 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.581 1.152 . . . . 0.0 111.282 -165.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.5 t -84.8 153.63 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.119 -165.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.02 154.21 31.7 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.448 1.023 . . . . 0.0 111.63 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.4 166.15 8.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 128.103 2.561 . . . . 0.0 105.831 172.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.02 162.22 12.57 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-O 121.439 0.466 . . . . 0.0 113.117 164.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 62.51 81.48 0.2 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.466 2.307 . . . . 0.0 111.185 -175.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 66.24 3.66 2.83 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 125.919 1.687 . . . . 0.0 111.339 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.0 t -102.56 99.31 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -145.99 33.4 1.01 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.168 0.987 . . . . 0.0 111.08 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -144.45 121.84 11.65 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.0 ttm -85.4 138.77 32.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 158.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 t -134.08 150.31 31.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.6 p -129.06 -173.92 3.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.445 0.698 . . . . 0.0 109.343 -170.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.672 0 CA-C-O 118.611 -1.105 . . . . 0.0 112.445 161.544 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -43.61 143.76 0.92 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.87 0.868 . . . . 0.0 111.601 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -146.86 157.62 27.47 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -171.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.4 m -136.65 154.6 50.6 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.888 0.875 . . . . 0.0 108.869 -172.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.29 141.61 49.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.795 1.238 . . . . 0.0 109.023 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 m -83.61 116.96 22.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 159.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -94.46 145.54 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -126.28 151.61 47.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.71 1.604 . . . . 0.0 109.722 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -58.65 -40.81 84.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 124.384 1.074 . . . . 0.0 109.766 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.2 175.85 39.47 Favored Glycine 0 C--O 1.221 -0.71 0 C-N-CA 116.097 -2.954 . . . . 0.0 120.434 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.9 m 32.29 80.84 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.875 2.87 . . . . 0.0 116.314 159.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.3 43.53 95.02 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 52.55 69.25 0.71 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.062 1.345 . . . . 0.0 111.902 171.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.12 175.93 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 C-N-CA 126.743 2.017 . . . . 0.0 107.921 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.6 -160.0 53.41 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ttp-105 -76.82 156.6 32.14 Favored 'General case' 0 CA--C 1.5 -0.956 0 O-C-N 121.934 -0.744 . . . . 0.0 109.585 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.42 144.24 34.35 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.864 -172.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 p -139.93 147.24 40.25 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.065 1.346 . . . . 0.0 108.466 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 t -85.57 113.06 21.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.4 tpt -86.14 139.41 31.12 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 165.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 50.8 m -139.06 143.04 38.2 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.2 t -150.77 123.53 4.17 Favored Pre-proline 0 CA--C 1.535 0.365 0 C-N-CA 124.134 0.974 . . . . 0.0 110.026 -170.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -52.99 157.35 8.25 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.943 2.428 . . . . 0.0 110.646 168.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.8 138.57 32.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.034 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 77.04 44.47 0.1 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 125.748 1.619 . . . . 0.0 109.192 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -149.9 169.3 21.48 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 164.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.6 t -113.15 139.14 48.99 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.018 1.727 . . . . 0.0 107.751 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 24.7 m -140.96 101.63 4.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -163.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -67.67 130.39 42.87 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.795 -0.566 . . . . 0.0 110.25 176.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.13 106.88 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.302 1.841 . . . . 0.0 106.954 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -166.39 71.02 0.13 Allowed 'General case' 0 N--CA 1.461 0.107 0 O-C-N 121.7 -0.625 . . . . 0.0 109.681 176.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 p -74.4 -160.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.124 0.488 . . . . 0.0 110.471 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.8 -24.66 60.41 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 121.374 -0.829 . . . . 0.0 111.783 168.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -118.26 153.89 33.18 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.525 1.163 . . . . 0.0 109.317 169.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -73.87 141.5 46.07 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 125.806 1.942 . . . . 0.0 107.093 163.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.06 136.21 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 124.137 0.975 . . . . 0.0 109.047 -168.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -106.76 -22.27 12.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 116.975 -1.488 . . . . 0.0 112.803 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -137.16 170.7 15.65 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 122.909 2.595 . . . . 0.0 113.316 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -160.11 166.84 29.06 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.069 0.548 . . . . 0.0 109.999 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.11 145.48 28.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -71.34 149.91 45.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.085 0.954 . . . . 0.0 112.312 -170.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.6 m -137.42 -7.4 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-N 120.814 1.643 . . . . 0.0 109.299 158.66 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.5 p90 . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.3 tt -136.22 91.51 2.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.394 1.478 . . . . 0.0 107.248 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.07 159.31 11.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.409 1.084 . . . . 0.0 109.568 174.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.72 166.85 10.82 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 126.169 1.788 . . . . 0.0 114.6 166.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 64.0 m -151.12 160.27 43.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.275 1.83 . . . . 0.0 109.555 -159.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.3 -39.42 78.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.572 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -138.98 -170.16 2.8 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 125.875 1.67 . . . . 0.0 108.056 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 t -76.05 3.59 10.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -107.04 104.32 51.5 Favored Pre-proline 0 CA--C 1.539 0.524 0 O-C-N 121.644 -0.66 . . . . 0.0 112.191 -164.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.39 -23.51 51.04 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.99 1.793 . . . . 0.0 112.27 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.52 -56.28 5.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.705 1.202 . . . . 0.0 109.648 -172.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.2 t -132.82 13.85 4.37 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 112.702 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.39 -45.91 58.57 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 168.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 t 76.9 124.63 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.264 1.426 . . . . 0.0 107.848 -164.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -136.58 140.12 42.65 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 125.633 1.573 . . . . 0.0 107.882 -164.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.254 7.5 p-10 -82.78 97.51 8.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 120.566 1.53 . . . . 0.0 110.363 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -82.74 53.23 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.901 2.08 . . . . 0.0 108.484 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -84.92 156.25 21.31 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 158.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.09 144.12 30.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 165.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -143.15 41.02 1.5 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.469 0.708 . . . . 0.0 109.347 -165.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -124.99 130.44 52.36 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -169.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 t30 51.13 55.71 9.11 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.448 0.699 . . . . 0.0 110.117 -172.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 t -160.39 146.88 15.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.761 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -79.57 71.88 6.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 128.8 2.84 . . . . 0.0 108.097 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.5 t -84.21 139.06 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 O-C-N 121.712 -0.617 . . . . 0.0 109.397 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.59 139.29 24.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.19 166.22 2.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 125.315 1.446 . . . . 0.0 107.238 168.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.27 170.07 34.77 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 57.65 100.9 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.865 2.066 . . . . 0.0 112.615 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.42 10.68 4.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.383 1.073 . . . . 0.0 112.566 169.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.19 113.1 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -146.75 18.12 1.29 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -138.31 114.14 9.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 48.1 ttp -85.4 124.75 32.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.43 94.86 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -93.97 127.49 39.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -171.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.833 0 CA-C-O 125.938 2.966 . . . . 0.0 110.024 168.958 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? . . . . . 0 N--CA 1.442 -0.834 0 CA-C-O 121.258 0.551 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -44.07 143.51 1.14 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.064 0.946 . . . . 0.0 110.549 164.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.89 144.0 16.85 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 170.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.7 m -138.85 152.27 47.68 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 119.382 1.591 . . . . 0.0 109.5 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.4 140.5 35.5 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.721 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.2 m -83.86 135.19 34.6 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 168.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 mt -122.82 152.7 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 27.2 m-90 -139.8 152.99 46.99 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.824 1.25 . . . . 0.0 113.997 -173.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -82.84 -39.8 21.17 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 126.591 1.956 . . . . 0.0 108.898 167.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.77 125.13 36.07 Favored Glycine 0 CA--C 1.522 0.488 0 O-C-N 119.36 -2.087 . . . . 0.0 108.987 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -67.8 107.1 2.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.71 42.21 2.35 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 125.789 1.661 . . . . 0.0 111.971 -169.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 25.6 p 45.4 46.99 10.75 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.448 1.899 . . . . 0.0 114.714 166.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 m -126.27 176.58 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 127.437 2.295 . . . . 0.0 107.843 166.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.46 -157.74 23.26 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 120.841 -1.162 . . . . 0.0 112.332 167.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -70.19 150.73 46.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.8 p -141.75 172.61 12.46 Favored 'General case' 0 N--CA 1.436 -1.158 0 O-C-N 124.023 0.827 . . . . 0.0 111.483 -166.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -144.01 -175.41 4.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 159.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 t -127.96 122.43 32.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 168.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.0 tpt -121.64 118.66 29.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 96.9 m -113.78 146.74 39.47 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.8 t -138.1 121.95 11.58 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 124.432 1.093 . . . . 0.0 108.382 -178.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.32 151.27 9.85 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.111 2.541 . . . . 0.0 112.347 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.02 143.59 47.49 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 54.84 61.63 2.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.003 1.721 . . . . 0.0 109.067 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -154.48 157.41 38.36 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.39 124.44 49.6 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 126.891 2.076 . . . . 0.0 108.957 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.4 m -129.36 113.8 15.41 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.667 1.587 . . . . 0.0 108.717 -168.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -71.2 127.24 31.93 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.551 -0.718 . . . . 0.0 110.037 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 mp -85.96 111.59 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 123.978 0.911 . . . . 0.0 108.644 174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -163.71 98.77 0.88 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 162.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.2 p -74.35 -157.53 0.06 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.03 -2.04 86.31 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.786 -1.196 . . . . 0.0 112.27 168.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -140.63 174.29 10.66 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 118.91 1.355 . . . . 0.0 108.953 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -79.78 133.65 36.32 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.89 133.3 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -167.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.7 mtt-85 -126.21 -36.31 2.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 118.328 -0.844 . . . . 0.0 113.095 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.93 163.21 33.5 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 119.482 1.037 . . . . 0.0 110.971 171.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.16 169.21 22.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.069 0.548 . . . . 0.0 111.258 165.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -157.09 126.0 5.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.183 172.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.423 HH21 ' C ' ' A' ' 88' ' ' GLU . 31.3 mtp180 -55.44 141.94 34.64 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.854 0.462 . . . . 0.0 110.763 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.4 m -96.95 -43.74 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 123.836 0.71 . . . . 0.0 109.295 163.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.423 ' C ' HH21 ' A' ' 86' ' ' ARG . 1.9 tt0 . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.063 0.945 . . . . 0.0 108.569 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 tt -138.75 116.09 11.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 162.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.83 158.84 23.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 126.613 1.965 . . . . 0.0 106.134 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -121.62 175.7 6.09 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.579 0.704 . . . . 0.0 110.427 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 93.7 m -153.16 154.58 35.05 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -159.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -77.6 1.95 18.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 115.095 1.516 . . . . 0.0 115.095 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -158.97 -172.79 3.94 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 125.537 1.535 . . . . 0.0 109.416 169.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.98 3.77 32.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.698 0.761 . . . . 0.0 112.504 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -113.27 130.12 23.93 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 124.07 0.948 . . . . 0.0 110.87 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.09 -46.77 7.52 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 119.85 0.982 . . . . 0.0 109.995 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -64.01 -50.66 67.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.704 0.802 . . . . 0.0 111.069 -161.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 t -110.65 14.34 22.36 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.695 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.79 -50.04 15.54 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t 71.11 116.29 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -158.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.9 m -136.13 148.56 48.28 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.069 -158.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -93.71 93.14 7.84 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 123.704 1.716 . . . . 0.0 110.833 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -83.66 58.04 4.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 111.359 -2.655 . . . . 0.0 103.929 158.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.26 177.51 4.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 127.444 2.298 . . . . 0.0 106.582 172.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -66.98 143.31 56.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 118.557 -1.257 . . . . 0.0 107.722 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -139.99 -12.24 1.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.835 1.254 . . . . 0.0 109.938 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -86.91 173.18 9.52 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.093 1.357 . . . . 0.0 108.57 -165.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -33.46 76.78 0.0 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 131.235 3.814 . . . . 0.0 113.846 -166.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -176.21 178.83 1.34 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 128.605 2.762 . . . . 0.0 108.179 168.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.8 t -72.27 127.36 32.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.752 0.821 . . . . 0.0 109.736 -173.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 t -127.4 133.86 67.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.43 161.79 53.01 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 121.829 -0.544 . . . . 0.0 111.865 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.7 mt -135.41 151.97 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.449 1.9 . . . . 0.0 106.065 165.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.22 156.72 7.96 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.242 0.474 . . . . 0.0 112.003 163.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.48 86.15 0.13 Allowed 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 128.186 2.594 . . . . 0.0 112.517 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 61.35 3.25 0.74 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 128.378 2.671 . . . . 0.0 112.409 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.1 t -86.51 98.76 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -146.04 29.3 1.09 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 89.4 m95 -144.77 113.67 6.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -173.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.9 ttm -87.59 140.03 29.93 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 168.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.61 95.7 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -174.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 p -93.94 151.7 19.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.994 1.317 . . . . 0.0 114.37 -158.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.747 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -177.942 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -52.73 154.2 2.84 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.793 -0.567 . . . . 0.0 110.669 171.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.75 140.87 12.49 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 106.199 -2.761 . . . . 0.0 106.199 168.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 m -130.73 158.1 41.02 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 117.574 0.687 . . . . 0.0 109.194 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.41 154.42 40.83 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.137 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -99.98 131.63 45.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 167.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 mm -114.88 144.64 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -167.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -132.78 151.7 51.94 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.357 0.98 . . . . 0.0 112.67 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -88.87 -33.62 17.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.07 1.748 . . . . 0.0 109.42 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.14 141.89 42.08 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 m -63.5 151.68 40.62 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 159.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.19 38.75 90.92 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.887 -174.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 30.1 p 44.85 50.97 8.7 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.287 1.835 . . . . 0.0 114.016 170.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -123.88 176.62 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.019 1.328 . . . . 0.0 108.002 169.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.22 -151.42 21.5 Favored Glycine 0 CA--C 1.52 0.377 0 O-C-N 121.313 -0.867 . . . . 0.0 111.592 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -80.2 150.85 29.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 p -147.55 174.46 11.71 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.53 0.681 . . . . 0.0 111.411 -164.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 t -147.31 -176.18 5.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 158.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.89 133.93 42.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 166.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.1 ttt -124.24 144.0 50.21 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.289 1.035 . . . . 0.0 108.849 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.4 m -115.88 151.38 35.41 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 37.5 t -142.45 122.41 8.04 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 123.516 0.726 . . . . 0.0 110.157 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -60.07 165.2 10.91 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.237 1.958 . . . . 0.0 110.061 171.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.1 174.88 8.05 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.621 173.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 p30 47.15 45.93 16.23 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 124.559 1.144 . . . . 0.0 109.977 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.1 m -143.09 139.46 30.47 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.407 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -101.97 113.85 27.45 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 167.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 120.95 41.21 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.07 2.148 . . . . 0.0 106.525 -168.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -84.75 111.22 19.4 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.803 0.841 . . . . 0.0 109.453 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.44 93.4 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.18 75.35 0.45 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -6.52 48.86 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -173.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.07 -43.08 1.45 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.47 156.4 29.36 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 117.891 0.845 . . . . 0.0 111.724 175.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -78.93 133.54 36.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 165.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.36 143.74 12.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.193 0.997 . . . . 0.0 108.973 -170.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -126.17 -25.89 3.47 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 171.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.94 165.07 30.91 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.37 179.53 9.05 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.426 1.49 . . . . 0.0 109.883 170.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -148.7 123.75 10.07 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.351 1.86 . . . . 0.0 106.783 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -75.8 139.18 41.63 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.643 1.565 . . . . 0.0 108.546 170.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.1 m -109.6 -35.43 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.749 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 CA--C 1.529 0.149 0 CA-C-N 119.671 1.123 . . . . 0.0 110.629 -174.829 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.8 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 69.12 126.62 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.119 1.767 . . . . 0.0 112.347 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -54.57 153.26 10.5 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.61 167.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -176.73 160.67 1.96 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.621 1.568 . . . . 0.0 108.745 169.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tp -132.94 60.19 1.71 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 pt -94.22 175.2 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.123 0.969 . . . . 0.0 110.867 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.7 ptm -138.37 166.89 23.09 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.881 1.273 . . . . 0.0 108.887 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 61.0 m -147.44 162.03 39.85 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.766 1.269 . . . . 0.0 110.707 -158.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -85.76 -29.5 23.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.07 -1.877 . . . . 0.0 110.28 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -126.07 -166.0 1.51 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.9 t -93.0 3.32 55.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -139.94 105.82 6.81 Favored Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 124.365 1.066 . . . . 0.0 112.824 -164.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.45 -20.89 58.85 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.853 1.702 . . . . 0.0 112.659 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -64.22 -44.12 92.88 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.65 1.114 . . . . 0.0 109.886 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 p -113.97 13.5 18.27 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -174.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.63 133.12 6.08 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 124.571 1.082 . . . . 0.0 110.769 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.14 94.25 1.13 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 174.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 70.9 m -77.53 148.19 35.39 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.35 129.74 36.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -111.99 59.84 0.63 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.7 2.8 . . . . 0.0 106.631 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -92.6 165.72 12.85 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 165.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -73.16 143.75 47.14 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 118.199 -1.4 . . . . 0.0 107.525 166.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -130.29 -14.12 3.84 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.726 1.611 . . . . 0.0 109.952 -172.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -79.04 112.82 16.63 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -172.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.6 t30 64.11 44.75 4.39 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.036 0.935 . . . . 0.0 111.36 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.32 141.37 30.94 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.947 0.899 . . . . 0.0 109.093 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.32 77.76 5.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.904 2.081 . . . . 0.0 109.127 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 t -92.64 127.64 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.51 139.68 16.14 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.948 1.261 . . . . 0.0 111.365 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 mm -134.5 165.84 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 126.73 2.012 . . . . 0.0 108.891 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.98 -170.71 40.83 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 163.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.77 80.54 0.2 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.599 1.96 . . . . 0.0 113.643 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 71.2 4.16 4.95 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 126.803 2.041 . . . . 0.0 111.182 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.0 111.44 22.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -146.37 25.75 1.21 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -137.48 114.46 10.69 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 119.729 1.15 . . . . 0.0 111.548 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 21.9 ttt -84.49 113.88 21.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.98 96.92 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -104.19 141.2 36.68 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.674 0.79 . . . . 0.0 109.855 -159.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.56 -173.71 43.01 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 123.374 0.512 . . . . 0.0 111.83 -169.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.39 35.63 4.19 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 124.752 1.168 . . . . 0.0 111.392 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.4 m -31.78 -61.22 0.23 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 129.289 3.036 . . . . 0.0 112.593 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.36 45.35 2.77 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -19.62 104.65 0.02 OUTLIER 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.963 2.505 . . . . 0.0 113.07 -175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.61 -56.37 0.74 Allowed Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 105.853 -2.899 . . . . 0.0 105.853 -171.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -74.15 107.06 6.11 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.33 1.052 . . . . 0.0 108.79 -175.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -46.94 157.61 0.15 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.845 1.658 . . . . 0.0 112.492 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.68 134.41 12.2 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 106.999 -2.44 . . . . 0.0 106.999 166.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.1 m -133.37 155.42 49.5 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.62 149.6 39.17 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.666 0.604 . . . . 0.0 111.36 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.0 m -84.5 126.41 33.26 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 159.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.2 mt -121.2 128.35 75.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -172.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.41 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 9.1 m-90 -111.13 153.68 25.38 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.739 1.615 . . . . 0.0 113.262 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.78 -45.68 74.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.409 2.284 . . . . 0.0 111.181 172.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.81 157.45 48.9 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 m -78.2 122.48 25.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 163.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.52 41.88 9.61 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 124.761 1.172 . . . . 0.0 111.058 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.5 p 45.79 57.04 5.37 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.454 1.902 . . . . 0.0 113.137 166.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 m -124.63 176.03 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 126.203 1.801 . . . . 0.0 106.95 164.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.54 -160.94 28.22 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -72.86 160.69 31.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 8.8 p -145.13 160.55 41.25 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.898 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.1 t -110.27 159.47 17.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 162.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -110.11 111.51 22.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 160.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.03 122.5 41.25 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.876 0.735 . . . . 0.0 110.767 -171.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.5 m -105.74 152.76 22.78 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.937 1.295 . . . . 0.0 111.967 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.7 t -151.93 143.73 16.18 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.258 169.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -64.81 172.24 7.35 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.837 1.691 . . . . 0.0 113.084 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.99 135.84 33.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.875 1.27 . . . . 0.0 110.97 -172.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 56.25 64.74 1.61 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -165.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 m -145.26 126.67 14.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.34 120.64 28.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.36 1.464 . . . . 0.0 108.725 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.5 m -130.73 105.44 7.8 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -162.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -68.24 112.95 5.45 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.003 0.521 . . . . 0.0 110.785 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.09 107.67 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -136.99 129.75 30.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 162.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -126.48 -169.72 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.677 1.126 . . . . 0.0 110.161 -172.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.71 11.69 67.86 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.34 174.87 10.97 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 125.098 1.359 . . . . 0.0 109.284 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -74.3 148.15 41.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 163.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.62 142.4 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -134.14 -66.75 0.61 Allowed 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.9 m -93.77 173.48 7.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 116.431 -2.108 . . . . 0.0 112.062 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -155.82 168.22 27.9 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.238 165.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.97 136.37 19.0 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 163.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.41 166.4 16.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.942 -171.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.64 -32.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 116.924 -1.513 . . . . 0.0 113.095 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 N--CA 1.466 0.341 0 C-N-CA 124.869 1.268 . . . . 0.0 108.581 -174.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.148 0 CA-C-O 119.4 -0.667 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 t70 68.21 -59.1 0.45 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.876 2.47 . . . . 0.0 109.503 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.3 148.44 42.41 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 159.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -128.04 171.95 11.39 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.772 1.629 . . . . 0.0 107.952 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.1 tt -144.16 126.23 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 161.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.78 170.95 12.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.3 ptm -117.35 168.49 10.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.876 0.846 . . . . 0.0 110.023 158.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.2 m -156.05 166.25 34.02 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.319 1.448 . . . . 0.0 108.374 -158.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -85.95 -20.52 28.84 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 170.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.2 p30 -136.9 -175.37 4.01 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.849 172.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 40.7 t -89.05 3.82 50.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.347 -170.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -138.02 94.42 11.28 Favored Pre-proline 0 N--CA 1.456 -0.141 0 C-N-CA 123.651 0.78 . . . . 0.0 110.984 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.08 -23.06 2.5 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.52 2.813 . . . . 0.0 114.679 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -63.65 -41.24 98.24 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 119.801 1.182 . . . . 0.0 110.123 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -111.41 14.12 21.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.677 0.791 . . . . 0.0 110.824 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.38 121.02 5.79 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 125.08 1.324 . . . . 0.0 109.85 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.0 m -65.32 123.26 19.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 159.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.4 m -135.93 159.1 42.71 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -172.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.86 92.99 8.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.677 1.227 . . . . 0.0 109.65 169.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -84.51 42.7 0.91 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.243 162.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 167.34 10.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 164.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -64.09 144.08 57.38 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.418 0.627 . . . . 0.0 109.327 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -122.25 -8.3 8.71 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.577 2.351 . . . . 0.0 110.015 167.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -58.78 94.13 0.02 OUTLIER 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.091 0.957 . . . . 0.0 110.093 169.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 41.46 55.79 3.37 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.413 1.485 . . . . 0.0 111.379 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.2 p -138.18 124.35 20.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 102.492 -3.151 . . . . 0.0 102.492 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.4 t -75.3 84.43 2.45 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.681 1.193 . . . . 0.0 109.343 -166.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.7 t -83.63 121.79 36.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -170.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.36 154.51 49.24 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.418 1.009 . . . . 0.0 111.222 174.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -128.27 142.21 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.577 1.951 . . . . 0.0 107.115 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.79 168.81 33.84 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 168.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 61.01 72.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 68.94 2.87 3.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 128.21 2.604 . . . . 0.0 111.259 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -83.71 97.56 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -146.35 34.38 0.97 Allowed 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -135.42 113.98 11.71 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 121.789 -0.569 . . . . 0.0 109.623 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.4 ttp -85.95 132.61 34.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.72 129.38 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.23 128.19 17.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -159.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.31 -160.48 24.42 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 172.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.35 -66.4 0.57 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 105.447 -3.061 . . . . 0.0 105.447 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 p -68.11 149.97 48.95 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.491 1.116 . . . . 0.0 109.29 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -42.88 59.5 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -99.75 96.3 7.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.03 -26.92 2.61 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.144 0.878 . . . . 0.0 113.875 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.4 mttp 61.93 137.04 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 127.461 2.305 . . . . 0.0 110.776 -160.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -51.75 143.46 12.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.004 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.96 133.17 11.51 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 107.484 -2.247 . . . . 0.0 107.484 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.6 m -119.3 147.33 44.42 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 117.749 0.775 . . . . 0.0 109.164 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.13 140.71 26.89 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 114.711 -1.132 . . . . 0.0 108.86 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.7 m -91.0 113.0 25.14 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.8 mt -95.7 143.79 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.401 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 22.7 m-90 -125.09 152.63 44.11 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.201 1.4 . . . . 0.0 113.076 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -81.15 -38.77 26.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.702 2.401 . . . . 0.0 109.787 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.38 136.66 23.82 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m -60.45 119.89 8.88 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 168.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.15 46.12 7.18 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 124.183 0.897 . . . . 0.0 111.619 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.6 p 44.67 51.69 8.09 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.268 1.827 . . . . 0.0 113.206 169.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 m -125.88 176.86 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 128.588 2.755 . . . . 0.0 106.452 171.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.37 -156.84 34.11 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.3 ttt85 -67.96 153.82 42.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.401 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.2 p -141.47 165.85 26.36 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 174.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.0 t -137.31 138.87 40.46 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -88.43 94.95 10.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 40.6 tpp -86.38 104.7 16.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 98.8 m -93.08 138.14 31.79 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 166.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.5 t -153.52 132.08 6.67 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.176 1.391 . . . . 0.0 109.801 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -63.18 163.6 22.51 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.404 2.069 . . . . 0.0 115.579 -167.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.07 122.97 25.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 83.11 62.72 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 128.011 2.524 . . . . 0.0 107.402 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.72 -176.91 6.2 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.343 1.068 . . . . 0.0 109.778 158.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.29 122.78 25.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 128.907 2.883 . . . . 0.0 106.42 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.23 113.28 24.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.633 1.973 . . . . 0.0 107.061 -171.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -66.47 115.12 6.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 167.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.21 120.62 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 165.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -150.47 66.95 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 170.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 p -78.2 161.56 27.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.581 -167.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -52.84 -30.17 35.82 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.021 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -111.12 159.89 17.41 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 124.575 1.15 . . . . 0.0 109.947 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -72.56 139.26 47.4 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.945 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.32 133.69 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.289 1.036 . . . . 0.0 110.252 -164.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -122.61 -41.05 2.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.906 0.882 . . . . 0.0 111.544 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.94 167.27 22.53 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -154.88 161.44 41.44 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.237 0.615 . . . . 0.0 111.852 163.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -138.29 145.62 41.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.829 2.052 . . . . 0.0 108.395 164.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.98 153.54 34.45 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.875 166.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.35 -17.84 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.811 1.644 . . . . 0.0 110.455 164.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 164.537 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.886 0 CA-C-O 118.16 -1.356 . . . . 0.0 115.2 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -76.83 61.11 1.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 120.081 1.94 . . . . 0.0 111.093 -170.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.38 133.24 12.53 Favored Glycine 0 N--CA 1.443 -0.857 0 O-C-N 121.179 -0.951 . . . . 0.0 110.826 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -113.18 159.4 19.32 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.866 1.267 . . . . 0.0 108.087 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 tt -139.18 103.76 4.84 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 159.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 pt -124.42 171.54 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.0 ptp -136.58 140.11 42.65 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.352 1.061 . . . . 0.0 111.181 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.4 m -125.04 168.8 12.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.108 1.363 . . . . 0.0 109.965 -159.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -79.55 -34.8 40.67 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.928 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -132.47 -168.68 2.1 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 128.033 2.533 . . . . 0.0 107.31 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -94.96 3.46 54.92 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.31 114.55 23.51 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 124.971 1.309 . . . . 0.0 111.229 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.76 -24.4 74.62 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.309 2.006 . . . . 0.0 111.838 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -44.95 91.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.617 1.099 . . . . 0.0 109.44 -177.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.2 p -103.95 13.66 32.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.934 0.894 . . . . 0.0 112.346 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.97 114.65 2.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 124.993 1.282 . . . . 0.0 111.408 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.53 94.21 1.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.0 m -87.72 173.15 9.18 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.563 0.745 . . . . 0.0 109.175 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 162.1 27.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 158.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -151.5 54.87 0.85 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 168.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -114.89 176.27 5.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.839 1.656 . . . . 0.0 108.259 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -63.98 153.4 37.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.215 0.606 . . . . 0.0 109.456 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -146.5 -23.45 0.43 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -103.07 33.67 3.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.565 -1.334 . . . . 0.0 109.67 -173.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -141.72 43.84 1.72 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.599 -167.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 89.98 177.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 173.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.3 t -47.44 109.89 0.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.515 1.526 . . . . 0.0 112.273 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.03 145.02 12.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 127.005 2.122 . . . . 0.0 107.241 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.74 134.94 14.29 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.7 mm -133.15 166.52 29.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 127.093 2.157 . . . . 0.0 108.613 -169.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.62 -166.98 21.65 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 106.598 -2.601 . . . . 0.0 106.598 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 48.72 89.45 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 164.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.4 m120 64.8 22.25 12.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 126.59 1.956 . . . . 0.0 111.517 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.3 t -133.91 101.14 3.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -146.53 25.8 1.19 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.713 1.205 . . . . 0.0 112.335 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -129.81 143.23 50.71 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 166.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 48.5 ttm -107.15 125.3 50.9 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 167.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.98 93.37 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -99.59 155.13 17.76 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.959 1.304 . . . . 0.0 109.002 -167.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.74 -161.56 35.33 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 175.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.24 -15.51 59.61 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 124.139 0.875 . . . . 0.0 114.06 164.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.07 -68.88 0.29 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.877 1.339 . . . . 0.0 109.855 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -163.44 -86.93 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -164.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -167.95 146.29 4.52 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.365 3.066 . . . . 0.0 106.518 159.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.09 23.44 68.81 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 118.342 0.519 . . . . 0.0 112.214 167.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -105.68 104.48 14.21 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.944 0.498 . . . . 0.0 110.012 166.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.63 167.58 3.42 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.237 1.015 . . . . 0.0 110.675 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.21 140.57 9.47 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 162.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 m -126.27 166.6 16.81 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.3 147.03 26.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.296 1.438 . . . . 0.0 110.118 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 m -83.5 123.06 29.35 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 161.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 mt -110.12 150.98 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.431 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 24.6 m-90 -129.65 156.77 43.69 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.855 1.662 . . . . 0.0 110.295 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -83.73 -36.01 23.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.35 1.06 . . . . 0.0 111.271 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.88 148.19 50.85 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.119 -0.988 . . . . 0.0 110.746 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m -78.27 53.98 1.32 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.099 0.96 . . . . 0.0 110.35 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.4 55.4 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -171.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 54.42 34.4 20.78 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 162.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 m -125.93 176.55 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 126.932 2.093 . . . . 0.0 109.763 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.52 -152.7 29.39 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -73.66 142.28 46.45 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.431 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.3 p -136.72 168.26 19.86 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.924 0.765 . . . . 0.0 111.411 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.1 t -152.91 140.9 20.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.803 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.8 m -72.67 100.46 2.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 158.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.87 119.39 24.81 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 166.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.7 m -101.46 153.81 19.37 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.7 t -142.61 119.71 7.05 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 123.718 0.807 . . . . 0.0 109.008 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.77 179.89 2.42 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.957 1.771 . . . . 0.0 110.545 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.72 151.54 40.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.831 -161.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.7 m120 50.91 53.34 13.2 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.231 161.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 t -156.08 179.97 8.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.296 0.57 . . . . 0.0 109.804 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 141.75 46.07 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.582 2.753 . . . . 0.0 108.754 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.0 m -143.32 117.69 9.65 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.617 1.167 . . . . 0.0 107.879 -168.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.94 103.96 5.35 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.454 0.57 . . . . 0.0 110.32 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.11 132.96 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t30 141.66 112.82 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 129.111 2.964 . . . . 0.0 104.254 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.45 9.13 19.63 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -174.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.07 -60.91 0.51 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 -159.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -82.73 156.97 23.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -168.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -73.94 133.81 43.09 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.332 -1.304 . . . . 0.0 107.746 172.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.6 128.23 55.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -166.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -136.71 -19.62 1.36 Allowed 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -166.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -142.6 163.24 33.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 119.631 1.105 . . . . 0.0 108.575 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.04 161.48 41.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.958 0.799 . . . . 0.0 112.918 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.37 129.08 12.35 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 171.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.4 mmm-85 -57.41 142.69 42.93 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.17 -3.07 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.193 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 CA--C 1.52 -0.2 0 C-N-CA 126.202 1.801 . . . . 0.0 107.493 177.403 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.604 0 N-CA-C 106.492 -2.643 . . . . 0.0 106.492 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 t70 63.83 -71.66 0.06 Allowed 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 128.134 2.574 . . . . 0.0 111.135 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.7 163.7 9.61 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 -161.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -168.92 172.73 7.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.38 119.45 12.03 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.43 151.98 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 126.552 1.941 . . . . 0.0 106.301 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.1 ptp -110.96 159.3 17.85 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.876 0.846 . . . . 0.0 112.187 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.5 m -145.31 154.56 42.47 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 122.753 1.263 . . . . 0.0 110.133 -159.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -86.14 -13.37 47.32 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 112.679 -2.055 . . . . 0.0 110.741 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -150.77 -179.93 7.68 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.849 1.66 . . . . 0.0 107.84 164.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 t -77.28 3.67 12.42 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -128.57 106.11 19.01 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -59.97 -21.12 63.54 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.618 1.545 . . . . 0.0 112.684 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.9 -33.46 75.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.538 0.608 . . . . 0.0 110.64 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 t -142.37 29.5 1.6 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.221 0.464 . . . . 0.0 111.592 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.22 139.19 10.75 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.11 126.58 28.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 164.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.2 m -135.61 137.14 41.62 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -96.28 103.38 15.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 111.559 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -103.71 56.45 0.73 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 129.266 3.027 . . . . 0.0 109.619 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -99.67 -175.76 3.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 159.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -64.01 147.06 52.99 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -143.52 -8.17 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.742 0.817 . . . . 0.0 112.641 -164.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -101.78 143.59 31.51 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 54.94 47.68 21.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.454 1.101 . . . . 0.0 111.991 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 t -144.05 -173.44 4.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.241 1.416 . . . . 0.0 109.322 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.7 t -151.52 66.79 0.88 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.622 1.969 . . . . 0.0 109.405 -173.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.3 t -104.05 120.62 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.47 1.108 . . . . 0.0 109.659 -167.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.8 128.31 8.38 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.147 0.879 . . . . 0.0 112.639 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.31 166.35 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 127.855 2.462 . . . . 0.0 106.09 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.63 -178.92 41.85 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.99 99.38 0.05 Allowed 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 127.537 2.335 . . . . 0.0 110.64 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 73.08 8.36 5.37 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.396 1.878 . . . . 0.0 110.98 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.7 t -84.57 97.62 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -143.25 28.96 1.48 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -143.63 127.41 17.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.6 ttm -104.9 132.93 50.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 162.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 t -125.16 81.29 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -94.66 151.65 19.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -168.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.86 -172.68 23.95 Favored Glycine 0 C--O 1.219 -0.796 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.25 -34.79 0.24 Allowed Glycine 0 CA--C 1.521 0.463 0 CA-C-N 119.097 1.448 . . . . 0.0 112.462 172.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -107.06 -96.14 0.36 Allowed 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 165.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -156.85 -63.13 0.1 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.03 50.09 1.77 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.637 2.375 . . . . 0.0 108.472 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.06 1.96 77.61 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.421 -0.655 . . . . 0.0 112.279 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt 60.81 163.33 0.07 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.832 2.053 . . . . 0.0 111.333 -169.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.92 159.66 33.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.844 168.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.32 173.04 31.5 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 164.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.2 m -129.86 159.82 35.42 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -163.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.18 140.53 35.92 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.8 m -83.23 124.45 30.57 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 159.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.2 mt -102.93 146.8 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -123.01 160.98 25.16 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.715 1.606 . . . . 0.0 110.936 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -79.54 -50.16 11.15 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.418 1.487 . . . . 0.0 110.919 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.27 121.05 5.3 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -169.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.71 108.87 0.23 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.05 2.14 . . . . 0.0 108.66 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 129.87 -74.75 0.44 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -172.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.1 p 163.03 55.1 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 129.298 3.039 . . . . 0.0 110.462 165.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.63 176.61 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.566 1.546 . . . . 0.0 107.908 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.78 -158.75 37.31 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -80.4 151.55 29.31 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.73 164.37 30.65 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.11 -169.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.57 128.88 10.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -170.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.0 p -82.3 92.74 7.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 41.2 tpp -83.73 129.78 34.95 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 96.7 m -130.58 134.3 46.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.925 0.784 . . . . 0.0 109.333 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 t -150.16 143.67 16.8 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.653 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -66.98 170.12 13.59 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.539 2.159 . . . . 0.0 113.93 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.61 148.75 42.6 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.1 m120 59.81 41.45 18.09 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.111 1.364 . . . . 0.0 109.007 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.4 m -127.9 131.41 49.39 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.2 t -88.49 124.82 34.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 170.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.4 m -121.18 105.79 10.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -160.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -78.04 104.84 8.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.624 0.647 . . . . 0.0 109.671 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.64 116.0 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -139.84 83.23 1.91 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 p -74.47 -174.87 2.18 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.965 -1.084 . . . . 0.0 108.966 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.65 -20.22 71.85 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.321 -0.862 . . . . 0.0 111.573 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -131.02 177.23 7.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.977 1.311 . . . . 0.0 109.838 -172.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -83.35 135.28 34.77 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.32 146.36 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.461 1.504 . . . . 0.0 110.522 -169.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.1 mtt85 -136.25 -85.78 0.35 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.172 0.989 . . . . 0.0 110.024 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.12 168.33 17.84 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.272 -159.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -157.93 165.15 35.91 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.76 123.65 6.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.393 1.477 . . . . 0.0 107.347 170.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -59.9 129.9 44.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -36.9 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 C-N-CA 126.571 1.948 . . . . 0.0 110.472 -167.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 177.528 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.816 0 CA-C-O 118.485 -1.175 . . . . 0.0 113.829 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 64.05 109.95 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.108 1.763 . . . . 0.0 110.297 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.71 172.84 7.86 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -167.24 179.1 5.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.753 1.221 . . . . 0.0 108.157 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.4 tt -149.91 91.67 1.81 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 pt -108.29 144.59 16.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.5 ptp -78.16 131.26 37.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 159.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 66.5 m -103.09 156.41 17.71 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -66.46 -39.84 89.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 117.414 -1.715 . . . . 0.0 108.688 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.421 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 39.8 p-10 -131.94 -165.9 1.65 Allowed 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 127.123 2.169 . . . . 0.0 108.53 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.0 t -82.99 3.82 28.55 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.397 -0.815 . . . . 0.0 112.609 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -106.84 114.29 61.82 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 123.267 0.627 . . . . 0.0 110.181 -170.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.39 -32.44 89.21 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.653 1.569 . . . . 0.0 111.504 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -100.56 -51.53 3.58 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.599 1.559 . . . . 0.0 111.757 -161.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -103.92 13.78 32.08 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.679 0.672 . . . . 0.0 112.148 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.45 -69.47 1.39 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 106.855 -2.498 . . . . 0.0 106.855 164.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t 94.22 122.05 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.282 2.633 . . . . 0.0 106.314 -163.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.2 m -136.46 159.75 40.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 126.671 1.989 . . . . 0.0 108.881 -165.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -89.25 94.37 9.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.464 2.078 . . . . 0.0 112.584 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -83.64 51.09 1.93 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.37 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -110.43 -176.65 3.03 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.929 2.492 . . . . 0.0 106.834 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 144.36 49.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 167.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -134.91 2.82 3.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 123.69 0.619 . . . . 0.0 110.016 171.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -93.51 125.66 38.23 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 -172.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 53.74 37.45 26.27 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.78 0.832 . . . . 0.0 111.88 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -133.9 151.44 51.51 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.322 1.849 . . . . 0.0 106.613 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -89.32 85.66 6.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -83.85 124.87 40.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -167.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.69 121.44 5.67 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 118.404 0.547 . . . . 0.0 112.04 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.2 mt -93.46 159.43 2.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 126.577 1.951 . . . . 0.0 108.405 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.91 166.13 28.06 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 169.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.23 74.05 0.21 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.768 2.427 . . . . 0.0 112.342 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 68.21 14.9 9.33 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.886 2.074 . . . . 0.0 110.821 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.1 t -133.53 99.49 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -145.8 39.9 1.15 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.725 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.421 ' CD1' ' HA ' ' A' ' 10' ' ' ASN . 60.2 m95 -135.16 132.11 37.6 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 19.5 ttp -106.58 123.23 47.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 165.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -124.03 117.09 49.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -99.47 -177.03 3.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -168.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -44.18 139.26 4.21 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.16 -51.24 5.84 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 106.052 -2.819 . . . . 0.0 106.052 165.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 m -62.92 170.97 2.38 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.559 -0.82 . . . . 0.0 111.939 174.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.14 46.15 22.05 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -168.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -59.97 72.88 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.116 2.166 . . . . 0.0 111.795 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.35 -26.81 0.87 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.975 1.274 . . . . 0.0 112.106 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -77.41 96.32 4.64 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.322 1.058 . . . . 0.0 108.522 167.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -66.78 150.99 48.33 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.329 165.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.76 147.91 18.68 Favored Glycine 0 C--O 1.238 0.402 0 N-CA-C 105.791 -2.924 . . . . 0.0 105.791 166.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.9 m -132.96 151.33 52.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.147 1.474 . . . . 0.0 108.721 -172.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.79 144.47 49.03 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.924 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.2 m -83.3 115.53 22.03 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 162.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.84 148.47 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -127.94 151.8 48.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.109 1.364 . . . . 0.0 111.504 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -87.91 -33.67 18.41 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.476 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.87 138.44 31.44 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 173.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.6 m -61.83 135.28 57.52 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 159.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.11 32.45 39.4 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 124.727 1.156 . . . . 0.0 111.006 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 12.1 p 45.39 52.29 9.03 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.643 2.377 . . . . 0.0 112.174 169.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.76 175.73 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 125.703 1.601 . . . . 0.0 107.711 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.71 -151.35 26.29 Favored Glycine 0 CA--C 1.523 0.549 0 O-C-N 121.368 -0.832 . . . . 0.0 111.992 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.2 142.85 49.02 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -170.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.99 147.58 28.03 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -167.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p -128.19 115.84 18.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.4 1.48 . . . . 0.0 108.204 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.8 88.33 0.25 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.054 1.342 . . . . 0.0 108.892 171.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -90.52 132.48 35.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.955 1.302 . . . . 0.0 107.984 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 64.5 m -118.51 143.19 46.9 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.1 t -134.2 114.26 12.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 123.729 0.812 . . . . 0.0 109.362 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -72.01 166.48 29.49 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.354 1.369 . . . . 0.0 113.516 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.3 154.25 40.21 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 45.9 53.5 8.89 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.223 1.009 . . . . 0.0 108.718 -164.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 m -144.4 106.64 4.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -73.93 126.08 29.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 169.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 86.4 m -121.57 139.73 53.14 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.942 1.297 . . . . 0.0 108.592 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -108.46 113.84 27.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 109.546 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 1.5 mp -93.4 71.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -168.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -123.98 84.04 2.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 p -73.97 170.83 14.6 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.01 -36.86 93.49 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -85.07 162.67 19.21 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 122.121 -0.635 . . . . 0.0 109.395 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -84.44 133.7 34.48 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.079 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.75 132.29 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.025 1.33 . . . . 0.0 109.769 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -118.58 -37.39 3.3 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 118.511 -0.757 . . . . 0.0 111.982 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 p -152.72 167.33 29.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -139.18 167.13 22.74 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.32 1.048 . . . . 0.0 112.036 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.8 139.68 40.15 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.013 1.725 . . . . 0.0 109.035 162.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.42 HH21 ' C ' ' A' ' 88' ' ' GLU . 49.3 mmm-85 -54.54 154.62 4.64 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.649 0.659 . . . . 0.0 112.095 170.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.67 -31.19 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 123.215 0.606 . . . . 0.0 110.985 165.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' C ' HH21 ' A' ' 86' ' ' ARG . 10.0 pt-20 . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 CA-C-O 118.803 -0.998 . . . . 0.0 113.054 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.1 123.89 0.03 OUTLIER 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.451 1.626 . . . . 0.0 109.358 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.72 147.56 16.71 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 123.386 0.517 . . . . 0.0 112.23 -171.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -84.28 155.87 22.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.163 0.982 . . . . 0.0 110.419 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 tt -141.25 110.57 6.31 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 159.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.52 111.23 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -169.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptm -72.38 148.6 45.11 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.686 -1.206 . . . . 0.0 108.478 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 71.4 m -129.78 157.05 43.27 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -172.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttt -72.65 -30.78 64.58 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 117.544 -1.662 . . . . 0.0 112.359 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -125.59 -166.55 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.589 1.955 . . . . 0.0 109.528 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 t -99.8 25.66 7.04 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.275 1.03 . . . . 0.0 111.909 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -119.63 101.74 48.17 Favored Pre-proline 0 C--N 1.327 -0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 111.81 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -58.27 -24.07 65.72 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 120.858 1.039 . . . . 0.0 113.028 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -66.61 -73.68 0.13 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.112 0.869 . . . . 0.0 111.052 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 t -122.28 37.56 4.36 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.159 0.983 . . . . 0.0 110.413 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.2 -37.37 71.85 Favored Glycine 0 N--CA 1.448 -0.557 0 O-C-N 120.925 -1.109 . . . . 0.0 110.928 161.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.98 114.37 0.05 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -159.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.2 m -136.04 137.26 40.97 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 112.46 -2.155 . . . . 0.0 106.663 -166.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -80.61 93.37 6.1 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 122.707 1.241 . . . . 0.0 109.974 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -83.25 41.95 0.79 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.473 1.909 . . . . 0.0 108.309 165.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -96.67 168.43 10.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 166.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -63.74 143.81 57.54 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 118.429 -1.309 . . . . 0.0 109.014 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -129.82 -44.37 1.2 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 126.807 2.043 . . . . 0.0 108.162 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . 0.3 6.4 t-105 -86.19 59.09 5.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.834 1.254 . . . . 0.0 108.212 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.13 -0.01 0.01 OUTLIER 'General case' 0 N--CA 1.46 0.067 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 173.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 t -167.15 142.06 3.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 120.292 1.405 . . . . 0.0 110.382 -158.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.9 t -65.75 75.42 0.07 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.995 2.518 . . . . 0.0 111.625 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 t -83.64 148.33 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 O-C-N 120.882 -1.136 . . . . 0.0 108.646 -167.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.88 144.7 19.62 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 124.337 0.97 . . . . 0.0 111.013 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -101.22 156.63 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 166.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.81 154.58 10.84 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 66.85 83.07 0.17 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.052 1.741 . . . . 0.0 114.323 165.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 67.67 3.76 3.57 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.395 1.478 . . . . 0.0 111.723 171.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.29 126.48 36.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 122.486 0.314 . . . . 0.0 110.256 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 30.25 1.02 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 169.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.516 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 68.0 m95 -138.35 127.3 23.95 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.986 0.812 . . . . 0.0 112.728 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.1 ttp -90.63 135.58 33.61 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 161.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.9 137.55 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 t -146.07 153.4 40.68 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 121.691 -0.63 . . . . 0.0 110.378 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.77 -156.14 27.93 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 118.373 0.533 . . . . 0.0 112.143 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.02 -53.94 3.97 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -39.18 -58.55 1.15 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.076 1.351 . . . . 0.0 112.209 -162.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.9 -87.55 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.803 1 N-CA-C 100.017 -4.068 . . . . 0.0 100.017 172.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -171.06 168.19 6.96 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.308 2.243 . . . . 0.0 108.642 158.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.34 -23.94 22.05 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.994 1.759 . . . . 0.0 109.877 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -86.27 69.26 10.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.851 1.31 . . . . 0.0 110.95 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -44.13 143.63 1.13 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 126.538 1.935 . . . . 0.0 110.665 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.79 137.38 12.38 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.7 m -125.24 153.74 42.7 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.46 143.69 46.01 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.855 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -88.25 130.88 34.97 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 159.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 mt -116.76 144.43 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -130.43 143.72 50.94 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.1 1.36 . . . . 0.0 110.475 -171.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -61.39 -51.96 66.62 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.32 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.46 145.99 36.68 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 124.392 0.996 . . . . 0.0 113.296 -163.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 m -55.13 116.98 3.1 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 162.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.13 51.14 5.9 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.4 p 43.29 53.17 5.56 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.73 1.612 . . . . 0.0 113.342 163.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -125.76 176.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 128.129 2.572 . . . . 0.0 106.35 167.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.91 -168.24 39.07 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 119.421 1.01 . . . . 0.0 110.814 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -69.41 128.36 36.28 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -170.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.92 165.06 15.74 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.811 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -150.66 151.29 32.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 m -87.02 111.07 20.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 164.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 34.9 tpp -87.02 144.06 27.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 167.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 55.4 m -147.37 136.14 22.05 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.3 t -135.03 137.71 27.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 124.78 1.232 . . . . 0.0 108.406 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.05 168.31 7.63 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.185 1.257 . . . . 0.0 110.759 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.8 150.33 41.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.308 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 54.51 48.47 20.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.942 1.297 . . . . 0.0 107.918 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.9 m -145.32 148.07 33.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.462 1.105 . . . . 0.0 108.181 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.516 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -101.17 137.17 39.88 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 128.559 2.744 . . . . 0.0 108.338 172.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 54.3 m -140.84 128.17 21.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.968 0.804 . . . . 0.0 110.398 -175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -73.36 135.84 44.33 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.186 0.994 . . . . 0.0 111.599 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.403 ' CD1' ' N ' ' A' ' 75' ' ' ILE . 1.3 mp -102.23 112.86 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 126.573 1.949 . . . . 0.0 106.233 173.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -150.71 77.35 1.28 Allowed 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.843 -0.535 . . . . 0.0 109.944 169.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.32 165.67 24.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.829 0.851 . . . . 0.0 109.28 172.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.99 -51.5 56.92 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -77.33 154.33 32.93 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.551 0.691 . . . . 0.0 110.096 171.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -86.2 137.12 32.87 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.384 -1.734 . . . . 0.0 109.918 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.48 127.76 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 124.665 1.186 . . . . 0.0 109.892 -170.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -109.01 -17.82 13.82 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.982 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -139.13 166.63 24.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -153.65 162.3 41.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.615 1.166 . . . . 0.0 111.651 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -137.59 143.96 41.76 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.108 1.763 . . . . 0.0 107.837 159.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 154.37 34.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 163.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 m -131.62 -22.99 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 165.855 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.621 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.56 95.78 2.8 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -172.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.31 124.36 0.2 Allowed Glycine 0 CA--C 1.512 -0.132 0 CA-C-O 122.838 1.243 . . . . 0.0 111.122 -163.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.2 p90 178.4 167.52 0.82 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 127.755 2.422 . . . . 0.0 107.92 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -147.55 121.17 9.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.3 pt -132.01 168.89 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 126.851 2.06 . . . . 0.0 106.537 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.2 ptp -120.57 144.34 48.14 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 158.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 70.9 m -117.29 156.06 28.44 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.5 pttt -60.87 -44.45 97.04 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 116.827 -1.949 . . . . 0.0 109.029 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -126.82 167.73 15.4 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.812 1.645 . . . . 0.0 109.191 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.9 t -72.72 3.88 4.63 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -101.87 100.65 15.26 Favored Pre-proline 0 N--CA 1.467 0.397 0 O-C-N 121.061 -1.024 . . . . 0.0 110.121 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.45 -27.91 83.5 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.958 1.772 . . . . 0.0 112.256 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -63.47 -60.11 3.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.378 0.535 . . . . 0.0 109.688 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.4 p -103.81 13.36 33.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.75 132.75 11.34 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 p -64.42 114.97 4.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 158.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -126.37 138.23 53.54 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -76.07 92.69 3.21 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.218 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.23 59.57 4.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 128.56 2.744 . . . . 0.0 104.489 166.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -127.53 168.92 14.28 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 170.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -64.3 143.86 57.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -134.22 -39.88 0.83 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.022 0.529 . . . . 0.0 109.813 -170.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.418 ' O ' ' CG ' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -77.62 33.57 0.17 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.443 1.116 . . . . 0.0 111.805 -175.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.83 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 119.182 -2.199 . . . . 0.0 111.838 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.26 146.83 23.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.958 0.409 . . . . 0.0 111.191 -170.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.7 t -77.78 81.87 4.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.614 1.166 . . . . 0.0 108.579 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.43 145.62 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 O-C-N 121.223 -0.923 . . . . 0.0 109.968 -173.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.75 169.24 44.5 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.597 1.094 . . . . 0.0 112.998 -175.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.22 135.72 56.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 126.321 1.848 . . . . 0.0 106.123 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.59 178.1 35.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 167.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 57.82 79.35 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.075 1.75 . . . . 0.0 113.349 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.7 m120 70.3 4.49 4.91 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.25 1.42 . . . . 0.0 111.669 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.23 117.25 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 119.111 0.869 . . . . 0.0 110.87 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -145.96 29.39 1.1 Allowed 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.46 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 79.9 m95 -137.6 121.71 17.93 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 119.377 0.989 . . . . 0.0 112.213 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.2 tpp -84.3 135.4 34.33 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 163.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.78 128.79 54.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -137.77 155.72 48.75 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.193 -0.942 . . . . 0.0 109.409 -171.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.94 -179.6 16.56 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.55 -21.93 4.45 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -159.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 t 66.56 -62.22 0.29 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 129.073 2.949 . . . . 0.0 113.398 158.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.7 p -129.82 -73.86 0.56 Allowed 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 158.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.55 33.18 1.28 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.447 0.641 . . . . 0.0 111.744 -159.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.43 -28.16 37.1 Favored Glycine 0 CA--C 1.524 0.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.963 168.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 73.7 134.66 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.586 2.354 . . . . 0.0 111.013 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -48.91 152.03 1.12 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.164 1.386 . . . . 0.0 111.628 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.95 153.11 17.3 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.3 m -139.33 153.81 47.78 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.16 149.84 51.68 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 124.076 0.86 . . . . 0.0 110.695 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 m -83.62 126.3 32.71 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 158.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.6 mm -101.35 146.67 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -129.02 156.92 43.05 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.017 0.913 . . . . 0.0 111.859 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -97.9 -33.79 11.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 127.441 2.296 . . . . 0.0 108.829 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 143.61 47.41 Favored Glycine 0 CA--C 1.521 0.421 0 O-C-N 120.991 -1.068 . . . . 0.0 110.904 170.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.1 m -77.35 59.09 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.062 0.931 . . . . 0.0 111.688 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.42 50.75 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.1 p 44.07 42.77 5.09 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.825 1.25 . . . . 0.0 112.925 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.2 176.41 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 171.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.68 -154.25 37.72 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -73.63 154.36 39.77 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.99 168.37 23.3 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.4 144.84 30.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.55 1.54 . . . . 0.0 107.85 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.76 123.35 28.69 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.06 108.35 15.62 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.595 1.558 . . . . 0.0 108.794 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.5 m -110.02 144.75 38.13 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.085 0.954 . . . . 0.0 111.274 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.7 t -152.47 136.86 10.45 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -67.49 159.52 52.1 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.9 2.4 . . . . 0.0 113.088 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.17 53.39 2.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.443 -159.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 156.73 50.49 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -163.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -156.04 167.38 30.59 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 165.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.46 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 13.0 t -103.08 127.28 50.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.261 1.825 . . . . 0.0 107.482 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.18 119.23 31.75 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.173 1.789 . . . . 0.0 107.25 -164.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -82.05 122.55 27.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.118 0.872 . . . . 0.0 110.685 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 75' ' ' ILE . 1.7 mp -92.28 86.46 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.26 83.84 2.16 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 166.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 p -73.66 179.36 4.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.678 1.191 . . . . 0.0 108.785 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.21 -30.12 63.77 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 121.65 -0.656 . . . . 0.0 112.419 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -119.28 171.23 8.45 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 127.1 2.16 . . . . 0.0 109.525 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -74.64 133.34 42.16 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.93 157.98 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.527 0.731 . . . . 0.0 110.734 -173.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.91 -40.65 0.6 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 167.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 p -147.69 170.09 18.28 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -156.68 158.01 36.2 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.311 0.959 . . . . 0.0 112.816 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.84 135.55 11.63 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 166.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -60.74 146.84 44.5 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.307 0.503 . . . . 0.0 112.228 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 m -107.76 -9.97 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.815 1.246 . . . . 0.0 111.915 171.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.175 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.444 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.83 -40.44 96.6 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.14 0.976 . . . . 0.0 108.435 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.1 165.1 48.58 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.676 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -146.8 168.66 20.84 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 128.022 2.529 . . . . 0.0 105.531 -171.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 tt -127.76 122.65 33.34 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 103.9 -2.63 . . . . 0.0 103.9 164.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 pt -140.74 168.21 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.21 169.0 9.02 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 122.729 1.252 . . . . 0.0 112.092 159.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 88.1 m -155.7 157.91 37.38 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.958 -159.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -64.02 -32.25 73.72 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.017 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -159.43 175.84 12.82 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.365 0.666 . . . . 0.0 109.742 -165.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.0 t -79.92 20.52 0.62 Allowed 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.024 1.73 . . . . 0.0 113.082 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -141.82 118.58 7.31 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.877 1.271 . . . . 0.0 110.714 171.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.19 -25.34 10.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.109 2.539 . . . . 0.0 111.463 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -63.94 -42.64 97.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.9 p -108.04 13.88 25.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.933 1.293 . . . . 0.0 112.124 177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.0 118.51 3.71 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 125.355 1.455 . . . . 0.0 109.901 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.21 120.82 15.64 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.2 m -122.18 158.96 28.23 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.708 0.803 . . . . 0.0 109.35 -169.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -95.76 93.77 7.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 125.394 2.521 . . . . 0.0 112.729 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -83.98 47.35 1.3 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.052 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.46 -178.03 1.04 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.135 1.774 . . . . 0.0 108.938 173.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -69.73 143.4 53.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 158.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -125.27 -24.44 3.97 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.226 0.61 . . . . 0.0 110.464 -166.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.23 -162.95 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 131.068 3.747 . . . . 0.0 115.948 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -45.57 62.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 130.886 3.675 . . . . 0.0 110.547 158.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 t -140.02 175.35 9.66 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 128.113 2.565 . . . . 0.0 109.555 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.4 t -139.65 67.19 1.38 Allowed 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.249 1.82 . . . . 0.0 107.701 -165.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.4 t -83.64 144.84 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 124.528 1.131 . . . . 0.0 108.323 -163.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.04 133.68 12.14 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mm -136.61 162.33 35.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 123.817 0.847 . . . . 0.0 110.825 -165.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.22 -148.8 19.73 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 52.19 88.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.774 2.03 . . . . 0.0 116.229 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.279 0.0 OUTLIER 53.68 16.31 0.96 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.156 2.183 . . . . 0.0 113.41 175.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.1 t -115.46 120.16 63.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.948 1.299 . . . . 0.0 107.895 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.4 24.28 1.27 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.771 0.828 . . . . 0.0 112.705 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.405 ' CZ3' ' HB2' ' A' ' 74' ' ' ASN . 60.7 m95 -130.75 117.11 18.92 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.0 ttm -83.54 146.57 28.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 165.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 t -141.12 135.02 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -146.32 154.35 41.58 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.3 156.68 13.3 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 128.363 2.887 . . . . 0.0 112.737 173.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.79 -64.25 0.13 Allowed Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 104.34 -3.504 . . . . 0.0 104.34 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.7 t -176.52 -108.6 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.962 2.505 . . . . 0.0 109.266 166.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 52.9 29.5 7.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.154 0.982 . . . . 0.0 109.475 -172.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 16.74 57.71 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 128.357 2.663 . . . . 0.0 113.037 -158.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.65 -43.74 91.3 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 124.923 1.249 . . . . 0.0 110.131 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? 70.45 -173.82 0.18 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 126.081 1.752 . . . . 0.0 108.595 -162.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -60.66 144.01 52.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -164.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.72 143.56 16.31 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 106.186 -2.765 . . . . 0.0 106.186 167.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.2 m -133.23 156.07 48.21 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 118.355 1.077 . . . . 0.0 108.335 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.06 147.6 47.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.126 0.97 . . . . 0.0 109.379 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.3 m -83.93 111.1 18.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 158.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.6 mt -83.04 151.8 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 166.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.454 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 13.7 m-90 -126.41 150.36 48.68 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.06 0.933 . . . . 0.0 110.567 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -63.21 -60.9 2.79 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.238 -1.346 . . . . 0.0 107.535 163.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.74 148.81 47.2 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-O 122.408 1.004 . . . . 0.0 112.74 -159.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.33 72.0 8.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.173 0.989 . . . . 0.0 109.747 -168.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.48 46.61 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 125.259 1.409 . . . . 0.0 110.908 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.3 p 44.09 49.97 7.45 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 125.973 1.709 . . . . 0.0 111.376 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.16 176.85 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 126.716 2.006 . . . . 0.0 107.708 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.87 -155.24 38.64 Favored Glycine 0 CA--C 1.518 0.233 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -75.34 159.62 31.24 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.454 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.6 p -127.87 156.23 42.9 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 124.725 1.266 . . . . 0.0 111.663 173.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.46 110.36 8.77 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.153 1.781 . . . . 0.0 106.92 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.3 t -68.25 108.45 3.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 174.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.2 tpt -113.65 106.48 14.56 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.019 0.927 . . . . 0.0 110.134 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.0 m -93.19 154.65 17.93 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.779 0.832 . . . . 0.0 109.353 171.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.5 t -155.13 132.36 6.29 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.453 0.701 . . . . 0.0 110.505 167.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.27 169.11 16.01 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.3 2.0 . . . . 0.0 113.212 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.67 147.4 43.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 59.07 51.65 6.93 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.492 1.117 . . . . 0.0 108.578 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -140.23 130.94 25.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.243 0.544 . . . . 0.0 110.102 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.5 137.04 32.69 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.874 1.67 . . . . 0.0 109.451 165.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 m -138.9 93.57 2.72 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.957 1.303 . . . . 0.0 109.238 -159.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.405 ' HB2' ' CZ3' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -70.23 122.7 20.0 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 119.906 -1.746 . . . . 0.0 110.268 -178.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.06 114.84 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.72 1.208 . . . . 0.0 109.644 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.16 108.52 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.58 -5.81 3.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.899 0.88 . . . . 0.0 110.439 -171.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.3 13.14 82.3 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 121.242 -0.911 . . . . 0.0 112.538 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -139.9 156.42 46.7 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 119.33 1.565 . . . . 0.0 108.411 159.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.82 133.24 43.19 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.33 131.71 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 125.225 1.41 . . . . 0.0 108.412 -169.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.47 -1.52 8.06 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.5 p -156.43 168.98 25.66 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 166.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -153.73 166.84 31.57 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.989 1.316 . . . . 0.0 111.102 165.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -137.01 124.51 22.14 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 128.082 2.553 . . . . 0.0 106.467 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -69.89 130.63 42.76 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 120.746 1.612 . . . . 0.0 107.522 169.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 m -98.26 -33.64 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.106 0.962 . . . . 0.0 111.098 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -177.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.686 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 178.78 118.02 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.805 1.642 . . . . 0.0 109.386 -159.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -167.64 -157.66 11.08 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 166.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -121.55 172.5 8.05 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.004 0.902 . . . . 0.0 110.294 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 tt -156.61 82.28 0.96 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.612 2.365 . . . . 0.0 108.081 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 pt -108.64 175.98 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 125.477 1.511 . . . . 0.0 107.642 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.3 ptm -124.37 169.53 11.72 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.521 0.677 . . . . 0.0 111.01 158.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.6 m -155.49 163.43 40.03 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.146 1.378 . . . . 0.0 109.14 -158.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.06 -28.97 29.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -121.37 177.95 4.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 169.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.47 3.46 11.2 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.218 1.007 . . . . 0.0 112.904 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -129.83 96.11 27.16 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.017 0.527 . . . . 0.0 110.687 -161.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -68.94 -12.37 34.21 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.56 1.507 . . . . 0.0 113.455 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -70.28 -50.69 36.88 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.196 -0.94 . . . . 0.0 109.678 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.9 p -111.72 22.81 14.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.194 0.998 . . . . 0.0 111.928 -170.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.03 137.24 9.15 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 124.394 0.997 . . . . 0.0 110.7 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.16 129.77 41.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 168.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.0 m -135.8 151.08 49.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.239 1.015 . . . . 0.0 108.672 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -86.16 95.46 9.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.562 1.172 . . . . 0.0 110.879 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -83.53 58.01 4.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.184 2.193 . . . . 0.0 106.877 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -124.36 161.29 26.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.042 1.337 . . . . 0.0 108.271 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -64.09 146.41 54.25 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.693 0.759 . . . . 0.0 109.049 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -145.98 7.76 1.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.763 1.625 . . . . 0.0 111.007 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -88.33 121.83 31.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 54.45 38.0 28.81 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.384 1.073 . . . . 0.0 111.452 167.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 t -135.82 148.3 48.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.99 1.716 . . . . 0.0 107.457 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.2 t -84.38 100.98 11.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.03 126.65 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 120.101 1.319 . . . . 0.0 109.765 -171.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.59 140.72 15.2 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 127.061 2.267 . . . . 0.0 111.632 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.2 152.52 20.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 128.43 2.692 . . . . 0.0 108.943 -163.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.02 -167.01 34.28 Favored Glycine 0 CA--C 1.525 0.656 0 O-C-N 121.468 -0.77 . . . . 0.0 111.329 168.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.263 . . 59.28 64.8 1.29 Allowed 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 126.884 2.074 . . . . 0.0 115.235 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 m120 64.7 3.58 2.04 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.581 2.352 . . . . 0.0 110.886 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.6 t -77.02 106.31 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.629 0.649 . . . . 0.0 109.696 -173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -146.13 29.86 1.06 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -136.43 113.51 10.54 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 121.766 -0.584 . . . . 0.0 109.962 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 59.9 ttp -84.43 142.46 30.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 172.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.09 118.41 21.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.3 118.28 36.23 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.05 12.74 35.44 Favored Glycine 0 C--O 1.224 -0.474 0 CA-C-O 123.157 1.421 . . . . 0.0 115.743 169.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.06 45.05 12.18 Favored Glycine 0 C--N 1.308 -1.021 0 C-N-CA 125.777 1.655 . . . . 0.0 110.946 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 t 11.31 -68.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 128.563 2.745 . . . . 0.0 115.562 159.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.2 t -156.23 -56.3 0.09 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.86 143.58 27.05 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.387 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.69 -24.61 58.09 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.312 0.958 . . . . 0.0 112.063 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -70.94 179.23 2.8 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.247 -0.561 . . . . 0.0 110.306 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -60.85 162.21 7.12 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 120.923 -1.111 . . . . 0.0 110.364 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.06 159.01 25.46 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 166.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.5 m -143.21 164.62 29.69 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 119.577 1.689 . . . . 0.0 111.293 -167.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.71 159.47 42.03 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 124.324 1.05 . . . . 0.0 109.998 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -84.47 130.46 34.76 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 158.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.62 150.3 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.453 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 20.8 m-90 -125.98 156.09 40.38 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 173.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -84.13 -34.01 24.16 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.728 1.611 . . . . 0.0 109.87 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.18 145.35 24.3 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 121.503 0.502 . . . . 0.0 112.312 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -76.17 85.41 3.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.783 1.633 . . . . 0.0 112.627 -161.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.59 -50.44 0.54 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.6 p 159.34 45.53 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 131.613 3.965 . . . . 0.0 107.622 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.52 176.32 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -171.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.37 -147.74 37.91 Favored Glycine 0 CA--C 1.521 0.466 0 O-C-N 121.328 -0.857 . . . . 0.0 111.053 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -71.28 151.74 43.94 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.681 1.192 . . . . 0.0 108.132 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.453 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.7 p -146.71 159.2 43.78 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.573 1.17 . . . . 0.0 112.22 171.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -139.26 155.58 47.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 170.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 m -83.99 121.4 27.34 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 38.7 tpp -104.06 118.86 37.66 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 20.3 m -108.84 152.91 24.25 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.866 0.866 . . . . 0.0 108.859 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.6 t -151.86 143.24 15.78 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 117.688 -1.148 . . . . 0.0 109.684 171.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.6 168.02 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.196 2.597 . . . . 0.0 111.689 169.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.5 166.76 16.04 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 56.7 47.19 18.74 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.727 0.811 . . . . 0.0 109.215 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -156.28 173.01 17.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.874 0.845 . . . . 0.0 111.438 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -109.14 144.21 37.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.962 2.905 . . . . 0.0 107.942 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.2 m -141.94 99.13 3.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.597 1.159 . . . . 0.0 107.917 -162.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -60.45 105.3 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.167 -0.958 . . . . 0.0 110.22 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.07 121.72 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 164.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -168.05 79.12 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 p -73.53 166.99 22.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.5 -37.02 91.52 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -81.18 158.71 24.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 123.452 0.701 . . . . 0.0 110.831 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.74 134.0 43.41 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.85 140.99 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 123.668 0.787 . . . . 0.0 109.531 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -129.65 -23.22 2.89 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 117.216 -1.374 . . . . 0.0 114.126 168.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -150.52 166.12 31.18 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 120.976 1.716 . . . . 0.0 111.877 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -157.79 157.68 33.82 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.399 0.545 . . . . 0.0 111.857 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -146.29 124.23 12.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.022 1.729 . . . . 0.0 108.407 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 153.69 18.01 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.508 0.595 . . . . 0.0 110.842 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.2 m -124.89 -37.51 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.32 0.648 . . . . 0.0 110.87 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.03 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.834 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -59.99 1.73 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.65 -160.61 21.87 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -159.71 165.79 31.84 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.526 1.131 . . . . 0.0 108.224 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.22 114.95 12.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 170.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.0 pt -129.72 174.9 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.771 1.628 . . . . 0.0 107.129 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.5 ptp -129.32 164.53 23.35 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 160.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.4 m -144.44 160.91 40.28 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.836 1.654 . . . . 0.0 107.777 -161.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -52.99 -53.57 47.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.637 0.732 . . . . 0.0 111.031 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -132.56 -173.36 3.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.413 1.885 . . . . 0.0 107.777 -169.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 t -72.99 4.03 4.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -100.02 105.22 33.94 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 123.201 0.601 . . . . 0.0 111.84 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.25 -34.51 55.78 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 120.864 1.043 . . . . 0.0 112.091 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -74.21 -47.8 33.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.932 -0.48 . . . . 0.0 110.77 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.8 t -125.89 17.9 7.92 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.37 -36.26 45.21 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 120.475 -1.39 . . . . 0.0 111.642 170.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m 73.25 115.53 0.06 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.906 1.683 . . . . 0.0 106.793 -158.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -136.26 152.72 51.02 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.072 0.949 . . . . 0.0 108.584 -166.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.93 93.21 9.27 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.849 1.309 . . . . 0.0 109.725 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -84.03 56.84 3.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.943 2.497 . . . . 0.0 105.591 162.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' CD ' ' H ' ' A' ' 22' ' ' GLN . 5.9 tmtt? -117.31 -175.06 2.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.376 1.871 . . . . 0.0 107.734 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 21' ' ' LYS . 16.6 tt0 -64.39 143.05 58.18 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 171.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -146.62 -15.52 0.43 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.327 1.851 . . . . 0.0 111.296 -159.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -119.15 163.43 17.06 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 129.139 2.976 . . . . 0.0 104.629 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 m120 33.93 58.68 0.58 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.32 1.848 . . . . 0.0 114.285 170.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.35 -173.89 2.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.511 1.924 . . . . 0.0 107.261 166.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.5 t -121.72 136.19 54.94 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.571 1.948 . . . . 0.0 108.335 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -147.46 142.49 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.99 1.268 . . . . 0.0 107.842 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.51 137.96 13.66 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.779 2.133 . . . . 0.0 112.235 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.646 ' CD1' ' HA ' ' A' ' 83' ' ' SER . 4.7 mp -126.71 165.73 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 128.201 2.6 . . . . 0.0 107.135 -166.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.03 -178.98 34.06 Favored Glycine 0 N--CA 1.451 -0.353 0 O-C-N 121.25 -0.906 . . . . 0.0 111.518 159.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 60.31 94.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.894 2.078 . . . . 0.0 112.35 169.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.28 0.0 OUTLIER 56.28 26.12 10.11 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.593 1.557 . . . . 0.0 111.922 -176.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.53 103.71 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -146.32 38.16 1.04 Allowed 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 170.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -138.25 114.24 10.02 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 118.801 0.728 . . . . 0.0 110.245 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.7 ttm -84.01 142.63 30.33 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 170.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.44 130.88 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 t -146.35 146.49 30.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.04 -132.63 5.46 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -173.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.72 -63.28 4.12 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 105.995 -2.842 . . . . 0.0 105.995 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.1 m -98.23 -161.19 0.85 Allowed 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 124.201 1.0 . . . . 0.0 111.654 -163.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.8 p -112.08 -85.44 0.57 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.249 1.819 . . . . 0.0 110.33 -158.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.83 77.49 5.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.25 -49.79 1.29 Allowed Glycine 0 C--O 1.227 -0.326 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.1 mttm 70.31 139.26 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.705 2.402 . . . . 0.0 110.207 -167.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' CB ' ' HA ' ' A' ' 68' ' ' PRO . 28.0 pt20 -64.23 143.43 57.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.182 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.46 152.11 17.19 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.5 m -127.5 154.56 44.97 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.36 133.58 24.49 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.525 1.13 . . . . 0.0 109.08 -174.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -83.63 117.74 23.37 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 mt -95.0 146.55 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -124.11 148.24 47.3 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.521 1.529 . . . . 0.0 110.648 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -74.61 -46.08 40.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.179 1.392 . . . . 0.0 108.193 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.1 144.54 42.08 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 121.619 0.566 . . . . 0.0 112.434 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.2 m -66.43 108.64 2.45 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 165.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.55 52.18 2.9 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 19.2 p 46.98 44.23 14.57 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.251 1.82 . . . . 0.0 113.34 165.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.57 176.41 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.053 1.341 . . . . 0.0 107.385 171.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.73 -146.02 25.38 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 173.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -79.89 147.58 31.63 Favored 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 125.905 1.682 . . . . 0.0 107.792 -170.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -138.76 166.94 23.09 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 123.882 0.739 . . . . 0.0 112.017 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -160.56 119.03 2.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -71.45 117.49 13.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.9 ttp -106.18 137.84 43.41 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 167.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 93.2 m -113.39 149.74 33.67 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.469 1.107 . . . . 0.0 108.75 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.2 t -153.06 123.53 3.46 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.15 0.58 . . . . 0.0 112.288 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.492 ' HA ' ' CB ' ' A' ' 47' ' ' GLN . 12.1 Cg_endo -71.82 149.18 53.58 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 N-CA-C 116.951 1.866 . . . . 0.0 116.951 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.73 108.47 6.58 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 107.47 44.06 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 130.13 3.372 . . . . 0.0 109.112 -174.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -150.57 156.88 42.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.647 1.213 . . . . 0.0 110.511 165.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -92.7 138.11 31.78 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.352 160.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 m -131.59 99.31 4.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 126.514 1.926 . . . . 0.0 108.369 -170.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -56.67 120.83 8.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 119.098 -0.477 . . . . 0.0 109.846 168.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.57 128.7 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 164.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -176.93 98.63 0.05 OUTLIER 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 164.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 p -89.16 -174.57 4.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.456 1.102 . . . . 0.0 108.915 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.69 -4.1 30.95 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.688 -0.633 . . . . 0.0 113.338 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -143.17 159.1 42.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.841 1.656 . . . . 0.0 107.159 174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -69.52 142.4 53.68 Favored 'General case' 0 N--CA 1.441 -0.885 0 O-C-N 124.765 1.291 . . . . 0.0 108.204 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.61 142.79 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 124.126 0.97 . . . . 0.0 109.249 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -129.51 -19.18 3.44 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.646 ' HA ' ' CD1' ' A' ' 30' ' ' ILE . 1.7 m -134.12 168.76 18.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.458 1.481 . . . . 0.0 109.862 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -163.07 167.84 21.78 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.579 0.627 . . . . 0.0 109.887 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -157.27 144.46 18.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 123.91 0.756 . . . . 0.0 109.579 158.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.09 137.43 57.05 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 m -106.47 -13.51 9.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.053 1.341 . . . . 0.0 111.752 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 158.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.229 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 74.08 -59.34 0.56 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.141 1.776 . . . . 0.0 108.481 -169.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.88 170.51 2.93 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 158.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -152.99 171.56 18.17 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 120.861 -1.376 . . . . 0.0 110.324 -163.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 tt -125.46 111.11 14.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 162.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.5 pt -119.8 168.63 11.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.9 ptp -118.91 152.88 35.51 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.022 0.439 . . . . 0.0 110.273 165.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.6 m -138.29 154.04 49.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.538 -158.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -72.26 -6.36 42.49 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.25 1.42 . . . . 0.0 112.6 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.7 p30 -164.15 -177.54 5.05 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.048 1.739 . . . . 0.0 107.297 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.6 t -81.8 4.0 23.8 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.087 0.955 . . . . 0.0 112.576 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -125.95 90.53 50.1 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.686 1.194 . . . . 0.0 110.081 -162.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.55 -20.29 69.26 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.901 1.734 . . . . 0.0 112.264 -172.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -66.9 -24.14 66.07 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.369 -0.832 . . . . 0.0 111.204 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.9 t -144.48 13.89 1.58 Allowed 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -167.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.43 138.54 14.85 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 165.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 p -75.19 93.44 2.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.948 1.374 . . . . 0.0 107.576 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.3 m -94.66 152.59 18.36 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -170.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.84 107.3 19.53 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.924 1.345 . . . . 0.0 111.112 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -83.8 35.78 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.358 2.263 . . . . 0.0 108.806 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -87.23 157.98 19.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.837 1.255 . . . . 0.0 107.994 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -63.38 144.72 56.72 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 166.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -145.88 20.78 1.45 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.007 0.523 . . . . 0.0 112.27 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -115.91 141.75 47.69 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.86 20.4 10.63 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.066 0.546 . . . . 0.0 112.399 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.6 p -141.35 133.08 27.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -171.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.9 t -85.53 75.91 10.1 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.81 144.62 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -166.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.38 160.86 42.42 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.569 1.081 . . . . 0.0 111.15 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 mt -122.14 135.44 62.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 171.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.89 143.69 9.9 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 119.571 1.078 . . . . 0.0 113.175 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 69.46 73.77 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.957 2.103 . . . . 0.0 114.881 161.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.8 9.86 6.36 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.564 1.546 . . . . 0.0 110.355 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.75 97.32 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 170.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -135.07 39.73 2.93 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.765 0.826 . . . . 0.0 110.722 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -145.42 134.84 23.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.0 ttm -114.96 132.88 56.43 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 165.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.94 111.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -170.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.94 72.67 3.0 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.335 1.064 . . . . 0.0 109.526 -170.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.87 173.62 28.36 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 123.028 1.349 . . . . 0.0 112.438 167.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.85 65.23 0.29 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 103.465 -3.854 . . . . 0.0 103.465 171.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.8 t -139.82 -114.36 0.14 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.481 1.112 . . . . 0.0 108.648 -163.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 p -144.91 -71.88 0.27 Allowed 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -159.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -12.62 94.87 0.01 OUTLIER 'General case' 0 C--O 1.232 0.169 0 C-N-CA 128.639 2.776 . . . . 0.0 112.605 160.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.89 7.9 33.55 Favored Glycine 0 CA--C 1.519 0.29 0 O-C-N 123.739 0.65 . . . . 0.0 112.345 -159.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -69.14 131.68 45.35 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 167.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -53.92 143.26 22.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 160.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.66 131.6 10.73 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 107.007 -2.437 . . . . 0.0 107.007 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 47.2 m -130.62 149.36 52.31 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -162.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.17 140.06 27.69 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.548 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.3 m -83.84 114.74 21.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 162.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 mt -100.99 136.98 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 4.9 m-90 -119.96 158.87 25.84 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.032 0.933 . . . . 0.0 110.029 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.86 -47.51 70.95 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.218 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.5 -179.4 48.86 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 114.119 -3.896 . . . . 0.0 121.365 175.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m 33.61 82.42 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.63 2.772 . . . . 0.0 114.372 161.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.41 25.32 59.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.425 ' HB2' ' CD2' ' A' ' 53' ' ' TRP . 2.9 p 44.73 65.11 1.15 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.729 1.212 . . . . 0.0 111.609 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.1 176.03 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 126.406 1.882 . . . . 0.0 107.638 172.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.04 -152.73 23.97 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.1 ttm-85 -74.5 159.51 32.14 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.434 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 5.9 p -145.66 167.96 21.84 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.208 0.528 . . . . 0.0 111.235 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -154.75 135.97 13.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 m -85.15 105.72 16.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.0 tpp -83.58 144.81 29.23 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.8 m -124.36 145.53 49.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 159.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.7 t -131.6 109.61 14.66 Favored Pre-proline 0 C--N 1.325 -0.461 0 C-N-CA 124.384 1.074 . . . . 0.0 108.253 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -50.01 146.93 15.92 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.979 2.452 . . . . 0.0 112.223 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.0 160.68 30.98 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.306 0.574 . . . . 0.0 110.571 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.16 39.79 9.51 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.31 160.18 39.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.923 0.868 . . . . 0.0 111.201 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.56 134.69 52.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 128.647 2.779 . . . . 0.0 108.079 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 99.3 m -127.06 136.65 52.47 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.456 1.102 . . . . 0.0 109.827 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -82.61 126.73 32.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.581 0.752 . . . . 0.0 111.569 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.1 88.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 127.297 2.239 . . . . 0.0 106.721 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -154.0 67.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 p -73.61 176.27 6.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.194 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -46.96 -50.34 15.62 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -90.85 161.34 15.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 125.057 1.343 . . . . 0.0 110.891 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -75.06 138.9 42.45 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.731 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.44 135.66 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.193 0.997 . . . . 0.0 109.714 -170.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.9 ttt85 -136.36 -20.19 1.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.3 m -132.46 174.05 10.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 121.068 1.758 . . . . 0.0 112.456 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -167.08 172.87 9.68 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 124.903 1.281 . . . . 0.0 110.884 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -149.33 124.07 9.86 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -67.12 138.74 57.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.801 1.182 . . . . 0.0 108.674 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 m -121.1 -28.23 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 175.721 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.716 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.1 t70 64.89 -57.06 0.27 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 129.049 2.94 . . . . 0.0 111.146 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.01 -162.1 23.87 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 125.45 1.5 . . . . 0.0 109.701 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -164.57 168.96 17.66 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.372 1.069 . . . . 0.0 108.799 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.8 136.56 52.86 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.933 1.693 . . . . 0.0 106.736 166.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 pt -144.39 148.65 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.4 ptp -96.8 138.25 34.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.5 m -129.43 164.71 23.08 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.659 0.784 . . . . 0.0 109.533 -170.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -75.49 -32.08 60.43 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.469 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -143.18 -177.24 5.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.6 t -84.1 7.62 18.14 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.312 1.045 . . . . 0.0 111.442 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -126.84 93.37 42.34 Favored Pre-proline 0 N--CA 1.447 -0.581 0 C-N-CA 125.317 1.447 . . . . 0.0 111.164 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.18 -14.25 40.67 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.629 1.553 . . . . 0.0 113.271 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -68.2 -40.57 82.15 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 119.146 0.885 . . . . 0.0 110.612 172.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -120.47 13.96 11.87 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.63 129.28 9.47 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 163.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.64 93.15 5.45 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 176.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.1 m -80.21 157.68 26.45 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.339 0.7 OUTLIER -96.16 102.6 14.42 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 122.99 1.376 . . . . 0.0 111.683 170.192 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -83.7 50.27 1.77 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 129.688 3.195 . . . . 0.0 107.329 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -117.45 176.52 5.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -166.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -63.8 143.71 57.63 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -164.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -131.04 -29.45 1.86 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.873 2.869 . . . . 0.0 111.38 -162.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -99.62 -163.95 1.08 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -172.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t30 85.27 -57.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.207 1.803 . . . . 0.0 113.669 161.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.65 156.63 4.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.238 0.472 . . . . 0.0 111.433 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -31.44 116.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 129.002 2.921 . . . . 0.0 113.849 169.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.46 150.29 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 126.354 1.861 . . . . 0.0 108.378 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.32 145.0 20.22 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.882 1.706 . . . . 0.0 111.498 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -131.81 157.26 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.662 1.585 . . . . 0.0 109.047 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.53 -166.73 39.92 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 165.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 72.0 78.37 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.078 2.151 . . . . 0.0 115.104 164.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 68.26 4.49 4.2 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.439 1.896 . . . . 0.0 110.671 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.8 t -82.42 115.54 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -146.66 38.62 1.03 Allowed 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 122.857 0.463 . . . . 0.0 111.805 163.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -144.81 138.68 27.25 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -116.83 130.12 56.51 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 168.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.78 120.08 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.16 148.72 31.26 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.385 1.074 . . . . 0.0 108.745 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.94 -149.79 21.8 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.626 162.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.67 40.6 7.64 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.204 1.383 . . . . 0.0 111.265 -175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 p -124.49 -82.71 0.64 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.209 1.504 . . . . 0.0 108.081 174.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 p -150.35 -75.52 0.15 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 160.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -155.34 -176.59 6.02 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.137 2.175 . . . . 0.0 107.166 168.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.07 23.91 53.82 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.555 1.074 . . . . 0.0 112.972 161.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -135.35 47.96 2.28 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.396 1.479 . . . . 0.0 110.949 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -50.18 155.87 0.9 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.497 170.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.97 -178.51 30.23 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 106.727 -2.549 . . . . 0.0 106.727 165.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.6 m -137.76 147.99 45.19 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.259 1.023 . . . . 0.0 110.404 -171.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.54 135.79 51.62 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.681 168.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.4 m -83.51 109.2 17.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 162.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.8 mt -95.06 143.78 11.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 22.0 m-90 -126.11 156.33 40.23 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.529 1.132 . . . . 0.0 112.799 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.98 -47.69 28.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.907 1.683 . . . . 0.0 111.281 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.54 159.48 30.26 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -82.05 54.45 2.5 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.288 -1.125 . . . . 0.0 111.174 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.46 75.35 0.22 Allowed Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -167.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.409 ' HA ' ' CG ' ' A' ' 53' ' ' TRP . 26.0 p 50.46 38.54 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 159.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.13 176.21 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 125.067 1.347 . . . . 0.0 107.588 163.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.48 -156.7 32.2 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -68.24 153.25 44.12 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.478 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 10.5 p -129.87 166.49 19.87 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 124.468 1.105 . . . . 0.0 111.52 161.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.45 156.77 47.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 159.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.8 p -103.35 80.37 1.81 Allowed 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 135.09 34.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -169.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.4 m -128.1 134.27 49.12 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -173.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.79 114.26 11.03 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.626 -170.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -62.86 165.28 16.64 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.661 2.241 . . . . 0.0 114.748 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.74 53.67 1.67 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.933 1.293 . . . . 0.0 113.713 -162.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 p30 157.54 14.24 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.606 2.762 . . . . 0.0 110.434 -167.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.1 m -104.98 136.45 44.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.04 127.14 37.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 160.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.7 m -121.63 136.68 54.94 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.918 1.687 . . . . 0.0 107.59 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -90.29 113.89 25.83 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.793 0.837 . . . . 0.0 111.408 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.3 mp -84.84 66.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 124.609 1.163 . . . . 0.0 108.535 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -130.86 73.82 1.56 Allowed 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 163.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.43 177.48 5.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 176.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.26 -30.66 71.55 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -80.68 155.74 26.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 163.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.29 158.45 34.0 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.66 123.98 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -169.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -136.89 -13.14 1.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 p -154.55 171.14 19.91 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.512 -0.742 . . . . 0.0 110.459 166.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -164.52 170.27 16.08 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -153.23 144.64 23.23 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 158.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -67.94 134.1 50.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 123.623 0.577 . . . . 0.0 109.772 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.39 -30.97 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.052 0.941 . . . . 0.0 111.668 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -137.27 81.36 1.87 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 -165.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.77 -173.21 34.75 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.434 1.493 . . . . 0.0 112.811 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -159.28 178.31 10.11 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.6 tt -158.41 111.6 2.38 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.199 0.999 . . . . 0.0 109.046 168.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.9 pt -120.3 163.08 18.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 124.207 1.003 . . . . 0.0 111.248 -173.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.09 152.3 18.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.238 1.415 . . . . 0.0 107.803 164.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.0 m -143.23 165.49 27.32 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.256 0.622 . . . . 0.0 109.757 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -79.07 -21.84 46.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.787 0.835 . . . . 0.0 112.476 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.49 172.25 18.87 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.34 3.86 1.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.882 1.273 . . . . 0.0 113.123 -175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -104.86 99.77 20.58 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.504 1.522 . . . . 0.0 109.961 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.12 -19.36 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.551 2.167 . . . . 0.0 112.275 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -70.72 -49.21 49.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.189 0.595 . . . . 0.0 109.566 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -127.69 16.4 6.95 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.7 -28.17 72.16 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 119.219 -2.176 . . . . 0.0 112.368 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 m 55.12 93.21 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -159.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.0 m -126.53 141.65 51.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -160.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.255 1.3 p-10 -85.15 102.71 13.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.475 1.131 . . . . 0.0 110.577 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -83.04 47.68 1.26 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.816 2.446 . . . . 0.0 107.375 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -96.71 172.14 8.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.96 1.704 . . . . 0.0 109.031 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.01 144.34 34.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -146.58 27.25 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.555 0.742 . . . . 0.0 112.345 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -100.16 114.5 27.95 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.098 0.959 . . . . 0.0 109.544 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 50.31 53.92 12.04 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.726 0.774 . . . . 0.0 110.127 174.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.9 t -148.23 138.67 22.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.0 t -67.23 99.49 0.7 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.315 1.446 . . . . 0.0 108.205 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.9 t -128.99 118.96 48.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.417 0.687 . . . . 0.0 109.456 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.2 135.19 23.8 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 125.683 1.611 . . . . 0.0 111.235 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.2 mt -84.14 159.82 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.796 2.038 . . . . 0.0 106.903 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 179.2 164.59 32.06 Favored Glycine 0 N--CA 1.449 -0.451 0 O-C-N 121.403 -0.811 . . . . 0.0 113.35 164.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.1 74.7 0.22 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.161 2.185 . . . . 0.0 113.983 166.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 67.71 3.58 3.51 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.631 2.372 . . . . 0.0 110.902 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.5 t -79.21 99.58 3.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 O-C-N 121.153 -0.967 . . . . 0.0 109.681 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -143.87 43.01 1.46 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.797 1.639 . . . . 0.0 109.226 170.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -139.34 139.26 37.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.05 136.99 45.98 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 164.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.34 117.51 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.2 p -94.74 160.98 14.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.24 25.71 1.56 Allowed Glycine 0 C--O 1.221 -0.687 0 C-N-CA 124.483 1.04 . . . . 0.0 113.597 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.11 45.08 2.22 Favored Glycine 0 C--N 1.312 -0.768 0 C-N-CA 129.179 3.276 . . . . 0.0 110.821 -168.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.8 t 50.09 -149.56 0.26 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.703 2.001 . . . . 0.0 109.204 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -90.65 -66.5 0.92 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 163.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.24 50.84 2.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.911 1.684 . . . . 0.0 108.653 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.07 29.1 3.56 Favored Glycine 0 CA--C 1.524 0.613 0 O-C-N 121.295 -0.878 . . . . 0.0 111.637 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.1 mttt 53.48 161.01 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -63.24 143.61 57.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.297 159.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.05 157.12 15.24 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-O 117.167 -1.907 . . . . 0.0 108.685 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 38.2 m -139.47 151.33 46.11 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 121.136 2.468 . . . . 0.0 108.561 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.26 140.16 52.04 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 124.642 1.177 . . . . 0.0 108.479 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.2 m -83.9 119.9 25.43 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 159.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 mt -97.19 147.87 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 126.398 1.879 . . . . 0.0 106.082 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.405 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 3.1 m-90 -125.27 158.2 34.72 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.105 1.762 . . . . 0.0 111.096 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -93.43 -34.02 13.6 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 125.086 1.354 . . . . 0.0 111.581 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.07 138.77 37.33 Favored Glycine 0 CA--C 1.523 0.57 0 O-C-N 120.454 -1.404 . . . . 0.0 110.074 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -70.57 75.44 0.58 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.746 1.219 . . . . 0.0 110.325 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.57 -65.14 0.16 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 21.2 p 156.66 41.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 129.824 3.249 . . . . 0.0 110.792 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 m -125.8 176.4 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.967 1.307 . . . . 0.0 108.023 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.87 -151.53 27.65 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -77.01 152.37 35.19 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.988 1.315 . . . . 0.0 108.011 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.405 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -152.84 151.45 30.43 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.622 0.576 . . . . 0.0 112.47 -167.166 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -145.06 138.69 26.87 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -85.02 99.85 11.29 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.333 0.653 . . . . 0.0 110.273 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -88.37 124.95 34.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 99.3 m -110.02 139.47 45.1 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.9 t -132.47 136.22 27.58 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.15 -0.929 . . . . 0.0 109.768 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.53 -179.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.334 2.689 . . . . 0.0 114.484 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.23 155.84 37.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.22 167.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 33.95 57.6 0.6 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.783 2.033 . . . . 0.0 114.134 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 t -154.71 165.73 35.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.883 0.849 . . . . 0.0 110.75 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.84 139.22 34.83 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.814 2.446 . . . . 0.0 109.478 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.9 m -131.77 135.96 47.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.613 1.565 . . . . 0.0 107.127 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -85.62 114.8 22.89 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.254 0.934 . . . . 0.0 110.731 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.77 72.74 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 108.817 -174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -110.57 152.43 26.44 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 158.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.2 p -144.66 -159.73 1.04 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.074 0.852 . . . . 0.0 108.822 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.49 -15.56 79.1 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.434 -0.648 . . . . 0.0 112.882 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -136.39 163.22 30.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 118.859 1.33 . . . . 0.0 108.687 173.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -69.21 133.82 48.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.37 129.78 54.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.04 0.936 . . . . 0.0 109.471 -162.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -123.96 -29.01 3.7 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -162.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.1 169.71 20.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 117.789 -1.1 . . . . 0.0 110.439 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -157.61 163.62 38.1 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 120.132 1.333 . . . . 0.0 112.906 169.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -125.25 128.65 48.62 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.608 1.963 . . . . 0.0 108.158 161.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.9 mmm-85 -58.86 134.23 56.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 161.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.42 -50.6 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -170.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . 0.357 15.9 pt-20 . . . . . 0 N--CA 1.429 -1.475 1 C-N-CA 132.926 4.491 . . . . 0.0 111.433 158.297 . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.814 0 CA-C-O 119.637 -0.535 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.46 -64.26 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.705 0.753 . . . . 0.0 111.061 -159.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.93 -168.09 0.43 Allowed Glycine 0 CA--C 1.532 1.096 0 CA-C-O 122.112 0.84 . . . . 0.0 111.022 159.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -176.59 -177.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 -162.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 tt -140.34 131.49 26.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.59 146.46 18.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.393 1.077 . . . . 0.0 109.426 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -95.02 141.85 28.19 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.24 0.616 . . . . 0.0 110.005 167.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.9 m -134.56 152.45 51.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.599 1.16 . . . . 0.0 108.555 -172.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -78.66 -16.65 57.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -143.82 -167.93 2.72 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.622 1.169 . . . . 0.0 109.331 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 40.2 t -90.27 4.01 51.93 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.666 0.786 . . . . 0.0 112.887 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -105.0 106.79 56.87 Favored Pre-proline 0 C--N 1.331 -0.217 0 C-N-CA 123.989 0.916 . . . . 0.0 109.319 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.38 -23.86 75.37 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 CA-C-N 120.009 1.039 . . . . 0.0 111.946 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -71.2 -63.93 1.01 Allowed 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 122.045 -0.409 . . . . 0.0 110.343 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -109.99 13.22 23.44 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.94 -30.5 59.26 Favored Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m 70.15 110.75 0.05 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -159.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.5 m -122.5 146.04 47.76 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.35 107.82 20.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.614 1.197 . . . . 0.0 110.806 169.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -83.72 48.32 1.42 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.669 2.388 . . . . 0.0 107.276 174.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -92.83 153.91 18.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.81 142.94 57.18 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 173.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -146.88 19.49 1.28 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.376 1.071 . . . . 0.0 112.307 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -95.13 129.43 42.23 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -166.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 53.31 43.94 30.78 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.129 0.572 . . . . 0.0 110.099 172.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 t -159.87 163.69 34.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.171 -0.956 . . . . 0.0 110.631 -170.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 54.1 t -92.79 96.0 9.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.97 2.108 . . . . 0.0 110.07 -166.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -111.99 104.12 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 119.373 0.988 . . . . 0.0 111.072 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.48 127.76 37.61 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 167.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.2 mt -84.05 156.86 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.327 2.251 . . . . 0.0 106.013 166.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.66 -166.29 22.27 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.281 . . 34.02 75.13 0.05 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 47.41 22.5 0.28 Allowed 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 125.099 1.359 . . . . 0.0 112.282 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.76 118.06 18.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 119.391 -0.924 . . . . 0.0 108.963 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.28 37.45 1.25 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.743 0.817 . . . . 0.0 111.025 171.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -142.88 134.24 26.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 45.4 ttm -113.47 127.34 56.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 165.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -123.64 91.11 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 t -108.3 155.46 20.48 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.603 0.716 . . . . 0.0 111.473 -158.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.46 -153.03 0.73 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 125.845 1.688 . . . . 0.0 112.764 -175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.05 13.12 0.61 Allowed Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.815 -0.991 . . . . 0.0 111.999 -175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 44' ' ' ASP 0.267 1.1 t -147.78 92.78 2.11 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.1 1.45 . . . . 0.0 110.027 -170.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 55.5 -10.32 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.84 2.056 . . . . 0.0 112.439 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -80.59 85.84 5.94 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.538 1.535 . . . . 0.0 107.871 -171.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.14 -0.47 82.85 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.637 158.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -82.41 105.59 13.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.21 -1.171 . . . . 0.0 108.865 169.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -57.28 169.69 0.57 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.018 1.327 . . . . 0.0 113.018 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -129.88 158.67 22.37 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 62.2 m -143.69 155.67 44.29 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 117.88 0.84 . . . . 0.0 109.118 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.43 148.14 40.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.875 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -84.03 144.54 29.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 162.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -127.19 152.11 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.441 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 21.8 m-90 -133.6 149.98 51.61 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.218 1.372 . . . . 0.0 112.916 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.69 -54.39 23.61 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.658 1.183 . . . . 0.0 109.067 164.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.38 124.63 11.15 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -168.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.54 67.49 0.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.448 3.099 . . . . 0.0 112.552 -162.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.69 -55.12 0.08 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 127.391 2.424 . . . . 0.0 107.919 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 20.0 p 163.65 50.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 130.544 3.538 . . . . 0.0 108.641 166.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.99 176.65 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.979 1.712 . . . . 0.0 108.281 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.79 -157.41 51.54 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.69 132.37 34.87 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 117.691 0.745 . . . . 0.0 109.017 -166.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.441 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 10.1 p -113.64 157.23 22.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 123.598 0.561 . . . . 0.0 112.428 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.83 -177.76 4.58 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 127.352 2.261 . . . . 0.0 106.856 174.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 t -135.15 136.86 42.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -142.32 114.78 8.44 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.044 0.538 . . . . 0.0 110.013 -173.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.7 m -96.05 143.22 27.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.819 1.248 . . . . 0.0 109.557 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.7 t -141.9 123.97 9.1 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.259 1.423 . . . . 0.0 110.511 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.87 145.6 72.15 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.225 1.95 . . . . 0.0 111.506 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.31 140.04 46.48 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 161.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 74.11 45.21 0.22 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -170.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -154.62 144.38 21.6 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 171.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.89 125.19 36.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.424 1.49 . . . . 0.0 108.086 164.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 55.6 m -116.21 136.8 52.69 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 124.905 1.282 . . . . 0.0 109.179 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -98.69 110.83 23.36 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.156 0.982 . . . . 0.0 109.55 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -82.75 96.29 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 122.167 0.984 . . . . 0.0 108.767 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.52 158.08 44.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 163.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.3 p -132.77 -150.1 0.4 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 167.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.31 -28.73 67.48 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 164.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -125.89 165.05 19.44 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.297 1.039 . . . . 0.0 110.082 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -80.58 137.39 36.38 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.64 148.89 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.107 0.963 . . . . 0.0 109.957 -170.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -134.97 -3.67 2.49 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 124.364 1.065 . . . . 0.0 113.333 -170.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.85 164.1 31.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 164.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -144.32 171.79 13.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.104 0.961 . . . . 0.0 112.267 166.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.46 123.88 10.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.52 1.928 . . . . 0.0 106.027 169.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -70.28 138.74 51.83 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 119.199 0.909 . . . . 0.0 109.01 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -104.69 -42.08 7.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 125.04 1.336 . . . . 0.0 110.873 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -177.615 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.299 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -118.92 85.41 2.36 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.658 1.183 . . . . 0.0 108.289 -173.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.34 141.94 48.16 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 160.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -169.03 -174.32 2.01 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.958 1.703 . . . . 0.0 107.448 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tt -141.57 103.14 4.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.71 161.13 39.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.4 ptp -125.61 154.46 42.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 122.619 1.2 . . . . 0.0 111.284 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -135.78 169.56 17.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.108 1.763 . . . . 0.0 107.261 -163.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -24.61 42.31 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 166.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -139.19 -176.63 4.58 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 172.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.8 t -83.28 3.61 30.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.869 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -113.11 113.95 48.92 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.942 0.897 . . . . 0.0 109.304 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.73 -39.23 21.17 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 120.997 1.392 . . . . 0.0 110.806 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -69.96 -34.01 72.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.482 1.913 . . . . 0.0 111.09 -165.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.8 t -135.46 15.03 3.45 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.37 -46.65 5.18 Favored Glycine 0 CA--C 1.519 0.309 0 O-C-N 120.463 -1.398 . . . . 0.0 110.755 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t 82.04 124.79 0.04 OUTLIER 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.605 1.562 . . . . 0.0 108.552 -166.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.85 170.75 11.32 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.059 1.743 . . . . 0.0 110.448 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -90.31 94.02 9.57 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 123.164 1.459 . . . . 0.0 113.122 165.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -83.43 45.68 1.07 Allowed 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.724 -1.235 . . . . 0.0 108.428 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -85.77 163.96 17.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.74 1.616 . . . . 0.0 109.592 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -70.98 143.34 50.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 161.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -137.3 -44.44 0.55 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -167.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -48.21 113.94 0.84 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.592 1.557 . . . . 0.0 109.614 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 55.85 19.51 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.403 1.481 . . . . 0.0 112.667 174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.34 179.76 3.86 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -175.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.0 t -149.36 74.85 1.26 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 121.183 1.811 . . . . 0.0 109.96 -166.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 t -83.81 163.94 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -166.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.73 115.81 5.21 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 124.631 1.11 . . . . 0.0 111.103 163.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.11 152.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 126.36 1.864 . . . . 0.0 107.551 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.92 -165.52 38.98 Favored Glycine 0 N--CA 1.444 -0.801 0 O-C-N 121.649 -0.657 . . . . 0.0 111.84 167.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 71.09 73.15 0.19 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.687 2.395 . . . . 0.0 113.548 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 61.11 11.27 3.35 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.568 1.547 . . . . 0.0 110.777 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.6 t -73.6 108.84 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -146.63 34.61 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 170.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -140.71 113.62 8.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.309 0.959 . . . . 0.0 111.756 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.3 ttp -84.07 138.92 32.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.06 101.54 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.2 p -93.6 49.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.429 -0.794 . . . . 0.0 111.595 -159.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.56 -155.3 16.18 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -171.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.53 -38.53 0.02 OUTLIER Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.395 0.998 . . . . 0.0 111.8 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 m -23.83 -92.6 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 128.01 2.524 . . . . 0.0 116.123 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -155.94 -89.36 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . 0.255 0.5 OUTLIER -123.7 178.82 5.04 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 101.517 -3.512 . . . . 0.0 101.517 160.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.86 -76.22 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 105.867 -2.893 . . . . 0.0 105.867 159.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.42 146.47 10.23 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 127.761 2.425 . . . . 0.0 106.744 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -59.51 164.78 3.24 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.0 132.68 8.73 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 170.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 86.0 m -132.99 149.14 52.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.9 140.5 16.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.67 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.8 m -86.66 117.3 25.33 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 166.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 mm -99.47 149.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -130.57 160.34 34.47 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.315 1.446 . . . . 0.0 112.002 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -89.49 -35.34 16.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.087 2.155 . . . . 0.0 111.322 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.75 144.48 38.49 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -76.75 64.02 2.26 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.93 33.73 0.02 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.26 27.9 p 44.65 42.4 5.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.557 1.543 . . . . 0.0 112.226 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -126.18 176.34 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 126.729 2.012 . . . . 0.0 107.695 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.17 -156.93 32.93 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -69.46 153.16 43.95 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.53 168.81 22.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.21 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.93 149.73 26.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.45 106.54 17.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -91.34 83.92 5.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.0 m -84.0 139.42 32.55 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 18.9 t -145.16 142.11 17.99 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 125.122 1.369 . . . . 0.0 109.446 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.33 177.27 2.16 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.974 1.782 . . . . 0.0 111.384 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.55 149.11 42.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.168 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 50.67 38.53 19.37 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.038 1.335 . . . . 0.0 110.094 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.4 m -115.52 137.3 52.21 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -98.17 114.09 26.2 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.26 106.01 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.84 2.056 . . . . 0.0 107.823 -162.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -64.42 136.15 56.81 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.887 0.851 . . . . 0.0 110.637 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 mm -101.86 117.45 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.79 65.57 1.05 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.5 p -73.94 161.79 29.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.269 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -54.14 -52.88 40.78 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -80.64 157.55 25.93 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.527 0.68 . . . . 0.0 110.62 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -76.15 134.43 39.95 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.893 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.09 132.79 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -168.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -135.93 -27.81 1.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -173.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 p -152.69 171.87 17.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.563 0.619 . . . . 0.0 111.251 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -156.32 170.06 23.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.633 0.651 . . . . 0.0 111.157 176.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -140.2 147.1 39.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.496 1.918 . . . . 0.0 109.31 159.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -63.58 163.53 11.04 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.624 0.769 . . . . 0.0 110.607 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.09 -36.51 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 117.809 0.277 . . . . 0.0 110.458 159.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 163.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.634 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . 0.293 0.1 OUTLIER 63.19 -52.66 0.2 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 129.372 3.069 . . . . 0.0 116.508 159.19 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.61 -178.07 9.0 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 163.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -172.83 -179.13 2.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -168.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.94 88.59 2.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 159.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pt -108.3 162.47 6.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 169.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 ptm -108.24 167.94 9.66 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.493 1.139 . . . . 0.0 110.118 161.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.2 m -153.58 163.22 40.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 124.5 1.12 . . . . 0.0 108.496 -158.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -85.58 -21.37 28.54 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -133.58 -175.15 3.73 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.811 0.444 . . . . 0.0 111.267 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.1 t -92.13 3.46 55.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.307 1.043 . . . . 0.0 111.811 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -132.98 88.71 36.2 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 126.011 1.725 . . . . 0.0 110.088 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -48.76 -26.77 10.06 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.203 3.268 . . . . 0.0 113.293 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -64.3 -44.32 91.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.46 -0.775 . . . . 0.0 111.495 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.7 p -104.13 13.83 31.65 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.65 135.3 7.48 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 123.966 0.793 . . . . 0.0 112.898 172.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -63.75 137.78 58.21 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.086 -0.655 . . . . 0.0 109.821 169.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -130.39 157.21 43.22 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 125.372 1.469 . . . . 0.0 107.317 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -85.07 93.43 8.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 123.677 1.704 . . . . 0.0 110.821 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -83.87 50.93 1.92 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.658 1.983 . . . . 0.0 107.122 169.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -119.23 -174.1 2.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.88 1.672 . . . . 0.0 108.255 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.11 143.12 50.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 167.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -146.5 5.69 0.93 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.693 -166.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.411 ' CG ' ' N ' ' A' ' 25' ' ' ASN . 19.8 t-105 -78.07 -163.63 0.45 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -165.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' N ' ' CG ' ' A' ' 24' ' ' TRP . 15.0 t-20 -68.31 61.55 0.09 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.526 2.731 . . . . 0.0 110.411 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 t -141.93 149.79 40.61 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 127.477 2.311 . . . . 0.0 105.692 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.2 t -72.56 69.8 0.89 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.433 1.493 . . . . 0.0 111.706 -164.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.3 t -93.42 124.84 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.125 0.97 . . . . 0.0 109.53 -165.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.77 132.39 11.34 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -83.71 153.3 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 169.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.13 158.52 29.86 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 68.87 69.38 0.28 Allowed 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 127.343 2.257 . . . . 0.0 115.835 169.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 49.84 19.26 0.42 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.596 1.159 . . . . 0.0 112.304 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.45 110.86 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -146.26 26.42 1.19 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.939 0.895 . . . . 0.0 112.771 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -138.56 121.45 16.58 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.295 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.1 tpp -83.62 134.7 34.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -131.05 120.21 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.1 p -104.14 45.37 0.96 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.184 0.993 . . . . 0.0 109.975 -159.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.06 -154.73 35.66 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.58 22.42 0.22 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.56 -56.78 2.31 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.521 0.728 . . . . 0.0 109.339 -174.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t 125.63 -40.33 0.01 OUTLIER 'General case' 0 C--O 1.232 0.171 0 C-N-CA 130.504 3.522 . . . . 0.0 108.422 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.88 34.14 0.39 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.171 1.388 . . . . 0.0 110.598 -166.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.88 -22.67 15.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 168.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm 68.0 157.11 0.13 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.044 2.138 . . . . 0.0 112.35 -165.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -53.96 146.19 14.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.564 1.146 . . . . 0.0 111.739 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.43 136.21 10.3 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 59.0 m -122.8 149.76 43.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.01 136.83 21.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.633 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.6 m -89.45 117.38 28.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 170.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.1 mt -106.53 137.92 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.028 1.731 . . . . 0.0 107.049 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 5.0 m-90 -122.14 160.63 24.69 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.54 1.536 . . . . 0.0 112.7 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -91.79 -33.89 14.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.494 2.318 . . . . 0.0 111.236 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.41 128.02 9.44 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 124.668 1.128 . . . . 0.0 111.736 -169.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -44.29 121.31 2.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.814 2.046 . . . . 0.0 112.087 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.38 -60.56 0.59 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 126.574 2.035 . . . . 0.0 109.593 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 30.6 p 168.94 43.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.385 1.874 . . . . 0.0 111.472 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 m -120.41 176.75 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.36 -157.93 28.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -73.59 158.57 34.55 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 126.246 1.818 . . . . 0.0 108.161 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.4 p -159.18 160.68 35.75 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.987 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.0 p -142.67 149.9 39.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.1 t -91.17 128.24 36.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -119.95 116.04 24.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.924 1.69 . . . . 0.0 108.491 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 11.5 m -98.09 146.73 25.26 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.516 0.726 . . . . 0.0 109.77 173.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.2 t -149.41 136.85 11.24 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.405 1.082 . . . . 0.0 111.01 173.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.88 177.75 3.32 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.912 1.741 . . . . 0.0 112.213 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.4 175.24 7.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 37.73 54.1 1.51 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 126.071 1.748 . . . . 0.0 112.265 171.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.24 168.44 25.98 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.923 0.868 . . . . 0.0 108.948 175.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.18 134.34 52.85 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.705 2.002 . . . . 0.0 107.244 172.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.83 118.16 20.38 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -169.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -78.55 122.94 26.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.951 -0.468 . . . . 0.0 110.013 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -102.42 104.19 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 169.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.05 69.86 1.26 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 169.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 p -74.01 176.01 6.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.238 1.815 . . . . 0.0 110.58 -162.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.99 -41.59 92.42 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -93.72 164.18 13.24 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.768 0.827 . . . . 0.0 110.545 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -80.93 133.82 35.61 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.85 129.89 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.086 0.554 . . . . 0.0 110.039 -169.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ttt85 -136.54 -13.2 1.76 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -172.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.84 169.32 16.76 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.454 -0.779 . . . . 0.0 111.708 -173.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -166.9 171.79 10.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.463 0.649 . . . . 0.0 112.46 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . 0.295 0.0 OUTLIER -137.56 135.83 37.04 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 129.281 3.033 . . . . 0.0 105.227 170.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -64.5 159.19 22.09 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 158.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.09 -41.54 3.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 119.351 0.978 . . . . 0.0 111.171 163.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 172.988 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.769 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 64.2 -74.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.677 2.391 . . . . 0.0 110.819 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.33 169.25 1.74 Allowed Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 125.208 1.385 . . . . 0.0 111.748 -159.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -176.15 168.7 2.87 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -170.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -150.01 103.98 3.25 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 pt -153.1 159.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.335 1.854 . . . . 0.0 107.843 -167.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.7 ptm -106.55 147.2 29.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.946 0.898 . . . . 0.0 110.088 166.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.87 162.31 18.32 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -62.86 -37.47 86.97 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 116.347 -2.141 . . . . 0.0 109.936 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -122.15 -171.25 2.21 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 126.831 2.053 . . . . 0.0 109.143 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 50.8 t -78.47 3.23 16.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -118.3 114.52 36.54 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 121.269 -0.894 . . . . 0.0 113.166 -164.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.67 -23.48 56.36 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 120.932 1.088 . . . . 0.0 111.834 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -64.54 -63.11 1.21 Allowed 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.448 1.022 . . . . 0.0 110.221 -176.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -118.92 13.76 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.9 -19.38 78.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.456 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.9 m 58.33 93.22 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -160.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -98.04 145.31 26.65 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -91.61 98.88 11.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.536 1.16 . . . . 0.0 109.474 172.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -83.38 45.56 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.801 2.04 . . . . 0.0 107.995 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.54 -177.68 6.79 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.373 1.469 . . . . 0.0 110.198 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -63.71 150.36 44.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 163.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -139.86 -15.7 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.029 0.932 . . . . 0.0 111.894 176.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -91.08 112.98 25.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 48.72 64.52 1.67 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.709 1.203 . . . . 0.0 110.044 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.21 -178.61 4.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.81 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.3 t -154.41 54.61 0.69 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -94.7 129.98 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 125.395 1.478 . . . . 0.0 109.384 -170.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.15 126.58 7.77 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.783 0.706 . . . . 0.0 112.41 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 mm -107.14 166.24 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 130.406 3.482 . . . . 0.0 108.426 -174.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.85 175.88 25.62 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 165.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 91.32 79.89 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 129.763 3.225 . . . . 0.0 112.343 174.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 80.61 6.96 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 129.34 3.056 . . . . 0.0 110.819 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -83.99 118.49 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 CA-C-N 118.912 0.778 . . . . 0.0 112.467 -164.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.476 ' CE1' ' HE1' ' A' ' 36' ' ' TRP . 4.4 p80 -146.55 35.53 0.96 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 163.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.476 ' HE1' ' CE1' ' A' ' 35' ' ' HIS . 74.6 m95 -140.67 124.47 17.16 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.148 1.34 . . . . 0.0 112.224 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.1 tpt -84.89 131.14 34.54 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 161.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.47 85.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -172.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 t -93.95 143.89 25.94 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.26 176.86 37.11 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 124.493 1.044 . . . . 0.0 111.286 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.64 -35.85 39.59 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 122.756 -0.261 . . . . 0.0 112.678 -171.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.11 -150.97 0.47 Allowed 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 122.798 0.439 . . . . 0.0 111.666 -168.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 85.94 -54.68 0.07 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 127.677 2.391 . . . . 0.0 105.985 174.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -105.88 151.55 24.4 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 159.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.95 -13.71 57.4 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 123.8 0.714 . . . . 0.0 111.349 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -124.47 164.6 19.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -53.03 144.46 15.12 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.56 153.6 16.9 Favored Glycine 0 C--O 1.239 0.442 0 N-CA-C 107.078 -2.409 . . . . 0.0 107.078 167.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.6 m -126.52 144.23 50.94 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.93 126.68 49.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.0 m -83.59 118.88 24.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 168.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 mt -96.65 150.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 -129.08 157.85 40.59 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.984 1.714 . . . . 0.0 111.549 -175.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -82.42 -44.28 16.26 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.09 2.156 . . . . 0.0 111.636 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.81 135.15 21.33 Favored Glycine 0 N--CA 1.449 -0.494 0 O-C-N 120.999 -1.063 . . . . 0.0 111.098 -173.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.1 m -54.48 102.54 0.06 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.587 0.755 . . . . 0.0 109.979 171.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.53 -75.92 0.4 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 24.0 p 158.69 42.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 128.692 2.797 . . . . 0.0 110.397 -174.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.38 176.28 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.33 -167.19 44.81 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 119.615 1.098 . . . . 0.0 110.592 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -73.84 149.57 41.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.497 -1.002 . . . . 0.0 108.874 -170.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.9 161.34 40.94 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.103 -163.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.53 117.05 4.66 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -167.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.5 m -71.55 100.25 2.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.317 0.647 . . . . 0.0 109.51 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.8 tpp -84.04 103.56 13.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.655 1.182 . . . . 0.0 107.836 172.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 50.7 m -84.7 146.45 27.43 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.3 t -155.53 108.31 2.2 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.447 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.2 162.13 14.82 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.844 2.363 . . . . 0.0 113.297 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.53 137.94 44.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 58.76 48.56 11.23 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.348 1.859 . . . . 0.0 110.853 -166.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m -124.44 116.81 23.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.314 0.578 . . . . 0.0 109.99 170.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.406 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -74.35 114.11 12.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 158.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.2 m -116.2 123.84 48.78 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.286 1.834 . . . . 0.0 107.922 -172.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -78.24 132.49 37.56 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 118.454 0.57 . . . . 0.0 110.364 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.407 ' N ' ' CD1' ' A' ' 75' ' ' ILE . 1.2 mp -98.35 107.54 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -123.52 144.63 49.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 p -142.35 -161.93 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 175.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.39 15.58 57.41 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.073 168.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.7 169.97 17.42 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 119.075 1.437 . . . . 0.0 109.425 -173.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -70.51 133.98 47.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 170.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.61 128.75 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.19 -46.97 0.64 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.559 -158.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -133.06 175.89 8.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 119.758 1.163 . . . . 0.0 110.424 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -160.64 163.86 32.25 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 119.779 1.172 . . . . 0.0 113.34 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.06 127.77 10.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 169.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -66.1 115.87 6.59 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.53 -39.33 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 C-N-CA 124.612 1.165 . . . . 0.0 110.047 -168.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.92 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.487 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.69 63.49 0.85 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.243 1.817 . . . . 0.0 111.897 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.14 161.37 34.33 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 118.847 -0.974 . . . . 0.0 112.742 164.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -119.04 -174.16 2.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 170.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 tt -140.98 117.71 11.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.211 1.404 . . . . 0.0 108.266 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.27 165.95 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 123.783 0.833 . . . . 0.0 110.077 174.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.6 ptm -105.51 142.39 35.34 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 108.541 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -138.46 158.53 44.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.651 1.181 . . . . 0.0 108.935 -165.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -82.57 -5.88 59.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.63 -172.44 3.12 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.219 1.408 . . . . 0.0 108.149 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.7 t -86.43 3.57 43.26 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.594 0.757 . . . . 0.0 112.081 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -128.43 105.71 19.35 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 118.754 -0.641 . . . . 0.0 111.574 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -58.14 -24.89 68.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.513 1.476 . . . . 0.0 111.581 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -63.83 -27.69 69.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.223 -0.923 . . . . 0.0 110.953 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.0 t -138.79 23.23 2.65 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.352 0.661 . . . . 0.0 111.338 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.05 123.7 5.98 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 164.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.14 94.59 4.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 171.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.5 m -92.44 149.77 21.19 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -171.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -96.29 98.9 10.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.798 0.808 . . . . 0.0 111.462 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -83.77 44.83 1.02 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 130.028 3.331 . . . . 0.0 111.304 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -101.28 174.13 6.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.748 1.219 . . . . 0.0 110.057 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -65.04 143.82 57.68 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.496 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.27 -27.35 8.71 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.931 1.292 . . . . 0.0 109.913 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -84.52 143.28 29.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.785 1.634 . . . . 0.0 106.812 -177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 44.92 43.57 7.23 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.818 1.647 . . . . 0.0 111.527 171.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 t -162.98 149.31 12.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 167.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.4 t -115.97 84.17 2.07 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.581 1.152 . . . . 0.0 111.282 -165.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.5 t -84.8 153.63 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.119 -165.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.02 154.21 31.7 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.448 1.023 . . . . 0.0 111.63 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.4 166.15 8.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 128.103 2.561 . . . . 0.0 105.831 172.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.02 162.22 12.57 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-O 121.439 0.466 . . . . 0.0 113.117 164.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 62.51 81.48 0.2 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.466 2.307 . . . . 0.0 111.185 -175.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 66.24 3.66 2.83 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 125.919 1.687 . . . . 0.0 111.339 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.0 t -102.56 99.31 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -145.99 33.4 1.01 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.168 0.987 . . . . 0.0 111.08 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -144.45 121.84 11.65 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.0 ttm -85.4 138.77 32.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 158.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 t -134.08 150.31 31.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.6 p -129.06 -173.92 3.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.445 0.698 . . . . 0.0 109.343 -170.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.47 -152.91 20.54 Favored Glycine 0 C--O 1.221 -0.672 0 CA-C-O 118.611 -1.105 . . . . 0.0 112.445 161.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 40.0 52.06 3.36 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.655 1.598 . . . . 0.0 113.285 173.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.7 t -143.37 -152.92 0.44 Allowed 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.768 -0.842 . . . . 0.0 112.495 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.2 t -121.98 -39.63 2.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.052 1.741 . . . . 0.0 109.528 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.1 129.84 11.61 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 120.652 -1.28 . . . . 0.0 109.071 175.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.27 78.09 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -173.28 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.012 1.325 . . . . 0.0 112.143 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -43.61 143.76 0.92 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.87 0.868 . . . . 0.0 111.601 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -146.86 157.62 27.47 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -171.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.4 m -136.65 154.6 50.6 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.888 0.875 . . . . 0.0 108.869 -172.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.29 141.61 49.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.795 1.238 . . . . 0.0 109.023 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 m -83.61 116.96 22.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 159.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -94.46 145.54 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -126.28 151.61 47.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.71 1.604 . . . . 0.0 109.722 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -58.65 -40.81 84.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 124.384 1.074 . . . . 0.0 109.766 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.2 175.85 39.47 Favored Glycine 0 C--O 1.221 -0.71 0 C-N-CA 116.097 -2.954 . . . . 0.0 120.434 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.9 m 32.29 80.84 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.875 2.87 . . . . 0.0 116.314 159.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.3 43.53 95.02 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 52.55 69.25 0.71 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.062 1.345 . . . . 0.0 111.902 171.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.12 175.93 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 C-N-CA 126.743 2.017 . . . . 0.0 107.921 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.6 -160.0 53.41 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ttp-105 -76.82 156.6 32.14 Favored 'General case' 0 CA--C 1.5 -0.956 0 O-C-N 121.934 -0.744 . . . . 0.0 109.585 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.42 144.24 34.35 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.864 -172.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 p -139.93 147.24 40.25 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.065 1.346 . . . . 0.0 108.466 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 t -85.57 113.06 21.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.4 tpt -86.14 139.41 31.12 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 165.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 50.8 m -139.06 143.04 38.2 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.2 t -150.77 123.53 4.17 Favored Pre-proline 0 CA--C 1.535 0.365 0 C-N-CA 124.134 0.974 . . . . 0.0 110.026 -170.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -52.99 157.35 8.25 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.943 2.428 . . . . 0.0 110.646 168.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.8 138.57 32.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.034 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 77.04 44.47 0.1 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 125.748 1.619 . . . . 0.0 109.192 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -149.9 169.3 21.48 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 164.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.6 t -113.15 139.14 48.99 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.018 1.727 . . . . 0.0 107.751 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 24.7 m -140.96 101.63 4.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -163.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -67.67 130.39 42.87 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.795 -0.566 . . . . 0.0 110.25 176.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.13 106.88 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.302 1.841 . . . . 0.0 106.954 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -166.39 71.02 0.13 Allowed 'General case' 0 N--CA 1.461 0.107 0 O-C-N 121.7 -0.625 . . . . 0.0 109.681 176.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 p -74.4 -160.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.124 0.488 . . . . 0.0 110.471 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.8 -24.66 60.41 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 121.374 -0.829 . . . . 0.0 111.783 168.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -118.26 153.89 33.18 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.525 1.163 . . . . 0.0 109.317 169.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -73.87 141.5 46.07 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 125.806 1.942 . . . . 0.0 107.093 163.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.06 136.21 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 124.137 0.975 . . . . 0.0 109.047 -168.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -106.76 -22.27 12.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 116.975 -1.488 . . . . 0.0 112.803 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -137.16 170.7 15.65 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 122.909 2.595 . . . . 0.0 113.316 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -160.11 166.84 29.06 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.069 0.548 . . . . 0.0 109.999 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.11 145.48 28.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -71.34 149.91 45.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.085 0.954 . . . . 0.0 112.312 -170.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.6 m -137.42 -7.4 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-N 120.814 1.643 . . . . 0.0 109.299 158.66 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.628 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.85 -38.82 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.992 2.117 . . . . 0.0 108.338 172.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.7 163.79 37.14 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-O 121.803 0.668 . . . . 0.0 112.449 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -168.38 166.45 12.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.3 tt -136.22 91.51 2.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.394 1.478 . . . . 0.0 107.248 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.07 159.31 11.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.409 1.084 . . . . 0.0 109.568 174.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.72 166.85 10.82 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 126.169 1.788 . . . . 0.0 114.6 166.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 64.0 m -151.12 160.27 43.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.275 1.83 . . . . 0.0 109.555 -159.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.3 -39.42 78.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.572 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -138.98 -170.16 2.8 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 125.875 1.67 . . . . 0.0 108.056 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 t -76.05 3.59 10.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -107.04 104.32 51.5 Favored Pre-proline 0 CA--C 1.539 0.524 0 O-C-N 121.644 -0.66 . . . . 0.0 112.191 -164.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.39 -23.51 51.04 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.99 1.793 . . . . 0.0 112.27 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.52 -56.28 5.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.705 1.202 . . . . 0.0 109.648 -172.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.2 t -132.82 13.85 4.37 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 112.702 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.39 -45.91 58.57 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 168.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 t 76.9 124.63 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.264 1.426 . . . . 0.0 107.848 -164.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -136.58 140.12 42.65 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 125.633 1.573 . . . . 0.0 107.882 -164.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.254 7.5 p-10 -82.78 97.51 8.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 120.566 1.53 . . . . 0.0 110.363 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -82.74 53.23 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.901 2.08 . . . . 0.0 108.484 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -84.92 156.25 21.31 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 158.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.09 144.12 30.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 165.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -143.15 41.02 1.5 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.469 0.708 . . . . 0.0 109.347 -165.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -124.99 130.44 52.36 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -169.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 t30 51.13 55.71 9.11 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.448 0.699 . . . . 0.0 110.117 -172.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 t -160.39 146.88 15.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.761 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -79.57 71.88 6.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 128.8 2.84 . . . . 0.0 108.097 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.5 t -84.21 139.06 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 O-C-N 121.712 -0.617 . . . . 0.0 109.397 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.59 139.29 24.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.19 166.22 2.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 125.315 1.446 . . . . 0.0 107.238 168.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.27 170.07 34.77 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 57.65 100.9 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.865 2.066 . . . . 0.0 112.615 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.42 10.68 4.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.383 1.073 . . . . 0.0 112.566 169.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.19 113.1 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -146.75 18.12 1.29 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -138.31 114.14 9.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 48.1 ttp -85.4 124.75 32.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.43 94.86 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -93.97 127.49 39.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -171.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.44 -59.87 5.89 Favored Glycine 0 CA--C 1.501 -0.833 0 CA-C-O 125.938 2.966 . . . . 0.0 110.024 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.6 25.96 2.38 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 108.408 -3.896 . . . . 0.0 111.658 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.31 155.63 39.37 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 120.754 -1.439 . . . . 0.0 110.952 -172.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.262 0.1 OUTLIER 73.47 -4.18 2.29 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.562 1.145 . . . . 0.0 111.545 -167.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -111.95 122.8 48.78 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 158.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.9 -30.02 56.45 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 166.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? -63.95 136.46 57.36 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.258 0.551 . . . . 0.0 110.283 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -44.07 143.51 1.14 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.064 0.946 . . . . 0.0 110.549 164.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.89 144.0 16.85 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 170.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.7 m -138.85 152.27 47.68 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 119.382 1.591 . . . . 0.0 109.5 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.4 140.5 35.5 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.721 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.2 m -83.86 135.19 34.6 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 168.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 mt -122.82 152.7 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 27.2 m-90 -139.8 152.99 46.99 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.824 1.25 . . . . 0.0 113.997 -173.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -82.84 -39.8 21.17 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 126.591 1.956 . . . . 0.0 108.898 167.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.77 125.13 36.07 Favored Glycine 0 CA--C 1.522 0.488 0 O-C-N 119.36 -2.087 . . . . 0.0 108.987 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -67.8 107.1 2.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.71 42.21 2.35 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 125.789 1.661 . . . . 0.0 111.971 -169.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 25.6 p 45.4 46.99 10.75 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.448 1.899 . . . . 0.0 114.714 166.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 m -126.27 176.58 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 127.437 2.295 . . . . 0.0 107.843 166.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.46 -157.74 23.26 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 120.841 -1.162 . . . . 0.0 112.332 167.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -70.19 150.73 46.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.8 p -141.75 172.61 12.46 Favored 'General case' 0 N--CA 1.436 -1.158 0 O-C-N 124.023 0.827 . . . . 0.0 111.483 -166.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -144.01 -175.41 4.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 159.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 t -127.96 122.43 32.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 168.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.0 tpt -121.64 118.66 29.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 96.9 m -113.78 146.74 39.47 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.8 t -138.1 121.95 11.58 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 124.432 1.093 . . . . 0.0 108.382 -178.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.32 151.27 9.85 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.111 2.541 . . . . 0.0 112.347 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.02 143.59 47.49 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 54.84 61.63 2.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.003 1.721 . . . . 0.0 109.067 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -154.48 157.41 38.36 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.39 124.44 49.6 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 126.891 2.076 . . . . 0.0 108.957 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.4 m -129.36 113.8 15.41 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.667 1.587 . . . . 0.0 108.717 -168.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -71.2 127.24 31.93 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.551 -0.718 . . . . 0.0 110.037 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 mp -85.96 111.59 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 123.978 0.911 . . . . 0.0 108.644 174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -163.71 98.77 0.88 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 162.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.2 p -74.35 -157.53 0.06 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.03 -2.04 86.31 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.786 -1.196 . . . . 0.0 112.27 168.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -140.63 174.29 10.66 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 118.91 1.355 . . . . 0.0 108.953 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -79.78 133.65 36.32 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.89 133.3 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -167.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.7 mtt-85 -126.21 -36.31 2.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 118.328 -0.844 . . . . 0.0 113.095 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.93 163.21 33.5 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 119.482 1.037 . . . . 0.0 110.971 171.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.16 169.21 22.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.069 0.548 . . . . 0.0 111.258 165.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -157.09 126.0 5.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.183 172.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.423 HH21 ' C ' ' A' ' 88' ' ' GLU . 31.3 mtp180 -55.44 141.94 34.64 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.854 0.462 . . . . 0.0 110.763 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.4 m -96.95 -43.74 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 123.836 0.71 . . . . 0.0 109.295 163.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.423 ' C ' HH21 ' A' ' 86' ' ' ARG . 1.9 tt0 . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.063 0.945 . . . . 0.0 108.569 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.419 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.77 126.28 0.23 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.167 2.587 . . . . 0.0 104.037 -176.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.86 156.91 49.87 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -179.27 174.8 0.99 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.123 0.969 . . . . 0.0 109.791 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 tt -138.75 116.09 11.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 162.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.83 158.84 23.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 126.613 1.965 . . . . 0.0 106.134 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -121.62 175.7 6.09 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.579 0.704 . . . . 0.0 110.427 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 93.7 m -153.16 154.58 35.05 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -159.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -77.6 1.95 18.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 115.095 1.516 . . . . 0.0 115.095 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -158.97 -172.79 3.94 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 125.537 1.535 . . . . 0.0 109.416 169.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.98 3.77 32.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.698 0.761 . . . . 0.0 112.504 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -113.27 130.12 23.93 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 124.07 0.948 . . . . 0.0 110.87 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.09 -46.77 7.52 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 119.85 0.982 . . . . 0.0 109.995 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -64.01 -50.66 67.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.704 0.802 . . . . 0.0 111.069 -161.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 t -110.65 14.34 22.36 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.695 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.79 -50.04 15.54 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t 71.11 116.29 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -158.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.9 m -136.13 148.56 48.28 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.069 -158.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -93.71 93.14 7.84 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 123.704 1.716 . . . . 0.0 110.833 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -83.66 58.04 4.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 111.359 -2.655 . . . . 0.0 103.929 158.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.26 177.51 4.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 127.444 2.298 . . . . 0.0 106.582 172.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -66.98 143.31 56.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 118.557 -1.257 . . . . 0.0 107.722 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -139.99 -12.24 1.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.835 1.254 . . . . 0.0 109.938 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -86.91 173.18 9.52 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.093 1.357 . . . . 0.0 108.57 -165.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -33.46 76.78 0.0 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 131.235 3.814 . . . . 0.0 113.846 -166.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -176.21 178.83 1.34 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 128.605 2.762 . . . . 0.0 108.179 168.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.8 t -72.27 127.36 32.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.752 0.821 . . . . 0.0 109.736 -173.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 t -127.4 133.86 67.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.43 161.79 53.01 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 121.829 -0.544 . . . . 0.0 111.865 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.7 mt -135.41 151.97 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.449 1.9 . . . . 0.0 106.065 165.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.22 156.72 7.96 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.242 0.474 . . . . 0.0 112.003 163.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.48 86.15 0.13 Allowed 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 128.186 2.594 . . . . 0.0 112.517 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 61.35 3.25 0.74 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 128.378 2.671 . . . . 0.0 112.409 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.1 t -86.51 98.76 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -146.04 29.3 1.09 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 89.4 m95 -144.77 113.67 6.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -173.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.9 ttm -87.59 140.03 29.93 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 168.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.61 95.7 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -174.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 p -93.94 151.7 19.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.994 1.317 . . . . 0.0 114.37 -158.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -124.08 143.73 15.01 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 69' ' ' ALA . . . -141.09 -32.49 0.14 Allowed Glycine 0 CA--C 1.498 -1.004 0 CA-C-O 121.795 0.664 . . . . 0.0 114.696 -158.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.352 27.5 m -35.83 158.67 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 125.014 1.325 . . . . 0.0 111.851 158.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 47.88 30.57 1.99 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.783 0.802 . . . . 0.0 110.068 -169.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.7 t70 58.8 38.49 24.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.978 1.37 . . . . 0.0 111.158 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -45.37 -47.35 11.49 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 125.216 1.389 . . . . 0.0 110.324 159.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 52.96 -173.79 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.388 1.075 . . . . 0.0 110.269 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -52.73 154.2 2.84 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.793 -0.567 . . . . 0.0 110.669 171.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.75 140.87 12.49 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 106.199 -2.761 . . . . 0.0 106.199 168.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 m -130.73 158.1 41.02 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 117.574 0.687 . . . . 0.0 109.194 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.41 154.42 40.83 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.137 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -99.98 131.63 45.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 167.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 mm -114.88 144.64 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -167.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -132.78 151.7 51.94 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.357 0.98 . . . . 0.0 112.67 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -88.87 -33.62 17.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.07 1.748 . . . . 0.0 109.42 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.14 141.89 42.08 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 m -63.5 151.68 40.62 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 159.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.19 38.75 90.92 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.887 -174.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 30.1 p 44.85 50.97 8.7 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.287 1.835 . . . . 0.0 114.016 170.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -123.88 176.62 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.019 1.328 . . . . 0.0 108.002 169.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.22 -151.42 21.5 Favored Glycine 0 CA--C 1.52 0.377 0 O-C-N 121.313 -0.867 . . . . 0.0 111.592 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -80.2 150.85 29.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 p -147.55 174.46 11.71 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.53 0.681 . . . . 0.0 111.411 -164.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 t -147.31 -176.18 5.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 158.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.89 133.93 42.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 166.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.1 ttt -124.24 144.0 50.21 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.289 1.035 . . . . 0.0 108.849 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.4 m -115.88 151.38 35.41 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 37.5 t -142.45 122.41 8.04 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 123.516 0.726 . . . . 0.0 110.157 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -60.07 165.2 10.91 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.237 1.958 . . . . 0.0 110.061 171.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.541 ' CB ' ' HA3' ' A' ' 41' ' ' GLY . . . -74.1 174.88 8.05 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.621 173.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 p30 47.15 45.93 16.23 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 124.559 1.144 . . . . 0.0 109.977 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.1 m -143.09 139.46 30.47 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.407 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -101.97 113.85 27.45 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 167.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 120.95 41.21 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.07 2.148 . . . . 0.0 106.525 -168.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -84.75 111.22 19.4 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.803 0.841 . . . . 0.0 109.453 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.44 93.4 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.18 75.35 0.45 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -6.52 48.86 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -173.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.07 -43.08 1.45 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.47 156.4 29.36 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 117.891 0.845 . . . . 0.0 111.724 175.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -78.93 133.54 36.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 165.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.36 143.74 12.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.193 0.997 . . . . 0.0 108.973 -170.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -126.17 -25.89 3.47 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 171.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.94 165.07 30.91 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.37 179.53 9.05 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.426 1.49 . . . . 0.0 109.883 170.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -148.7 123.75 10.07 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.351 1.86 . . . . 0.0 106.783 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -75.8 139.18 41.63 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.643 1.565 . . . . 0.0 108.546 170.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.1 m -109.6 -35.43 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.749 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 CA--C 1.529 0.149 0 CA-C-N 119.671 1.123 . . . . 0.0 110.629 -174.829 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 p90 . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tp -132.94 60.19 1.71 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.478 HD13 ' CE2' ' A' ' 20' ' ' TRP . 4.2 pt -94.22 175.2 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.123 0.969 . . . . 0.0 110.867 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.7 ptm -138.37 166.89 23.09 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.881 1.273 . . . . 0.0 108.887 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 61.0 m -147.44 162.03 39.85 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.766 1.269 . . . . 0.0 110.707 -158.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -85.76 -29.5 23.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.07 -1.877 . . . . 0.0 110.28 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -126.07 -166.0 1.51 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.9 t -93.0 3.32 55.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -139.94 105.82 6.81 Favored Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 124.365 1.066 . . . . 0.0 112.824 -164.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.45 -20.89 58.85 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.853 1.702 . . . . 0.0 112.659 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -64.22 -44.12 92.88 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.65 1.114 . . . . 0.0 109.886 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 p -113.97 13.5 18.27 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -174.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.63 133.12 6.08 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 124.571 1.082 . . . . 0.0 110.769 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.14 94.25 1.13 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 174.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 70.9 m -77.53 148.19 35.39 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.35 129.74 36.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.478 ' CE2' HD13 ' A' ' 6' ' ' ILE . 73.3 m95 -111.99 59.84 0.63 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.7 2.8 . . . . 0.0 106.631 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -92.6 165.72 12.85 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 165.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -73.16 143.75 47.14 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 118.199 -1.4 . . . . 0.0 107.525 166.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -130.29 -14.12 3.84 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.726 1.611 . . . . 0.0 109.952 -172.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.418 ' CE3' ' HG3' ' A' ' 86' ' ' ARG . 21.7 m95 -79.04 112.82 16.63 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -172.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.6 t30 64.11 44.75 4.39 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.036 0.935 . . . . 0.0 111.36 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.32 141.37 30.94 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.947 0.899 . . . . 0.0 109.093 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.32 77.76 5.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.904 2.081 . . . . 0.0 109.127 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 t -92.64 127.64 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.51 139.68 16.14 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.948 1.261 . . . . 0.0 111.365 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 mm -134.5 165.84 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 126.73 2.012 . . . . 0.0 108.891 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.98 -170.71 40.83 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 163.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.77 80.54 0.2 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.599 1.96 . . . . 0.0 113.643 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 71.2 4.16 4.95 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 126.803 2.041 . . . . 0.0 111.182 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.0 111.44 22.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -146.37 25.75 1.21 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -137.48 114.46 10.69 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 119.729 1.15 . . . . 0.0 111.548 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.525 ' H ' HD13 ' A' ' 75' ' ' ILE . 21.9 ttt -84.49 113.88 21.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 169.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.98 96.92 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -104.19 141.2 36.68 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.674 0.79 . . . . 0.0 109.855 -159.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.358 0 C-N-CA 123.374 0.512 . . . . 0.0 111.83 -169.126 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 mttm . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -46.94 157.61 0.15 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.845 1.658 . . . . 0.0 112.492 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.68 134.41 12.2 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 106.999 -2.44 . . . . 0.0 106.999 166.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.1 m -133.37 155.42 49.5 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.62 149.6 39.17 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.666 0.604 . . . . 0.0 111.36 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.0 m -84.5 126.41 33.26 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 159.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.2 mt -121.2 128.35 75.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -172.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 9.1 m-90 -111.13 153.68 25.38 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.739 1.615 . . . . 0.0 113.262 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.78 -45.68 74.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.409 2.284 . . . . 0.0 111.181 172.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.81 157.45 48.9 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 m -78.2 122.48 25.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 163.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.52 41.88 9.61 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 124.761 1.172 . . . . 0.0 111.058 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.5 p 45.79 57.04 5.37 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.454 1.902 . . . . 0.0 113.137 166.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 m -124.63 176.03 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 126.203 1.801 . . . . 0.0 106.95 164.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.54 -160.94 28.22 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -72.86 160.69 31.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 8.8 p -145.13 160.55 41.25 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.898 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.1 t -110.27 159.47 17.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 162.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -110.11 111.51 22.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 160.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.03 122.5 41.25 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.876 0.735 . . . . 0.0 110.767 -171.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.5 m -105.74 152.76 22.78 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.937 1.295 . . . . 0.0 111.967 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.417 ' SG ' ' HD2' ' A' ' 68' ' ' PRO . 1.7 t -151.93 143.73 16.18 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.258 169.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 23.3 Cg_endo -64.81 172.24 7.35 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.837 1.691 . . . . 0.0 113.084 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.99 135.84 33.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.875 1.27 . . . . 0.0 110.97 -172.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 56.25 64.74 1.61 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -165.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 m -145.26 126.67 14.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.34 120.64 28.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.36 1.464 . . . . 0.0 108.725 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.5 m -130.73 105.44 7.8 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -162.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -68.24 112.95 5.45 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.003 0.521 . . . . 0.0 110.785 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -74.09 107.67 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.99 129.75 30.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 162.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -126.48 -169.72 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.677 1.126 . . . . 0.0 110.161 -172.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.71 11.69 67.86 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.34 174.87 10.97 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 125.098 1.359 . . . . 0.0 109.284 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -74.3 148.15 41.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 163.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -113.62 142.4 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.436 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -134.14 -66.75 0.61 Allowed 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.9 m -93.77 173.48 7.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 116.431 -2.108 . . . . 0.0 112.062 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -155.82 168.22 27.9 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.238 165.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.97 136.37 19.0 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 163.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.418 ' HG3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -68.41 166.4 16.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.942 -171.33 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.64 -32.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 116.924 -1.513 . . . . 0.0 113.095 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 N--CA 1.466 0.341 0 C-N-CA 124.869 1.268 . . . . 0.0 108.581 -174.974 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.6 p90 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.522 HD13 HH21 ' A' ' 86' ' ' ARG . 5.1 tt -144.16 126.23 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 161.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.78 170.95 12.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.3 ptm -117.35 168.49 10.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.876 0.846 . . . . 0.0 110.023 158.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 73.2 m -156.05 166.25 34.02 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.319 1.448 . . . . 0.0 108.374 -158.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -85.95 -20.52 28.84 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 170.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.2 p30 -136.9 -175.37 4.01 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.849 172.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 40.7 t -89.05 3.82 50.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.347 -170.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -138.02 94.42 11.28 Favored Pre-proline 0 N--CA 1.456 -0.141 0 C-N-CA 123.651 0.78 . . . . 0.0 110.984 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.08 -23.06 2.5 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.52 2.813 . . . . 0.0 114.679 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -63.65 -41.24 98.24 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 119.801 1.182 . . . . 0.0 110.123 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -111.41 14.12 21.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.677 0.791 . . . . 0.0 110.824 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.38 121.02 5.79 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 125.08 1.324 . . . . 0.0 109.85 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.0 m -65.32 123.26 19.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 159.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 96.4 m -135.93 159.1 42.71 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -172.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.86 92.99 8.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.677 1.227 . . . . 0.0 109.65 169.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -84.51 42.7 0.91 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.243 162.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 167.34 10.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 164.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -64.09 144.08 57.38 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.418 0.627 . . . . 0.0 109.327 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -122.25 -8.3 8.71 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.577 2.351 . . . . 0.0 110.015 167.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -58.78 94.13 0.02 OUTLIER 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.091 0.957 . . . . 0.0 110.093 169.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 41.46 55.79 3.37 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.413 1.485 . . . . 0.0 111.379 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.2 p -138.18 124.35 20.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 102.492 -3.151 . . . . 0.0 102.492 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.4 t -75.3 84.43 2.45 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.681 1.193 . . . . 0.0 109.343 -166.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.7 t -83.63 121.79 36.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -170.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.36 154.51 49.24 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.418 1.009 . . . . 0.0 111.222 174.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -128.27 142.21 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.577 1.951 . . . . 0.0 107.115 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.79 168.81 33.84 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 168.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 61.01 72.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 68.94 2.87 3.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 128.21 2.604 . . . . 0.0 111.259 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -83.71 97.56 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -146.35 34.38 0.97 Allowed 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -135.42 113.98 11.71 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 121.789 -0.569 . . . . 0.0 109.623 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.471 ' H ' HD13 ' A' ' 75' ' ' ILE . 25.4 ttp -85.95 132.61 34.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.72 129.38 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.501 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -144.23 128.19 17.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -159.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 172.875 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.4 mttp . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.369 0.128 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -51.75 143.46 12.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.004 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.96 133.17 11.51 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 107.484 -2.247 . . . . 0.0 107.484 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 74.6 m -119.3 147.33 44.42 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 117.749 0.775 . . . . 0.0 109.164 172.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.13 140.71 26.89 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 114.711 -1.132 . . . . 0.0 108.86 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.7 m -91.0 113.0 25.14 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.8 mt -95.7 143.79 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 22.7 m-90 -125.09 152.63 44.11 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.201 1.4 . . . . 0.0 113.076 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -81.15 -38.77 26.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.702 2.401 . . . . 0.0 109.787 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.38 136.66 23.82 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m -60.45 119.89 8.88 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 168.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.15 46.12 7.18 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 124.183 0.897 . . . . 0.0 111.619 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.6 p 44.67 51.69 8.09 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.268 1.827 . . . . 0.0 113.206 169.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 m -125.88 176.86 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 128.588 2.755 . . . . 0.0 106.452 171.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.37 -156.84 34.11 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.3 ttt85 -67.96 153.82 42.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.408 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.2 p -141.47 165.85 26.36 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 174.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.0 t -137.31 138.87 40.46 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -88.43 94.95 10.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 40.6 tpp -86.38 104.7 16.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 98.8 m -93.08 138.14 31.79 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 166.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.5 t -153.52 132.08 6.67 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.176 1.391 . . . . 0.0 109.801 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -63.18 163.6 22.51 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.404 2.069 . . . . 0.0 115.579 -167.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.07 122.97 25.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 83.11 62.72 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 128.011 2.524 . . . . 0.0 107.402 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.72 -176.91 6.2 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.343 1.068 . . . . 0.0 109.778 158.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.29 122.78 25.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 128.907 2.883 . . . . 0.0 106.42 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.23 113.28 24.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.633 1.973 . . . . 0.0 107.061 -171.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -66.47 115.12 6.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 167.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -77.21 120.62 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 165.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -150.47 66.95 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 170.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 p -78.2 161.56 27.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.581 -167.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -52.84 -30.17 35.82 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.021 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -111.12 159.89 17.41 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 124.575 1.15 . . . . 0.0 109.947 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -72.56 139.26 47.4 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.945 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.32 133.69 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.289 1.036 . . . . 0.0 110.252 -164.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -122.61 -41.05 2.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.906 0.882 . . . . 0.0 111.544 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.94 167.27 22.53 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -154.88 161.44 41.44 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.237 0.615 . . . . 0.0 111.852 163.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -138.29 145.62 41.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.829 2.052 . . . . 0.0 108.395 164.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.522 HH21 HD13 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -76.98 153.54 34.45 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.875 166.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.35 -17.84 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.811 1.644 . . . . 0.0 110.455 164.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 164.537 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 p90 . . . . . 0 N--CA 1.446 -0.628 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 tt -139.18 103.76 4.84 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 159.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.405 HD13 ' CE2' ' A' ' 20' ' ' TRP . 2.5 pt -124.42 171.54 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.0 ptp -136.58 140.11 42.65 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.352 1.061 . . . . 0.0 111.181 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.4 m -125.04 168.8 12.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.108 1.363 . . . . 0.0 109.965 -159.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -79.55 -34.8 40.67 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.928 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -132.47 -168.68 2.1 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 128.033 2.533 . . . . 0.0 107.31 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -94.96 3.46 54.92 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.31 114.55 23.51 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 124.971 1.309 . . . . 0.0 111.229 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.76 -24.4 74.62 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.309 2.006 . . . . 0.0 111.838 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -44.95 91.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.617 1.099 . . . . 0.0 109.44 -177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.2 p -103.95 13.66 32.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.934 0.894 . . . . 0.0 112.346 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.97 114.65 2.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 124.993 1.282 . . . . 0.0 111.408 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.53 94.21 1.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.0 m -87.72 173.15 9.18 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.563 0.745 . . . . 0.0 109.175 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 162.1 27.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 158.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.405 ' CE2' HD13 ' A' ' 6' ' ' ILE . 93.5 m95 -151.5 54.87 0.85 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 168.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -114.89 176.27 5.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.839 1.656 . . . . 0.0 108.259 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -63.98 153.4 37.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.215 0.606 . . . . 0.0 109.456 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -146.5 -23.45 0.43 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -103.07 33.67 3.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.565 -1.334 . . . . 0.0 109.67 -173.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -141.72 43.84 1.72 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.599 -167.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 89.98 177.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 173.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.3 t -47.44 109.89 0.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.515 1.526 . . . . 0.0 112.273 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.03 145.02 12.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 127.005 2.122 . . . . 0.0 107.241 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.74 134.94 14.29 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.7 mm -133.15 166.52 29.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 127.093 2.157 . . . . 0.0 108.613 -169.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.62 -166.98 21.65 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 106.598 -2.601 . . . . 0.0 106.598 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 48.72 89.45 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 164.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.4 m120 64.8 22.25 12.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 126.59 1.956 . . . . 0.0 111.517 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.3 t -133.91 101.14 3.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -146.53 25.8 1.19 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.713 1.205 . . . . 0.0 112.335 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -129.81 143.23 50.71 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 166.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 48.5 ttm -107.15 125.3 50.9 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 167.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.98 93.37 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -99.59 155.13 17.76 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.959 1.304 . . . . 0.0 109.002 -167.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.422 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 175.123 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.63 167.58 3.42 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.237 1.015 . . . . 0.0 110.675 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.21 140.57 9.47 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 162.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 m -126.27 166.6 16.81 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.3 147.03 26.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.296 1.438 . . . . 0.0 110.118 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 m -83.5 123.06 29.35 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 161.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 mt -110.12 150.98 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.446 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 24.6 m-90 -129.65 156.77 43.69 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.855 1.662 . . . . 0.0 110.295 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -83.73 -36.01 23.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.35 1.06 . . . . 0.0 111.271 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.88 148.19 50.85 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.119 -0.988 . . . . 0.0 110.746 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m -78.27 53.98 1.32 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.099 0.96 . . . . 0.0 110.35 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.4 55.4 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -171.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 54.42 34.4 20.78 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 162.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 m -125.93 176.55 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 126.932 2.093 . . . . 0.0 109.763 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.52 -152.7 29.39 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -73.66 142.28 46.45 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.3 p -136.72 168.26 19.86 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.924 0.765 . . . . 0.0 111.411 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.1 t -152.91 140.9 20.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.803 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.8 m -72.67 100.46 2.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 158.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.87 119.39 24.81 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 166.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.7 m -101.46 153.81 19.37 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.7 t -142.61 119.71 7.05 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 123.718 0.807 . . . . 0.0 109.008 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.77 179.89 2.42 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.957 1.771 . . . . 0.0 110.545 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.72 151.54 40.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.831 -161.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.7 m120 50.91 53.34 13.2 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.231 161.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 t -156.08 179.97 8.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.296 0.57 . . . . 0.0 109.804 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 141.75 46.07 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.582 2.753 . . . . 0.0 108.754 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.0 m -143.32 117.69 9.65 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.617 1.167 . . . . 0.0 107.879 -168.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -74.94 103.96 5.35 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.454 0.57 . . . . 0.0 110.32 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.11 132.96 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t30 141.66 112.82 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 129.111 2.964 . . . . 0.0 104.254 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.45 9.13 19.63 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -174.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.07 -60.91 0.51 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 -159.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -82.73 156.97 23.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -168.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -73.94 133.81 43.09 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.332 -1.304 . . . . 0.0 107.746 172.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.6 128.23 55.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -166.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -136.71 -19.62 1.36 Allowed 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -166.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -142.6 163.24 33.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 119.631 1.105 . . . . 0.0 108.575 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.04 161.48 41.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.958 0.799 . . . . 0.0 112.918 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.37 129.08 12.35 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 171.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.4 mmm-85 -57.41 142.69 42.93 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.17 -3.07 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.193 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 CA--C 1.52 -0.2 0 C-N-CA 126.202 1.801 . . . . 0.0 107.493 177.403 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.3 p90 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.506 HD11 ' SD ' ' A' ' 37' ' ' MET . 0.8 OUTLIER -141.38 119.45 12.03 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 175.412 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.43 151.98 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 126.552 1.941 . . . . 0.0 106.301 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.1 ptp -110.96 159.3 17.85 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.876 0.846 . . . . 0.0 112.187 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.5 m -145.31 154.56 42.47 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 122.753 1.263 . . . . 0.0 110.133 -159.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -86.14 -13.37 47.32 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 112.679 -2.055 . . . . 0.0 110.741 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -150.77 -179.93 7.68 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.849 1.66 . . . . 0.0 107.84 164.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 t -77.28 3.67 12.42 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -128.57 106.11 19.01 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -59.97 -21.12 63.54 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.618 1.545 . . . . 0.0 112.684 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.9 -33.46 75.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.538 0.608 . . . . 0.0 110.64 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 t -142.37 29.5 1.6 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.221 0.464 . . . . 0.0 111.592 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.22 139.19 10.75 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.11 126.58 28.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 164.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.2 m -135.61 137.14 41.62 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -96.28 103.38 15.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 111.559 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -103.71 56.45 0.73 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 129.266 3.027 . . . . 0.0 109.619 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -99.67 -175.76 3.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 159.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -64.01 147.06 52.99 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -143.52 -8.17 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.742 0.817 . . . . 0.0 112.641 -164.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -101.78 143.59 31.51 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 54.94 47.68 21.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.454 1.101 . . . . 0.0 111.991 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 t -144.05 -173.44 4.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.241 1.416 . . . . 0.0 109.322 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.7 t -151.52 66.79 0.88 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.622 1.969 . . . . 0.0 109.405 -173.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.3 t -104.05 120.62 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.47 1.108 . . . . 0.0 109.659 -167.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.8 128.31 8.38 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.147 0.879 . . . . 0.0 112.639 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.439 HG22 HG21 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -125.31 166.35 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 127.855 2.462 . . . . 0.0 106.09 178.007 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.63 -178.92 41.85 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.99 99.38 0.05 Allowed 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 127.537 2.335 . . . . 0.0 110.64 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 73.08 8.36 5.37 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.396 1.878 . . . . 0.0 110.98 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 30' ' ' ILE . 62.7 t -84.57 97.62 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -143.25 28.96 1.48 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -143.63 127.41 17.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.506 ' SD ' HD11 ' A' ' 5' ' ' LEU . 43.6 ttm -104.9 132.93 50.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 162.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 t -125.16 81.29 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -94.66 151.65 19.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -168.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.523 ' CA ' ' H ' ' A' ' 70' ' ' ASN . . . . . . . . 0 C--O 1.219 -0.796 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.295 0.569 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.92 159.66 33.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.844 168.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.32 173.04 31.5 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 164.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.2 m -129.86 159.82 35.42 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -163.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.18 140.53 35.92 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.8 m -83.23 124.45 30.57 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 159.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.2 mt -102.93 146.8 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -123.01 160.98 25.16 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.715 1.606 . . . . 0.0 110.936 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -79.54 -50.16 11.15 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.418 1.487 . . . . 0.0 110.919 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.27 121.05 5.3 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -169.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.71 108.87 0.23 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.05 2.14 . . . . 0.0 108.66 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 129.87 -74.75 0.44 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -172.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.1 p 163.03 55.1 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 129.298 3.039 . . . . 0.0 110.462 165.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.63 176.61 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.566 1.546 . . . . 0.0 107.908 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.78 -158.75 37.31 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -80.4 151.55 29.31 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -172.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.73 164.37 30.65 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.11 -169.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.57 128.88 10.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -170.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.0 p -82.3 92.74 7.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 41.2 tpp -83.73 129.78 34.95 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 96.7 m -130.58 134.3 46.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.925 0.784 . . . . 0.0 109.333 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 t -150.16 143.67 16.8 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.653 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -66.98 170.12 13.59 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.539 2.159 . . . . 0.0 113.93 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.61 148.75 42.6 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.523 ' H ' ' CA ' ' A' ' 40' ' ' GLY . 20.1 m120 59.81 41.45 18.09 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.111 1.364 . . . . 0.0 109.007 172.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.4 m -127.9 131.41 49.39 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.2 t -88.49 124.82 34.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 170.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.4 m -121.18 105.79 10.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -160.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -78.04 104.84 8.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.624 0.647 . . . . 0.0 109.671 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.477 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -76.64 116.0 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -139.84 83.23 1.91 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 p -74.47 -174.87 2.18 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.965 -1.084 . . . . 0.0 108.966 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.65 -20.22 71.85 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.321 -0.862 . . . . 0.0 111.573 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -131.02 177.23 7.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.977 1.311 . . . . 0.0 109.838 -172.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -83.35 135.28 34.77 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.32 146.36 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.461 1.504 . . . . 0.0 110.522 -169.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.1 mtt85 -136.25 -85.78 0.35 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.172 0.989 . . . . 0.0 110.024 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.12 168.33 17.84 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.272 -159.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -157.93 165.15 35.91 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.76 123.65 6.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.393 1.477 . . . . 0.0 107.347 170.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -59.9 129.9 44.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -36.9 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 C-N-CA 126.571 1.948 . . . . 0.0 110.472 -167.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 177.528 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.3 p90 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.585 HD21 ' SD ' ' A' ' 37' ' ' MET . 9.4 tt -149.91 91.67 1.81 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 171.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 pt -108.29 144.59 16.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.5 ptp -78.16 131.26 37.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 159.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 66.5 m -103.09 156.41 17.71 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 14.5 pttt -66.46 -39.84 89.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 117.414 -1.715 . . . . 0.0 108.688 178.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.423 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 39.8 p-10 -131.94 -165.9 1.65 Allowed 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 127.123 2.169 . . . . 0.0 108.53 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.0 t -82.99 3.82 28.55 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.397 -0.815 . . . . 0.0 112.609 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -106.84 114.29 61.82 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 123.267 0.627 . . . . 0.0 110.181 -170.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.39 -32.44 89.21 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.653 1.569 . . . . 0.0 111.504 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -100.56 -51.53 3.58 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.599 1.559 . . . . 0.0 111.757 -161.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -103.92 13.78 32.08 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.679 0.672 . . . . 0.0 112.148 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.45 -69.47 1.39 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 106.855 -2.498 . . . . 0.0 106.855 164.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t 94.22 122.05 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.282 2.633 . . . . 0.0 106.314 -163.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.2 m -136.46 159.75 40.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 126.671 1.989 . . . . 0.0 108.881 -165.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -89.25 94.37 9.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.464 2.078 . . . . 0.0 112.584 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -83.64 51.09 1.93 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.37 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -110.43 -176.65 3.03 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.929 2.492 . . . . 0.0 106.834 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 144.36 49.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 167.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -134.91 2.82 3.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 123.69 0.619 . . . . 0.0 110.016 171.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -93.51 125.66 38.23 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 -172.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 53.74 37.45 26.27 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.78 0.832 . . . . 0.0 111.88 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -133.9 151.44 51.51 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.322 1.849 . . . . 0.0 106.613 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -89.32 85.66 6.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -83.85 124.87 40.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -167.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.69 121.44 5.67 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 118.404 0.547 . . . . 0.0 112.04 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.2 mt -93.46 159.43 2.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 126.577 1.951 . . . . 0.0 108.405 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.91 166.13 28.06 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 169.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.23 74.05 0.21 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.768 2.427 . . . . 0.0 112.342 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 68.21 14.9 9.33 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.886 2.074 . . . . 0.0 110.821 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 97.1 t -133.53 99.49 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -145.8 39.9 1.15 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.725 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CD1' ' HA ' ' A' ' 10' ' ' ASN . 60.2 m95 -135.16 132.11 37.6 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.585 ' SD ' HD21 ' A' ' 5' ' ' LEU . 19.5 ttp -106.58 123.23 47.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 165.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -124.03 117.09 49.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -99.47 -177.03 3.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -168.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.96 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 173.712 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.2 mttp . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 122.322 1.058 . . . . 0.0 108.522 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -66.78 150.99 48.33 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.329 165.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.76 147.91 18.68 Favored Glycine 0 C--O 1.238 0.402 0 N-CA-C 105.791 -2.924 . . . . 0.0 105.791 166.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.9 m -132.96 151.33 52.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.147 1.474 . . . . 0.0 108.721 -172.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.79 144.47 49.03 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.924 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.2 m -83.3 115.53 22.03 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 162.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.84 148.47 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -127.94 151.8 48.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.109 1.364 . . . . 0.0 111.504 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -87.91 -33.67 18.41 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.476 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.87 138.44 31.44 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 173.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.6 m -61.83 135.28 57.52 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 159.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.11 32.45 39.4 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 124.727 1.156 . . . . 0.0 111.006 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 12.1 p 45.39 52.29 9.03 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.643 2.377 . . . . 0.0 112.174 169.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.76 175.73 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 125.703 1.601 . . . . 0.0 107.711 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.71 -151.35 26.29 Favored Glycine 0 CA--C 1.523 0.549 0 O-C-N 121.368 -0.832 . . . . 0.0 111.992 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.2 142.85 49.02 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -170.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.99 147.58 28.03 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -167.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p -128.19 115.84 18.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.4 1.48 . . . . 0.0 108.204 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.8 88.33 0.25 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.054 1.342 . . . . 0.0 108.892 171.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -90.52 132.48 35.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.955 1.302 . . . . 0.0 107.984 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 64.5 m -118.51 143.19 46.9 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.1 t -134.2 114.26 12.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 123.729 0.812 . . . . 0.0 109.362 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -72.01 166.48 29.49 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.354 1.369 . . . . 0.0 113.516 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.3 154.25 40.21 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 45.9 53.5 8.89 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.223 1.009 . . . . 0.0 108.718 -164.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 m -144.4 106.64 4.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -73.93 126.08 29.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 169.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 86.4 m -121.57 139.73 53.14 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.942 1.297 . . . . 0.0 108.592 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -108.46 113.84 27.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 109.546 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 75' ' ' ILE . 1.5 mp -93.4 71.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -168.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -123.98 84.04 2.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 p -73.97 170.83 14.6 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.01 -36.86 93.49 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -85.07 162.67 19.21 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 122.121 -0.635 . . . . 0.0 109.395 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -84.44 133.7 34.48 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.079 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.75 132.29 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.025 1.33 . . . . 0.0 109.769 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -118.58 -37.39 3.3 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 118.511 -0.757 . . . . 0.0 111.982 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 p -152.72 167.33 29.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -139.18 167.13 22.74 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.32 1.048 . . . . 0.0 112.036 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.8 139.68 40.15 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.013 1.725 . . . . 0.0 109.035 162.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.491 ' HD3' HD22 ' A' ' 5' ' ' LEU . 49.3 mmm-85 -54.54 154.62 4.64 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.649 0.659 . . . . 0.0 112.095 170.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.67 -31.19 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 123.215 0.606 . . . . 0.0 110.985 165.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.597 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.3 p90 . . . . . 0 N--CA 1.443 -0.78 0 CA-C-O 122.163 0.982 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.409 HD13 ' HG2' ' A' ' 86' ' ' ARG . 10.2 tt -141.25 110.57 6.31 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 159.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.52 111.23 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -169.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptm -72.38 148.6 45.11 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.686 -1.206 . . . . 0.0 108.478 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 71.4 m -129.78 157.05 43.27 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -172.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 19.1 pttt -72.65 -30.78 64.58 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 117.544 -1.662 . . . . 0.0 112.359 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -125.59 -166.55 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.589 1.955 . . . . 0.0 109.528 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 t -99.8 25.66 7.04 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.275 1.03 . . . . 0.0 111.909 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -119.63 101.74 48.17 Favored Pre-proline 0 C--N 1.327 -0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 111.81 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -58.27 -24.07 65.72 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 120.858 1.039 . . . . 0.0 113.028 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -66.61 -73.68 0.13 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.112 0.869 . . . . 0.0 111.052 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 t -122.28 37.56 4.36 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.159 0.983 . . . . 0.0 110.413 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.2 -37.37 71.85 Favored Glycine 0 N--CA 1.448 -0.557 0 O-C-N 120.925 -1.109 . . . . 0.0 110.928 161.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.98 114.37 0.05 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -159.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 80.2 m -136.04 137.26 40.97 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 112.46 -2.155 . . . . 0.0 106.663 -166.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -80.61 93.37 6.1 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 122.707 1.241 . . . . 0.0 109.974 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -83.25 41.95 0.79 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.473 1.909 . . . . 0.0 108.309 165.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -96.67 168.43 10.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 166.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -63.74 143.81 57.54 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 118.429 -1.309 . . . . 0.0 109.014 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -129.82 -44.37 1.2 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 126.807 2.043 . . . . 0.0 108.162 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . 0.3 6.4 t-105 -86.19 59.09 5.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.834 1.254 . . . . 0.0 108.212 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.13 -0.01 0.01 OUTLIER 'General case' 0 N--CA 1.46 0.067 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 173.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 t -167.15 142.06 3.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 120.292 1.405 . . . . 0.0 110.382 -158.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.9 t -65.75 75.42 0.07 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.995 2.518 . . . . 0.0 111.625 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 t -83.64 148.33 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 O-C-N 120.882 -1.136 . . . . 0.0 108.646 -167.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.88 144.7 19.62 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 124.337 0.97 . . . . 0.0 111.013 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -101.22 156.63 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 166.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.81 154.58 10.84 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 66.85 83.07 0.17 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.052 1.741 . . . . 0.0 114.323 165.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 67.67 3.76 3.57 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.395 1.478 . . . . 0.0 111.723 171.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 53.3 t -75.29 126.48 36.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 122.486 0.314 . . . . 0.0 110.256 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 30.25 1.02 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 169.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.516 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 68.0 m95 -138.35 127.3 23.95 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.986 0.812 . . . . 0.0 112.728 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.56 ' H ' HD13 ' A' ' 75' ' ' ILE . 64.1 ttp -90.63 135.58 33.61 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 161.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.9 137.55 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 t -146.07 153.4 40.68 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 121.691 -0.63 . . . . 0.0 110.378 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' HA2' ' H ' ' A' ' 70' ' ' ASN . . . . . . . . 0 C--N 1.336 0.547 0 CA-C-N 118.373 0.533 . . . . 0.0 112.143 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.2 mttm . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 122.851 1.31 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -44.13 143.63 1.13 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 126.538 1.935 . . . . 0.0 110.665 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.79 137.38 12.38 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.7 m -125.24 153.74 42.7 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.46 143.69 46.01 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.855 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -88.25 130.88 34.97 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 159.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 mt -116.76 144.43 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -130.43 143.72 50.94 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.1 1.36 . . . . 0.0 110.475 -171.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -61.39 -51.96 66.62 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.32 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.46 145.99 36.68 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 124.392 0.996 . . . . 0.0 113.296 -163.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 m -55.13 116.98 3.1 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 162.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.13 51.14 5.9 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.4 p 43.29 53.17 5.56 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.73 1.612 . . . . 0.0 113.342 163.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -125.76 176.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 128.129 2.572 . . . . 0.0 106.35 167.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.91 -168.24 39.07 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 119.421 1.01 . . . . 0.0 110.814 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -69.41 128.36 36.28 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -170.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.92 165.06 15.74 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.811 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -150.66 151.29 32.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 m -87.02 111.07 20.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 164.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 34.9 tpp -87.02 144.06 27.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 167.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 55.4 m -147.37 136.14 22.05 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.3 t -135.03 137.71 27.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 124.78 1.232 . . . . 0.0 108.406 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.05 168.31 7.63 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.185 1.257 . . . . 0.0 110.759 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.8 150.33 41.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.308 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.451 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 65.5 m-80 54.51 48.47 20.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.942 1.297 . . . . 0.0 107.918 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.9 m -145.32 148.07 33.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.462 1.105 . . . . 0.0 108.181 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.516 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -101.17 137.17 39.88 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 128.559 2.744 . . . . 0.0 108.338 172.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 54.3 m -140.84 128.17 21.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.968 0.804 . . . . 0.0 110.398 -175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -73.36 135.84 44.33 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.186 0.994 . . . . 0.0 111.599 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 37' ' ' MET . 1.3 mp -102.23 112.86 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 126.573 1.949 . . . . 0.0 106.233 173.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -150.71 77.35 1.28 Allowed 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.843 -0.535 . . . . 0.0 109.944 169.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.32 165.67 24.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.829 0.851 . . . . 0.0 109.28 172.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.99 -51.5 56.92 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -77.33 154.33 32.93 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.551 0.691 . . . . 0.0 110.096 171.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -86.2 137.12 32.87 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.384 -1.734 . . . . 0.0 109.918 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -100.48 127.76 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 124.665 1.186 . . . . 0.0 109.892 -170.489 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -109.01 -17.82 13.82 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.982 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -139.13 166.63 24.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -153.65 162.3 41.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.615 1.166 . . . . 0.0 111.651 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -137.59 143.96 41.76 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.108 1.763 . . . . 0.0 107.837 159.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG2' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -64.16 154.37 34.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 163.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 m -131.62 -22.99 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 165.855 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.2 p90 . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.525 HD21 ' SD ' ' A' ' 37' ' ' MET . 5.2 tt -147.55 121.17 9.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 18' ' ' CYS . 24.3 pt -132.01 168.89 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 126.851 2.06 . . . . 0.0 106.537 -177.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.2 ptp -120.57 144.34 48.14 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 158.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 70.9 m -117.29 156.06 28.44 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 28.5 pttt -60.87 -44.45 97.04 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 116.827 -1.949 . . . . 0.0 109.029 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -126.82 167.73 15.4 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.812 1.645 . . . . 0.0 109.191 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.9 t -72.72 3.88 4.63 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -101.87 100.65 15.26 Favored Pre-proline 0 N--CA 1.467 0.397 0 O-C-N 121.061 -1.024 . . . . 0.0 110.121 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.45 -27.91 83.5 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.958 1.772 . . . . 0.0 112.256 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -63.47 -60.11 3.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.378 0.535 . . . . 0.0 109.688 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.4 p -103.81 13.36 33.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.75 132.75 11.34 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 p -64.42 114.97 4.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 158.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB3' HD12 ' A' ' 6' ' ' ILE . 74.2 m -126.37 138.23 53.54 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -172.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 6' ' ' ILE . 6.0 p30 -76.07 92.69 3.21 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.218 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.472 ' CZ2' HD13 ' A' ' 6' ' ' ILE . 98.7 m95 -90.23 59.57 4.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 128.56 2.744 . . . . 0.0 104.489 166.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -127.53 168.92 14.28 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 170.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -64.3 143.86 57.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -134.22 -39.88 0.83 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.022 0.529 . . . . 0.0 109.813 -170.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.427 ' HA ' ' HB2' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -77.62 33.57 0.17 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.443 1.116 . . . . 0.0 111.805 -175.026 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.83 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 119.182 -2.199 . . . . 0.0 111.838 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.26 146.83 23.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.958 0.409 . . . . 0.0 111.191 -170.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.7 t -77.78 81.87 4.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.614 1.166 . . . . 0.0 108.579 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.43 145.62 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 O-C-N 121.223 -0.923 . . . . 0.0 109.968 -173.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.75 169.24 44.5 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.597 1.094 . . . . 0.0 112.998 -175.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.22 135.72 56.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 126.321 1.848 . . . . 0.0 106.123 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.59 178.1 35.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 167.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 57.82 79.35 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.075 1.75 . . . . 0.0 113.349 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.7 m120 70.3 4.49 4.91 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.25 1.42 . . . . 0.0 111.669 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 98.7 t -100.23 117.25 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 119.111 0.869 . . . . 0.0 110.87 -175.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -145.96 29.39 1.1 Allowed 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.46 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 79.9 m95 -137.6 121.71 17.93 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 119.377 0.989 . . . . 0.0 112.213 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.644 ' H ' HD13 ' A' ' 75' ' ' ILE . 23.2 tpp -84.3 135.4 34.33 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 163.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.78 128.79 54.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -137.77 155.72 48.75 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.193 -0.942 . . . . 0.0 109.409 -171.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.02 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 178.803 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -48.91 152.03 1.12 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.164 1.386 . . . . 0.0 111.628 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.95 153.11 17.3 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.3 m -139.33 153.81 47.78 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 86' ' ' ARG . . . -130.16 149.84 51.68 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 124.076 0.86 . . . . 0.0 110.695 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 m -83.62 126.3 32.71 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 158.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.6 mm -101.35 146.67 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -129.02 156.92 43.05 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.017 0.913 . . . . 0.0 111.859 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -97.9 -33.79 11.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 127.441 2.296 . . . . 0.0 108.829 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 143.61 47.41 Favored Glycine 0 CA--C 1.521 0.421 0 O-C-N 120.991 -1.068 . . . . 0.0 110.904 170.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.1 m -77.35 59.09 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.062 0.931 . . . . 0.0 111.688 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.42 50.75 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.1 p 44.07 42.77 5.09 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.825 1.25 . . . . 0.0 112.925 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.2 176.41 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 171.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.68 -154.25 37.72 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -73.63 154.36 39.77 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.99 168.37 23.3 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.4 144.84 30.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.55 1.54 . . . . 0.0 107.85 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.76 123.35 28.69 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.06 108.35 15.62 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.595 1.558 . . . . 0.0 108.794 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.5 m -110.02 144.75 38.13 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.085 0.954 . . . . 0.0 111.274 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.7 t -152.47 136.86 10.45 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -67.49 159.52 52.1 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.9 2.4 . . . . 0.0 113.088 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.17 53.39 2.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.443 -159.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 156.73 50.49 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -163.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -156.04 167.38 30.59 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 165.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.46 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 13.0 t -103.08 127.28 50.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.261 1.825 . . . . 0.0 107.482 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.18 119.23 31.75 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.173 1.789 . . . . 0.0 107.25 -164.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -82.05 122.55 27.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.118 0.872 . . . . 0.0 110.685 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -92.28 86.46 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -130.26 83.84 2.16 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 166.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 p -73.66 179.36 4.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.678 1.191 . . . . 0.0 108.785 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.21 -30.12 63.77 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 121.65 -0.656 . . . . 0.0 112.419 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -119.28 171.23 8.45 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 127.1 2.16 . . . . 0.0 109.525 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -74.64 133.34 42.16 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.93 157.98 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.527 0.731 . . . . 0.0 110.734 -173.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.91 -40.65 0.6 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 167.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 p -147.69 170.09 18.28 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -156.68 158.01 36.2 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.311 0.959 . . . . 0.0 112.816 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.84 135.55 11.63 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 166.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 1.5 mtm180 -60.74 146.84 44.5 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.307 0.503 . . . . 0.0 112.228 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 m -107.76 -9.97 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.815 1.246 . . . . 0.0 111.915 171.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.175 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 tt -127.76 122.65 33.34 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 103.9 -2.63 . . . . 0.0 103.9 164.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 pt -140.74 168.21 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.21 169.0 9.02 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 122.729 1.252 . . . . 0.0 112.092 159.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 88.1 m -155.7 157.91 37.38 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.958 -159.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -64.02 -32.25 73.72 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.017 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -159.43 175.84 12.82 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.365 0.666 . . . . 0.0 109.742 -165.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.0 t -79.92 20.52 0.62 Allowed 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.024 1.73 . . . . 0.0 113.082 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -141.82 118.58 7.31 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.877 1.271 . . . . 0.0 110.714 171.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.19 -25.34 10.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.109 2.539 . . . . 0.0 111.463 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -63.94 -42.64 97.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.9 p -108.04 13.88 25.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.933 1.293 . . . . 0.0 112.124 177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.0 118.51 3.71 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 125.355 1.455 . . . . 0.0 109.901 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.21 120.82 15.64 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.2 m -122.18 158.96 28.23 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.708 0.803 . . . . 0.0 109.35 -169.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -95.76 93.77 7.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 125.394 2.521 . . . . 0.0 112.729 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -83.98 47.35 1.3 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.052 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.46 -178.03 1.04 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.135 1.774 . . . . 0.0 108.938 173.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -69.73 143.4 53.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 158.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -125.27 -24.44 3.97 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.226 0.61 . . . . 0.0 110.464 -166.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.23 -162.95 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 131.068 3.747 . . . . 0.0 115.948 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -45.57 62.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 130.886 3.675 . . . . 0.0 110.547 158.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 t -140.02 175.35 9.66 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 128.113 2.565 . . . . 0.0 109.555 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.4 t -139.65 67.19 1.38 Allowed 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.249 1.82 . . . . 0.0 107.701 -165.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.4 t -83.64 144.84 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 124.528 1.131 . . . . 0.0 108.323 -163.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.04 133.68 12.14 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mm -136.61 162.33 35.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 123.817 0.847 . . . . 0.0 110.825 -165.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.22 -148.8 19.73 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 52.19 88.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.774 2.03 . . . . 0.0 116.229 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.279 0.0 OUTLIER 53.68 16.31 0.96 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.156 2.183 . . . . 0.0 113.41 175.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.1 t -115.46 120.16 63.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.948 1.299 . . . . 0.0 107.895 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.4 24.28 1.27 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.771 0.828 . . . . 0.0 112.705 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CZ3' ' HB2' ' A' ' 74' ' ' ASN . 60.7 m95 -130.75 117.11 18.92 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.472 ' H ' HD13 ' A' ' 75' ' ' ILE . 46.0 ttm -83.54 146.57 28.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 165.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 t -141.12 135.02 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -146.32 154.35 41.58 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 C-N-CA 128.363 2.887 . . . . 0.0 112.737 173.923 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? . . . . . 0 N--CA 1.441 -0.915 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -60.66 144.01 52.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -164.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.72 143.56 16.31 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 106.186 -2.765 . . . . 0.0 106.186 167.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.2 m -133.23 156.07 48.21 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 118.355 1.077 . . . . 0.0 108.335 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.06 147.6 47.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.126 0.97 . . . . 0.0 109.379 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.3 m -83.93 111.1 18.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 158.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.6 mt -83.04 151.8 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 166.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.451 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 13.7 m-90 -126.41 150.36 48.68 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.06 0.933 . . . . 0.0 110.567 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -63.21 -60.9 2.79 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.238 -1.346 . . . . 0.0 107.535 163.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.74 148.81 47.2 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-O 122.408 1.004 . . . . 0.0 112.74 -159.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.33 72.0 8.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.173 0.989 . . . . 0.0 109.747 -168.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.48 46.61 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 125.259 1.409 . . . . 0.0 110.908 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.3 p 44.09 49.97 7.45 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 125.973 1.709 . . . . 0.0 111.376 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.16 176.85 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 126.716 2.006 . . . . 0.0 107.708 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.87 -155.24 38.64 Favored Glycine 0 CA--C 1.518 0.233 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -75.34 159.62 31.24 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.451 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.6 p -127.87 156.23 42.9 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 124.725 1.266 . . . . 0.0 111.663 173.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.46 110.36 8.77 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.153 1.781 . . . . 0.0 106.92 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.3 t -68.25 108.45 3.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 174.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.2 tpt -113.65 106.48 14.56 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.019 0.927 . . . . 0.0 110.134 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.0 m -93.19 154.65 17.93 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.779 0.832 . . . . 0.0 109.353 171.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.5 t -155.13 132.36 6.29 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.453 0.701 . . . . 0.0 110.505 167.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.27 169.11 16.01 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.3 2.0 . . . . 0.0 113.212 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.67 147.4 43.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 59.07 51.65 6.93 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.492 1.117 . . . . 0.0 108.578 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -140.23 130.94 25.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.243 0.544 . . . . 0.0 110.102 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.5 137.04 32.69 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.874 1.67 . . . . 0.0 109.451 165.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 m -138.9 93.57 2.72 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.957 1.303 . . . . 0.0 109.238 -159.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HB2' ' CZ3' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -70.23 122.7 20.0 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 119.906 -1.746 . . . . 0.0 110.268 -178.212 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 37' ' ' MET . 1.5 mp -79.06 114.84 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.72 1.208 . . . . 0.0 109.644 176.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.16 108.52 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.58 -5.81 3.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.899 0.88 . . . . 0.0 110.439 -171.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.3 13.14 82.3 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 121.242 -0.911 . . . . 0.0 112.538 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -139.9 156.42 46.7 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 119.33 1.565 . . . . 0.0 108.411 159.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.82 133.24 43.19 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.33 131.71 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 125.225 1.41 . . . . 0.0 108.412 -169.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.47 -1.52 8.06 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.5 p -156.43 168.98 25.66 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 166.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -153.73 166.84 31.57 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.989 1.316 . . . . 0.0 111.102 165.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -137.01 124.51 22.14 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 128.082 2.553 . . . . 0.0 106.467 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HE ' ' C ' ' A' ' 88' ' ' GLU . 48.9 ttt180 -69.89 130.63 42.76 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 120.746 1.612 . . . . 0.0 107.522 169.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 m -98.26 -33.64 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.106 0.962 . . . . 0.0 111.098 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.402 ' C ' ' HE ' ' A' ' 86' ' ' ARG . 2.9 pt-20 . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.2 p90 . . . . . 0 C--O 1.236 0.376 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.418 HD22 ' HD3' ' A' ' 86' ' ' ARG . 4.8 tt -156.61 82.28 0.96 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.612 2.365 . . . . 0.0 108.081 171.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 pt -108.64 175.98 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 125.477 1.511 . . . . 0.0 107.642 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.3 ptm -124.37 169.53 11.72 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.521 0.677 . . . . 0.0 111.01 158.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.6 m -155.49 163.43 40.03 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.146 1.378 . . . . 0.0 109.14 -158.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER -83.06 -28.97 29.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.058 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -121.37 177.95 4.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 169.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.47 3.46 11.2 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.218 1.007 . . . . 0.0 112.904 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -129.83 96.11 27.16 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.017 0.527 . . . . 0.0 110.687 -161.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -68.94 -12.37 34.21 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.56 1.507 . . . . 0.0 113.455 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -70.28 -50.69 36.88 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.196 -0.94 . . . . 0.0 109.678 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.9 p -111.72 22.81 14.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.194 0.998 . . . . 0.0 111.928 -170.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.03 137.24 9.15 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 124.394 0.997 . . . . 0.0 110.7 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.16 129.77 41.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 168.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.0 m -135.8 151.08 49.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.239 1.015 . . . . 0.0 108.672 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -86.16 95.46 9.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.562 1.172 . . . . 0.0 110.879 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -83.53 58.01 4.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.184 2.193 . . . . 0.0 106.877 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -124.36 161.29 26.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.042 1.337 . . . . 0.0 108.271 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -64.09 146.41 54.25 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.693 0.759 . . . . 0.0 109.049 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -145.98 7.76 1.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.763 1.625 . . . . 0.0 111.007 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -88.33 121.83 31.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 54.45 38.0 28.81 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.384 1.073 . . . . 0.0 111.452 167.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 t -135.82 148.3 48.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.99 1.716 . . . . 0.0 107.457 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.2 t -84.38 100.98 11.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.03 126.65 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 120.101 1.319 . . . . 0.0 109.765 -171.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.59 140.72 15.2 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 127.061 2.267 . . . . 0.0 111.632 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.2 152.52 20.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 128.43 2.692 . . . . 0.0 108.943 -163.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.02 -167.01 34.28 Favored Glycine 0 CA--C 1.525 0.656 0 O-C-N 121.468 -0.77 . . . . 0.0 111.329 168.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.263 . . 59.28 64.8 1.29 Allowed 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 126.884 2.074 . . . . 0.0 115.235 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 m120 64.7 3.58 2.04 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.581 2.352 . . . . 0.0 110.886 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 75.6 t -77.02 106.31 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.629 0.649 . . . . 0.0 109.696 -173.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -146.13 29.86 1.06 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -136.43 113.51 10.54 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 121.766 -0.584 . . . . 0.0 109.962 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.457 ' H ' HD13 ' A' ' 75' ' ' ILE . 59.9 ttp -84.43 142.46 30.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.09 118.41 21.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.3 118.28 36.23 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.474 0 CA-C-O 123.157 1.421 . . . . 0.0 115.743 169.792 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.6 pttt . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -60.85 162.21 7.12 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 120.923 -1.111 . . . . 0.0 110.364 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.06 159.01 25.46 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 166.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.5 m -143.21 164.62 29.69 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 119.577 1.689 . . . . 0.0 111.293 -167.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' HB2' ' HE ' ' A' ' 86' ' ' ARG . . . -138.71 159.47 42.03 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 124.324 1.05 . . . . 0.0 109.998 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -84.47 130.46 34.76 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 158.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.62 150.3 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 20.8 m-90 -125.98 156.09 40.38 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 173.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -84.13 -34.01 24.16 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.728 1.611 . . . . 0.0 109.87 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.18 145.35 24.3 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 121.503 0.502 . . . . 0.0 112.312 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -76.17 85.41 3.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.783 1.633 . . . . 0.0 112.627 -161.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.59 -50.44 0.54 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.6 p 159.34 45.53 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 131.613 3.965 . . . . 0.0 107.622 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.52 176.32 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -171.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.37 -147.74 37.91 Favored Glycine 0 CA--C 1.521 0.466 0 O-C-N 121.328 -0.857 . . . . 0.0 111.053 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -71.28 151.74 43.94 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.681 1.192 . . . . 0.0 108.132 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.467 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.7 p -146.71 159.2 43.78 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.573 1.17 . . . . 0.0 112.22 171.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -139.26 155.58 47.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 170.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 m -83.99 121.4 27.34 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 38.7 tpp -104.06 118.86 37.66 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 20.3 m -108.84 152.91 24.25 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.866 0.866 . . . . 0.0 108.859 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.6 t -151.86 143.24 15.78 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 117.688 -1.148 . . . . 0.0 109.684 171.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.6 168.02 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.196 2.597 . . . . 0.0 111.689 169.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.5 166.76 16.04 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 56.7 47.19 18.74 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.727 0.811 . . . . 0.0 109.215 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -156.28 173.01 17.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.874 0.845 . . . . 0.0 111.438 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -109.14 144.21 37.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.962 2.905 . . . . 0.0 107.942 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.2 m -141.94 99.13 3.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.597 1.159 . . . . 0.0 107.917 -162.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -60.45 105.3 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.167 -0.958 . . . . 0.0 110.22 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -74.07 121.72 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 164.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -168.05 79.12 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 p -73.53 166.99 22.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.5 -37.02 91.52 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -81.18 158.71 24.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 123.452 0.701 . . . . 0.0 110.831 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.74 134.0 43.41 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.85 140.99 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 123.668 0.787 . . . . 0.0 109.531 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -129.65 -23.22 2.89 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 117.216 -1.374 . . . . 0.0 114.126 168.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -150.52 166.12 31.18 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 120.976 1.716 . . . . 0.0 111.877 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -157.79 157.68 33.82 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.399 0.545 . . . . 0.0 111.857 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -146.29 124.23 12.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.022 1.729 . . . . 0.0 108.407 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' HE ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -59.25 153.69 18.01 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.508 0.595 . . . . 0.0 110.842 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.2 m -124.89 -37.51 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.32 0.648 . . . . 0.0 110.87 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.03 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.4 p90 . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.22 114.95 12.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 170.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.0 pt -129.72 174.9 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.771 1.628 . . . . 0.0 107.129 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.5 ptp -129.32 164.53 23.35 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 160.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.4 m -144.44 160.91 40.28 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.836 1.654 . . . . 0.0 107.777 -161.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -52.99 -53.57 47.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.637 0.732 . . . . 0.0 111.031 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -132.56 -173.36 3.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.413 1.885 . . . . 0.0 107.777 -169.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 t -72.99 4.03 4.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -100.02 105.22 33.94 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 123.201 0.601 . . . . 0.0 111.84 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.25 -34.51 55.78 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 120.864 1.043 . . . . 0.0 112.091 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -74.21 -47.8 33.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.932 -0.48 . . . . 0.0 110.77 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.8 t -125.89 17.9 7.92 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.37 -36.26 45.21 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 120.475 -1.39 . . . . 0.0 111.642 170.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m 73.25 115.53 0.06 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.906 1.683 . . . . 0.0 106.793 -158.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -136.26 152.72 51.02 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.072 0.949 . . . . 0.0 108.584 -166.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.93 93.21 9.27 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.849 1.309 . . . . 0.0 109.725 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -84.03 56.84 3.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.943 2.497 . . . . 0.0 105.591 162.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -117.31 -175.06 2.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.376 1.871 . . . . 0.0 107.734 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -64.39 143.05 58.18 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 171.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -146.62 -15.52 0.43 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.327 1.851 . . . . 0.0 111.296 -159.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -119.15 163.43 17.06 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 129.139 2.976 . . . . 0.0 104.629 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 m120 33.93 58.68 0.58 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.32 1.848 . . . . 0.0 114.285 170.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.35 -173.89 2.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.511 1.924 . . . . 0.0 107.261 166.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.5 t -121.72 136.19 54.94 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.571 1.948 . . . . 0.0 108.335 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -147.46 142.49 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.99 1.268 . . . . 0.0 107.842 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.51 137.96 13.66 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.779 2.133 . . . . 0.0 112.235 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.653 ' CD1' ' HA ' ' A' ' 83' ' ' SER . 4.7 mp -126.71 165.73 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 128.201 2.6 . . . . 0.0 107.135 -166.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.03 -178.98 34.06 Favored Glycine 0 N--CA 1.451 -0.353 0 O-C-N 121.25 -0.906 . . . . 0.0 111.518 159.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 60.31 94.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.894 2.078 . . . . 0.0 112.35 169.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.28 0.0 OUTLIER 56.28 26.12 10.11 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.593 1.557 . . . . 0.0 111.922 -176.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.53 103.71 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -146.32 38.16 1.04 Allowed 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 170.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -138.25 114.24 10.02 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 118.801 0.728 . . . . 0.0 110.245 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.419 ' H ' HD13 ' A' ' 75' ' ' ILE . 6.7 ttm -84.01 142.63 30.33 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 170.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.44 130.88 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 68' ' ' PRO . 1.3 t -146.35 146.49 30.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -173.948 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.1 mttm . . . . . 0 N--CA 1.444 -0.757 0 CA-C-O 121.134 0.492 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.488 ' CB ' ' HA ' ' A' ' 68' ' ' PRO . 28.0 pt20 -64.23 143.43 57.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.182 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.46 152.11 17.19 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.5 m -127.5 154.56 44.97 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.36 133.58 24.49 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.525 1.13 . . . . 0.0 109.08 -174.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -83.63 117.74 23.37 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 mt -95.0 146.55 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -124.11 148.24 47.3 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.521 1.529 . . . . 0.0 110.648 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -74.61 -46.08 40.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.179 1.392 . . . . 0.0 108.193 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.1 144.54 42.08 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 121.619 0.566 . . . . 0.0 112.434 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.2 m -66.43 108.64 2.45 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 165.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.55 52.18 2.9 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 19.2 p 46.98 44.23 14.57 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.251 1.82 . . . . 0.0 113.34 165.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.57 176.41 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.053 1.341 . . . . 0.0 107.385 171.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.73 -146.02 25.38 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 173.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -79.89 147.58 31.63 Favored 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 125.905 1.682 . . . . 0.0 107.792 -170.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -138.76 166.94 23.09 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 123.882 0.739 . . . . 0.0 112.017 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -160.56 119.03 2.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -71.45 117.49 13.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.9 ttp -106.18 137.84 43.41 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 167.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 93.2 m -113.39 149.74 33.67 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.469 1.107 . . . . 0.0 108.75 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.2 t -153.06 123.53 3.46 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.15 0.58 . . . . 0.0 112.288 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HA ' ' CB ' ' A' ' 47' ' ' GLN . 12.1 Cg_endo -71.82 149.18 53.58 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 N-CA-C 116.951 1.866 . . . . 0.0 116.951 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.73 108.47 6.58 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 107.47 44.06 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 130.13 3.372 . . . . 0.0 109.112 -174.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -150.57 156.88 42.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.647 1.213 . . . . 0.0 110.511 165.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -92.7 138.11 31.78 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.352 160.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 m -131.59 99.31 4.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 126.514 1.926 . . . . 0.0 108.369 -170.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -56.67 120.83 8.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 119.098 -0.477 . . . . 0.0 109.846 168.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 37' ' ' MET . 1.6 mp -78.57 128.7 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 164.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -176.93 98.63 0.05 OUTLIER 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 164.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 p -89.16 -174.57 4.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.456 1.102 . . . . 0.0 108.915 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.69 -4.1 30.95 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.688 -0.633 . . . . 0.0 113.338 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -143.17 159.1 42.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.841 1.656 . . . . 0.0 107.159 174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -69.52 142.4 53.68 Favored 'General case' 0 N--CA 1.441 -0.885 0 O-C-N 124.765 1.291 . . . . 0.0 108.204 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -116.61 142.79 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 124.126 0.97 . . . . 0.0 109.249 -171.619 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -129.51 -19.18 3.44 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.653 ' HA ' ' CD1' ' A' ' 30' ' ' ILE . 1.7 m -134.12 168.76 18.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.458 1.481 . . . . 0.0 109.862 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -163.07 167.84 21.78 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.579 0.627 . . . . 0.0 109.887 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -157.27 144.46 18.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 123.91 0.756 . . . . 0.0 109.579 158.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.09 137.43 57.05 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 m -106.47 -13.51 9.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.053 1.341 . . . . 0.0 111.752 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 158.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.6 p90 . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.701 0.286 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 tt -125.46 111.11 14.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 162.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' A' ' 20' ' ' TRP . 13.5 pt -119.8 168.63 11.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 169.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.9 ptp -118.91 152.88 35.51 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.022 0.439 . . . . 0.0 110.273 165.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.6 m -138.29 154.04 49.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.538 -158.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -72.26 -6.36 42.49 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.25 1.42 . . . . 0.0 112.6 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.7 p30 -164.15 -177.54 5.05 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.048 1.739 . . . . 0.0 107.297 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.6 t -81.8 4.0 23.8 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.087 0.955 . . . . 0.0 112.576 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.556 ' CG ' HG22 ' A' ' 15' ' ' THR . 46.0 t0 -125.95 90.53 50.1 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.686 1.194 . . . . 0.0 110.081 -162.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.55 -20.29 69.26 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.901 1.734 . . . . 0.0 112.264 -172.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -66.9 -24.14 66.07 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.369 -0.832 . . . . 0.0 111.204 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.556 HG22 ' CG ' ' A' ' 12' ' ' ASP . 10.9 t -144.48 13.89 1.58 Allowed 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -167.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.43 138.54 14.85 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 165.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 p -75.19 93.44 2.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.948 1.374 . . . . 0.0 107.576 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.3 m -94.66 152.59 18.36 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -170.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.84 107.3 19.53 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.924 1.345 . . . . 0.0 111.112 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.406 ' HA ' HG22 ' A' ' 6' ' ' ILE . 59.9 m95 -83.8 35.78 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.358 2.263 . . . . 0.0 108.806 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -87.23 157.98 19.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.837 1.255 . . . . 0.0 107.994 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -63.38 144.72 56.72 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 166.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -145.88 20.78 1.45 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.007 0.523 . . . . 0.0 112.27 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -115.91 141.75 47.69 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.86 20.4 10.63 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.066 0.546 . . . . 0.0 112.399 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.6 p -141.35 133.08 27.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -171.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.9 t -85.53 75.91 10.1 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.81 144.62 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -166.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.38 160.86 42.42 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.569 1.081 . . . . 0.0 111.15 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 mt -122.14 135.44 62.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 171.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.89 143.69 9.9 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 119.571 1.078 . . . . 0.0 113.175 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 69.46 73.77 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.957 2.103 . . . . 0.0 114.881 161.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.8 9.86 6.36 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.564 1.546 . . . . 0.0 110.355 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.75 97.32 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 170.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -135.07 39.73 2.93 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.765 0.826 . . . . 0.0 110.722 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -145.42 134.84 23.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.414 ' H ' HD13 ' A' ' 75' ' ' ILE . 49.0 ttm -114.96 132.88 56.43 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 165.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.94 111.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -170.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.94 72.67 3.0 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.335 1.064 . . . . 0.0 109.526 -170.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.873 0 CA-C-O 123.028 1.349 . . . . 0.0 112.438 167.142 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -53.92 143.26 22.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 160.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.66 131.6 10.73 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 107.007 -2.437 . . . . 0.0 107.007 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 47.2 m -130.62 149.36 52.31 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -162.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.17 140.06 27.69 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.548 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.3 m -83.84 114.74 21.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 162.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 mt -100.99 136.98 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.467 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 4.9 m-90 -119.96 158.87 25.84 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.032 0.933 . . . . 0.0 110.029 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.86 -47.51 70.95 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.218 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.5 -179.4 48.86 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 114.119 -3.896 . . . . 0.0 121.365 175.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m 33.61 82.42 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.63 2.772 . . . . 0.0 114.372 161.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.41 25.32 59.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.467 ' HB2' ' CD2' ' A' ' 53' ' ' TRP . 2.9 p 44.73 65.11 1.15 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.729 1.212 . . . . 0.0 111.609 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.1 176.03 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 126.406 1.882 . . . . 0.0 107.638 172.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.04 -152.73 23.97 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.1 ttm-85 -74.5 159.51 32.14 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.456 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 5.9 p -145.66 167.96 21.84 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.208 0.528 . . . . 0.0 111.235 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.551 HG21 HG21 ' A' ' 77' ' ' THR . 6.5 t -154.75 135.97 13.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 m -85.15 105.72 16.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.0 tpp -83.58 144.81 29.23 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.8 m -124.36 145.53 49.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 159.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.7 t -131.6 109.61 14.66 Favored Pre-proline 0 C--N 1.325 -0.461 0 C-N-CA 124.384 1.074 . . . . 0.0 108.253 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -50.01 146.93 15.92 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.979 2.452 . . . . 0.0 112.223 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.0 160.68 30.98 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.306 0.574 . . . . 0.0 110.571 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.16 39.79 9.51 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.31 160.18 39.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.923 0.868 . . . . 0.0 111.201 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.56 134.69 52.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 128.647 2.779 . . . . 0.0 108.079 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 99.3 m -127.06 136.65 52.47 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.456 1.102 . . . . 0.0 109.827 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -82.61 126.73 32.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.581 0.752 . . . . 0.0 111.569 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.414 HD13 ' H ' ' A' ' 37' ' ' MET . 1.5 mp -95.1 88.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 127.297 2.239 . . . . 0.0 106.721 178.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.0 67.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.551 HG21 HG21 ' A' ' 63' ' ' THR . 1.2 p -73.61 176.27 6.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.194 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -46.96 -50.34 15.62 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -90.85 161.34 15.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 125.057 1.343 . . . . 0.0 110.891 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -75.06 138.9 42.45 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.731 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -114.44 135.66 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.193 0.997 . . . . 0.0 109.714 -170.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.9 ttt85 -136.36 -20.19 1.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.3 m -132.46 174.05 10.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 121.068 1.758 . . . . 0.0 112.456 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -167.08 172.87 9.68 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 124.903 1.281 . . . . 0.0 110.884 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -149.33 124.07 9.86 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -67.12 138.74 57.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.801 1.182 . . . . 0.0 108.674 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 m -121.1 -28.23 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 175.721 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.5 p90 . . . . . 0 C--O 1.235 0.303 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.8 136.56 52.86 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.933 1.693 . . . . 0.0 106.736 166.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 20' ' ' TRP . 9.2 pt -144.39 148.65 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 168.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.4 ptp -96.8 138.25 34.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.5 m -129.43 164.71 23.08 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.659 0.784 . . . . 0.0 109.533 -170.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -75.49 -32.08 60.43 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.469 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -143.18 -177.24 5.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.6 t -84.1 7.62 18.14 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.312 1.045 . . . . 0.0 111.442 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -126.84 93.37 42.34 Favored Pre-proline 0 N--CA 1.447 -0.581 0 C-N-CA 125.317 1.447 . . . . 0.0 111.164 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.18 -14.25 40.67 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.629 1.553 . . . . 0.0 113.271 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -68.2 -40.57 82.15 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 119.146 0.885 . . . . 0.0 110.612 172.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -120.47 13.96 11.87 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.63 129.28 9.47 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 163.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.64 93.15 5.45 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 176.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.1 m -80.21 157.68 26.45 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.339 0.7 OUTLIER -96.16 102.6 14.42 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 122.99 1.376 . . . . 0.0 111.683 170.192 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.488 ' HA ' HG22 ' A' ' 6' ' ' ILE . 71.7 m95 -83.7 50.27 1.77 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 129.688 3.195 . . . . 0.0 107.329 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -117.45 176.52 5.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -166.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -63.8 143.71 57.63 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -164.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -131.04 -29.45 1.86 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.873 2.869 . . . . 0.0 111.38 -162.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -99.62 -163.95 1.08 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -172.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t30 85.27 -57.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.207 1.803 . . . . 0.0 113.669 161.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.65 156.63 4.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.238 0.472 . . . . 0.0 111.433 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -31.44 116.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 129.002 2.921 . . . . 0.0 113.849 169.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.46 150.29 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 126.354 1.861 . . . . 0.0 108.378 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.32 145.0 20.22 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.882 1.706 . . . . 0.0 111.498 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -131.81 157.26 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.662 1.585 . . . . 0.0 109.047 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.53 -166.73 39.92 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 165.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 72.0 78.37 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.078 2.151 . . . . 0.0 115.104 164.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 68.26 4.49 4.2 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.439 1.896 . . . . 0.0 110.671 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.8 t -82.42 115.54 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -146.66 38.62 1.03 Allowed 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 122.857 0.463 . . . . 0.0 111.805 163.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -144.81 138.68 27.25 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -116.83 130.12 56.51 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 168.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.78 120.08 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.16 148.72 31.26 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.385 1.074 . . . . 0.0 108.745 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.532 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.626 162.053 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 mttp . . . . . 0 C--O 1.235 0.309 0 CA-C-O 123.119 1.438 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -50.18 155.87 0.9 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.497 170.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.97 -178.51 30.23 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 106.727 -2.549 . . . . 0.0 106.727 165.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.6 m -137.76 147.99 45.19 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.259 1.023 . . . . 0.0 110.404 -171.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.54 135.79 51.62 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.681 168.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.4 m -83.51 109.2 17.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 162.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.8 mt -95.06 143.78 11.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.484 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 22.0 m-90 -126.11 156.33 40.23 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.529 1.132 . . . . 0.0 112.799 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.98 -47.69 28.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.907 1.683 . . . . 0.0 111.281 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.54 159.48 30.26 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -82.05 54.45 2.5 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.288 -1.125 . . . . 0.0 111.174 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.46 75.35 0.22 Allowed Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -167.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.437 ' HA ' ' CG ' ' A' ' 53' ' ' TRP . 26.0 p 50.46 38.54 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 159.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.13 176.21 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 125.067 1.347 . . . . 0.0 107.588 163.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.48 -156.7 32.2 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -68.24 153.25 44.12 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.484 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 10.5 p -129.87 166.49 19.87 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 124.468 1.105 . . . . 0.0 111.52 161.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.45 156.77 47.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 159.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.8 p -103.35 80.37 1.81 Allowed 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 135.09 34.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -169.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.4 m -128.1 134.27 49.12 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -173.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.79 114.26 11.03 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.626 -170.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -62.86 165.28 16.64 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.661 2.241 . . . . 0.0 114.748 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.74 53.67 1.67 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.933 1.293 . . . . 0.0 113.713 -162.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.416 ' H ' ' H ' ' A' ' 71' ' ' THR . 6.4 p30 157.54 14.24 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.606 2.762 . . . . 0.0 110.434 -167.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.416 ' H ' ' H ' ' A' ' 70' ' ' ASN . 95.1 m -104.98 136.45 44.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.04 127.14 37.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 160.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.7 m -121.63 136.68 54.94 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.918 1.687 . . . . 0.0 107.59 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -90.29 113.89 25.83 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.793 0.837 . . . . 0.0 111.408 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 75' ' ' ILE . 1.3 mp -84.84 66.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 124.609 1.163 . . . . 0.0 108.535 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -130.86 73.82 1.56 Allowed 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 163.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.43 177.48 5.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 176.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.26 -30.66 71.55 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -80.68 155.74 26.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 163.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.29 158.45 34.0 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.66 123.98 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -169.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -136.89 -13.14 1.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 p -154.55 171.14 19.91 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.512 -0.742 . . . . 0.0 110.459 166.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -164.52 170.27 16.08 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 6.1 tpt180 -153.23 144.64 23.23 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 158.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -67.94 134.1 50.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 123.623 0.577 . . . . 0.0 109.772 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.39 -30.97 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.052 0.941 . . . . 0.0 111.668 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 p90 . . . . . 0 C--O 1.234 0.258 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.6 tt -158.41 111.6 2.38 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.199 0.999 . . . . 0.0 109.046 168.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.41 HG22 ' HA ' ' A' ' 20' ' ' TRP . 27.9 pt -120.3 163.08 18.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 124.207 1.003 . . . . 0.0 111.248 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.09 152.3 18.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.238 1.415 . . . . 0.0 107.803 164.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.0 m -143.23 165.49 27.32 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.256 0.622 . . . . 0.0 109.757 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -79.07 -21.84 46.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.787 0.835 . . . . 0.0 112.476 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.49 172.25 18.87 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.34 3.86 1.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.882 1.273 . . . . 0.0 113.123 -175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -104.86 99.77 20.58 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.504 1.522 . . . . 0.0 109.961 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.12 -19.36 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.551 2.167 . . . . 0.0 112.275 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -70.72 -49.21 49.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.189 0.595 . . . . 0.0 109.566 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -127.69 16.4 6.95 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.7 -28.17 72.16 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 119.219 -2.176 . . . . 0.0 112.368 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 m 55.12 93.21 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -159.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.0 m -126.53 141.65 51.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -160.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.255 1.3 p-10 -85.15 102.71 13.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.475 1.131 . . . . 0.0 110.577 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.41 ' HA ' HG22 ' A' ' 6' ' ' ILE . 83.5 m95 -83.04 47.68 1.26 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.816 2.446 . . . . 0.0 107.375 171.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -96.71 172.14 8.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.96 1.704 . . . . 0.0 109.031 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.01 144.34 34.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -146.58 27.25 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.555 0.742 . . . . 0.0 112.345 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -100.16 114.5 27.95 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.098 0.959 . . . . 0.0 109.544 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 50.31 53.92 12.04 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.726 0.774 . . . . 0.0 110.127 174.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.9 t -148.23 138.67 22.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.0 t -67.23 99.49 0.7 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.315 1.446 . . . . 0.0 108.205 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.9 t -128.99 118.96 48.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.417 0.687 . . . . 0.0 109.456 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.2 135.19 23.8 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 125.683 1.611 . . . . 0.0 111.235 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.2 mt -84.14 159.82 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.796 2.038 . . . . 0.0 106.903 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 179.2 164.59 32.06 Favored Glycine 0 N--CA 1.449 -0.451 0 O-C-N 121.403 -0.811 . . . . 0.0 113.35 164.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.1 74.7 0.22 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.161 2.185 . . . . 0.0 113.983 166.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 67.71 3.58 3.51 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.631 2.372 . . . . 0.0 110.902 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.5 t -79.21 99.58 3.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 O-C-N 121.153 -0.967 . . . . 0.0 109.681 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -143.87 43.01 1.46 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.797 1.639 . . . . 0.0 109.226 170.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -139.34 139.26 37.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.421 ' H ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -107.05 136.99 45.98 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 164.304 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.34 117.51 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.2 p -94.74 160.98 14.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.687 0 C-N-CA 124.483 1.04 . . . . 0.0 113.597 -178.497 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.1 mttt . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -63.24 143.61 57.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.297 159.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.05 157.12 15.24 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-O 117.167 -1.907 . . . . 0.0 108.685 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 38.2 m -139.47 151.33 46.11 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 121.136 2.468 . . . . 0.0 108.561 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.26 140.16 52.04 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 124.642 1.177 . . . . 0.0 108.479 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.2 m -83.9 119.9 25.43 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 159.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 mt -97.19 147.87 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 126.398 1.879 . . . . 0.0 106.082 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 3.1 m-90 -125.27 158.2 34.72 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.105 1.762 . . . . 0.0 111.096 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -93.43 -34.02 13.6 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 125.086 1.354 . . . . 0.0 111.581 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.07 138.77 37.33 Favored Glycine 0 CA--C 1.523 0.57 0 O-C-N 120.454 -1.404 . . . . 0.0 110.074 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -70.57 75.44 0.58 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.746 1.219 . . . . 0.0 110.325 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.57 -65.14 0.16 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 21.2 p 156.66 41.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 129.824 3.249 . . . . 0.0 110.792 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 m -125.8 176.4 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.967 1.307 . . . . 0.0 108.023 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.87 -151.53 27.65 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -77.01 152.37 35.19 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.988 1.315 . . . . 0.0 108.011 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -152.84 151.45 30.43 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.622 0.576 . . . . 0.0 112.47 -167.166 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -145.06 138.69 26.87 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -85.02 99.85 11.29 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.333 0.653 . . . . 0.0 110.273 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -88.37 124.95 34.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 99.3 m -110.02 139.47 45.1 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.9 t -132.47 136.22 27.58 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.15 -0.929 . . . . 0.0 109.768 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.53 -179.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.334 2.689 . . . . 0.0 114.484 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.23 155.84 37.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.22 167.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 33.95 57.6 0.6 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.783 2.033 . . . . 0.0 114.134 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 t -154.71 165.73 35.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.883 0.849 . . . . 0.0 110.75 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.84 139.22 34.83 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.814 2.446 . . . . 0.0 109.478 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.9 m -131.77 135.96 47.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.613 1.565 . . . . 0.0 107.127 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -85.62 114.8 22.89 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.254 0.934 . . . . 0.0 110.731 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.456 HG22 HG13 ' A' ' 81' ' ' ILE . 1.7 mp -86.77 72.74 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 108.817 -174.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -110.57 152.43 26.44 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 158.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.2 p -144.66 -159.73 1.04 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.074 0.852 . . . . 0.0 108.822 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.49 -15.56 79.1 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.434 -0.648 . . . . 0.0 112.882 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -136.39 163.22 30.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 118.859 1.33 . . . . 0.0 108.687 173.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -69.21 133.82 48.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.456 HG13 HG22 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -103.37 129.78 54.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.04 0.936 . . . . 0.0 109.471 -162.298 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -123.96 -29.01 3.7 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -162.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.1 169.71 20.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 117.789 -1.1 . . . . 0.0 110.439 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -157.61 163.62 38.1 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 120.132 1.333 . . . . 0.0 112.906 169.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -125.25 128.65 48.62 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.608 1.963 . . . . 0.0 108.158 161.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.9 mmm-85 -58.86 134.23 56.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 161.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.42 -50.6 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -170.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . 0.357 15.9 pt-20 . . . . . 0 N--CA 1.429 -1.475 1 C-N-CA 132.926 4.491 . . . . 0.0 111.433 158.297 . . . . . . . . 2 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.0 p90 . . . . . 0 CA--C 1.516 -0.344 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 tt -140.34 131.49 26.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 20' ' ' TRP . 12.7 pt -147.59 146.46 18.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.393 1.077 . . . . 0.0 109.426 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -95.02 141.85 28.19 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.24 0.616 . . . . 0.0 110.005 167.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.9 m -134.56 152.45 51.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.599 1.16 . . . . 0.0 108.555 -172.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -78.66 -16.65 57.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -143.82 -167.93 2.72 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.622 1.169 . . . . 0.0 109.331 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 40.2 t -90.27 4.01 51.93 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.666 0.786 . . . . 0.0 112.887 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -105.0 106.79 56.87 Favored Pre-proline 0 C--N 1.331 -0.217 0 C-N-CA 123.989 0.916 . . . . 0.0 109.319 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.38 -23.86 75.37 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 CA-C-N 120.009 1.039 . . . . 0.0 111.946 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -71.2 -63.93 1.01 Allowed 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 122.045 -0.409 . . . . 0.0 110.343 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -109.99 13.22 23.44 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.94 -30.5 59.26 Favored Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m 70.15 110.75 0.05 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -159.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.5 m -122.5 146.04 47.76 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.35 107.82 20.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.614 1.197 . . . . 0.0 110.806 169.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.411 ' HA ' HG22 ' A' ' 6' ' ' ILE . 63.7 m95 -83.72 48.32 1.42 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.669 2.388 . . . . 0.0 107.276 174.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -92.83 153.91 18.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.81 142.94 57.18 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 173.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -146.88 19.49 1.28 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.376 1.071 . . . . 0.0 112.307 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -95.13 129.43 42.23 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -166.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 53.31 43.94 30.78 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.129 0.572 . . . . 0.0 110.099 172.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 t -159.87 163.69 34.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.171 -0.956 . . . . 0.0 110.631 -170.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 54.1 t -92.79 96.0 9.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.97 2.108 . . . . 0.0 110.07 -166.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -111.99 104.12 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 119.373 0.988 . . . . 0.0 111.072 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.48 127.76 37.61 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 167.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.2 mt -84.05 156.86 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.327 2.251 . . . . 0.0 106.013 166.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.66 -166.29 22.27 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.281 . . 34.02 75.13 0.05 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 47.41 22.5 0.28 Allowed 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 125.099 1.359 . . . . 0.0 112.282 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.76 118.06 18.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 119.391 -0.924 . . . . 0.0 108.963 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.28 37.45 1.25 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.743 0.817 . . . . 0.0 111.025 171.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -142.88 134.24 26.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 45.4 ttm -113.47 127.34 56.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 165.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -123.64 91.11 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 t -108.3 155.46 20.48 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.603 0.716 . . . . 0.0 111.473 -158.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.623 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.389 0 C-N-CA 125.845 1.688 . . . . 0.0 112.764 -175.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -57.28 169.69 0.57 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.018 1.327 . . . . 0.0 113.018 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -129.88 158.67 22.37 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 62.2 m -143.69 155.67 44.29 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 117.88 0.84 . . . . 0.0 109.118 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.43 148.14 40.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.875 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -84.03 144.54 29.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 162.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -127.19 152.11 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.445 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 21.8 m-90 -133.6 149.98 51.61 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.218 1.372 . . . . 0.0 112.916 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.69 -54.39 23.61 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.658 1.183 . . . . 0.0 109.067 164.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.38 124.63 11.15 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -168.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.54 67.49 0.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.448 3.099 . . . . 0.0 112.552 -162.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.69 -55.12 0.08 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 127.391 2.424 . . . . 0.0 107.919 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 20.0 p 163.65 50.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 130.544 3.538 . . . . 0.0 108.641 166.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.99 176.65 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.979 1.712 . . . . 0.0 108.281 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.79 -157.41 51.54 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.69 132.37 34.87 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 117.691 0.745 . . . . 0.0 109.017 -166.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 10.1 p -113.64 157.23 22.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 123.598 0.561 . . . . 0.0 112.428 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.83 -177.76 4.58 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 127.352 2.261 . . . . 0.0 106.856 174.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 t -135.15 136.86 42.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -142.32 114.78 8.44 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.044 0.538 . . . . 0.0 110.013 -173.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.7 m -96.05 143.22 27.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.819 1.248 . . . . 0.0 109.557 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.7 t -141.9 123.97 9.1 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.259 1.423 . . . . 0.0 110.511 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.87 145.6 72.15 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.225 1.95 . . . . 0.0 111.506 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.623 ' HB1' ' HA3' ' A' ' 40' ' ' GLY . . . -73.31 140.04 46.48 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 161.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.6 m120 74.11 45.21 0.22 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -170.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -154.62 144.38 21.6 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 171.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.89 125.19 36.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.424 1.49 . . . . 0.0 108.086 164.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 55.6 m -116.21 136.8 52.69 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 124.905 1.282 . . . . 0.0 109.179 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -98.69 110.83 23.36 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.156 0.982 . . . . 0.0 109.55 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -82.75 96.29 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 122.167 0.984 . . . . 0.0 108.767 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.52 158.08 44.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 163.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.3 p -132.77 -150.1 0.4 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 167.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.31 -28.73 67.48 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 164.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -125.89 165.05 19.44 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.297 1.039 . . . . 0.0 110.082 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -80.58 137.39 36.38 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.558 ' N ' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -113.64 148.89 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.107 0.963 . . . . 0.0 109.957 -170.716 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -134.97 -3.67 2.49 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 124.364 1.065 . . . . 0.0 113.333 -170.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.85 164.1 31.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 164.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -144.32 171.79 13.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.104 0.961 . . . . 0.0 112.267 166.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.46 123.88 10.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.52 1.928 . . . . 0.0 106.027 169.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -70.28 138.74 51.83 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 119.199 0.909 . . . . 0.0 109.01 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -104.69 -42.08 7.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 125.04 1.336 . . . . 0.0 110.873 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -177.615 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.52 -0.194 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tt -141.57 103.14 4.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.71 161.13 39.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.4 ptp -125.61 154.46 42.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 122.619 1.2 . . . . 0.0 111.284 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 1.3 m -135.78 169.56 17.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.108 1.763 . . . . 0.0 107.261 -163.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -79.45 -24.61 42.31 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 166.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -139.19 -176.63 4.58 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 172.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.8 t -83.28 3.61 30.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.869 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -113.11 113.95 48.92 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.942 0.897 . . . . 0.0 109.304 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.73 -39.23 21.17 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 120.997 1.392 . . . . 0.0 110.806 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -69.96 -34.01 72.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.482 1.913 . . . . 0.0 111.09 -165.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.8 t -135.46 15.03 3.45 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.37 -46.65 5.18 Favored Glycine 0 CA--C 1.519 0.309 0 O-C-N 120.463 -1.398 . . . . 0.0 110.755 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t 82.04 124.79 0.04 OUTLIER 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.605 1.562 . . . . 0.0 108.552 -166.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 1.2 m -125.85 170.75 11.32 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.059 1.743 . . . . 0.0 110.448 -177.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -90.31 94.02 9.57 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 123.164 1.459 . . . . 0.0 113.122 165.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -83.43 45.68 1.07 Allowed 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.724 -1.235 . . . . 0.0 108.428 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -85.77 163.96 17.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.74 1.616 . . . . 0.0 109.592 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -70.98 143.34 50.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 161.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -137.3 -44.44 0.55 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -167.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -48.21 113.94 0.84 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.592 1.557 . . . . 0.0 109.614 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 55.85 19.51 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.403 1.481 . . . . 0.0 112.667 174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -114.34 179.76 3.86 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -175.334 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.0 t -149.36 74.85 1.26 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 121.183 1.811 . . . . 0.0 109.96 -166.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 t -83.81 163.94 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -166.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.73 115.81 5.21 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 124.631 1.11 . . . . 0.0 111.103 163.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.11 152.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 126.36 1.864 . . . . 0.0 107.551 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.92 -165.52 38.98 Favored Glycine 0 N--CA 1.444 -0.801 0 O-C-N 121.649 -0.657 . . . . 0.0 111.84 167.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 71.09 73.15 0.19 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.687 2.395 . . . . 0.0 113.548 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 61.11 11.27 3.35 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.568 1.547 . . . . 0.0 110.777 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 24.6 t -73.6 108.84 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -173.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -146.63 34.61 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 170.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -140.71 113.62 8.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.309 0.959 . . . . 0.0 111.756 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.472 ' HB2' HD11 ' A' ' 75' ' ' ILE . 44.3 ttp -84.07 138.92 32.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.06 101.54 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.2 p -93.6 49.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.429 -0.794 . . . . 0.0 111.595 -159.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.391 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -171.209 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -59.51 164.78 3.24 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.0 132.68 8.73 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 170.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 86.0 m -132.99 149.14 52.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.9 140.5 16.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.67 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.8 m -86.66 117.3 25.33 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 166.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 mm -99.47 149.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -130.57 160.34 34.47 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.315 1.446 . . . . 0.0 112.002 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -89.49 -35.34 16.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.087 2.155 . . . . 0.0 111.322 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.75 144.48 38.49 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -76.75 64.02 2.26 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.93 33.73 0.02 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.26 27.9 p 44.65 42.4 5.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.557 1.543 . . . . 0.0 112.226 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -126.18 176.34 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 126.729 2.012 . . . . 0.0 107.695 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.17 -156.93 32.93 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -69.46 153.16 43.95 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.53 168.81 22.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.21 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.93 149.73 26.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.45 106.54 17.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -91.34 83.92 5.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.0 m -84.0 139.42 32.55 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 18.9 t -145.16 142.11 17.99 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 125.122 1.369 . . . . 0.0 109.446 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.33 177.27 2.16 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.974 1.782 . . . . 0.0 111.384 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.55 149.11 42.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.168 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 50.67 38.53 19.37 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.038 1.335 . . . . 0.0 110.094 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.4 m -115.52 137.3 52.21 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -98.17 114.09 26.2 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.26 106.01 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.84 2.056 . . . . 0.0 107.823 -162.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -64.42 136.15 56.81 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.887 0.851 . . . . 0.0 110.637 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 37' ' ' MET . 12.5 mm -101.86 117.45 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.79 65.57 1.05 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.5 p -73.94 161.79 29.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.269 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -54.14 -52.88 40.78 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -80.64 157.55 25.93 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.527 0.68 . . . . 0.0 110.62 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -76.15 134.43 39.95 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.893 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.09 132.79 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -168.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -135.93 -27.81 1.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -173.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 p -152.69 171.87 17.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.563 0.619 . . . . 0.0 111.251 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -156.32 170.06 23.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.633 0.651 . . . . 0.0 111.157 176.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 26' ' ' THR . 14.5 mtt180 -140.2 147.1 39.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.496 1.918 . . . . 0.0 109.31 159.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -63.58 163.53 11.04 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.624 0.769 . . . . 0.0 110.607 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.09 -36.51 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 117.809 0.277 . . . . 0.0 110.458 159.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 163.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.9 p90 . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.94 88.59 2.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 159.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pt -108.3 162.47 6.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 169.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 ptm -108.24 167.94 9.66 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.493 1.139 . . . . 0.0 110.118 161.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 82.2 m -153.58 163.22 40.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 124.5 1.12 . . . . 0.0 108.496 -158.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -85.58 -21.37 28.54 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -133.58 -175.15 3.73 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.811 0.444 . . . . 0.0 111.267 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.1 t -92.13 3.46 55.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.307 1.043 . . . . 0.0 111.811 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -132.98 88.71 36.2 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 126.011 1.725 . . . . 0.0 110.088 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -48.76 -26.77 10.06 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.203 3.268 . . . . 0.0 113.293 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -64.3 -44.32 91.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.46 -0.775 . . . . 0.0 111.495 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.7 p -104.13 13.83 31.65 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.65 135.3 7.48 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 123.966 0.793 . . . . 0.0 112.898 172.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -63.75 137.78 58.21 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.086 -0.655 . . . . 0.0 109.821 169.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 89.3 m -130.39 157.21 43.22 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 125.372 1.469 . . . . 0.0 107.317 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -85.07 93.43 8.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 123.677 1.704 . . . . 0.0 110.821 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -83.87 50.93 1.92 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.658 1.983 . . . . 0.0 107.122 169.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -119.23 -174.1 2.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.88 1.672 . . . . 0.0 108.255 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.11 143.12 50.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 167.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -146.5 5.69 0.93 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.693 -166.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.411 ' CG ' ' N ' ' A' ' 25' ' ' ASN . 19.8 t-105 -78.07 -163.63 0.45 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -165.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' N ' ' CG ' ' A' ' 24' ' ' TRP . 15.0 t-20 -68.31 61.55 0.09 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.526 2.731 . . . . 0.0 110.411 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 t -141.93 149.79 40.61 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 127.477 2.311 . . . . 0.0 105.692 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.2 t -72.56 69.8 0.89 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.433 1.493 . . . . 0.0 111.706 -164.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.3 t -93.42 124.84 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.125 0.97 . . . . 0.0 109.53 -165.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.77 132.39 11.34 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -83.71 153.3 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 169.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.13 158.52 29.86 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 68.87 69.38 0.28 Allowed 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 127.343 2.257 . . . . 0.0 115.835 169.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 49.84 19.26 0.42 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.596 1.159 . . . . 0.0 112.304 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.45 110.86 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -146.26 26.42 1.19 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.939 0.895 . . . . 0.0 112.771 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -138.56 121.45 16.58 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.295 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.587 ' H ' HD13 ' A' ' 75' ' ' ILE . 53.1 tpp -83.62 134.7 34.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -131.05 120.21 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.1 p -104.14 45.37 0.96 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.184 0.993 . . . . 0.0 109.975 -159.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -175.465 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.274 0.559 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -53.96 146.19 14.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.564 1.146 . . . . 0.0 111.739 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.43 136.21 10.3 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 59.0 m -122.8 149.76 43.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.01 136.83 21.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.633 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.6 m -89.45 117.38 28.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 170.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.1 mt -106.53 137.92 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.028 1.731 . . . . 0.0 107.049 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.451 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 5.0 m-90 -122.14 160.63 24.69 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.54 1.536 . . . . 0.0 112.7 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -91.79 -33.89 14.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.494 2.318 . . . . 0.0 111.236 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.41 128.02 9.44 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 124.668 1.128 . . . . 0.0 111.736 -169.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -44.29 121.31 2.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.814 2.046 . . . . 0.0 112.087 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.38 -60.56 0.59 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 126.574 2.035 . . . . 0.0 109.593 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 30.6 p 168.94 43.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.385 1.874 . . . . 0.0 111.472 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 m -120.41 176.75 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.36 -157.93 28.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -73.59 158.57 34.55 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 126.246 1.818 . . . . 0.0 108.161 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.451 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.4 p -159.18 160.68 35.75 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.987 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.0 p -142.67 149.9 39.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.1 t -91.17 128.24 36.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -119.95 116.04 24.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.924 1.69 . . . . 0.0 108.491 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 11.5 m -98.09 146.73 25.26 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.516 0.726 . . . . 0.0 109.77 173.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.2 t -149.41 136.85 11.24 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.405 1.082 . . . . 0.0 111.01 173.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.88 177.75 3.32 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.912 1.741 . . . . 0.0 112.213 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.4 175.24 7.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 37.73 54.1 1.51 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 126.071 1.748 . . . . 0.0 112.265 171.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.24 168.44 25.98 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.923 0.868 . . . . 0.0 108.948 175.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.18 134.34 52.85 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.705 2.002 . . . . 0.0 107.244 172.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.83 118.16 20.38 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -169.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -78.55 122.94 26.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.951 -0.468 . . . . 0.0 110.013 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.587 HD13 ' H ' ' A' ' 37' ' ' MET . 1.9 mp -102.42 104.19 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 169.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.05 69.86 1.26 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 169.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 p -74.01 176.01 6.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.238 1.815 . . . . 0.0 110.58 -162.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.99 -41.59 92.42 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -93.72 164.18 13.24 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.768 0.827 . . . . 0.0 110.545 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -80.93 133.82 35.61 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.85 129.89 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.086 0.554 . . . . 0.0 110.039 -169.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ttt85 -136.54 -13.2 1.76 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -172.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.84 169.32 16.76 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.454 -0.779 . . . . 0.0 111.708 -173.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -166.9 171.79 10.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.463 0.649 . . . . 0.0 112.46 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . 0.295 0.0 OUTLIER -137.56 135.83 37.04 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 129.281 3.033 . . . . 0.0 105.227 170.549 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -64.5 159.19 22.09 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 158.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.09 -41.54 3.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 119.351 0.978 . . . . 0.0 111.171 163.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 172.988 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.8 p90 . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -150.01 103.98 3.25 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 pt -153.1 159.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.335 1.854 . . . . 0.0 107.843 -167.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.7 ptm -106.55 147.2 29.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.946 0.898 . . . . 0.0 110.088 166.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 1.3 m -117.87 162.31 18.32 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 10.8 pttt -62.86 -37.47 86.97 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 116.347 -2.141 . . . . 0.0 109.936 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -122.15 -171.25 2.21 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 126.831 2.053 . . . . 0.0 109.143 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 50.8 t -78.47 3.23 16.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -118.3 114.52 36.54 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 121.269 -0.894 . . . . 0.0 113.166 -164.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.67 -23.48 56.36 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 120.932 1.088 . . . . 0.0 111.834 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -64.54 -63.11 1.21 Allowed 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.448 1.022 . . . . 0.0 110.221 -176.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -118.92 13.76 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.9 -19.38 78.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.456 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.9 m 58.33 93.22 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -160.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 1.2 m -98.04 145.31 26.65 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -91.61 98.88 11.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.536 1.16 . . . . 0.0 109.474 172.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -83.38 45.56 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.801 2.04 . . . . 0.0 107.995 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.54 -177.68 6.79 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.373 1.469 . . . . 0.0 110.198 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -63.71 150.36 44.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 163.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -139.86 -15.7 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.029 0.932 . . . . 0.0 111.894 176.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -91.08 112.98 25.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 48.72 64.52 1.67 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.709 1.203 . . . . 0.0 110.044 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.21 -178.61 4.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.81 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.3 t -154.41 54.61 0.69 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -94.7 129.98 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 125.395 1.478 . . . . 0.0 109.384 -170.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.15 126.58 7.77 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.783 0.706 . . . . 0.0 112.41 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 mm -107.14 166.24 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 130.406 3.482 . . . . 0.0 108.426 -174.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.85 175.88 25.62 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 165.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 91.32 79.89 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 129.763 3.225 . . . . 0.0 112.343 174.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 80.61 6.96 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 129.34 3.056 . . . . 0.0 110.819 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 62.1 t -83.99 118.49 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 CA-C-N 118.912 0.778 . . . . 0.0 112.467 -164.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.414 ' CE1' ' HE1' ' A' ' 36' ' ' TRP . 4.4 p80 -146.55 35.53 0.96 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 163.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.414 ' HE1' ' CE1' ' A' ' 35' ' ' HIS . 74.6 m95 -140.67 124.47 17.16 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.148 1.34 . . . . 0.0 112.224 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.567 ' H ' HD13 ' A' ' 75' ' ' ILE . 14.1 tpt -84.89 131.14 34.54 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 161.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.47 85.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -172.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 t -93.95 143.89 25.94 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 C-N-CA 124.493 1.044 . . . . 0.0 111.286 -178.016 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -53.03 144.46 15.12 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.56 153.6 16.9 Favored Glycine 0 C--O 1.239 0.442 0 N-CA-C 107.078 -2.409 . . . . 0.0 107.078 167.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.6 m -126.52 144.23 50.94 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.93 126.68 49.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.0 m -83.59 118.88 24.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 168.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 mt -96.65 150.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 -129.08 157.85 40.59 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.984 1.714 . . . . 0.0 111.549 -175.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -82.42 -44.28 16.26 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.09 2.156 . . . . 0.0 111.636 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.81 135.15 21.33 Favored Glycine 0 N--CA 1.449 -0.494 0 O-C-N 120.999 -1.063 . . . . 0.0 111.098 -173.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.1 m -54.48 102.54 0.06 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.587 0.755 . . . . 0.0 109.979 171.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.53 -75.92 0.4 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 24.0 p 158.69 42.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 128.692 2.797 . . . . 0.0 110.397 -174.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.38 176.28 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.33 -167.19 44.81 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 119.615 1.098 . . . . 0.0 110.592 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -73.84 149.57 41.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.497 -1.002 . . . . 0.0 108.874 -170.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.9 161.34 40.94 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.103 -163.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.53 117.05 4.66 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -167.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.5 m -71.55 100.25 2.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.317 0.647 . . . . 0.0 109.51 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.8 tpp -84.04 103.56 13.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.655 1.182 . . . . 0.0 107.836 172.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 50.7 m -84.7 146.45 27.43 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.3 t -155.53 108.31 2.2 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.447 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.2 162.13 14.82 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.844 2.363 . . . . 0.0 113.297 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.53 137.94 44.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 58.76 48.56 11.23 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.348 1.859 . . . . 0.0 110.853 -166.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m -124.44 116.81 23.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.314 0.578 . . . . 0.0 109.99 170.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.406 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -74.35 114.11 12.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 158.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.2 m -116.2 123.84 48.78 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.286 1.834 . . . . 0.0 107.922 -172.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -78.24 132.49 37.56 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 118.454 0.57 . . . . 0.0 110.364 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 37' ' ' MET . 1.2 mp -98.35 107.54 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -123.52 144.63 49.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 p -142.35 -161.93 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 175.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.39 15.58 57.41 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.073 168.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.7 169.97 17.42 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 119.075 1.437 . . . . 0.0 109.425 -173.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -70.51 133.98 47.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 170.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.61 128.75 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.19 -46.97 0.64 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.559 -158.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -133.06 175.89 8.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 119.758 1.163 . . . . 0.0 110.424 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -160.64 163.86 32.25 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 119.779 1.172 . . . . 0.0 113.34 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.06 127.77 10.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 169.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -66.1 115.87 6.59 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.53 -39.33 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 C-N-CA 124.612 1.165 . . . . 0.0 110.047 -168.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.92 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 p90 . . . . . 0 C--O 1.235 0.297 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 tt -140.98 117.71 11.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.211 1.404 . . . . 0.0 108.266 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.27 165.95 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 123.783 0.833 . . . . 0.0 110.077 174.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.6 ptm -105.51 142.39 35.34 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 108.541 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -138.46 158.53 44.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.651 1.181 . . . . 0.0 108.935 -165.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -82.57 -5.88 59.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.63 -172.44 3.12 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.219 1.408 . . . . 0.0 108.149 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.7 t -86.43 3.57 43.26 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.594 0.757 . . . . 0.0 112.081 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -128.43 105.71 19.35 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 118.754 -0.641 . . . . 0.0 111.574 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -58.14 -24.89 68.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.513 1.476 . . . . 0.0 111.581 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -63.83 -27.69 69.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.223 -0.923 . . . . 0.0 110.953 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.0 t -138.79 23.23 2.65 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.352 0.661 . . . . 0.0 111.338 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.05 123.7 5.98 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 164.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.14 94.59 4.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 171.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.5 m -92.44 149.77 21.19 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -171.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -96.29 98.9 10.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.798 0.808 . . . . 0.0 111.462 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -83.77 44.83 1.02 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 130.028 3.331 . . . . 0.0 111.304 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -101.28 174.13 6.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.748 1.219 . . . . 0.0 110.057 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -65.04 143.82 57.68 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.496 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.27 -27.35 8.71 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.931 1.292 . . . . 0.0 109.913 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -84.52 143.28 29.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.785 1.634 . . . . 0.0 106.812 -177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 44.92 43.57 7.23 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.818 1.647 . . . . 0.0 111.527 171.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 t -162.98 149.31 12.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 167.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.4 t -115.97 84.17 2.07 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.581 1.152 . . . . 0.0 111.282 -165.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.5 t -84.8 153.63 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.119 -165.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.02 154.21 31.7 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.448 1.023 . . . . 0.0 111.63 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.4 166.15 8.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 128.103 2.561 . . . . 0.0 105.831 172.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.02 162.22 12.57 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-O 121.439 0.466 . . . . 0.0 113.117 164.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 62.51 81.48 0.2 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.466 2.307 . . . . 0.0 111.185 -175.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 66.24 3.66 2.83 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 125.919 1.687 . . . . 0.0 111.339 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.0 t -102.56 99.31 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -145.99 33.4 1.01 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.168 0.987 . . . . 0.0 111.08 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -144.45 121.84 11.65 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.598 ' H ' HD13 ' A' ' 75' ' ' ILE . 43.0 ttm -85.4 138.77 32.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 158.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 t -134.08 150.31 31.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.6 p -129.06 -173.92 3.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.445 0.698 . . . . 0.0 109.343 -170.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.672 0 CA-C-O 118.611 -1.105 . . . . 0.0 112.445 161.544 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -43.61 143.76 0.92 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.87 0.868 . . . . 0.0 111.601 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -146.86 157.62 27.47 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -171.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.4 m -136.65 154.6 50.6 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.888 0.875 . . . . 0.0 108.869 -172.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.29 141.61 49.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.795 1.238 . . . . 0.0 109.023 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 m -83.61 116.96 22.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 159.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -94.46 145.54 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -126.28 151.61 47.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.71 1.604 . . . . 0.0 109.722 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -58.65 -40.81 84.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 124.384 1.074 . . . . 0.0 109.766 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 82' ' ' ARG . . . -163.2 175.85 39.47 Favored Glycine 0 C--O 1.221 -0.71 0 C-N-CA 116.097 -2.954 . . . . 0.0 120.434 175.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.9 m 32.29 80.84 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.875 2.87 . . . . 0.0 116.314 159.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.3 43.53 95.02 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 52.55 69.25 0.71 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.062 1.345 . . . . 0.0 111.902 171.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.12 175.93 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 C-N-CA 126.743 2.017 . . . . 0.0 107.921 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.6 -160.0 53.41 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ttp-105 -76.82 156.6 32.14 Favored 'General case' 0 CA--C 1.5 -0.956 0 O-C-N 121.934 -0.744 . . . . 0.0 109.585 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.42 144.24 34.35 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.864 -172.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 p -139.93 147.24 40.25 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.065 1.346 . . . . 0.0 108.466 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 t -85.57 113.06 21.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.4 tpt -86.14 139.41 31.12 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 165.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 50.8 m -139.06 143.04 38.2 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.2 t -150.77 123.53 4.17 Favored Pre-proline 0 CA--C 1.535 0.365 0 C-N-CA 124.134 0.974 . . . . 0.0 110.026 -170.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -52.99 157.35 8.25 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.943 2.428 . . . . 0.0 110.646 168.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.8 138.57 32.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.034 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 77.04 44.47 0.1 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 125.748 1.619 . . . . 0.0 109.192 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -149.9 169.3 21.48 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 164.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.6 t -113.15 139.14 48.99 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.018 1.727 . . . . 0.0 107.751 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 24.7 m -140.96 101.63 4.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -163.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -67.67 130.39 42.87 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.795 -0.566 . . . . 0.0 110.25 176.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.598 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -94.13 106.88 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.302 1.841 . . . . 0.0 106.954 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -166.39 71.02 0.13 Allowed 'General case' 0 N--CA 1.461 0.107 0 O-C-N 121.7 -0.625 . . . . 0.0 109.681 176.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 p -74.4 -160.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.124 0.488 . . . . 0.0 110.471 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.8 -24.66 60.41 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 121.374 -0.829 . . . . 0.0 111.783 168.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -118.26 153.89 33.18 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.525 1.163 . . . . 0.0 109.317 169.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -73.87 141.5 46.07 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 125.806 1.942 . . . . 0.0 107.093 163.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.06 136.21 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 124.137 0.975 . . . . 0.0 109.047 -168.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.412 ' HB3' ' HA2' ' A' ' 55' ' ' GLY . 46.6 ttt180 -106.76 -22.27 12.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 116.975 -1.488 . . . . 0.0 112.803 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -137.16 170.7 15.65 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 122.909 2.595 . . . . 0.0 113.316 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -160.11 166.84 29.06 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.069 0.548 . . . . 0.0 109.999 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.11 145.48 28.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -71.34 149.91 45.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.085 0.954 . . . . 0.0 112.312 -170.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.6 m -137.42 -7.4 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-N 120.814 1.643 . . . . 0.0 109.299 158.66 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.5 p90 . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.517 HD21 ' SD ' ' A' ' 37' ' ' MET . 1.3 tt -136.22 91.51 2.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.394 1.478 . . . . 0.0 107.248 176.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.07 159.31 11.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.409 1.084 . . . . 0.0 109.568 174.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.469 ' HB2' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -111.72 166.85 10.82 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 126.169 1.788 . . . . 0.0 114.6 166.117 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 64.0 m -151.12 160.27 43.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.275 1.83 . . . . 0.0 109.555 -159.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.3 -39.42 78.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.572 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -138.98 -170.16 2.8 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 125.875 1.67 . . . . 0.0 108.056 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 t -76.05 3.59 10.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -107.04 104.32 51.5 Favored Pre-proline 0 CA--C 1.539 0.524 0 O-C-N 121.644 -0.66 . . . . 0.0 112.191 -164.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.39 -23.51 51.04 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.99 1.793 . . . . 0.0 112.27 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.52 -56.28 5.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.705 1.202 . . . . 0.0 109.648 -172.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.2 t -132.82 13.85 4.37 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 112.702 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.39 -45.91 58.57 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 168.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 t 76.9 124.63 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.264 1.426 . . . . 0.0 107.848 -164.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 83.4 m -136.58 140.12 42.65 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 125.633 1.573 . . . . 0.0 107.882 -164.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.254 7.5 p-10 -82.78 97.51 8.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 120.566 1.53 . . . . 0.0 110.363 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -82.74 53.23 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.901 2.08 . . . . 0.0 108.484 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -84.92 156.25 21.31 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 158.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.09 144.12 30.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 165.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -143.15 41.02 1.5 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.469 0.708 . . . . 0.0 109.347 -165.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -124.99 130.44 52.36 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -169.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 t30 51.13 55.71 9.11 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.448 0.699 . . . . 0.0 110.117 -172.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 t -160.39 146.88 15.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.761 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -79.57 71.88 6.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 128.8 2.84 . . . . 0.0 108.097 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.5 t -84.21 139.06 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 O-C-N 121.712 -0.617 . . . . 0.0 109.397 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.59 139.29 24.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 31' ' ' GLY . 45.7 mm -98.19 166.22 2.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 125.315 1.446 . . . . 0.0 107.238 168.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.427 ' N ' HG22 ' A' ' 30' ' ' ILE . . . 96.27 170.07 34.77 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 57.65 100.9 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.865 2.066 . . . . 0.0 112.615 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.42 10.68 4.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.383 1.073 . . . . 0.0 112.566 169.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.469 HG13 ' HB2' ' A' ' 7' ' ' MET . 1.6 t -136.19 113.1 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -146.75 18.12 1.29 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -138.31 114.14 9.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.517 ' SD ' HD21 ' A' ' 5' ' ' LEU . 48.1 ttp -85.4 124.75 32.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.43 94.86 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -93.97 127.49 39.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -171.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.833 0 CA-C-O 125.938 2.966 . . . . 0.0 110.024 168.958 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? . . . . . 0 N--CA 1.442 -0.834 0 CA-C-O 121.258 0.551 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -44.07 143.51 1.14 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.064 0.946 . . . . 0.0 110.549 164.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.89 144.0 16.85 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 170.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.7 m -138.85 152.27 47.68 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 119.382 1.591 . . . . 0.0 109.5 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.4 140.5 35.5 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.721 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.2 m -83.86 135.19 34.6 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 168.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 mt -122.82 152.7 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.402 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 27.2 m-90 -139.8 152.99 46.99 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.824 1.25 . . . . 0.0 113.997 -173.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -82.84 -39.8 21.17 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 126.591 1.956 . . . . 0.0 108.898 167.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.77 125.13 36.07 Favored Glycine 0 CA--C 1.522 0.488 0 O-C-N 119.36 -2.087 . . . . 0.0 108.987 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -67.8 107.1 2.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.71 42.21 2.35 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 125.789 1.661 . . . . 0.0 111.971 -169.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 25.6 p 45.4 46.99 10.75 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.448 1.899 . . . . 0.0 114.714 166.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 m -126.27 176.58 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 127.437 2.295 . . . . 0.0 107.843 166.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.46 -157.74 23.26 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 120.841 -1.162 . . . . 0.0 112.332 167.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -70.19 150.73 46.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.402 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 5.8 p -141.75 172.61 12.46 Favored 'General case' 0 N--CA 1.436 -1.158 0 O-C-N 124.023 0.827 . . . . 0.0 111.483 -166.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -144.01 -175.41 4.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 159.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 t -127.96 122.43 32.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 168.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.0 tpt -121.64 118.66 29.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 96.9 m -113.78 146.74 39.47 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.8 t -138.1 121.95 11.58 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 124.432 1.093 . . . . 0.0 108.382 -178.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.32 151.27 9.85 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.111 2.541 . . . . 0.0 112.347 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.02 143.59 47.49 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 54.84 61.63 2.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.003 1.721 . . . . 0.0 109.067 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -154.48 157.41 38.36 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.39 124.44 49.6 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 126.891 2.076 . . . . 0.0 108.957 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.4 m -129.36 113.8 15.41 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.667 1.587 . . . . 0.0 108.717 -168.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -71.2 127.24 31.93 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.551 -0.718 . . . . 0.0 110.037 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.509 HD13 ' H ' ' A' ' 37' ' ' MET . 1.6 mp -85.96 111.59 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 123.978 0.911 . . . . 0.0 108.644 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -163.71 98.77 0.88 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 162.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.2 p -74.35 -157.53 0.06 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.03 -2.04 86.31 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.786 -1.196 . . . . 0.0 112.27 168.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -140.63 174.29 10.66 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 118.91 1.355 . . . . 0.0 108.953 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -79.78 133.65 36.32 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.408 ' HB ' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -95.89 133.3 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -167.612 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.7 mtt-85 -126.21 -36.31 2.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 118.328 -0.844 . . . . 0.0 113.095 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.93 163.21 33.5 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 119.482 1.037 . . . . 0.0 110.971 171.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.417 ' CD1' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -151.16 169.21 22.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.069 0.548 . . . . 0.0 111.258 165.567 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -157.09 126.0 5.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.183 172.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.465 HH21 ' C ' ' A' ' 88' ' ' GLU . 31.3 mtp180 -55.44 141.94 34.64 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.854 0.462 . . . . 0.0 110.763 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.4 m -96.95 -43.74 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 123.836 0.71 . . . . 0.0 109.295 163.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.465 ' C ' HH21 ' A' ' 86' ' ' ARG . 1.9 tt0 . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.063 0.945 . . . . 0.0 108.569 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 tt -138.75 116.09 11.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 162.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.83 158.84 23.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 126.613 1.965 . . . . 0.0 106.134 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -121.62 175.7 6.09 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.579 0.704 . . . . 0.0 110.427 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 93.7 m -153.16 154.58 35.05 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -159.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -77.6 1.95 18.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 115.095 1.516 . . . . 0.0 115.095 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -158.97 -172.79 3.94 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 125.537 1.535 . . . . 0.0 109.416 169.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.98 3.77 32.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.698 0.761 . . . . 0.0 112.504 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -113.27 130.12 23.93 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 124.07 0.948 . . . . 0.0 110.87 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.09 -46.77 7.52 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 119.85 0.982 . . . . 0.0 109.995 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -64.01 -50.66 67.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.704 0.802 . . . . 0.0 111.069 -161.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 t -110.65 14.34 22.36 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.695 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.79 -50.04 15.54 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t 71.11 116.29 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -158.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.9 m -136.13 148.56 48.28 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.069 -158.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -93.71 93.14 7.84 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 123.704 1.716 . . . . 0.0 110.833 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -83.66 58.04 4.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 111.359 -2.655 . . . . 0.0 103.929 158.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.26 177.51 4.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 127.444 2.298 . . . . 0.0 106.582 172.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -66.98 143.31 56.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 118.557 -1.257 . . . . 0.0 107.722 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -139.99 -12.24 1.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.835 1.254 . . . . 0.0 109.938 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -86.91 173.18 9.52 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.093 1.357 . . . . 0.0 108.57 -165.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -33.46 76.78 0.0 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 131.235 3.814 . . . . 0.0 113.846 -166.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -176.21 178.83 1.34 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 128.605 2.762 . . . . 0.0 108.179 168.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.8 t -72.27 127.36 32.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.752 0.821 . . . . 0.0 109.736 -173.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 t -127.4 133.86 67.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.43 161.79 53.01 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 121.829 -0.544 . . . . 0.0 111.865 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.7 mt -135.41 151.97 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.449 1.9 . . . . 0.0 106.065 165.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.22 156.72 7.96 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.242 0.474 . . . . 0.0 112.003 163.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.48 86.15 0.13 Allowed 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 128.186 2.594 . . . . 0.0 112.517 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 61.35 3.25 0.74 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 128.378 2.671 . . . . 0.0 112.409 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.1 t -86.51 98.76 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -146.04 29.3 1.09 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 89.4 m95 -144.77 113.67 6.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -173.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.459 ' H ' HD13 ' A' ' 75' ' ' ILE . 43.9 ttm -87.59 140.03 29.93 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 168.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.61 95.7 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -174.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 p -93.94 151.7 19.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.994 1.317 . . . . 0.0 114.37 -158.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.747 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -177.942 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -52.73 154.2 2.84 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.793 -0.567 . . . . 0.0 110.669 171.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.75 140.87 12.49 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 106.199 -2.761 . . . . 0.0 106.199 168.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 m -130.73 158.1 41.02 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 117.574 0.687 . . . . 0.0 109.194 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.41 154.42 40.83 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.137 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -99.98 131.63 45.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 167.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 mm -114.88 144.64 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -167.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -132.78 151.7 51.94 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.357 0.98 . . . . 0.0 112.67 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -88.87 -33.62 17.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.07 1.748 . . . . 0.0 109.42 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.14 141.89 42.08 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 m -63.5 151.68 40.62 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 159.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.19 38.75 90.92 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.887 -174.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 30.1 p 44.85 50.97 8.7 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.287 1.835 . . . . 0.0 114.016 170.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -123.88 176.62 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.019 1.328 . . . . 0.0 108.002 169.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.22 -151.42 21.5 Favored Glycine 0 CA--C 1.52 0.377 0 O-C-N 121.313 -0.867 . . . . 0.0 111.592 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -80.2 150.85 29.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 p -147.55 174.46 11.71 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.53 0.681 . . . . 0.0 111.411 -164.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 t -147.31 -176.18 5.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 158.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.89 133.93 42.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 166.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.1 ttt -124.24 144.0 50.21 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.289 1.035 . . . . 0.0 108.849 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.4 m -115.88 151.38 35.41 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 37.5 t -142.45 122.41 8.04 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 123.516 0.726 . . . . 0.0 110.157 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -60.07 165.2 10.91 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.237 1.958 . . . . 0.0 110.061 171.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.1 174.88 8.05 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.621 173.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 p30 47.15 45.93 16.23 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 124.559 1.144 . . . . 0.0 109.977 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.1 m -143.09 139.46 30.47 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.407 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -101.97 113.85 27.45 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 167.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 120.95 41.21 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.07 2.148 . . . . 0.0 106.525 -168.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -84.75 111.22 19.4 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.803 0.841 . . . . 0.0 109.453 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -80.44 93.4 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.18 75.35 0.45 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -6.52 48.86 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -173.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.07 -43.08 1.45 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.47 156.4 29.36 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 117.891 0.845 . . . . 0.0 111.724 175.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -78.93 133.54 36.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 165.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.36 143.74 12.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.193 0.997 . . . . 0.0 108.973 -170.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -126.17 -25.89 3.47 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 171.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.94 165.07 30.91 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.37 179.53 9.05 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.426 1.49 . . . . 0.0 109.883 170.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -148.7 123.75 10.07 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.351 1.86 . . . . 0.0 106.783 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -75.8 139.18 41.63 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.643 1.565 . . . . 0.0 108.546 170.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.1 m -109.6 -35.43 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.749 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 CA--C 1.529 0.149 0 CA-C-N 119.671 1.123 . . . . 0.0 110.629 -174.829 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.8 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 69.12 126.62 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.119 1.767 . . . . 0.0 112.347 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -54.57 153.26 10.5 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.61 167.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -176.73 160.67 1.96 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.621 1.568 . . . . 0.0 108.745 169.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tp -132.94 60.19 1.71 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.478 HD13 ' CE2' ' A' ' 20' ' ' TRP . 4.2 pt -94.22 175.2 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.123 0.969 . . . . 0.0 110.867 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.7 ptm -138.37 166.89 23.09 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.881 1.273 . . . . 0.0 108.887 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 61.0 m -147.44 162.03 39.85 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.766 1.269 . . . . 0.0 110.707 -158.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -85.76 -29.5 23.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.07 -1.877 . . . . 0.0 110.28 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -126.07 -166.0 1.51 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.9 t -93.0 3.32 55.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -139.94 105.82 6.81 Favored Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 124.365 1.066 . . . . 0.0 112.824 -164.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.45 -20.89 58.85 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.853 1.702 . . . . 0.0 112.659 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -64.22 -44.12 92.88 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.65 1.114 . . . . 0.0 109.886 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 p -113.97 13.5 18.27 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -174.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.63 133.12 6.08 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 124.571 1.082 . . . . 0.0 110.769 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.14 94.25 1.13 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 174.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 70.9 m -77.53 148.19 35.39 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.35 129.74 36.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.478 ' CE2' HD13 ' A' ' 6' ' ' ILE . 73.3 m95 -111.99 59.84 0.63 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.7 2.8 . . . . 0.0 106.631 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -92.6 165.72 12.85 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 165.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -73.16 143.75 47.14 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 118.199 -1.4 . . . . 0.0 107.525 166.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -130.29 -14.12 3.84 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.726 1.611 . . . . 0.0 109.952 -172.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.418 ' CE3' ' HG3' ' A' ' 86' ' ' ARG . 21.7 m95 -79.04 112.82 16.63 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -172.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.6 t30 64.11 44.75 4.39 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.036 0.935 . . . . 0.0 111.36 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.32 141.37 30.94 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.947 0.899 . . . . 0.0 109.093 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.32 77.76 5.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.904 2.081 . . . . 0.0 109.127 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 t -92.64 127.64 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.51 139.68 16.14 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.948 1.261 . . . . 0.0 111.365 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 mm -134.5 165.84 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 126.73 2.012 . . . . 0.0 108.891 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.98 -170.71 40.83 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 163.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.77 80.54 0.2 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.599 1.96 . . . . 0.0 113.643 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 71.2 4.16 4.95 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 126.803 2.041 . . . . 0.0 111.182 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.0 111.44 22.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -146.37 25.75 1.21 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -137.48 114.46 10.69 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 119.729 1.15 . . . . 0.0 111.548 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.525 ' H ' HD13 ' A' ' 75' ' ' ILE . 21.9 ttt -84.49 113.88 21.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 169.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.98 96.92 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -104.19 141.2 36.68 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.674 0.79 . . . . 0.0 109.855 -159.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.56 -173.71 43.01 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 123.374 0.512 . . . . 0.0 111.83 -169.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.39 35.63 4.19 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 124.752 1.168 . . . . 0.0 111.392 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.4 m -31.78 -61.22 0.23 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 129.289 3.036 . . . . 0.0 112.593 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.36 45.35 2.77 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -19.62 104.65 0.02 OUTLIER 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.963 2.505 . . . . 0.0 113.07 -175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.61 -56.37 0.74 Allowed Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 105.853 -2.899 . . . . 0.0 105.853 -171.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -74.15 107.06 6.11 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.33 1.052 . . . . 0.0 108.79 -175.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -46.94 157.61 0.15 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.845 1.658 . . . . 0.0 112.492 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.68 134.41 12.2 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 106.999 -2.44 . . . . 0.0 106.999 166.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.1 m -133.37 155.42 49.5 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.62 149.6 39.17 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.666 0.604 . . . . 0.0 111.36 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.0 m -84.5 126.41 33.26 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 159.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.2 mt -121.2 128.35 75.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -172.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 9.1 m-90 -111.13 153.68 25.38 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.739 1.615 . . . . 0.0 113.262 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.78 -45.68 74.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.409 2.284 . . . . 0.0 111.181 172.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.81 157.45 48.9 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 m -78.2 122.48 25.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 163.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.52 41.88 9.61 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 124.761 1.172 . . . . 0.0 111.058 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.5 p 45.79 57.04 5.37 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.454 1.902 . . . . 0.0 113.137 166.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 m -124.63 176.03 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 126.203 1.801 . . . . 0.0 106.95 164.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.54 -160.94 28.22 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -72.86 160.69 31.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 8.8 p -145.13 160.55 41.25 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.898 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.1 t -110.27 159.47 17.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 162.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -110.11 111.51 22.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 160.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.03 122.5 41.25 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.876 0.735 . . . . 0.0 110.767 -171.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.5 m -105.74 152.76 22.78 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.937 1.295 . . . . 0.0 111.967 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.417 ' SG ' ' HD2' ' A' ' 68' ' ' PRO . 1.7 t -151.93 143.73 16.18 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.258 169.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 23.3 Cg_endo -64.81 172.24 7.35 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.837 1.691 . . . . 0.0 113.084 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.99 135.84 33.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.875 1.27 . . . . 0.0 110.97 -172.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.9 m120 56.25 64.74 1.61 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -165.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 m -145.26 126.67 14.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.34 120.64 28.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.36 1.464 . . . . 0.0 108.725 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.5 m -130.73 105.44 7.8 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -162.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -68.24 112.95 5.45 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.003 0.521 . . . . 0.0 110.785 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -74.09 107.67 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.99 129.75 30.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 162.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -126.48 -169.72 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.677 1.126 . . . . 0.0 110.161 -172.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.71 11.69 67.86 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.34 174.87 10.97 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 125.098 1.359 . . . . 0.0 109.284 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -74.3 148.15 41.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 163.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -113.62 142.4 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -134.14 -66.75 0.61 Allowed 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.9 m -93.77 173.48 7.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 116.431 -2.108 . . . . 0.0 112.062 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -155.82 168.22 27.9 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.238 165.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.97 136.37 19.0 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 163.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.418 ' HG3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -68.41 166.4 16.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.942 -171.33 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.64 -32.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 116.924 -1.513 . . . . 0.0 113.095 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 N--CA 1.466 0.341 0 C-N-CA 124.869 1.268 . . . . 0.0 108.581 -174.974 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.148 0 CA-C-O 119.4 -0.667 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 t70 68.21 -59.1 0.45 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.876 2.47 . . . . 0.0 109.503 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.3 148.44 42.41 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 159.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -128.04 171.95 11.39 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.772 1.629 . . . . 0.0 107.952 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.522 HD13 HH21 ' A' ' 86' ' ' ARG . 5.1 tt -144.16 126.23 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 161.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.78 170.95 12.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.3 ptm -117.35 168.49 10.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.876 0.846 . . . . 0.0 110.023 158.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 73.2 m -156.05 166.25 34.02 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.319 1.448 . . . . 0.0 108.374 -158.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -85.95 -20.52 28.84 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 170.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.2 p30 -136.9 -175.37 4.01 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.849 172.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 40.7 t -89.05 3.82 50.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.347 -170.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -138.02 94.42 11.28 Favored Pre-proline 0 N--CA 1.456 -0.141 0 C-N-CA 123.651 0.78 . . . . 0.0 110.984 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.08 -23.06 2.5 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.52 2.813 . . . . 0.0 114.679 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -63.65 -41.24 98.24 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 119.801 1.182 . . . . 0.0 110.123 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -111.41 14.12 21.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.677 0.791 . . . . 0.0 110.824 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.38 121.02 5.79 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 125.08 1.324 . . . . 0.0 109.85 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.0 m -65.32 123.26 19.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 159.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 96.4 m -135.93 159.1 42.71 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -172.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.86 92.99 8.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.677 1.227 . . . . 0.0 109.65 169.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -84.51 42.7 0.91 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.243 162.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 167.34 10.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 164.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -64.09 144.08 57.38 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.418 0.627 . . . . 0.0 109.327 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -122.25 -8.3 8.71 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.577 2.351 . . . . 0.0 110.015 167.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -58.78 94.13 0.02 OUTLIER 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.091 0.957 . . . . 0.0 110.093 169.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 41.46 55.79 3.37 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.413 1.485 . . . . 0.0 111.379 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.2 p -138.18 124.35 20.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 102.492 -3.151 . . . . 0.0 102.492 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.4 t -75.3 84.43 2.45 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.681 1.193 . . . . 0.0 109.343 -166.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.7 t -83.63 121.79 36.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -170.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.36 154.51 49.24 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.418 1.009 . . . . 0.0 111.222 174.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -128.27 142.21 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.577 1.951 . . . . 0.0 107.115 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.79 168.81 33.84 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 168.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 61.01 72.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 68.94 2.87 3.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 128.21 2.604 . . . . 0.0 111.259 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -83.71 97.56 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -146.35 34.38 0.97 Allowed 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -135.42 113.98 11.71 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 121.789 -0.569 . . . . 0.0 109.623 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.471 ' H ' HD13 ' A' ' 75' ' ' ILE . 25.4 ttp -85.95 132.61 34.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.72 129.38 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.501 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -144.23 128.19 17.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -159.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.31 -160.48 24.42 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 172.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.35 -66.4 0.57 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 105.447 -3.061 . . . . 0.0 105.447 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 p -68.11 149.97 48.95 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.491 1.116 . . . . 0.0 109.29 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -42.88 59.5 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -99.75 96.3 7.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.03 -26.92 2.61 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.144 0.878 . . . . 0.0 113.875 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.4 mttp 61.93 137.04 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 127.461 2.305 . . . . 0.0 110.776 -160.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -51.75 143.46 12.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.004 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.96 133.17 11.51 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 107.484 -2.247 . . . . 0.0 107.484 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 74.6 m -119.3 147.33 44.42 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 117.749 0.775 . . . . 0.0 109.164 172.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.13 140.71 26.89 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 114.711 -1.132 . . . . 0.0 108.86 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.7 m -91.0 113.0 25.14 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.8 mt -95.7 143.79 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 22.7 m-90 -125.09 152.63 44.11 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.201 1.4 . . . . 0.0 113.076 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -81.15 -38.77 26.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.702 2.401 . . . . 0.0 109.787 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.38 136.66 23.82 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m -60.45 119.89 8.88 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 168.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.15 46.12 7.18 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 124.183 0.897 . . . . 0.0 111.619 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.6 p 44.67 51.69 8.09 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.268 1.827 . . . . 0.0 113.206 169.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 m -125.88 176.86 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 128.588 2.755 . . . . 0.0 106.452 171.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.37 -156.84 34.11 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.3 ttt85 -67.96 153.82 42.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.408 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.2 p -141.47 165.85 26.36 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 174.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.0 t -137.31 138.87 40.46 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -88.43 94.95 10.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 40.6 tpp -86.38 104.7 16.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 98.8 m -93.08 138.14 31.79 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 166.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.5 t -153.52 132.08 6.67 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.176 1.391 . . . . 0.0 109.801 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -63.18 163.6 22.51 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.404 2.069 . . . . 0.0 115.579 -167.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.07 122.97 25.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 83.11 62.72 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 128.011 2.524 . . . . 0.0 107.402 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.72 -176.91 6.2 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.343 1.068 . . . . 0.0 109.778 158.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.29 122.78 25.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 128.907 2.883 . . . . 0.0 106.42 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.23 113.28 24.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.633 1.973 . . . . 0.0 107.061 -171.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -66.47 115.12 6.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 167.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -77.21 120.62 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 165.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -150.47 66.95 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 170.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 p -78.2 161.56 27.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.581 -167.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -52.84 -30.17 35.82 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.021 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -111.12 159.89 17.41 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 124.575 1.15 . . . . 0.0 109.947 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -72.56 139.26 47.4 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.945 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.32 133.69 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.289 1.036 . . . . 0.0 110.252 -164.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -122.61 -41.05 2.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.906 0.882 . . . . 0.0 111.544 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.94 167.27 22.53 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -154.88 161.44 41.44 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.237 0.615 . . . . 0.0 111.852 163.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -138.29 145.62 41.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.829 2.052 . . . . 0.0 108.395 164.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.522 HH21 HD13 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -76.98 153.54 34.45 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.875 166.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.35 -17.84 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.811 1.644 . . . . 0.0 110.455 164.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 164.537 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.886 0 CA-C-O 118.16 -1.356 . . . . 0.0 115.2 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -76.83 61.11 1.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 120.081 1.94 . . . . 0.0 111.093 -170.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.38 133.24 12.53 Favored Glycine 0 N--CA 1.443 -0.857 0 O-C-N 121.179 -0.951 . . . . 0.0 110.826 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -113.18 159.4 19.32 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.866 1.267 . . . . 0.0 108.087 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 tt -139.18 103.76 4.84 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 159.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.405 HD13 ' CE2' ' A' ' 20' ' ' TRP . 2.5 pt -124.42 171.54 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.0 ptp -136.58 140.11 42.65 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.352 1.061 . . . . 0.0 111.181 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.4 m -125.04 168.8 12.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.108 1.363 . . . . 0.0 109.965 -159.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -79.55 -34.8 40.67 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.928 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -132.47 -168.68 2.1 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 128.033 2.533 . . . . 0.0 107.31 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -94.96 3.46 54.92 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.31 114.55 23.51 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 124.971 1.309 . . . . 0.0 111.229 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.76 -24.4 74.62 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.309 2.006 . . . . 0.0 111.838 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -44.95 91.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.617 1.099 . . . . 0.0 109.44 -177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.2 p -103.95 13.66 32.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.934 0.894 . . . . 0.0 112.346 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.97 114.65 2.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 124.993 1.282 . . . . 0.0 111.408 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.53 94.21 1.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.0 m -87.72 173.15 9.18 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.563 0.745 . . . . 0.0 109.175 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 162.1 27.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 158.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.405 ' CE2' HD13 ' A' ' 6' ' ' ILE . 93.5 m95 -151.5 54.87 0.85 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 168.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -114.89 176.27 5.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.839 1.656 . . . . 0.0 108.259 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -63.98 153.4 37.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.215 0.606 . . . . 0.0 109.456 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -146.5 -23.45 0.43 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -103.07 33.67 3.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.565 -1.334 . . . . 0.0 109.67 -173.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -141.72 43.84 1.72 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.599 -167.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 89.98 177.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 173.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.3 t -47.44 109.89 0.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.515 1.526 . . . . 0.0 112.273 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.03 145.02 12.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 127.005 2.122 . . . . 0.0 107.241 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.74 134.94 14.29 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.7 mm -133.15 166.52 29.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 127.093 2.157 . . . . 0.0 108.613 -169.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.62 -166.98 21.65 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 106.598 -2.601 . . . . 0.0 106.598 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 48.72 89.45 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 164.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.4 m120 64.8 22.25 12.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 126.59 1.956 . . . . 0.0 111.517 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.3 t -133.91 101.14 3.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -146.53 25.8 1.19 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.713 1.205 . . . . 0.0 112.335 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -129.81 143.23 50.71 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 166.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 48.5 ttm -107.15 125.3 50.9 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 167.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.98 93.37 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -99.59 155.13 17.76 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.959 1.304 . . . . 0.0 109.002 -167.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.74 -161.56 35.33 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 175.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.24 -15.51 59.61 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 124.139 0.875 . . . . 0.0 114.06 164.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.07 -68.88 0.29 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.877 1.339 . . . . 0.0 109.855 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -163.44 -86.93 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -164.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -167.95 146.29 4.52 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.365 3.066 . . . . 0.0 106.518 159.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.09 23.44 68.81 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 118.342 0.519 . . . . 0.0 112.214 167.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -105.68 104.48 14.21 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.944 0.498 . . . . 0.0 110.012 166.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.63 167.58 3.42 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.237 1.015 . . . . 0.0 110.675 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.21 140.57 9.47 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 162.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 m -126.27 166.6 16.81 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.3 147.03 26.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.296 1.438 . . . . 0.0 110.118 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 m -83.5 123.06 29.35 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 161.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 mt -110.12 150.98 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.446 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 24.6 m-90 -129.65 156.77 43.69 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.855 1.662 . . . . 0.0 110.295 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -83.73 -36.01 23.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.35 1.06 . . . . 0.0 111.271 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.88 148.19 50.85 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.119 -0.988 . . . . 0.0 110.746 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m -78.27 53.98 1.32 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.099 0.96 . . . . 0.0 110.35 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.4 55.4 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -171.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 54.42 34.4 20.78 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 162.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 m -125.93 176.55 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 126.932 2.093 . . . . 0.0 109.763 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.52 -152.7 29.39 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -73.66 142.28 46.45 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.3 p -136.72 168.26 19.86 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.924 0.765 . . . . 0.0 111.411 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.1 t -152.91 140.9 20.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.803 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.8 m -72.67 100.46 2.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 158.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.87 119.39 24.81 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 166.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.7 m -101.46 153.81 19.37 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.7 t -142.61 119.71 7.05 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 123.718 0.807 . . . . 0.0 109.008 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.77 179.89 2.42 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.957 1.771 . . . . 0.0 110.545 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.72 151.54 40.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.831 -161.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.7 m120 50.91 53.34 13.2 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.231 161.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 t -156.08 179.97 8.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.296 0.57 . . . . 0.0 109.804 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 141.75 46.07 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.582 2.753 . . . . 0.0 108.754 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.0 m -143.32 117.69 9.65 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.617 1.167 . . . . 0.0 107.879 -168.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -74.94 103.96 5.35 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.454 0.57 . . . . 0.0 110.32 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.11 132.96 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t30 141.66 112.82 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 129.111 2.964 . . . . 0.0 104.254 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.45 9.13 19.63 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -174.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.07 -60.91 0.51 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 -159.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -82.73 156.97 23.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -168.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -73.94 133.81 43.09 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.332 -1.304 . . . . 0.0 107.746 172.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.6 128.23 55.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -166.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -136.71 -19.62 1.36 Allowed 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -166.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -142.6 163.24 33.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 119.631 1.105 . . . . 0.0 108.575 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.04 161.48 41.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.958 0.799 . . . . 0.0 112.918 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.37 129.08 12.35 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 171.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.4 mmm-85 -57.41 142.69 42.93 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.17 -3.07 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.193 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 CA--C 1.52 -0.2 0 C-N-CA 126.202 1.801 . . . . 0.0 107.493 177.403 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.604 0 N-CA-C 106.492 -2.643 . . . . 0.0 106.492 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 t70 63.83 -71.66 0.06 Allowed 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 128.134 2.574 . . . . 0.0 111.135 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.7 163.7 9.61 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 -161.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -168.92 172.73 7.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.506 HD11 ' SD ' ' A' ' 37' ' ' MET . 0.8 OUTLIER -141.38 119.45 12.03 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 175.412 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.43 151.98 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 126.552 1.941 . . . . 0.0 106.301 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.1 ptp -110.96 159.3 17.85 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.876 0.846 . . . . 0.0 112.187 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.5 m -145.31 154.56 42.47 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 122.753 1.263 . . . . 0.0 110.133 -159.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -86.14 -13.37 47.32 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 112.679 -2.055 . . . . 0.0 110.741 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -150.77 -179.93 7.68 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.849 1.66 . . . . 0.0 107.84 164.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 t -77.28 3.67 12.42 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -128.57 106.11 19.01 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -59.97 -21.12 63.54 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.618 1.545 . . . . 0.0 112.684 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.9 -33.46 75.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.538 0.608 . . . . 0.0 110.64 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 t -142.37 29.5 1.6 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.221 0.464 . . . . 0.0 111.592 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.22 139.19 10.75 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.11 126.58 28.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 164.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.2 m -135.61 137.14 41.62 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -96.28 103.38 15.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 111.559 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -103.71 56.45 0.73 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 129.266 3.027 . . . . 0.0 109.619 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -99.67 -175.76 3.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 159.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -64.01 147.06 52.99 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -143.52 -8.17 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.742 0.817 . . . . 0.0 112.641 -164.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -101.78 143.59 31.51 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 54.94 47.68 21.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.454 1.101 . . . . 0.0 111.991 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 t -144.05 -173.44 4.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.241 1.416 . . . . 0.0 109.322 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.7 t -151.52 66.79 0.88 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.622 1.969 . . . . 0.0 109.405 -173.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.3 t -104.05 120.62 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.47 1.108 . . . . 0.0 109.659 -167.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.8 128.31 8.38 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.147 0.879 . . . . 0.0 112.639 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.439 HG22 HG21 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -125.31 166.35 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 127.855 2.462 . . . . 0.0 106.09 178.007 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.63 -178.92 41.85 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.99 99.38 0.05 Allowed 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 127.537 2.335 . . . . 0.0 110.64 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 73.08 8.36 5.37 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.396 1.878 . . . . 0.0 110.98 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 30' ' ' ILE . 62.7 t -84.57 97.62 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -143.25 28.96 1.48 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -143.63 127.41 17.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.506 ' SD ' HD11 ' A' ' 5' ' ' LEU . 43.6 ttm -104.9 132.93 50.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 162.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 t -125.16 81.29 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -94.66 151.65 19.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -168.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.523 ' CA ' ' H ' ' A' ' 70' ' ' ASN . . . 141.86 -172.68 23.95 Favored Glycine 0 C--O 1.219 -0.796 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.25 -34.79 0.24 Allowed Glycine 0 CA--C 1.521 0.463 0 CA-C-N 119.097 1.448 . . . . 0.0 112.462 172.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -107.06 -96.14 0.36 Allowed 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 165.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -156.85 -63.13 0.1 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.03 50.09 1.77 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.637 2.375 . . . . 0.0 108.472 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.06 1.96 77.61 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.421 -0.655 . . . . 0.0 112.279 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt 60.81 163.33 0.07 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.832 2.053 . . . . 0.0 111.333 -169.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.92 159.66 33.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.844 168.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.32 173.04 31.5 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 164.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.2 m -129.86 159.82 35.42 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -163.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.18 140.53 35.92 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.8 m -83.23 124.45 30.57 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 159.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.2 mt -102.93 146.8 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -123.01 160.98 25.16 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.715 1.606 . . . . 0.0 110.936 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -79.54 -50.16 11.15 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.418 1.487 . . . . 0.0 110.919 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.27 121.05 5.3 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -169.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.71 108.87 0.23 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.05 2.14 . . . . 0.0 108.66 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 129.87 -74.75 0.44 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -172.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.1 p 163.03 55.1 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 129.298 3.039 . . . . 0.0 110.462 165.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.63 176.61 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.566 1.546 . . . . 0.0 107.908 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.78 -158.75 37.31 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -80.4 151.55 29.31 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -172.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.73 164.37 30.65 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.11 -169.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.57 128.88 10.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -170.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.0 p -82.3 92.74 7.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 41.2 tpp -83.73 129.78 34.95 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 96.7 m -130.58 134.3 46.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.925 0.784 . . . . 0.0 109.333 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 t -150.16 143.67 16.8 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.653 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -66.98 170.12 13.59 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.539 2.159 . . . . 0.0 113.93 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.61 148.75 42.6 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.523 ' H ' ' CA ' ' A' ' 40' ' ' GLY . 20.1 m120 59.81 41.45 18.09 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.111 1.364 . . . . 0.0 109.007 172.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.4 m -127.9 131.41 49.39 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.2 t -88.49 124.82 34.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 170.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.4 m -121.18 105.79 10.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -160.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -78.04 104.84 8.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.624 0.647 . . . . 0.0 109.671 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.477 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -76.64 116.0 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -139.84 83.23 1.91 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 p -74.47 -174.87 2.18 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.965 -1.084 . . . . 0.0 108.966 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.65 -20.22 71.85 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.321 -0.862 . . . . 0.0 111.573 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -131.02 177.23 7.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.977 1.311 . . . . 0.0 109.838 -172.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -83.35 135.28 34.77 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.32 146.36 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.461 1.504 . . . . 0.0 110.522 -169.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.1 mtt85 -136.25 -85.78 0.35 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.172 0.989 . . . . 0.0 110.024 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.12 168.33 17.84 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.272 -159.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -157.93 165.15 35.91 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.76 123.65 6.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.393 1.477 . . . . 0.0 107.347 170.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -59.9 129.9 44.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -36.9 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 C-N-CA 126.571 1.948 . . . . 0.0 110.472 -167.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 177.528 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.816 0 CA-C-O 118.485 -1.175 . . . . 0.0 113.829 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 64.05 109.95 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.108 1.763 . . . . 0.0 110.297 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.71 172.84 7.86 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -167.24 179.1 5.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.753 1.221 . . . . 0.0 108.157 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.585 HD21 ' SD ' ' A' ' 37' ' ' MET . 9.4 tt -149.91 91.67 1.81 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 171.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 pt -108.29 144.59 16.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.5 ptp -78.16 131.26 37.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 159.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 66.5 m -103.09 156.41 17.71 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 14.5 pttt -66.46 -39.84 89.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 117.414 -1.715 . . . . 0.0 108.688 178.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.423 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 39.8 p-10 -131.94 -165.9 1.65 Allowed 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 127.123 2.169 . . . . 0.0 108.53 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.0 t -82.99 3.82 28.55 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.397 -0.815 . . . . 0.0 112.609 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -106.84 114.29 61.82 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 123.267 0.627 . . . . 0.0 110.181 -170.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.39 -32.44 89.21 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.653 1.569 . . . . 0.0 111.504 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -100.56 -51.53 3.58 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.599 1.559 . . . . 0.0 111.757 -161.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -103.92 13.78 32.08 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.679 0.672 . . . . 0.0 112.148 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.45 -69.47 1.39 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 106.855 -2.498 . . . . 0.0 106.855 164.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t 94.22 122.05 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.282 2.633 . . . . 0.0 106.314 -163.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.2 m -136.46 159.75 40.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 126.671 1.989 . . . . 0.0 108.881 -165.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -89.25 94.37 9.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.464 2.078 . . . . 0.0 112.584 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -83.64 51.09 1.93 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.37 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -110.43 -176.65 3.03 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.929 2.492 . . . . 0.0 106.834 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 144.36 49.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 167.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -134.91 2.82 3.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 123.69 0.619 . . . . 0.0 110.016 171.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -93.51 125.66 38.23 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 -172.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 53.74 37.45 26.27 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.78 0.832 . . . . 0.0 111.88 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -133.9 151.44 51.51 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.322 1.849 . . . . 0.0 106.613 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -89.32 85.66 6.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -83.85 124.87 40.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -167.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.69 121.44 5.67 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 118.404 0.547 . . . . 0.0 112.04 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.2 mt -93.46 159.43 2.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 126.577 1.951 . . . . 0.0 108.405 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.91 166.13 28.06 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 169.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.23 74.05 0.21 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.768 2.427 . . . . 0.0 112.342 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 68.21 14.9 9.33 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.886 2.074 . . . . 0.0 110.821 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 97.1 t -133.53 99.49 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -145.8 39.9 1.15 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.725 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CD1' ' HA ' ' A' ' 10' ' ' ASN . 60.2 m95 -135.16 132.11 37.6 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.585 ' SD ' HD21 ' A' ' 5' ' ' LEU . 19.5 ttp -106.58 123.23 47.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 165.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -124.03 117.09 49.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -99.47 -177.03 3.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -168.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -44.18 139.26 4.21 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.16 -51.24 5.84 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 106.052 -2.819 . . . . 0.0 106.052 165.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 m -62.92 170.97 2.38 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.559 -0.82 . . . . 0.0 111.939 174.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.14 46.15 22.05 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -168.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -59.97 72.88 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.116 2.166 . . . . 0.0 111.795 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.35 -26.81 0.87 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.975 1.274 . . . . 0.0 112.106 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -77.41 96.32 4.64 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.322 1.058 . . . . 0.0 108.522 167.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -66.78 150.99 48.33 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.329 165.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.76 147.91 18.68 Favored Glycine 0 C--O 1.238 0.402 0 N-CA-C 105.791 -2.924 . . . . 0.0 105.791 166.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.9 m -132.96 151.33 52.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.147 1.474 . . . . 0.0 108.721 -172.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.79 144.47 49.03 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.924 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.2 m -83.3 115.53 22.03 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 162.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.84 148.47 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -127.94 151.8 48.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.109 1.364 . . . . 0.0 111.504 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -87.91 -33.67 18.41 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.476 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.87 138.44 31.44 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 173.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.6 m -61.83 135.28 57.52 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 159.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.11 32.45 39.4 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 124.727 1.156 . . . . 0.0 111.006 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 12.1 p 45.39 52.29 9.03 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.643 2.377 . . . . 0.0 112.174 169.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.76 175.73 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 125.703 1.601 . . . . 0.0 107.711 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.71 -151.35 26.29 Favored Glycine 0 CA--C 1.523 0.549 0 O-C-N 121.368 -0.832 . . . . 0.0 111.992 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.2 142.85 49.02 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -170.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.99 147.58 28.03 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -167.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p -128.19 115.84 18.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.4 1.48 . . . . 0.0 108.204 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.8 88.33 0.25 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.054 1.342 . . . . 0.0 108.892 171.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -90.52 132.48 35.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.955 1.302 . . . . 0.0 107.984 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 64.5 m -118.51 143.19 46.9 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.1 t -134.2 114.26 12.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 123.729 0.812 . . . . 0.0 109.362 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -72.01 166.48 29.49 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.354 1.369 . . . . 0.0 113.516 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.3 154.25 40.21 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 45.9 53.5 8.89 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.223 1.009 . . . . 0.0 108.718 -164.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 m -144.4 106.64 4.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -73.93 126.08 29.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 169.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 86.4 m -121.57 139.73 53.14 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.942 1.297 . . . . 0.0 108.592 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -108.46 113.84 27.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 109.546 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 75' ' ' ILE . 1.5 mp -93.4 71.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -168.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -123.98 84.04 2.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 p -73.97 170.83 14.6 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.01 -36.86 93.49 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -85.07 162.67 19.21 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 122.121 -0.635 . . . . 0.0 109.395 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -84.44 133.7 34.48 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.079 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.75 132.29 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.025 1.33 . . . . 0.0 109.769 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -118.58 -37.39 3.3 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 118.511 -0.757 . . . . 0.0 111.982 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 p -152.72 167.33 29.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -139.18 167.13 22.74 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.32 1.048 . . . . 0.0 112.036 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.8 139.68 40.15 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.013 1.725 . . . . 0.0 109.035 162.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.491 ' HD3' HD22 ' A' ' 5' ' ' LEU . 49.3 mmm-85 -54.54 154.62 4.64 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.649 0.659 . . . . 0.0 112.095 170.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.67 -31.19 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 123.215 0.606 . . . . 0.0 110.985 165.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.597 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 CA-C-O 118.803 -0.998 . . . . 0.0 113.054 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.1 123.89 0.03 OUTLIER 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.451 1.626 . . . . 0.0 109.358 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.72 147.56 16.71 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 123.386 0.517 . . . . 0.0 112.23 -171.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -84.28 155.87 22.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.163 0.982 . . . . 0.0 110.419 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.409 HD13 ' HG2' ' A' ' 86' ' ' ARG . 10.2 tt -141.25 110.57 6.31 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 159.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.52 111.23 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -169.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptm -72.38 148.6 45.11 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.686 -1.206 . . . . 0.0 108.478 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 71.4 m -129.78 157.05 43.27 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -172.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 19.1 pttt -72.65 -30.78 64.58 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 117.544 -1.662 . . . . 0.0 112.359 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -125.59 -166.55 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.589 1.955 . . . . 0.0 109.528 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 t -99.8 25.66 7.04 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.275 1.03 . . . . 0.0 111.909 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -119.63 101.74 48.17 Favored Pre-proline 0 C--N 1.327 -0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 111.81 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -58.27 -24.07 65.72 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 120.858 1.039 . . . . 0.0 113.028 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -66.61 -73.68 0.13 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.112 0.869 . . . . 0.0 111.052 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 t -122.28 37.56 4.36 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.159 0.983 . . . . 0.0 110.413 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.2 -37.37 71.85 Favored Glycine 0 N--CA 1.448 -0.557 0 O-C-N 120.925 -1.109 . . . . 0.0 110.928 161.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.98 114.37 0.05 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -159.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 80.2 m -136.04 137.26 40.97 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 112.46 -2.155 . . . . 0.0 106.663 -166.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -80.61 93.37 6.1 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 122.707 1.241 . . . . 0.0 109.974 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -83.25 41.95 0.79 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.473 1.909 . . . . 0.0 108.309 165.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -96.67 168.43 10.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 166.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -63.74 143.81 57.54 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 118.429 -1.309 . . . . 0.0 109.014 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -129.82 -44.37 1.2 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 126.807 2.043 . . . . 0.0 108.162 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . 0.3 6.4 t-105 -86.19 59.09 5.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.834 1.254 . . . . 0.0 108.212 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.13 -0.01 0.01 OUTLIER 'General case' 0 N--CA 1.46 0.067 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 173.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 t -167.15 142.06 3.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 120.292 1.405 . . . . 0.0 110.382 -158.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.9 t -65.75 75.42 0.07 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.995 2.518 . . . . 0.0 111.625 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 t -83.64 148.33 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 O-C-N 120.882 -1.136 . . . . 0.0 108.646 -167.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.88 144.7 19.62 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 124.337 0.97 . . . . 0.0 111.013 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -101.22 156.63 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 166.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.81 154.58 10.84 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 66.85 83.07 0.17 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.052 1.741 . . . . 0.0 114.323 165.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 67.67 3.76 3.57 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.395 1.478 . . . . 0.0 111.723 171.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 53.3 t -75.29 126.48 36.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 122.486 0.314 . . . . 0.0 110.256 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 30.25 1.02 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 169.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.516 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 68.0 m95 -138.35 127.3 23.95 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.986 0.812 . . . . 0.0 112.728 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.56 ' H ' HD13 ' A' ' 75' ' ' ILE . 64.1 ttp -90.63 135.58 33.61 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 161.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.9 137.55 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 t -146.07 153.4 40.68 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 121.691 -0.63 . . . . 0.0 110.378 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' HA2' ' H ' ' A' ' 70' ' ' ASN . . . 164.77 -156.14 27.93 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 118.373 0.533 . . . . 0.0 112.143 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.02 -53.94 3.97 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -39.18 -58.55 1.15 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.076 1.351 . . . . 0.0 112.209 -162.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.9 -87.55 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.803 1 N-CA-C 100.017 -4.068 . . . . 0.0 100.017 172.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -171.06 168.19 6.96 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.308 2.243 . . . . 0.0 108.642 158.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.34 -23.94 22.05 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.994 1.759 . . . . 0.0 109.877 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -86.27 69.26 10.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.851 1.31 . . . . 0.0 110.95 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -44.13 143.63 1.13 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 126.538 1.935 . . . . 0.0 110.665 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.79 137.38 12.38 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.7 m -125.24 153.74 42.7 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.46 143.69 46.01 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.855 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -88.25 130.88 34.97 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 159.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 mt -116.76 144.43 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -130.43 143.72 50.94 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.1 1.36 . . . . 0.0 110.475 -171.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -61.39 -51.96 66.62 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.32 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.46 145.99 36.68 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 124.392 0.996 . . . . 0.0 113.296 -163.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 m -55.13 116.98 3.1 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 162.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.13 51.14 5.9 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.4 p 43.29 53.17 5.56 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.73 1.612 . . . . 0.0 113.342 163.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -125.76 176.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 128.129 2.572 . . . . 0.0 106.35 167.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.91 -168.24 39.07 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 119.421 1.01 . . . . 0.0 110.814 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -69.41 128.36 36.28 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -170.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.92 165.06 15.74 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.811 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -150.66 151.29 32.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 m -87.02 111.07 20.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 164.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 34.9 tpp -87.02 144.06 27.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 167.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 55.4 m -147.37 136.14 22.05 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.3 t -135.03 137.71 27.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 124.78 1.232 . . . . 0.0 108.406 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.05 168.31 7.63 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.185 1.257 . . . . 0.0 110.759 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.8 150.33 41.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.308 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.451 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 65.5 m-80 54.51 48.47 20.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.942 1.297 . . . . 0.0 107.918 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.9 m -145.32 148.07 33.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.462 1.105 . . . . 0.0 108.181 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.516 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -101.17 137.17 39.88 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 128.559 2.744 . . . . 0.0 108.338 172.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 54.3 m -140.84 128.17 21.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.968 0.804 . . . . 0.0 110.398 -175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -73.36 135.84 44.33 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.186 0.994 . . . . 0.0 111.599 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 37' ' ' MET . 1.3 mp -102.23 112.86 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 126.573 1.949 . . . . 0.0 106.233 173.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -150.71 77.35 1.28 Allowed 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.843 -0.535 . . . . 0.0 109.944 169.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.32 165.67 24.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.829 0.851 . . . . 0.0 109.28 172.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.99 -51.5 56.92 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -77.33 154.33 32.93 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.551 0.691 . . . . 0.0 110.096 171.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -86.2 137.12 32.87 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.384 -1.734 . . . . 0.0 109.918 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -100.48 127.76 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 124.665 1.186 . . . . 0.0 109.892 -170.489 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -109.01 -17.82 13.82 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.982 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -139.13 166.63 24.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -153.65 162.3 41.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.615 1.166 . . . . 0.0 111.651 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -137.59 143.96 41.76 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.108 1.763 . . . . 0.0 107.837 159.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG2' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -64.16 154.37 34.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 163.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 m -131.62 -22.99 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 165.855 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.621 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.56 95.78 2.8 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -172.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.31 124.36 0.2 Allowed Glycine 0 CA--C 1.512 -0.132 0 CA-C-O 122.838 1.243 . . . . 0.0 111.122 -163.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.2 p90 178.4 167.52 0.82 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 127.755 2.422 . . . . 0.0 107.92 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.525 HD21 ' SD ' ' A' ' 37' ' ' MET . 5.2 tt -147.55 121.17 9.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 18' ' ' CYS . 24.3 pt -132.01 168.89 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 126.851 2.06 . . . . 0.0 106.537 -177.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.2 ptp -120.57 144.34 48.14 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 158.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 70.9 m -117.29 156.06 28.44 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 28.5 pttt -60.87 -44.45 97.04 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 116.827 -1.949 . . . . 0.0 109.029 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -126.82 167.73 15.4 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.812 1.645 . . . . 0.0 109.191 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.9 t -72.72 3.88 4.63 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -101.87 100.65 15.26 Favored Pre-proline 0 N--CA 1.467 0.397 0 O-C-N 121.061 -1.024 . . . . 0.0 110.121 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.45 -27.91 83.5 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.958 1.772 . . . . 0.0 112.256 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -63.47 -60.11 3.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.378 0.535 . . . . 0.0 109.688 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.4 p -103.81 13.36 33.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.75 132.75 11.34 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 p -64.42 114.97 4.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 158.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB3' HD12 ' A' ' 6' ' ' ILE . 74.2 m -126.37 138.23 53.54 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -172.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 6' ' ' ILE . 6.0 p30 -76.07 92.69 3.21 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.218 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.472 ' CZ2' HD13 ' A' ' 6' ' ' ILE . 98.7 m95 -90.23 59.57 4.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 128.56 2.744 . . . . 0.0 104.489 166.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -127.53 168.92 14.28 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 170.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -64.3 143.86 57.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -134.22 -39.88 0.83 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.022 0.529 . . . . 0.0 109.813 -170.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.427 ' HA ' ' HB2' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -77.62 33.57 0.17 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.443 1.116 . . . . 0.0 111.805 -175.026 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.83 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 119.182 -2.199 . . . . 0.0 111.838 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.26 146.83 23.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.958 0.409 . . . . 0.0 111.191 -170.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.7 t -77.78 81.87 4.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.614 1.166 . . . . 0.0 108.579 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.43 145.62 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 O-C-N 121.223 -0.923 . . . . 0.0 109.968 -173.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.75 169.24 44.5 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.597 1.094 . . . . 0.0 112.998 -175.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.22 135.72 56.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 126.321 1.848 . . . . 0.0 106.123 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.59 178.1 35.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 167.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 57.82 79.35 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.075 1.75 . . . . 0.0 113.349 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.7 m120 70.3 4.49 4.91 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.25 1.42 . . . . 0.0 111.669 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 98.7 t -100.23 117.25 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 119.111 0.869 . . . . 0.0 110.87 -175.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -145.96 29.39 1.1 Allowed 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.46 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 79.9 m95 -137.6 121.71 17.93 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 119.377 0.989 . . . . 0.0 112.213 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.644 ' H ' HD13 ' A' ' 75' ' ' ILE . 23.2 tpp -84.3 135.4 34.33 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 163.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.78 128.79 54.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -137.77 155.72 48.75 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.193 -0.942 . . . . 0.0 109.409 -171.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.94 -179.6 16.56 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.55 -21.93 4.45 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -159.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 t 66.56 -62.22 0.29 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 129.073 2.949 . . . . 0.0 113.398 158.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.7 p -129.82 -73.86 0.56 Allowed 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 158.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.55 33.18 1.28 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.447 0.641 . . . . 0.0 111.744 -159.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.43 -28.16 37.1 Favored Glycine 0 CA--C 1.524 0.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.963 168.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 73.7 134.66 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.586 2.354 . . . . 0.0 111.013 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -48.91 152.03 1.12 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.164 1.386 . . . . 0.0 111.628 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.95 153.11 17.3 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.3 m -139.33 153.81 47.78 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 86' ' ' ARG . . . -130.16 149.84 51.68 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 124.076 0.86 . . . . 0.0 110.695 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 m -83.62 126.3 32.71 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 158.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.6 mm -101.35 146.67 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -129.02 156.92 43.05 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.017 0.913 . . . . 0.0 111.859 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -97.9 -33.79 11.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 127.441 2.296 . . . . 0.0 108.829 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 143.61 47.41 Favored Glycine 0 CA--C 1.521 0.421 0 O-C-N 120.991 -1.068 . . . . 0.0 110.904 170.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.1 m -77.35 59.09 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.062 0.931 . . . . 0.0 111.688 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.42 50.75 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.1 p 44.07 42.77 5.09 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.825 1.25 . . . . 0.0 112.925 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.2 176.41 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 171.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.68 -154.25 37.72 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -73.63 154.36 39.77 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.99 168.37 23.3 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.4 144.84 30.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.55 1.54 . . . . 0.0 107.85 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.76 123.35 28.69 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.06 108.35 15.62 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.595 1.558 . . . . 0.0 108.794 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.5 m -110.02 144.75 38.13 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.085 0.954 . . . . 0.0 111.274 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.7 t -152.47 136.86 10.45 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -67.49 159.52 52.1 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.9 2.4 . . . . 0.0 113.088 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.17 53.39 2.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.443 -159.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 156.73 50.49 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -163.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -156.04 167.38 30.59 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 165.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.46 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 13.0 t -103.08 127.28 50.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.261 1.825 . . . . 0.0 107.482 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.18 119.23 31.75 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.173 1.789 . . . . 0.0 107.25 -164.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -82.05 122.55 27.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.118 0.872 . . . . 0.0 110.685 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -92.28 86.46 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -130.26 83.84 2.16 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 166.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 p -73.66 179.36 4.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.678 1.191 . . . . 0.0 108.785 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.21 -30.12 63.77 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 121.65 -0.656 . . . . 0.0 112.419 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -119.28 171.23 8.45 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 127.1 2.16 . . . . 0.0 109.525 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -74.64 133.34 42.16 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.93 157.98 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.527 0.731 . . . . 0.0 110.734 -173.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.91 -40.65 0.6 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 167.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 p -147.69 170.09 18.28 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -156.68 158.01 36.2 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.311 0.959 . . . . 0.0 112.816 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.84 135.55 11.63 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 166.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 1.5 mtm180 -60.74 146.84 44.5 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.307 0.503 . . . . 0.0 112.228 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 m -107.76 -9.97 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.815 1.246 . . . . 0.0 111.915 171.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.175 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.444 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.83 -40.44 96.6 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.14 0.976 . . . . 0.0 108.435 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.1 165.1 48.58 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.676 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -146.8 168.66 20.84 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 128.022 2.529 . . . . 0.0 105.531 -171.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 tt -127.76 122.65 33.34 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 103.9 -2.63 . . . . 0.0 103.9 164.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 pt -140.74 168.21 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.21 169.0 9.02 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 122.729 1.252 . . . . 0.0 112.092 159.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 88.1 m -155.7 157.91 37.38 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.958 -159.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -64.02 -32.25 73.72 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.017 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -159.43 175.84 12.82 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.365 0.666 . . . . 0.0 109.742 -165.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.0 t -79.92 20.52 0.62 Allowed 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.024 1.73 . . . . 0.0 113.082 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -141.82 118.58 7.31 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.877 1.271 . . . . 0.0 110.714 171.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.19 -25.34 10.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.109 2.539 . . . . 0.0 111.463 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -63.94 -42.64 97.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.9 p -108.04 13.88 25.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.933 1.293 . . . . 0.0 112.124 177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.0 118.51 3.71 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 125.355 1.455 . . . . 0.0 109.901 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.21 120.82 15.64 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.2 m -122.18 158.96 28.23 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.708 0.803 . . . . 0.0 109.35 -169.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -95.76 93.77 7.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 125.394 2.521 . . . . 0.0 112.729 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -83.98 47.35 1.3 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.052 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.46 -178.03 1.04 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.135 1.774 . . . . 0.0 108.938 173.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -69.73 143.4 53.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 158.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -125.27 -24.44 3.97 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.226 0.61 . . . . 0.0 110.464 -166.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.23 -162.95 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 131.068 3.747 . . . . 0.0 115.948 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -45.57 62.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 130.886 3.675 . . . . 0.0 110.547 158.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 t -140.02 175.35 9.66 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 128.113 2.565 . . . . 0.0 109.555 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.4 t -139.65 67.19 1.38 Allowed 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.249 1.82 . . . . 0.0 107.701 -165.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.4 t -83.64 144.84 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 124.528 1.131 . . . . 0.0 108.323 -163.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.04 133.68 12.14 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mm -136.61 162.33 35.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 123.817 0.847 . . . . 0.0 110.825 -165.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.22 -148.8 19.73 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 52.19 88.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.774 2.03 . . . . 0.0 116.229 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.279 0.0 OUTLIER 53.68 16.31 0.96 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.156 2.183 . . . . 0.0 113.41 175.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.1 t -115.46 120.16 63.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.948 1.299 . . . . 0.0 107.895 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.4 24.28 1.27 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.771 0.828 . . . . 0.0 112.705 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CZ3' ' HB2' ' A' ' 74' ' ' ASN . 60.7 m95 -130.75 117.11 18.92 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.472 ' H ' HD13 ' A' ' 75' ' ' ILE . 46.0 ttm -83.54 146.57 28.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 165.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 t -141.12 135.02 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -146.32 154.35 41.58 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.3 156.68 13.3 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 128.363 2.887 . . . . 0.0 112.737 173.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.79 -64.25 0.13 Allowed Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 104.34 -3.504 . . . . 0.0 104.34 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.7 t -176.52 -108.6 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.962 2.505 . . . . 0.0 109.266 166.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 52.9 29.5 7.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.154 0.982 . . . . 0.0 109.475 -172.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 16.74 57.71 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 128.357 2.663 . . . . 0.0 113.037 -158.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.65 -43.74 91.3 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 124.923 1.249 . . . . 0.0 110.131 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? 70.45 -173.82 0.18 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 126.081 1.752 . . . . 0.0 108.595 -162.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -60.66 144.01 52.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -164.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.72 143.56 16.31 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 106.186 -2.765 . . . . 0.0 106.186 167.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.2 m -133.23 156.07 48.21 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 118.355 1.077 . . . . 0.0 108.335 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.06 147.6 47.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.126 0.97 . . . . 0.0 109.379 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.3 m -83.93 111.1 18.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 158.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.6 mt -83.04 151.8 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 166.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.451 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 13.7 m-90 -126.41 150.36 48.68 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.06 0.933 . . . . 0.0 110.567 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -63.21 -60.9 2.79 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.238 -1.346 . . . . 0.0 107.535 163.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.74 148.81 47.2 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-O 122.408 1.004 . . . . 0.0 112.74 -159.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.33 72.0 8.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.173 0.989 . . . . 0.0 109.747 -168.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.48 46.61 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 125.259 1.409 . . . . 0.0 110.908 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.3 p 44.09 49.97 7.45 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 125.973 1.709 . . . . 0.0 111.376 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.16 176.85 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 126.716 2.006 . . . . 0.0 107.708 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.87 -155.24 38.64 Favored Glycine 0 CA--C 1.518 0.233 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -75.34 159.62 31.24 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.451 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.6 p -127.87 156.23 42.9 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 124.725 1.266 . . . . 0.0 111.663 173.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.46 110.36 8.77 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.153 1.781 . . . . 0.0 106.92 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.3 t -68.25 108.45 3.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 174.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.2 tpt -113.65 106.48 14.56 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.019 0.927 . . . . 0.0 110.134 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.0 m -93.19 154.65 17.93 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.779 0.832 . . . . 0.0 109.353 171.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.5 t -155.13 132.36 6.29 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.453 0.701 . . . . 0.0 110.505 167.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.27 169.11 16.01 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.3 2.0 . . . . 0.0 113.212 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.67 147.4 43.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 59.07 51.65 6.93 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.492 1.117 . . . . 0.0 108.578 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -140.23 130.94 25.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.243 0.544 . . . . 0.0 110.102 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.5 137.04 32.69 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.874 1.67 . . . . 0.0 109.451 165.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 m -138.9 93.57 2.72 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.957 1.303 . . . . 0.0 109.238 -159.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HB2' ' CZ3' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -70.23 122.7 20.0 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 119.906 -1.746 . . . . 0.0 110.268 -178.212 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 37' ' ' MET . 1.5 mp -79.06 114.84 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.72 1.208 . . . . 0.0 109.644 176.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.16 108.52 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.58 -5.81 3.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.899 0.88 . . . . 0.0 110.439 -171.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.3 13.14 82.3 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 121.242 -0.911 . . . . 0.0 112.538 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -139.9 156.42 46.7 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 119.33 1.565 . . . . 0.0 108.411 159.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.82 133.24 43.19 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.33 131.71 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 125.225 1.41 . . . . 0.0 108.412 -169.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.47 -1.52 8.06 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.5 p -156.43 168.98 25.66 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 166.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -153.73 166.84 31.57 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.989 1.316 . . . . 0.0 111.102 165.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -137.01 124.51 22.14 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 128.082 2.553 . . . . 0.0 106.467 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HE ' ' C ' ' A' ' 88' ' ' GLU . 48.9 ttt180 -69.89 130.63 42.76 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 120.746 1.612 . . . . 0.0 107.522 169.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 m -98.26 -33.64 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.106 0.962 . . . . 0.0 111.098 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.402 ' C ' ' HE ' ' A' ' 86' ' ' ARG . 2.9 pt-20 . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.686 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 178.78 118.02 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.805 1.642 . . . . 0.0 109.386 -159.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -167.64 -157.66 11.08 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 166.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -121.55 172.5 8.05 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.004 0.902 . . . . 0.0 110.294 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.418 HD22 ' HD3' ' A' ' 86' ' ' ARG . 4.8 tt -156.61 82.28 0.96 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.612 2.365 . . . . 0.0 108.081 171.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 pt -108.64 175.98 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 125.477 1.511 . . . . 0.0 107.642 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.3 ptm -124.37 169.53 11.72 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.521 0.677 . . . . 0.0 111.01 158.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.6 m -155.49 163.43 40.03 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.146 1.378 . . . . 0.0 109.14 -158.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER -83.06 -28.97 29.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.058 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -121.37 177.95 4.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 169.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.47 3.46 11.2 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.218 1.007 . . . . 0.0 112.904 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -129.83 96.11 27.16 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.017 0.527 . . . . 0.0 110.687 -161.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -68.94 -12.37 34.21 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.56 1.507 . . . . 0.0 113.455 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -70.28 -50.69 36.88 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.196 -0.94 . . . . 0.0 109.678 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.9 p -111.72 22.81 14.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.194 0.998 . . . . 0.0 111.928 -170.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.03 137.24 9.15 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 124.394 0.997 . . . . 0.0 110.7 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.16 129.77 41.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 168.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.0 m -135.8 151.08 49.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.239 1.015 . . . . 0.0 108.672 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -86.16 95.46 9.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.562 1.172 . . . . 0.0 110.879 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -83.53 58.01 4.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.184 2.193 . . . . 0.0 106.877 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -124.36 161.29 26.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.042 1.337 . . . . 0.0 108.271 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -64.09 146.41 54.25 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.693 0.759 . . . . 0.0 109.049 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -145.98 7.76 1.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.763 1.625 . . . . 0.0 111.007 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -88.33 121.83 31.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 54.45 38.0 28.81 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.384 1.073 . . . . 0.0 111.452 167.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 t -135.82 148.3 48.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.99 1.716 . . . . 0.0 107.457 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.2 t -84.38 100.98 11.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.03 126.65 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 120.101 1.319 . . . . 0.0 109.765 -171.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.59 140.72 15.2 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 127.061 2.267 . . . . 0.0 111.632 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.2 152.52 20.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 128.43 2.692 . . . . 0.0 108.943 -163.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.02 -167.01 34.28 Favored Glycine 0 CA--C 1.525 0.656 0 O-C-N 121.468 -0.77 . . . . 0.0 111.329 168.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.263 . . 59.28 64.8 1.29 Allowed 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 126.884 2.074 . . . . 0.0 115.235 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 m120 64.7 3.58 2.04 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.581 2.352 . . . . 0.0 110.886 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 75.6 t -77.02 106.31 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.629 0.649 . . . . 0.0 109.696 -173.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -146.13 29.86 1.06 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -136.43 113.51 10.54 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 121.766 -0.584 . . . . 0.0 109.962 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.457 ' H ' HD13 ' A' ' 75' ' ' ILE . 59.9 ttp -84.43 142.46 30.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.09 118.41 21.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.3 118.28 36.23 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.05 12.74 35.44 Favored Glycine 0 C--O 1.224 -0.474 0 CA-C-O 123.157 1.421 . . . . 0.0 115.743 169.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.06 45.05 12.18 Favored Glycine 0 C--N 1.308 -1.021 0 C-N-CA 125.777 1.655 . . . . 0.0 110.946 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 t 11.31 -68.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 128.563 2.745 . . . . 0.0 115.562 159.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.2 t -156.23 -56.3 0.09 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.86 143.58 27.05 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.387 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.69 -24.61 58.09 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.312 0.958 . . . . 0.0 112.063 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -70.94 179.23 2.8 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.247 -0.561 . . . . 0.0 110.306 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -60.85 162.21 7.12 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 120.923 -1.111 . . . . 0.0 110.364 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.06 159.01 25.46 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 166.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.5 m -143.21 164.62 29.69 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 119.577 1.689 . . . . 0.0 111.293 -167.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' HB2' ' HE ' ' A' ' 86' ' ' ARG . . . -138.71 159.47 42.03 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 124.324 1.05 . . . . 0.0 109.998 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -84.47 130.46 34.76 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 158.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.62 150.3 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 20.8 m-90 -125.98 156.09 40.38 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 173.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -84.13 -34.01 24.16 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.728 1.611 . . . . 0.0 109.87 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.18 145.35 24.3 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 121.503 0.502 . . . . 0.0 112.312 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -76.17 85.41 3.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.783 1.633 . . . . 0.0 112.627 -161.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.59 -50.44 0.54 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.6 p 159.34 45.53 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 131.613 3.965 . . . . 0.0 107.622 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.52 176.32 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -171.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.37 -147.74 37.91 Favored Glycine 0 CA--C 1.521 0.466 0 O-C-N 121.328 -0.857 . . . . 0.0 111.053 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -71.28 151.74 43.94 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.681 1.192 . . . . 0.0 108.132 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.467 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.7 p -146.71 159.2 43.78 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.573 1.17 . . . . 0.0 112.22 171.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -139.26 155.58 47.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 170.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 m -83.99 121.4 27.34 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 38.7 tpp -104.06 118.86 37.66 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 20.3 m -108.84 152.91 24.25 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.866 0.866 . . . . 0.0 108.859 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.6 t -151.86 143.24 15.78 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 117.688 -1.148 . . . . 0.0 109.684 171.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.6 168.02 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.196 2.597 . . . . 0.0 111.689 169.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.5 166.76 16.04 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 56.7 47.19 18.74 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.727 0.811 . . . . 0.0 109.215 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -156.28 173.01 17.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.874 0.845 . . . . 0.0 111.438 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -109.14 144.21 37.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.962 2.905 . . . . 0.0 107.942 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.2 m -141.94 99.13 3.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.597 1.159 . . . . 0.0 107.917 -162.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -60.45 105.3 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.167 -0.958 . . . . 0.0 110.22 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -74.07 121.72 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 164.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -168.05 79.12 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 p -73.53 166.99 22.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.5 -37.02 91.52 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -81.18 158.71 24.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 123.452 0.701 . . . . 0.0 110.831 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.74 134.0 43.41 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.85 140.99 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 123.668 0.787 . . . . 0.0 109.531 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -129.65 -23.22 2.89 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 117.216 -1.374 . . . . 0.0 114.126 168.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -150.52 166.12 31.18 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 120.976 1.716 . . . . 0.0 111.877 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -157.79 157.68 33.82 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.399 0.545 . . . . 0.0 111.857 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -146.29 124.23 12.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.022 1.729 . . . . 0.0 108.407 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' HE ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -59.25 153.69 18.01 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.508 0.595 . . . . 0.0 110.842 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.2 m -124.89 -37.51 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.32 0.648 . . . . 0.0 110.87 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.03 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.834 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -59.99 1.73 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.65 -160.61 21.87 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -159.71 165.79 31.84 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.526 1.131 . . . . 0.0 108.224 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.22 114.95 12.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 170.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.0 pt -129.72 174.9 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.771 1.628 . . . . 0.0 107.129 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.5 ptp -129.32 164.53 23.35 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 160.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.4 m -144.44 160.91 40.28 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.836 1.654 . . . . 0.0 107.777 -161.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -52.99 -53.57 47.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.637 0.732 . . . . 0.0 111.031 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -132.56 -173.36 3.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.413 1.885 . . . . 0.0 107.777 -169.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 t -72.99 4.03 4.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -100.02 105.22 33.94 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 123.201 0.601 . . . . 0.0 111.84 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.25 -34.51 55.78 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 120.864 1.043 . . . . 0.0 112.091 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -74.21 -47.8 33.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.932 -0.48 . . . . 0.0 110.77 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.8 t -125.89 17.9 7.92 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.37 -36.26 45.21 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 120.475 -1.39 . . . . 0.0 111.642 170.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m 73.25 115.53 0.06 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.906 1.683 . . . . 0.0 106.793 -158.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -136.26 152.72 51.02 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.072 0.949 . . . . 0.0 108.584 -166.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.93 93.21 9.27 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.849 1.309 . . . . 0.0 109.725 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -84.03 56.84 3.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.943 2.497 . . . . 0.0 105.591 162.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -117.31 -175.06 2.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.376 1.871 . . . . 0.0 107.734 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -64.39 143.05 58.18 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 171.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -146.62 -15.52 0.43 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.327 1.851 . . . . 0.0 111.296 -159.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -119.15 163.43 17.06 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 129.139 2.976 . . . . 0.0 104.629 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 m120 33.93 58.68 0.58 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.32 1.848 . . . . 0.0 114.285 170.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.35 -173.89 2.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.511 1.924 . . . . 0.0 107.261 166.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.5 t -121.72 136.19 54.94 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.571 1.948 . . . . 0.0 108.335 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -147.46 142.49 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.99 1.268 . . . . 0.0 107.842 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.51 137.96 13.66 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.779 2.133 . . . . 0.0 112.235 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.653 ' CD1' ' HA ' ' A' ' 83' ' ' SER . 4.7 mp -126.71 165.73 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 128.201 2.6 . . . . 0.0 107.135 -166.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.03 -178.98 34.06 Favored Glycine 0 N--CA 1.451 -0.353 0 O-C-N 121.25 -0.906 . . . . 0.0 111.518 159.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 60.31 94.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.894 2.078 . . . . 0.0 112.35 169.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.28 0.0 OUTLIER 56.28 26.12 10.11 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.593 1.557 . . . . 0.0 111.922 -176.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.53 103.71 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -146.32 38.16 1.04 Allowed 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 170.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -138.25 114.24 10.02 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 118.801 0.728 . . . . 0.0 110.245 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.419 ' H ' HD13 ' A' ' 75' ' ' ILE . 6.7 ttm -84.01 142.63 30.33 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 170.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.44 130.88 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 68' ' ' PRO . 1.3 t -146.35 146.49 30.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.04 -132.63 5.46 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -173.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.72 -63.28 4.12 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 105.995 -2.842 . . . . 0.0 105.995 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.1 m -98.23 -161.19 0.85 Allowed 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 124.201 1.0 . . . . 0.0 111.654 -163.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.8 p -112.08 -85.44 0.57 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.249 1.819 . . . . 0.0 110.33 -158.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.83 77.49 5.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.25 -49.79 1.29 Allowed Glycine 0 C--O 1.227 -0.326 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.1 mttm 70.31 139.26 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.705 2.402 . . . . 0.0 110.207 -167.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.488 ' CB ' ' HA ' ' A' ' 68' ' ' PRO . 28.0 pt20 -64.23 143.43 57.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.182 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.46 152.11 17.19 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.5 m -127.5 154.56 44.97 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.36 133.58 24.49 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.525 1.13 . . . . 0.0 109.08 -174.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -83.63 117.74 23.37 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 mt -95.0 146.55 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -124.11 148.24 47.3 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.521 1.529 . . . . 0.0 110.648 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -74.61 -46.08 40.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.179 1.392 . . . . 0.0 108.193 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.1 144.54 42.08 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 121.619 0.566 . . . . 0.0 112.434 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.2 m -66.43 108.64 2.45 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 165.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.55 52.18 2.9 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 19.2 p 46.98 44.23 14.57 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.251 1.82 . . . . 0.0 113.34 165.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.57 176.41 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.053 1.341 . . . . 0.0 107.385 171.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.73 -146.02 25.38 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 173.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -79.89 147.58 31.63 Favored 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 125.905 1.682 . . . . 0.0 107.792 -170.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -138.76 166.94 23.09 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 123.882 0.739 . . . . 0.0 112.017 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -160.56 119.03 2.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -71.45 117.49 13.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.9 ttp -106.18 137.84 43.41 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 167.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 93.2 m -113.39 149.74 33.67 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.469 1.107 . . . . 0.0 108.75 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.2 t -153.06 123.53 3.46 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.15 0.58 . . . . 0.0 112.288 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HA ' ' CB ' ' A' ' 47' ' ' GLN . 12.1 Cg_endo -71.82 149.18 53.58 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 N-CA-C 116.951 1.866 . . . . 0.0 116.951 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.73 108.47 6.58 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 107.47 44.06 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 130.13 3.372 . . . . 0.0 109.112 -174.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -150.57 156.88 42.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.647 1.213 . . . . 0.0 110.511 165.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -92.7 138.11 31.78 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.352 160.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 m -131.59 99.31 4.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 126.514 1.926 . . . . 0.0 108.369 -170.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -56.67 120.83 8.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 119.098 -0.477 . . . . 0.0 109.846 168.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 37' ' ' MET . 1.6 mp -78.57 128.7 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 164.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -176.93 98.63 0.05 OUTLIER 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 164.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 p -89.16 -174.57 4.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.456 1.102 . . . . 0.0 108.915 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.69 -4.1 30.95 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.688 -0.633 . . . . 0.0 113.338 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -143.17 159.1 42.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.841 1.656 . . . . 0.0 107.159 174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -69.52 142.4 53.68 Favored 'General case' 0 N--CA 1.441 -0.885 0 O-C-N 124.765 1.291 . . . . 0.0 108.204 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -116.61 142.79 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 124.126 0.97 . . . . 0.0 109.249 -171.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -129.51 -19.18 3.44 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.653 ' HA ' ' CD1' ' A' ' 30' ' ' ILE . 1.7 m -134.12 168.76 18.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.458 1.481 . . . . 0.0 109.862 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -163.07 167.84 21.78 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.579 0.627 . . . . 0.0 109.887 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -157.27 144.46 18.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 123.91 0.756 . . . . 0.0 109.579 158.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.09 137.43 57.05 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 m -106.47 -13.51 9.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.053 1.341 . . . . 0.0 111.752 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 158.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.229 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 74.08 -59.34 0.56 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.141 1.776 . . . . 0.0 108.481 -169.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.88 170.51 2.93 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 158.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -152.99 171.56 18.17 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 120.861 -1.376 . . . . 0.0 110.324 -163.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 tt -125.46 111.11 14.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 162.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' A' ' 20' ' ' TRP . 13.5 pt -119.8 168.63 11.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 169.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.9 ptp -118.91 152.88 35.51 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.022 0.439 . . . . 0.0 110.273 165.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.6 m -138.29 154.04 49.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.538 -158.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -72.26 -6.36 42.49 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.25 1.42 . . . . 0.0 112.6 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.7 p30 -164.15 -177.54 5.05 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.048 1.739 . . . . 0.0 107.297 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.6 t -81.8 4.0 23.8 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.087 0.955 . . . . 0.0 112.576 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.556 ' CG ' HG22 ' A' ' 15' ' ' THR . 46.0 t0 -125.95 90.53 50.1 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.686 1.194 . . . . 0.0 110.081 -162.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.55 -20.29 69.26 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.901 1.734 . . . . 0.0 112.264 -172.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -66.9 -24.14 66.07 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.369 -0.832 . . . . 0.0 111.204 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.556 HG22 ' CG ' ' A' ' 12' ' ' ASP . 10.9 t -144.48 13.89 1.58 Allowed 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -167.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.43 138.54 14.85 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 165.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 p -75.19 93.44 2.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.948 1.374 . . . . 0.0 107.576 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.3 m -94.66 152.59 18.36 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -170.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.84 107.3 19.53 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.924 1.345 . . . . 0.0 111.112 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.406 ' HA ' HG22 ' A' ' 6' ' ' ILE . 59.9 m95 -83.8 35.78 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.358 2.263 . . . . 0.0 108.806 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -87.23 157.98 19.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.837 1.255 . . . . 0.0 107.994 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -63.38 144.72 56.72 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 166.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -145.88 20.78 1.45 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.007 0.523 . . . . 0.0 112.27 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -115.91 141.75 47.69 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.86 20.4 10.63 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.066 0.546 . . . . 0.0 112.399 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.6 p -141.35 133.08 27.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -171.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.9 t -85.53 75.91 10.1 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.81 144.62 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -166.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.38 160.86 42.42 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.569 1.081 . . . . 0.0 111.15 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 mt -122.14 135.44 62.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 171.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.89 143.69 9.9 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 119.571 1.078 . . . . 0.0 113.175 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 69.46 73.77 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.957 2.103 . . . . 0.0 114.881 161.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.8 9.86 6.36 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.564 1.546 . . . . 0.0 110.355 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.75 97.32 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 170.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -135.07 39.73 2.93 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.765 0.826 . . . . 0.0 110.722 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -145.42 134.84 23.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.414 ' H ' HD13 ' A' ' 75' ' ' ILE . 49.0 ttm -114.96 132.88 56.43 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 165.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.94 111.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -170.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.94 72.67 3.0 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.335 1.064 . . . . 0.0 109.526 -170.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.87 173.62 28.36 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 123.028 1.349 . . . . 0.0 112.438 167.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.85 65.23 0.29 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 103.465 -3.854 . . . . 0.0 103.465 171.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.8 t -139.82 -114.36 0.14 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.481 1.112 . . . . 0.0 108.648 -163.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 p -144.91 -71.88 0.27 Allowed 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -159.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -12.62 94.87 0.01 OUTLIER 'General case' 0 C--O 1.232 0.169 0 C-N-CA 128.639 2.776 . . . . 0.0 112.605 160.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.89 7.9 33.55 Favored Glycine 0 CA--C 1.519 0.29 0 O-C-N 123.739 0.65 . . . . 0.0 112.345 -159.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -69.14 131.68 45.35 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 167.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -53.92 143.26 22.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 160.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.66 131.6 10.73 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 107.007 -2.437 . . . . 0.0 107.007 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 47.2 m -130.62 149.36 52.31 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -162.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.17 140.06 27.69 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.548 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.3 m -83.84 114.74 21.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 162.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 mt -100.99 136.98 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.467 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 4.9 m-90 -119.96 158.87 25.84 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.032 0.933 . . . . 0.0 110.029 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.86 -47.51 70.95 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.218 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.5 -179.4 48.86 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 114.119 -3.896 . . . . 0.0 121.365 175.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m 33.61 82.42 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.63 2.772 . . . . 0.0 114.372 161.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.41 25.32 59.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.467 ' HB2' ' CD2' ' A' ' 53' ' ' TRP . 2.9 p 44.73 65.11 1.15 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.729 1.212 . . . . 0.0 111.609 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.1 176.03 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 126.406 1.882 . . . . 0.0 107.638 172.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.04 -152.73 23.97 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.1 ttm-85 -74.5 159.51 32.14 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.456 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 5.9 p -145.66 167.96 21.84 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.208 0.528 . . . . 0.0 111.235 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.551 HG21 HG21 ' A' ' 77' ' ' THR . 6.5 t -154.75 135.97 13.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 m -85.15 105.72 16.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.0 tpp -83.58 144.81 29.23 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.8 m -124.36 145.53 49.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 159.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.7 t -131.6 109.61 14.66 Favored Pre-proline 0 C--N 1.325 -0.461 0 C-N-CA 124.384 1.074 . . . . 0.0 108.253 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -50.01 146.93 15.92 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.979 2.452 . . . . 0.0 112.223 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.0 160.68 30.98 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.306 0.574 . . . . 0.0 110.571 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.16 39.79 9.51 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.31 160.18 39.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.923 0.868 . . . . 0.0 111.201 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.56 134.69 52.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 128.647 2.779 . . . . 0.0 108.079 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 99.3 m -127.06 136.65 52.47 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.456 1.102 . . . . 0.0 109.827 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -82.61 126.73 32.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.581 0.752 . . . . 0.0 111.569 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.414 HD13 ' H ' ' A' ' 37' ' ' MET . 1.5 mp -95.1 88.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 127.297 2.239 . . . . 0.0 106.721 178.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.0 67.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.551 HG21 HG21 ' A' ' 63' ' ' THR . 1.2 p -73.61 176.27 6.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.194 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -46.96 -50.34 15.62 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -90.85 161.34 15.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 125.057 1.343 . . . . 0.0 110.891 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -75.06 138.9 42.45 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.731 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -114.44 135.66 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.193 0.997 . . . . 0.0 109.714 -170.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.9 ttt85 -136.36 -20.19 1.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.3 m -132.46 174.05 10.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 121.068 1.758 . . . . 0.0 112.456 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -167.08 172.87 9.68 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 124.903 1.281 . . . . 0.0 110.884 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -149.33 124.07 9.86 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -67.12 138.74 57.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.801 1.182 . . . . 0.0 108.674 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 m -121.1 -28.23 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 175.721 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.716 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.1 t70 64.89 -57.06 0.27 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 129.049 2.94 . . . . 0.0 111.146 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.01 -162.1 23.87 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 125.45 1.5 . . . . 0.0 109.701 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -164.57 168.96 17.66 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.372 1.069 . . . . 0.0 108.799 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.8 136.56 52.86 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.933 1.693 . . . . 0.0 106.736 166.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 20' ' ' TRP . 9.2 pt -144.39 148.65 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 168.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.4 ptp -96.8 138.25 34.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.5 m -129.43 164.71 23.08 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.659 0.784 . . . . 0.0 109.533 -170.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -75.49 -32.08 60.43 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.469 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -143.18 -177.24 5.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.6 t -84.1 7.62 18.14 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.312 1.045 . . . . 0.0 111.442 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -126.84 93.37 42.34 Favored Pre-proline 0 N--CA 1.447 -0.581 0 C-N-CA 125.317 1.447 . . . . 0.0 111.164 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.18 -14.25 40.67 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.629 1.553 . . . . 0.0 113.271 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -68.2 -40.57 82.15 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 119.146 0.885 . . . . 0.0 110.612 172.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -120.47 13.96 11.87 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.63 129.28 9.47 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 163.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.64 93.15 5.45 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 176.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.1 m -80.21 157.68 26.45 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.339 0.7 OUTLIER -96.16 102.6 14.42 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 122.99 1.376 . . . . 0.0 111.683 170.192 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.488 ' HA ' HG22 ' A' ' 6' ' ' ILE . 71.7 m95 -83.7 50.27 1.77 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 129.688 3.195 . . . . 0.0 107.329 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -117.45 176.52 5.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -166.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -63.8 143.71 57.63 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -164.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -131.04 -29.45 1.86 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.873 2.869 . . . . 0.0 111.38 -162.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -99.62 -163.95 1.08 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -172.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t30 85.27 -57.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.207 1.803 . . . . 0.0 113.669 161.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.65 156.63 4.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.238 0.472 . . . . 0.0 111.433 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -31.44 116.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 129.002 2.921 . . . . 0.0 113.849 169.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.46 150.29 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 126.354 1.861 . . . . 0.0 108.378 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.32 145.0 20.22 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.882 1.706 . . . . 0.0 111.498 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -131.81 157.26 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.662 1.585 . . . . 0.0 109.047 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.53 -166.73 39.92 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 165.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 72.0 78.37 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.078 2.151 . . . . 0.0 115.104 164.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 68.26 4.49 4.2 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.439 1.896 . . . . 0.0 110.671 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.8 t -82.42 115.54 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -146.66 38.62 1.03 Allowed 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 122.857 0.463 . . . . 0.0 111.805 163.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -144.81 138.68 27.25 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -116.83 130.12 56.51 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 168.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.78 120.08 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.16 148.72 31.26 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.385 1.074 . . . . 0.0 108.745 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.94 -149.79 21.8 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.626 162.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.67 40.6 7.64 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.204 1.383 . . . . 0.0 111.265 -175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 p -124.49 -82.71 0.64 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.209 1.504 . . . . 0.0 108.081 174.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 p -150.35 -75.52 0.15 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 160.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -155.34 -176.59 6.02 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.137 2.175 . . . . 0.0 107.166 168.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.07 23.91 53.82 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.555 1.074 . . . . 0.0 112.972 161.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -135.35 47.96 2.28 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.396 1.479 . . . . 0.0 110.949 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -50.18 155.87 0.9 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.497 170.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.97 -178.51 30.23 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 106.727 -2.549 . . . . 0.0 106.727 165.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.6 m -137.76 147.99 45.19 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.259 1.023 . . . . 0.0 110.404 -171.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.54 135.79 51.62 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.681 168.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.4 m -83.51 109.2 17.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 162.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.8 mt -95.06 143.78 11.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.484 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 22.0 m-90 -126.11 156.33 40.23 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.529 1.132 . . . . 0.0 112.799 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.98 -47.69 28.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.907 1.683 . . . . 0.0 111.281 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.54 159.48 30.26 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -82.05 54.45 2.5 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.288 -1.125 . . . . 0.0 111.174 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.46 75.35 0.22 Allowed Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -167.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.437 ' HA ' ' CG ' ' A' ' 53' ' ' TRP . 26.0 p 50.46 38.54 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 159.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.13 176.21 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 125.067 1.347 . . . . 0.0 107.588 163.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.48 -156.7 32.2 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -68.24 153.25 44.12 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.484 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 10.5 p -129.87 166.49 19.87 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 124.468 1.105 . . . . 0.0 111.52 161.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.45 156.77 47.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 159.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.8 p -103.35 80.37 1.81 Allowed 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 135.09 34.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -169.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.4 m -128.1 134.27 49.12 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -173.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.79 114.26 11.03 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.626 -170.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -62.86 165.28 16.64 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.661 2.241 . . . . 0.0 114.748 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.74 53.67 1.67 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.933 1.293 . . . . 0.0 113.713 -162.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.416 ' H ' ' H ' ' A' ' 71' ' ' THR . 0.5 OUTLIER 157.54 14.24 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.606 2.762 . . . . 0.0 110.434 -167.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.416 ' H ' ' H ' ' A' ' 70' ' ' ASN . 95.1 m -104.98 136.45 44.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.04 127.14 37.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 160.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.7 m -121.63 136.68 54.94 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.918 1.687 . . . . 0.0 107.59 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -90.29 113.89 25.83 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.793 0.837 . . . . 0.0 111.408 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 75' ' ' ILE . 1.3 mp -84.84 66.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 124.609 1.163 . . . . 0.0 108.535 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -130.86 73.82 1.56 Allowed 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 163.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.43 177.48 5.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 176.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.26 -30.66 71.55 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -80.68 155.74 26.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 163.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.29 158.45 34.0 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.66 123.98 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -169.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -136.89 -13.14 1.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 p -154.55 171.14 19.91 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.512 -0.742 . . . . 0.0 110.459 166.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -164.52 170.27 16.08 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 6.1 tpt180 -153.23 144.64 23.23 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 158.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -67.94 134.1 50.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 123.623 0.577 . . . . 0.0 109.772 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.39 -30.97 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.052 0.941 . . . . 0.0 111.668 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -137.27 81.36 1.87 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 -165.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.77 -173.21 34.75 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.434 1.493 . . . . 0.0 112.811 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -159.28 178.31 10.11 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.6 tt -158.41 111.6 2.38 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.199 0.999 . . . . 0.0 109.046 168.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.41 HG22 ' HA ' ' A' ' 20' ' ' TRP . 27.9 pt -120.3 163.08 18.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 124.207 1.003 . . . . 0.0 111.248 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.09 152.3 18.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.238 1.415 . . . . 0.0 107.803 164.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.0 m -143.23 165.49 27.32 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.256 0.622 . . . . 0.0 109.757 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -79.07 -21.84 46.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.787 0.835 . . . . 0.0 112.476 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.49 172.25 18.87 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.34 3.86 1.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.882 1.273 . . . . 0.0 113.123 -175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -104.86 99.77 20.58 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.504 1.522 . . . . 0.0 109.961 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.12 -19.36 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.551 2.167 . . . . 0.0 112.275 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -70.72 -49.21 49.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.189 0.595 . . . . 0.0 109.566 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -127.69 16.4 6.95 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.7 -28.17 72.16 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 119.219 -2.176 . . . . 0.0 112.368 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 m 55.12 93.21 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -159.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.0 m -126.53 141.65 51.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -160.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.255 1.3 p-10 -85.15 102.71 13.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.475 1.131 . . . . 0.0 110.577 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.41 ' HA ' HG22 ' A' ' 6' ' ' ILE . 83.5 m95 -83.04 47.68 1.26 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.816 2.446 . . . . 0.0 107.375 171.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -96.71 172.14 8.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.96 1.704 . . . . 0.0 109.031 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.01 144.34 34.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -146.58 27.25 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.555 0.742 . . . . 0.0 112.345 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -100.16 114.5 27.95 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.098 0.959 . . . . 0.0 109.544 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 50.31 53.92 12.04 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.726 0.774 . . . . 0.0 110.127 174.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.9 t -148.23 138.67 22.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.0 t -67.23 99.49 0.7 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.315 1.446 . . . . 0.0 108.205 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.9 t -128.99 118.96 48.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.417 0.687 . . . . 0.0 109.456 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.2 135.19 23.8 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 125.683 1.611 . . . . 0.0 111.235 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.2 mt -84.14 159.82 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.796 2.038 . . . . 0.0 106.903 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 179.2 164.59 32.06 Favored Glycine 0 N--CA 1.449 -0.451 0 O-C-N 121.403 -0.811 . . . . 0.0 113.35 164.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.1 74.7 0.22 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.161 2.185 . . . . 0.0 113.983 166.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 67.71 3.58 3.51 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.631 2.372 . . . . 0.0 110.902 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.5 t -79.21 99.58 3.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 O-C-N 121.153 -0.967 . . . . 0.0 109.681 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -143.87 43.01 1.46 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.797 1.639 . . . . 0.0 109.226 170.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -139.34 139.26 37.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.421 ' H ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -107.05 136.99 45.98 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 164.304 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.34 117.51 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.2 p -94.74 160.98 14.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.24 25.71 1.56 Allowed Glycine 0 C--O 1.221 -0.687 0 C-N-CA 124.483 1.04 . . . . 0.0 113.597 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.11 45.08 2.22 Favored Glycine 0 C--N 1.312 -0.768 0 C-N-CA 129.179 3.276 . . . . 0.0 110.821 -168.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.8 t 50.09 -149.56 0.26 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.703 2.001 . . . . 0.0 109.204 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -90.65 -66.5 0.92 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 163.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.24 50.84 2.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.911 1.684 . . . . 0.0 108.653 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.07 29.1 3.56 Favored Glycine 0 CA--C 1.524 0.613 0 O-C-N 121.295 -0.878 . . . . 0.0 111.637 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.1 mttt 53.48 161.01 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -63.24 143.61 57.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.297 159.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.05 157.12 15.24 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-O 117.167 -1.907 . . . . 0.0 108.685 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 38.2 m -139.47 151.33 46.11 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 121.136 2.468 . . . . 0.0 108.561 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.26 140.16 52.04 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 124.642 1.177 . . . . 0.0 108.479 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.2 m -83.9 119.9 25.43 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 159.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 mt -97.19 147.87 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 126.398 1.879 . . . . 0.0 106.082 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 3.1 m-90 -125.27 158.2 34.72 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.105 1.762 . . . . 0.0 111.096 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -93.43 -34.02 13.6 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 125.086 1.354 . . . . 0.0 111.581 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.07 138.77 37.33 Favored Glycine 0 CA--C 1.523 0.57 0 O-C-N 120.454 -1.404 . . . . 0.0 110.074 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -70.57 75.44 0.58 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.746 1.219 . . . . 0.0 110.325 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.57 -65.14 0.16 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 21.2 p 156.66 41.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 129.824 3.249 . . . . 0.0 110.792 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 m -125.8 176.4 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.967 1.307 . . . . 0.0 108.023 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.87 -151.53 27.65 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -77.01 152.37 35.19 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.988 1.315 . . . . 0.0 108.011 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -152.84 151.45 30.43 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.622 0.576 . . . . 0.0 112.47 -167.166 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -145.06 138.69 26.87 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -85.02 99.85 11.29 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.333 0.653 . . . . 0.0 110.273 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -88.37 124.95 34.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 99.3 m -110.02 139.47 45.1 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.9 t -132.47 136.22 27.58 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.15 -0.929 . . . . 0.0 109.768 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.53 -179.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.334 2.689 . . . . 0.0 114.484 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.23 155.84 37.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.22 167.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 33.95 57.6 0.6 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.783 2.033 . . . . 0.0 114.134 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 t -154.71 165.73 35.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.883 0.849 . . . . 0.0 110.75 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.84 139.22 34.83 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.814 2.446 . . . . 0.0 109.478 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.9 m -131.77 135.96 47.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.613 1.565 . . . . 0.0 107.127 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -85.62 114.8 22.89 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.254 0.934 . . . . 0.0 110.731 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.456 HG22 HG13 ' A' ' 81' ' ' ILE . 1.7 mp -86.77 72.74 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 108.817 -174.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -110.57 152.43 26.44 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 158.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.2 p -144.66 -159.73 1.04 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.074 0.852 . . . . 0.0 108.822 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.49 -15.56 79.1 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.434 -0.648 . . . . 0.0 112.882 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -136.39 163.22 30.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 118.859 1.33 . . . . 0.0 108.687 173.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -69.21 133.82 48.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.456 HG13 HG22 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -103.37 129.78 54.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.04 0.936 . . . . 0.0 109.471 -162.298 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -123.96 -29.01 3.7 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -162.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.1 169.71 20.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 117.789 -1.1 . . . . 0.0 110.439 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -157.61 163.62 38.1 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 120.132 1.333 . . . . 0.0 112.906 169.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -125.25 128.65 48.62 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.608 1.963 . . . . 0.0 108.158 161.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.9 mmm-85 -58.86 134.23 56.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 161.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.42 -50.6 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -170.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . 0.357 15.9 pt-20 . . . . . 0 N--CA 1.429 -1.475 1 C-N-CA 132.926 4.491 . . . . 0.0 111.433 158.297 . . . . . . . . 2 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.814 0 CA-C-O 119.637 -0.535 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.46 -64.26 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.705 0.753 . . . . 0.0 111.061 -159.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.93 -168.09 0.43 Allowed Glycine 0 CA--C 1.532 1.096 0 CA-C-O 122.112 0.84 . . . . 0.0 111.022 159.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -176.59 -177.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 -162.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 tt -140.34 131.49 26.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 20' ' ' TRP . 12.7 pt -147.59 146.46 18.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.393 1.077 . . . . 0.0 109.426 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -95.02 141.85 28.19 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.24 0.616 . . . . 0.0 110.005 167.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.9 m -134.56 152.45 51.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.599 1.16 . . . . 0.0 108.555 -172.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -78.66 -16.65 57.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -143.82 -167.93 2.72 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.622 1.169 . . . . 0.0 109.331 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 40.2 t -90.27 4.01 51.93 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.666 0.786 . . . . 0.0 112.887 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -105.0 106.79 56.87 Favored Pre-proline 0 C--N 1.331 -0.217 0 C-N-CA 123.989 0.916 . . . . 0.0 109.319 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.38 -23.86 75.37 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 CA-C-N 120.009 1.039 . . . . 0.0 111.946 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -71.2 -63.93 1.01 Allowed 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 122.045 -0.409 . . . . 0.0 110.343 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -109.99 13.22 23.44 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.94 -30.5 59.26 Favored Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m 70.15 110.75 0.05 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -159.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.5 m -122.5 146.04 47.76 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.35 107.82 20.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.614 1.197 . . . . 0.0 110.806 169.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.411 ' HA ' HG22 ' A' ' 6' ' ' ILE . 63.7 m95 -83.72 48.32 1.42 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.669 2.388 . . . . 0.0 107.276 174.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -92.83 153.91 18.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.81 142.94 57.18 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 173.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -146.88 19.49 1.28 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.376 1.071 . . . . 0.0 112.307 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -95.13 129.43 42.23 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -166.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 53.31 43.94 30.78 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.129 0.572 . . . . 0.0 110.099 172.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 t -159.87 163.69 34.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.171 -0.956 . . . . 0.0 110.631 -170.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 54.1 t -92.79 96.0 9.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.97 2.108 . . . . 0.0 110.07 -166.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -111.99 104.12 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 119.373 0.988 . . . . 0.0 111.072 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.48 127.76 37.61 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 167.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.2 mt -84.05 156.86 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.327 2.251 . . . . 0.0 106.013 166.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.66 -166.29 22.27 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.281 . . 34.02 75.13 0.05 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 47.41 22.5 0.28 Allowed 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 125.099 1.359 . . . . 0.0 112.282 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.76 118.06 18.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 119.391 -0.924 . . . . 0.0 108.963 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.28 37.45 1.25 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.743 0.817 . . . . 0.0 111.025 171.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -142.88 134.24 26.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 45.4 ttm -113.47 127.34 56.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 165.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -123.64 91.11 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 t -108.3 155.46 20.48 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.603 0.716 . . . . 0.0 111.473 -158.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.623 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . 45.46 -153.03 0.73 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 125.845 1.688 . . . . 0.0 112.764 -175.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.05 13.12 0.61 Allowed Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.815 -0.991 . . . . 0.0 111.999 -175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 44' ' ' ASP 0.267 1.1 t -147.78 92.78 2.11 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.1 1.45 . . . . 0.0 110.027 -170.221 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 55.5 -10.32 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.84 2.056 . . . . 0.0 112.439 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.758 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -80.59 85.84 5.94 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.538 1.535 . . . . 0.0 107.871 -171.674 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.14 -0.47 82.85 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.637 158.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -82.41 105.59 13.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.21 -1.171 . . . . 0.0 108.865 169.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -57.28 169.69 0.57 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.018 1.327 . . . . 0.0 113.018 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -129.88 158.67 22.37 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 62.2 m -143.69 155.67 44.29 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 117.88 0.84 . . . . 0.0 109.118 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.43 148.14 40.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.875 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -84.03 144.54 29.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 162.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -127.19 152.11 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.445 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 21.8 m-90 -133.6 149.98 51.61 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.218 1.372 . . . . 0.0 112.916 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.69 -54.39 23.61 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.658 1.183 . . . . 0.0 109.067 164.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.38 124.63 11.15 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -168.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.54 67.49 0.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.448 3.099 . . . . 0.0 112.552 -162.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.69 -55.12 0.08 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 127.391 2.424 . . . . 0.0 107.919 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 20.0 p 163.65 50.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 130.544 3.538 . . . . 0.0 108.641 166.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.99 176.65 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.979 1.712 . . . . 0.0 108.281 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.79 -157.41 51.54 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.69 132.37 34.87 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 117.691 0.745 . . . . 0.0 109.017 -166.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 10.1 p -113.64 157.23 22.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 123.598 0.561 . . . . 0.0 112.428 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.83 -177.76 4.58 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 127.352 2.261 . . . . 0.0 106.856 174.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 t -135.15 136.86 42.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -142.32 114.78 8.44 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.044 0.538 . . . . 0.0 110.013 -173.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.7 m -96.05 143.22 27.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.819 1.248 . . . . 0.0 109.557 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.7 t -141.9 123.97 9.1 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.259 1.423 . . . . 0.0 110.511 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.87 145.6 72.15 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.225 1.95 . . . . 0.0 111.506 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -73.31 140.04 46.48 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 161.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 74.11 45.21 0.22 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -170.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -154.62 144.38 21.6 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 171.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.89 125.19 36.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.424 1.49 . . . . 0.0 108.086 164.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 55.6 m -116.21 136.8 52.69 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 124.905 1.282 . . . . 0.0 109.179 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -98.69 110.83 23.36 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.156 0.982 . . . . 0.0 109.55 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -82.75 96.29 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 122.167 0.984 . . . . 0.0 108.767 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.52 158.08 44.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 163.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.3 p -132.77 -150.1 0.4 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 167.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.31 -28.73 67.48 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 164.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -125.89 165.05 19.44 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.297 1.039 . . . . 0.0 110.082 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -80.58 137.39 36.38 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.558 ' N ' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -113.64 148.89 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.107 0.963 . . . . 0.0 109.957 -170.716 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -134.97 -3.67 2.49 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 124.364 1.065 . . . . 0.0 113.333 -170.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.85 164.1 31.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 164.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -144.32 171.79 13.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.104 0.961 . . . . 0.0 112.267 166.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.46 123.88 10.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.52 1.928 . . . . 0.0 106.027 169.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -70.28 138.74 51.83 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 119.199 0.909 . . . . 0.0 109.01 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -104.69 -42.08 7.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 125.04 1.336 . . . . 0.0 110.873 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -177.615 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.299 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -118.92 85.41 2.36 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.658 1.183 . . . . 0.0 108.289 -173.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.34 141.94 48.16 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 160.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -169.03 -174.32 2.01 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.958 1.703 . . . . 0.0 107.448 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tt -141.57 103.14 4.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.71 161.13 39.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.4 ptp -125.61 154.46 42.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 122.619 1.2 . . . . 0.0 111.284 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 1.3 m -135.78 169.56 17.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.108 1.763 . . . . 0.0 107.261 -163.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -79.45 -24.61 42.31 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 166.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -139.19 -176.63 4.58 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 172.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.8 t -83.28 3.61 30.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.869 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -113.11 113.95 48.92 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.942 0.897 . . . . 0.0 109.304 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.73 -39.23 21.17 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 120.997 1.392 . . . . 0.0 110.806 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -69.96 -34.01 72.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.482 1.913 . . . . 0.0 111.09 -165.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.8 t -135.46 15.03 3.45 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.37 -46.65 5.18 Favored Glycine 0 CA--C 1.519 0.309 0 O-C-N 120.463 -1.398 . . . . 0.0 110.755 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t 82.04 124.79 0.04 OUTLIER 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.605 1.562 . . . . 0.0 108.552 -166.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 1.2 m -125.85 170.75 11.32 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.059 1.743 . . . . 0.0 110.448 -177.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -90.31 94.02 9.57 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 123.164 1.459 . . . . 0.0 113.122 165.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -83.43 45.68 1.07 Allowed 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.724 -1.235 . . . . 0.0 108.428 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -85.77 163.96 17.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.74 1.616 . . . . 0.0 109.592 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -70.98 143.34 50.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 161.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -137.3 -44.44 0.55 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -167.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -48.21 113.94 0.84 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.592 1.557 . . . . 0.0 109.614 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 55.85 19.51 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.403 1.481 . . . . 0.0 112.667 174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -114.34 179.76 3.86 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -175.334 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.0 t -149.36 74.85 1.26 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 121.183 1.811 . . . . 0.0 109.96 -166.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 t -83.81 163.94 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -166.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.73 115.81 5.21 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 124.631 1.11 . . . . 0.0 111.103 163.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.11 152.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 126.36 1.864 . . . . 0.0 107.551 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.92 -165.52 38.98 Favored Glycine 0 N--CA 1.444 -0.801 0 O-C-N 121.649 -0.657 . . . . 0.0 111.84 167.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 71.09 73.15 0.19 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.687 2.395 . . . . 0.0 113.548 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 61.11 11.27 3.35 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.568 1.547 . . . . 0.0 110.777 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 24.6 t -73.6 108.84 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -173.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -146.63 34.61 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 170.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -140.71 113.62 8.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.309 0.959 . . . . 0.0 111.756 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.472 ' HB2' HD11 ' A' ' 75' ' ' ILE . 44.3 ttp -84.07 138.92 32.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.06 101.54 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.2 p -93.6 49.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.429 -0.794 . . . . 0.0 111.595 -159.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.56 -155.3 16.18 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -171.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.53 -38.53 0.02 OUTLIER Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.395 0.998 . . . . 0.0 111.8 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 m -23.83 -92.6 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 128.01 2.524 . . . . 0.0 116.123 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.728 HG23 ' H ' ' A' ' 44' ' ' ASP . 14.5 t -155.94 -89.36 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -173.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.728 ' H ' HG23 ' A' ' 43' ' ' THR 0.255 0.5 OUTLIER -123.7 178.82 5.04 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 101.517 -3.512 . . . . 0.0 101.517 160.643 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.86 -76.22 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 105.867 -2.893 . . . . 0.0 105.867 159.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.42 146.47 10.23 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 127.761 2.425 . . . . 0.0 106.744 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -59.51 164.78 3.24 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.0 132.68 8.73 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 170.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 86.0 m -132.99 149.14 52.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.9 140.5 16.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.67 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.8 m -86.66 117.3 25.33 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 166.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 mm -99.47 149.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -130.57 160.34 34.47 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.315 1.446 . . . . 0.0 112.002 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -89.49 -35.34 16.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.087 2.155 . . . . 0.0 111.322 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.75 144.48 38.49 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -76.75 64.02 2.26 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.93 33.73 0.02 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.26 27.9 p 44.65 42.4 5.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.557 1.543 . . . . 0.0 112.226 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -126.18 176.34 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 126.729 2.012 . . . . 0.0 107.695 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.17 -156.93 32.93 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -69.46 153.16 43.95 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.53 168.81 22.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.21 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.93 149.73 26.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.45 106.54 17.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -91.34 83.92 5.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.0 m -84.0 139.42 32.55 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 18.9 t -145.16 142.11 17.99 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 125.122 1.369 . . . . 0.0 109.446 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.33 177.27 2.16 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.974 1.782 . . . . 0.0 111.384 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.55 149.11 42.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.168 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 50.67 38.53 19.37 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.038 1.335 . . . . 0.0 110.094 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.4 m -115.52 137.3 52.21 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -98.17 114.09 26.2 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.26 106.01 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.84 2.056 . . . . 0.0 107.823 -162.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -64.42 136.15 56.81 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.887 0.851 . . . . 0.0 110.637 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 37' ' ' MET . 12.5 mm -101.86 117.45 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.79 65.57 1.05 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.5 p -73.94 161.79 29.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.269 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -54.14 -52.88 40.78 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -80.64 157.55 25.93 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.527 0.68 . . . . 0.0 110.62 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -76.15 134.43 39.95 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.893 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.09 132.79 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -168.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -135.93 -27.81 1.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -173.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 p -152.69 171.87 17.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.563 0.619 . . . . 0.0 111.251 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -156.32 170.06 23.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.633 0.651 . . . . 0.0 111.157 176.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 26' ' ' THR . 14.5 mtt180 -140.2 147.1 39.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.496 1.918 . . . . 0.0 109.31 159.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -63.58 163.53 11.04 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.624 0.769 . . . . 0.0 110.607 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.09 -36.51 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 117.809 0.277 . . . . 0.0 110.458 159.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 163.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.634 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . 0.293 0.1 OUTLIER 63.19 -52.66 0.2 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 129.372 3.069 . . . . 0.0 116.508 159.19 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.61 -178.07 9.0 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 163.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -172.83 -179.13 2.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -168.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.94 88.59 2.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 159.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pt -108.3 162.47 6.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 169.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 ptm -108.24 167.94 9.66 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.493 1.139 . . . . 0.0 110.118 161.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 82.2 m -153.58 163.22 40.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 124.5 1.12 . . . . 0.0 108.496 -158.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -85.58 -21.37 28.54 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -133.58 -175.15 3.73 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.811 0.444 . . . . 0.0 111.267 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.1 t -92.13 3.46 55.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.307 1.043 . . . . 0.0 111.811 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -132.98 88.71 36.2 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 126.011 1.725 . . . . 0.0 110.088 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -48.76 -26.77 10.06 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.203 3.268 . . . . 0.0 113.293 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -64.3 -44.32 91.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.46 -0.775 . . . . 0.0 111.495 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.7 p -104.13 13.83 31.65 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.65 135.3 7.48 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 123.966 0.793 . . . . 0.0 112.898 172.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -63.75 137.78 58.21 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.086 -0.655 . . . . 0.0 109.821 169.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 89.3 m -130.39 157.21 43.22 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 125.372 1.469 . . . . 0.0 107.317 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -85.07 93.43 8.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 123.677 1.704 . . . . 0.0 110.821 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -83.87 50.93 1.92 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.658 1.983 . . . . 0.0 107.122 169.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -119.23 -174.1 2.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.88 1.672 . . . . 0.0 108.255 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.11 143.12 50.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 167.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -146.5 5.69 0.93 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.693 -166.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.411 ' CG ' ' N ' ' A' ' 25' ' ' ASN . 19.8 t-105 -78.07 -163.63 0.45 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -165.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' N ' ' CG ' ' A' ' 24' ' ' TRP . 15.0 t-20 -68.31 61.55 0.09 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.526 2.731 . . . . 0.0 110.411 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 t -141.93 149.79 40.61 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 127.477 2.311 . . . . 0.0 105.692 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.2 t -72.56 69.8 0.89 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.433 1.493 . . . . 0.0 111.706 -164.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.3 t -93.42 124.84 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.125 0.97 . . . . 0.0 109.53 -165.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.77 132.39 11.34 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -83.71 153.3 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 169.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.13 158.52 29.86 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 68.87 69.38 0.28 Allowed 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 127.343 2.257 . . . . 0.0 115.835 169.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 49.84 19.26 0.42 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.596 1.159 . . . . 0.0 112.304 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.45 110.86 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -146.26 26.42 1.19 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.939 0.895 . . . . 0.0 112.771 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -138.56 121.45 16.58 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.295 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.587 ' H ' HD13 ' A' ' 75' ' ' ILE . 53.1 tpp -83.62 134.7 34.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -131.05 120.21 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.1 p -104.14 45.37 0.96 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.184 0.993 . . . . 0.0 109.975 -159.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.06 -154.73 35.66 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.58 22.42 0.22 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.56 -56.78 2.31 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.521 0.728 . . . . 0.0 109.339 -174.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t 125.63 -40.33 0.01 OUTLIER 'General case' 0 C--O 1.232 0.171 0 C-N-CA 130.504 3.522 . . . . 0.0 108.422 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.88 34.14 0.39 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.171 1.388 . . . . 0.0 110.598 -166.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.88 -22.67 15.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 168.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm 68.0 157.11 0.13 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.044 2.138 . . . . 0.0 112.35 -165.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -53.96 146.19 14.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.564 1.146 . . . . 0.0 111.739 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.43 136.21 10.3 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 59.0 m -122.8 149.76 43.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.01 136.83 21.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.633 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.6 m -89.45 117.38 28.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 170.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.1 mt -106.53 137.92 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.028 1.731 . . . . 0.0 107.049 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.451 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 5.0 m-90 -122.14 160.63 24.69 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.54 1.536 . . . . 0.0 112.7 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -91.79 -33.89 14.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.494 2.318 . . . . 0.0 111.236 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.41 128.02 9.44 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 124.668 1.128 . . . . 0.0 111.736 -169.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -44.29 121.31 2.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.814 2.046 . . . . 0.0 112.087 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.38 -60.56 0.59 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 126.574 2.035 . . . . 0.0 109.593 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 30.6 p 168.94 43.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.385 1.874 . . . . 0.0 111.472 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 m -120.41 176.75 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.36 -157.93 28.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -73.59 158.57 34.55 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 126.246 1.818 . . . . 0.0 108.161 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.451 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.4 p -159.18 160.68 35.75 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.987 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.0 p -142.67 149.9 39.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.1 t -91.17 128.24 36.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -119.95 116.04 24.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.924 1.69 . . . . 0.0 108.491 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 11.5 m -98.09 146.73 25.26 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.516 0.726 . . . . 0.0 109.77 173.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.2 t -149.41 136.85 11.24 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.405 1.082 . . . . 0.0 111.01 173.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.88 177.75 3.32 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.912 1.741 . . . . 0.0 112.213 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.4 175.24 7.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 37.73 54.1 1.51 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 126.071 1.748 . . . . 0.0 112.265 171.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.24 168.44 25.98 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.923 0.868 . . . . 0.0 108.948 175.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.18 134.34 52.85 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.705 2.002 . . . . 0.0 107.244 172.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.83 118.16 20.38 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -169.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -78.55 122.94 26.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.951 -0.468 . . . . 0.0 110.013 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.587 HD13 ' H ' ' A' ' 37' ' ' MET . 1.9 mp -102.42 104.19 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 169.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.05 69.86 1.26 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 169.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 p -74.01 176.01 6.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.238 1.815 . . . . 0.0 110.58 -162.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.99 -41.59 92.42 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -93.72 164.18 13.24 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.768 0.827 . . . . 0.0 110.545 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -80.93 133.82 35.61 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.85 129.89 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.086 0.554 . . . . 0.0 110.039 -169.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ttt85 -136.54 -13.2 1.76 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -172.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.84 169.32 16.76 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.454 -0.779 . . . . 0.0 111.708 -173.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -166.9 171.79 10.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.463 0.649 . . . . 0.0 112.46 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . 0.295 0.0 OUTLIER -137.56 135.83 37.04 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 129.281 3.033 . . . . 0.0 105.227 170.549 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -64.5 159.19 22.09 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 158.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.09 -41.54 3.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 119.351 0.978 . . . . 0.0 111.171 163.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 172.988 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.769 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 64.2 -74.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.677 2.391 . . . . 0.0 110.819 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.33 169.25 1.74 Allowed Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 125.208 1.385 . . . . 0.0 111.748 -159.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -176.15 168.7 2.87 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -170.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -150.01 103.98 3.25 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 pt -153.1 159.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.335 1.854 . . . . 0.0 107.843 -167.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.7 ptm -106.55 147.2 29.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.946 0.898 . . . . 0.0 110.088 166.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 1.3 m -117.87 162.31 18.32 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 10.8 pttt -62.86 -37.47 86.97 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 116.347 -2.141 . . . . 0.0 109.936 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -122.15 -171.25 2.21 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 126.831 2.053 . . . . 0.0 109.143 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 50.8 t -78.47 3.23 16.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -118.3 114.52 36.54 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 121.269 -0.894 . . . . 0.0 113.166 -164.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.67 -23.48 56.36 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 120.932 1.088 . . . . 0.0 111.834 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -64.54 -63.11 1.21 Allowed 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.448 1.022 . . . . 0.0 110.221 -176.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -118.92 13.76 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.9 -19.38 78.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.456 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.9 m 58.33 93.22 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -160.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 1.2 m -98.04 145.31 26.65 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -91.61 98.88 11.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.536 1.16 . . . . 0.0 109.474 172.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -83.38 45.56 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.801 2.04 . . . . 0.0 107.995 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.54 -177.68 6.79 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.373 1.469 . . . . 0.0 110.198 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -63.71 150.36 44.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 163.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -139.86 -15.7 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.029 0.932 . . . . 0.0 111.894 176.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -91.08 112.98 25.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 48.72 64.52 1.67 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.709 1.203 . . . . 0.0 110.044 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.21 -178.61 4.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.81 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.3 t -154.41 54.61 0.69 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -94.7 129.98 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 125.395 1.478 . . . . 0.0 109.384 -170.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.15 126.58 7.77 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.783 0.706 . . . . 0.0 112.41 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 mm -107.14 166.24 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 130.406 3.482 . . . . 0.0 108.426 -174.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.85 175.88 25.62 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 165.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 91.32 79.89 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 129.763 3.225 . . . . 0.0 112.343 174.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 80.61 6.96 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 129.34 3.056 . . . . 0.0 110.819 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 62.1 t -83.99 118.49 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 CA-C-N 118.912 0.778 . . . . 0.0 112.467 -164.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.414 ' CE1' ' HE1' ' A' ' 36' ' ' TRP . 4.4 p80 -146.55 35.53 0.96 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 163.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.414 ' HE1' ' CE1' ' A' ' 35' ' ' HIS . 74.6 m95 -140.67 124.47 17.16 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.148 1.34 . . . . 0.0 112.224 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.567 ' H ' HD13 ' A' ' 75' ' ' ILE . 14.1 tpt -84.89 131.14 34.54 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 161.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.47 85.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -172.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 t -93.95 143.89 25.94 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.26 176.86 37.11 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 124.493 1.044 . . . . 0.0 111.286 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.499 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -76.64 -35.85 39.59 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 122.756 -0.261 . . . . 0.0 112.678 -171.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.11 -150.97 0.47 Allowed 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 122.798 0.439 . . . . 0.0 111.666 -168.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 85.94 -54.68 0.07 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 127.677 2.391 . . . . 0.0 105.985 174.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -105.88 151.55 24.4 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 159.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.95 -13.71 57.4 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 123.8 0.714 . . . . 0.0 111.349 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -124.47 164.6 19.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -53.03 144.46 15.12 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.56 153.6 16.9 Favored Glycine 0 C--O 1.239 0.442 0 N-CA-C 107.078 -2.409 . . . . 0.0 107.078 167.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.6 m -126.52 144.23 50.94 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.93 126.68 49.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.0 m -83.59 118.88 24.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 168.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 mt -96.65 150.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 -129.08 157.85 40.59 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.984 1.714 . . . . 0.0 111.549 -175.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -82.42 -44.28 16.26 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.09 2.156 . . . . 0.0 111.636 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.81 135.15 21.33 Favored Glycine 0 N--CA 1.449 -0.494 0 O-C-N 120.999 -1.063 . . . . 0.0 111.098 -173.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.1 m -54.48 102.54 0.06 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.587 0.755 . . . . 0.0 109.979 171.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.53 -75.92 0.4 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 24.0 p 158.69 42.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 128.692 2.797 . . . . 0.0 110.397 -174.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.38 176.28 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.33 -167.19 44.81 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 119.615 1.098 . . . . 0.0 110.592 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -73.84 149.57 41.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.497 -1.002 . . . . 0.0 108.874 -170.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.9 161.34 40.94 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.103 -163.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.53 117.05 4.66 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -167.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.5 m -71.55 100.25 2.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.317 0.647 . . . . 0.0 109.51 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.8 tpp -84.04 103.56 13.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.655 1.182 . . . . 0.0 107.836 172.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 50.7 m -84.7 146.45 27.43 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.3 t -155.53 108.31 2.2 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.447 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.2 162.13 14.82 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.844 2.363 . . . . 0.0 113.297 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 41' ' ' GLY . . . -73.53 137.94 44.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 -174.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 58.76 48.56 11.23 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.348 1.859 . . . . 0.0 110.853 -166.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m -124.44 116.81 23.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.314 0.578 . . . . 0.0 109.99 170.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.406 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -74.35 114.11 12.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 158.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.2 m -116.2 123.84 48.78 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.286 1.834 . . . . 0.0 107.922 -172.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -78.24 132.49 37.56 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 118.454 0.57 . . . . 0.0 110.364 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 37' ' ' MET . 1.2 mp -98.35 107.54 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -123.52 144.63 49.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 p -142.35 -161.93 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 175.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.39 15.58 57.41 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.073 168.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.7 169.97 17.42 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 119.075 1.437 . . . . 0.0 109.425 -173.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -70.51 133.98 47.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 170.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.61 128.75 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.19 -46.97 0.64 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.559 -158.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -133.06 175.89 8.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 119.758 1.163 . . . . 0.0 110.424 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -160.64 163.86 32.25 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 119.779 1.172 . . . . 0.0 113.34 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.06 127.77 10.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 169.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -66.1 115.87 6.59 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.53 -39.33 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 C-N-CA 124.612 1.165 . . . . 0.0 110.047 -168.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.92 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.487 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.69 63.49 0.85 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.243 1.817 . . . . 0.0 111.897 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' C ' ' HB3' ' A' ' 42' ' ' SER . . . -164.14 161.37 34.33 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 118.847 -0.974 . . . . 0.0 112.742 164.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -119.04 -174.16 2.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 170.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 tt -140.98 117.71 11.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.211 1.404 . . . . 0.0 108.266 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.27 165.95 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 123.783 0.833 . . . . 0.0 110.077 174.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.6 ptm -105.51 142.39 35.34 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 108.541 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -138.46 158.53 44.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.651 1.181 . . . . 0.0 108.935 -165.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -82.57 -5.88 59.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.63 -172.44 3.12 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.219 1.408 . . . . 0.0 108.149 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.7 t -86.43 3.57 43.26 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.594 0.757 . . . . 0.0 112.081 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -128.43 105.71 19.35 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 118.754 -0.641 . . . . 0.0 111.574 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -58.14 -24.89 68.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.513 1.476 . . . . 0.0 111.581 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -63.83 -27.69 69.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.223 -0.923 . . . . 0.0 110.953 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.0 t -138.79 23.23 2.65 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.352 0.661 . . . . 0.0 111.338 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.05 123.7 5.98 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 164.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.14 94.59 4.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 171.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.5 m -92.44 149.77 21.19 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -171.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -96.29 98.9 10.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.798 0.808 . . . . 0.0 111.462 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -83.77 44.83 1.02 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 130.028 3.331 . . . . 0.0 111.304 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -101.28 174.13 6.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.748 1.219 . . . . 0.0 110.057 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -65.04 143.82 57.68 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.496 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.27 -27.35 8.71 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.931 1.292 . . . . 0.0 109.913 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -84.52 143.28 29.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.785 1.634 . . . . 0.0 106.812 -177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 44.92 43.57 7.23 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.818 1.647 . . . . 0.0 111.527 171.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 t -162.98 149.31 12.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 167.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.4 t -115.97 84.17 2.07 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.581 1.152 . . . . 0.0 111.282 -165.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.5 t -84.8 153.63 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.119 -165.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.02 154.21 31.7 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.448 1.023 . . . . 0.0 111.63 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.4 166.15 8.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 128.103 2.561 . . . . 0.0 105.831 172.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.02 162.22 12.57 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-O 121.439 0.466 . . . . 0.0 113.117 164.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 62.51 81.48 0.2 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.466 2.307 . . . . 0.0 111.185 -175.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 66.24 3.66 2.83 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 125.919 1.687 . . . . 0.0 111.339 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.0 t -102.56 99.31 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -145.99 33.4 1.01 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.168 0.987 . . . . 0.0 111.08 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -144.45 121.84 11.65 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.598 ' H ' HD13 ' A' ' 75' ' ' ILE . 43.0 ttm -85.4 138.77 32.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 158.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 t -134.08 150.31 31.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.6 p -129.06 -173.92 3.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.445 0.698 . . . . 0.0 109.343 -170.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.47 -152.91 20.54 Favored Glycine 0 C--O 1.221 -0.672 0 CA-C-O 118.611 -1.105 . . . . 0.0 112.445 161.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 40.0 52.06 3.36 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.655 1.598 . . . . 0.0 113.285 173.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.403 ' HB3' ' C ' ' A' ' 3' ' ' GLY . 6.7 t -143.37 -152.92 0.44 Allowed 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.768 -0.842 . . . . 0.0 112.495 -177.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.2 t -121.98 -39.63 2.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.052 1.741 . . . . 0.0 109.528 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.1 129.84 11.61 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 120.652 -1.28 . . . . 0.0 109.071 175.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.27 78.09 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -173.28 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.012 1.325 . . . . 0.0 112.143 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -43.61 143.76 0.92 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.87 0.868 . . . . 0.0 111.601 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -146.86 157.62 27.47 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -171.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.4 m -136.65 154.6 50.6 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.888 0.875 . . . . 0.0 108.869 -172.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.29 141.61 49.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.795 1.238 . . . . 0.0 109.023 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 m -83.61 116.96 22.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 159.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -94.46 145.54 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -126.28 151.61 47.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.71 1.604 . . . . 0.0 109.722 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -58.65 -40.81 84.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 124.384 1.074 . . . . 0.0 109.766 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 82' ' ' ARG . . . -163.2 175.85 39.47 Favored Glycine 0 C--O 1.221 -0.71 0 C-N-CA 116.097 -2.954 . . . . 0.0 120.434 175.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.9 m 32.29 80.84 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.875 2.87 . . . . 0.0 116.314 159.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.3 43.53 95.02 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 52.55 69.25 0.71 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.062 1.345 . . . . 0.0 111.902 171.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.12 175.93 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 C-N-CA 126.743 2.017 . . . . 0.0 107.921 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.6 -160.0 53.41 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ttp-105 -76.82 156.6 32.14 Favored 'General case' 0 CA--C 1.5 -0.956 0 O-C-N 121.934 -0.744 . . . . 0.0 109.585 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.42 144.24 34.35 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.864 -172.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 p -139.93 147.24 40.25 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.065 1.346 . . . . 0.0 108.466 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 t -85.57 113.06 21.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.4 tpt -86.14 139.41 31.12 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 165.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 50.8 m -139.06 143.04 38.2 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.2 t -150.77 123.53 4.17 Favored Pre-proline 0 CA--C 1.535 0.365 0 C-N-CA 124.134 0.974 . . . . 0.0 110.026 -170.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -52.99 157.35 8.25 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.943 2.428 . . . . 0.0 110.646 168.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.8 138.57 32.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.034 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 77.04 44.47 0.1 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 125.748 1.619 . . . . 0.0 109.192 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -149.9 169.3 21.48 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 164.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.6 t -113.15 139.14 48.99 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.018 1.727 . . . . 0.0 107.751 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 24.7 m -140.96 101.63 4.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -163.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -67.67 130.39 42.87 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.795 -0.566 . . . . 0.0 110.25 176.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.598 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -94.13 106.88 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.302 1.841 . . . . 0.0 106.954 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -166.39 71.02 0.13 Allowed 'General case' 0 N--CA 1.461 0.107 0 O-C-N 121.7 -0.625 . . . . 0.0 109.681 176.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 p -74.4 -160.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.124 0.488 . . . . 0.0 110.471 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.8 -24.66 60.41 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 121.374 -0.829 . . . . 0.0 111.783 168.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -118.26 153.89 33.18 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.525 1.163 . . . . 0.0 109.317 169.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -73.87 141.5 46.07 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 125.806 1.942 . . . . 0.0 107.093 163.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.06 136.21 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 124.137 0.975 . . . . 0.0 109.047 -168.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.412 ' HB3' ' HA2' ' A' ' 55' ' ' GLY . 46.6 ttt180 -106.76 -22.27 12.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 116.975 -1.488 . . . . 0.0 112.803 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -137.16 170.7 15.65 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 122.909 2.595 . . . . 0.0 113.316 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -160.11 166.84 29.06 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.069 0.548 . . . . 0.0 109.999 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.11 145.48 28.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -71.34 149.91 45.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.085 0.954 . . . . 0.0 112.312 -170.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.6 m -137.42 -7.4 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-N 120.814 1.643 . . . . 0.0 109.299 158.66 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.628 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.85 -38.82 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.992 2.117 . . . . 0.0 108.338 172.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.7 163.79 37.14 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-O 121.803 0.668 . . . . 0.0 112.449 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' H ' ' H ' ' A' ' 41' ' ' GLY . 18.5 p90 -168.38 166.45 12.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.517 HD21 ' SD ' ' A' ' 37' ' ' MET . 1.3 tt -136.22 91.51 2.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.394 1.478 . . . . 0.0 107.248 176.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.07 159.31 11.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.409 1.084 . . . . 0.0 109.568 174.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.469 ' HB2' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -111.72 166.85 10.82 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 126.169 1.788 . . . . 0.0 114.6 166.117 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 64.0 m -151.12 160.27 43.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.275 1.83 . . . . 0.0 109.555 -159.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.3 -39.42 78.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.572 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -138.98 -170.16 2.8 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 125.875 1.67 . . . . 0.0 108.056 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 t -76.05 3.59 10.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -107.04 104.32 51.5 Favored Pre-proline 0 CA--C 1.539 0.524 0 O-C-N 121.644 -0.66 . . . . 0.0 112.191 -164.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.39 -23.51 51.04 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.99 1.793 . . . . 0.0 112.27 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.52 -56.28 5.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.705 1.202 . . . . 0.0 109.648 -172.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.2 t -132.82 13.85 4.37 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 112.702 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.39 -45.91 58.57 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 168.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 t 76.9 124.63 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.264 1.426 . . . . 0.0 107.848 -164.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 83.4 m -136.58 140.12 42.65 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 125.633 1.573 . . . . 0.0 107.882 -164.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.254 7.5 p-10 -82.78 97.51 8.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 120.566 1.53 . . . . 0.0 110.363 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -82.74 53.23 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.901 2.08 . . . . 0.0 108.484 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -84.92 156.25 21.31 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 158.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.09 144.12 30.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 165.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -143.15 41.02 1.5 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.469 0.708 . . . . 0.0 109.347 -165.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -124.99 130.44 52.36 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -169.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 t30 51.13 55.71 9.11 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.448 0.699 . . . . 0.0 110.117 -172.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 t -160.39 146.88 15.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.761 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -79.57 71.88 6.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 128.8 2.84 . . . . 0.0 108.097 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.5 t -84.21 139.06 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 O-C-N 121.712 -0.617 . . . . 0.0 109.397 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.59 139.29 24.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 31' ' ' GLY . 45.7 mm -98.19 166.22 2.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 125.315 1.446 . . . . 0.0 107.238 168.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.427 ' N ' HG22 ' A' ' 30' ' ' ILE . . . 96.27 170.07 34.77 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 57.65 100.9 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.865 2.066 . . . . 0.0 112.615 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.42 10.68 4.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.383 1.073 . . . . 0.0 112.566 169.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.469 HG13 ' HB2' ' A' ' 7' ' ' MET . 1.6 t -136.19 113.1 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -146.75 18.12 1.29 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -138.31 114.14 9.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.517 ' SD ' HD21 ' A' ' 5' ' ' LEU . 48.1 ttp -85.4 124.75 32.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.43 94.86 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -93.97 127.49 39.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -171.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.44 -59.87 5.89 Favored Glycine 0 CA--C 1.501 -0.833 0 CA-C-O 125.938 2.966 . . . . 0.0 110.024 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.498 ' H ' ' H ' ' A' ' 4' ' ' TYR . . . 46.6 25.96 2.38 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 108.408 -3.896 . . . . 0.0 111.658 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.31 155.63 39.37 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 120.754 -1.439 . . . . 0.0 110.952 -172.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.262 0.1 OUTLIER 73.47 -4.18 2.29 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.562 1.145 . . . . 0.0 111.545 -167.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -111.95 122.8 48.78 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 158.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.9 -30.02 56.45 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 166.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? -63.95 136.46 57.36 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.258 0.551 . . . . 0.0 110.283 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -44.07 143.51 1.14 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.064 0.946 . . . . 0.0 110.549 164.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.89 144.0 16.85 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 170.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.7 m -138.85 152.27 47.68 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 119.382 1.591 . . . . 0.0 109.5 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.4 140.5 35.5 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.721 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.2 m -83.86 135.19 34.6 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 168.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 mt -122.82 152.7 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.402 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 27.2 m-90 -139.8 152.99 46.99 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.824 1.25 . . . . 0.0 113.997 -173.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -82.84 -39.8 21.17 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 126.591 1.956 . . . . 0.0 108.898 167.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.77 125.13 36.07 Favored Glycine 0 CA--C 1.522 0.488 0 O-C-N 119.36 -2.087 . . . . 0.0 108.987 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -67.8 107.1 2.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.71 42.21 2.35 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 125.789 1.661 . . . . 0.0 111.971 -169.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 25.6 p 45.4 46.99 10.75 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.448 1.899 . . . . 0.0 114.714 166.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 m -126.27 176.58 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 127.437 2.295 . . . . 0.0 107.843 166.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.46 -157.74 23.26 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 120.841 -1.162 . . . . 0.0 112.332 167.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -70.19 150.73 46.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.402 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 5.8 p -141.75 172.61 12.46 Favored 'General case' 0 N--CA 1.436 -1.158 0 O-C-N 124.023 0.827 . . . . 0.0 111.483 -166.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -144.01 -175.41 4.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 159.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 t -127.96 122.43 32.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 168.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.0 tpt -121.64 118.66 29.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 96.9 m -113.78 146.74 39.47 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.8 t -138.1 121.95 11.58 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 124.432 1.093 . . . . 0.0 108.382 -178.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.32 151.27 9.85 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.111 2.541 . . . . 0.0 112.347 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.02 143.59 47.49 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 54.84 61.63 2.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.003 1.721 . . . . 0.0 109.067 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -154.48 157.41 38.36 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.39 124.44 49.6 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 126.891 2.076 . . . . 0.0 108.957 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.4 m -129.36 113.8 15.41 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.667 1.587 . . . . 0.0 108.717 -168.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -71.2 127.24 31.93 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.551 -0.718 . . . . 0.0 110.037 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.509 HD13 ' H ' ' A' ' 37' ' ' MET . 1.6 mp -85.96 111.59 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 123.978 0.911 . . . . 0.0 108.644 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -163.71 98.77 0.88 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 162.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.2 p -74.35 -157.53 0.06 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.03 -2.04 86.31 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.786 -1.196 . . . . 0.0 112.27 168.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -140.63 174.29 10.66 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 118.91 1.355 . . . . 0.0 108.953 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -79.78 133.65 36.32 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.408 ' HB ' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -95.89 133.3 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -167.612 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.7 mtt-85 -126.21 -36.31 2.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 118.328 -0.844 . . . . 0.0 113.095 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.93 163.21 33.5 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 119.482 1.037 . . . . 0.0 110.971 171.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.417 ' CD1' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -151.16 169.21 22.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.069 0.548 . . . . 0.0 111.258 165.567 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -157.09 126.0 5.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.183 172.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.465 HH21 ' C ' ' A' ' 88' ' ' GLU . 31.3 mtp180 -55.44 141.94 34.64 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.854 0.462 . . . . 0.0 110.763 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.4 m -96.95 -43.74 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 123.836 0.71 . . . . 0.0 109.295 163.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.465 ' C ' HH21 ' A' ' 86' ' ' ARG . 1.9 tt0 . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.063 0.945 . . . . 0.0 108.569 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.419 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.77 126.28 0.23 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.167 2.587 . . . . 0.0 104.037 -176.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.668 ' H ' HG22 ' A' ' 43' ' ' THR . . . -74.86 156.91 49.87 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -179.27 174.8 0.99 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.123 0.969 . . . . 0.0 109.791 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 tt -138.75 116.09 11.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 162.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.83 158.84 23.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 126.613 1.965 . . . . 0.0 106.134 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -121.62 175.7 6.09 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.579 0.704 . . . . 0.0 110.427 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 93.7 m -153.16 154.58 35.05 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -159.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -77.6 1.95 18.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 115.095 1.516 . . . . 0.0 115.095 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -158.97 -172.79 3.94 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 125.537 1.535 . . . . 0.0 109.416 169.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.98 3.77 32.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.698 0.761 . . . . 0.0 112.504 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -113.27 130.12 23.93 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 124.07 0.948 . . . . 0.0 110.87 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.09 -46.77 7.52 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 119.85 0.982 . . . . 0.0 109.995 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -64.01 -50.66 67.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.704 0.802 . . . . 0.0 111.069 -161.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 t -110.65 14.34 22.36 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.695 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.79 -50.04 15.54 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t 71.11 116.29 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -158.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.9 m -136.13 148.56 48.28 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.069 -158.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -93.71 93.14 7.84 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 123.704 1.716 . . . . 0.0 110.833 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -83.66 58.04 4.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 111.359 -2.655 . . . . 0.0 103.929 158.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.26 177.51 4.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 127.444 2.298 . . . . 0.0 106.582 172.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -66.98 143.31 56.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 118.557 -1.257 . . . . 0.0 107.722 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -139.99 -12.24 1.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.835 1.254 . . . . 0.0 109.938 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -86.91 173.18 9.52 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.093 1.357 . . . . 0.0 108.57 -165.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -33.46 76.78 0.0 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 131.235 3.814 . . . . 0.0 113.846 -166.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -176.21 178.83 1.34 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 128.605 2.762 . . . . 0.0 108.179 168.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.8 t -72.27 127.36 32.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.752 0.821 . . . . 0.0 109.736 -173.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 t -127.4 133.86 67.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.43 161.79 53.01 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 121.829 -0.544 . . . . 0.0 111.865 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.7 mt -135.41 151.97 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.449 1.9 . . . . 0.0 106.065 165.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.22 156.72 7.96 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.242 0.474 . . . . 0.0 112.003 163.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.48 86.15 0.13 Allowed 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 128.186 2.594 . . . . 0.0 112.517 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 61.35 3.25 0.74 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 128.378 2.671 . . . . 0.0 112.409 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.1 t -86.51 98.76 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -146.04 29.3 1.09 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 89.4 m95 -144.77 113.67 6.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -173.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.459 ' H ' HD13 ' A' ' 75' ' ' ILE . 43.9 ttm -87.59 140.03 29.93 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 168.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.61 95.7 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -174.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 p -93.94 151.7 19.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.994 1.317 . . . . 0.0 114.37 -158.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -124.08 143.73 15.01 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.717 ' HA3' ' CB ' ' A' ' 69' ' ' ALA . . . -141.09 -32.49 0.14 Allowed Glycine 0 CA--C 1.498 -1.004 0 CA-C-O 121.795 0.664 . . . . 0.0 114.696 -158.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.352 27.5 m -35.83 158.67 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 125.014 1.325 . . . . 0.0 111.851 158.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 3' ' ' GLY . 0.4 OUTLIER 47.88 30.57 1.99 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.783 0.802 . . . . 0.0 110.068 -169.52 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.7 t70 58.8 38.49 24.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.978 1.37 . . . . 0.0 111.158 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -45.37 -47.35 11.49 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 125.216 1.389 . . . . 0.0 110.324 159.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 52.96 -173.79 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.388 1.075 . . . . 0.0 110.269 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -52.73 154.2 2.84 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.793 -0.567 . . . . 0.0 110.669 171.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.75 140.87 12.49 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 106.199 -2.761 . . . . 0.0 106.199 168.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 m -130.73 158.1 41.02 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 117.574 0.687 . . . . 0.0 109.194 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.41 154.42 40.83 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.137 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -99.98 131.63 45.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 167.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 mm -114.88 144.64 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -167.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -132.78 151.7 51.94 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.357 0.98 . . . . 0.0 112.67 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -88.87 -33.62 17.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.07 1.748 . . . . 0.0 109.42 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.14 141.89 42.08 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 m -63.5 151.68 40.62 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 159.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.19 38.75 90.92 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.887 -174.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 30.1 p 44.85 50.97 8.7 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.287 1.835 . . . . 0.0 114.016 170.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -123.88 176.62 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.019 1.328 . . . . 0.0 108.002 169.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.22 -151.42 21.5 Favored Glycine 0 CA--C 1.52 0.377 0 O-C-N 121.313 -0.867 . . . . 0.0 111.592 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -80.2 150.85 29.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 p -147.55 174.46 11.71 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.53 0.681 . . . . 0.0 111.411 -164.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 t -147.31 -176.18 5.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 158.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.89 133.93 42.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 166.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.1 ttt -124.24 144.0 50.21 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.289 1.035 . . . . 0.0 108.849 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.4 m -115.88 151.38 35.41 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 37.5 t -142.45 122.41 8.04 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 123.516 0.726 . . . . 0.0 110.157 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -60.07 165.2 10.91 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.237 1.958 . . . . 0.0 110.061 171.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.717 ' CB ' ' HA3' ' A' ' 41' ' ' GLY . . . -74.1 174.88 8.05 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.621 173.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 p30 47.15 45.93 16.23 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 124.559 1.144 . . . . 0.0 109.977 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.1 m -143.09 139.46 30.47 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.407 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -101.97 113.85 27.45 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 167.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 120.95 41.21 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.07 2.148 . . . . 0.0 106.525 -168.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -84.75 111.22 19.4 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.803 0.841 . . . . 0.0 109.453 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -80.44 93.4 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.18 75.35 0.45 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -6.52 48.86 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -173.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.07 -43.08 1.45 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.47 156.4 29.36 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 117.891 0.845 . . . . 0.0 111.724 175.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -78.93 133.54 36.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 165.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.36 143.74 12.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.193 0.997 . . . . 0.0 108.973 -170.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -126.17 -25.89 3.47 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 171.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.94 165.07 30.91 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.37 179.53 9.05 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.426 1.49 . . . . 0.0 109.883 170.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -148.7 123.75 10.07 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.351 1.86 . . . . 0.0 106.783 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -75.8 139.18 41.63 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.643 1.565 . . . . 0.0 108.546 170.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.1 m -109.6 -35.43 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.749 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 CA--C 1.529 0.149 0 CA-C-N 119.671 1.123 . . . . 0.0 110.629 -174.829 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 p90 . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tp -132.94 60.19 1.71 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.478 HD13 ' CE2' ' A' ' 20' ' ' TRP . 4.2 pt -94.22 175.2 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.123 0.969 . . . . 0.0 110.867 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.7 ptm -138.37 166.89 23.09 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.881 1.273 . . . . 0.0 108.887 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 61.0 m -147.44 162.03 39.85 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.766 1.269 . . . . 0.0 110.707 -158.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -85.76 -29.5 23.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.07 -1.877 . . . . 0.0 110.28 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -126.07 -166.0 1.51 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.9 t -93.0 3.32 55.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -139.94 105.82 6.81 Favored Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 124.365 1.066 . . . . 0.0 112.824 -164.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.45 -20.89 58.85 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.853 1.702 . . . . 0.0 112.659 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -64.22 -44.12 92.88 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.65 1.114 . . . . 0.0 109.886 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 p -113.97 13.5 18.27 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -174.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.63 133.12 6.08 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 124.571 1.082 . . . . 0.0 110.769 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.14 94.25 1.13 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 174.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 70.9 m -77.53 148.19 35.39 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.35 129.74 36.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.478 ' CE2' HD13 ' A' ' 6' ' ' ILE . 73.3 m95 -111.99 59.84 0.63 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.7 2.8 . . . . 0.0 106.631 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -92.6 165.72 12.85 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 165.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -73.16 143.75 47.14 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 118.199 -1.4 . . . . 0.0 107.525 166.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -130.29 -14.12 3.84 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.726 1.611 . . . . 0.0 109.952 -172.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.418 ' CE3' ' HG3' ' A' ' 86' ' ' ARG . 21.7 m95 -79.04 112.82 16.63 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -172.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.6 t30 64.11 44.75 4.39 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.036 0.935 . . . . 0.0 111.36 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.32 141.37 30.94 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.947 0.899 . . . . 0.0 109.093 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.32 77.76 5.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.904 2.081 . . . . 0.0 109.127 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 t -92.64 127.64 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.51 139.68 16.14 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.948 1.261 . . . . 0.0 111.365 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 mm -134.5 165.84 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 126.73 2.012 . . . . 0.0 108.891 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.98 -170.71 40.83 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 163.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.77 80.54 0.2 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.599 1.96 . . . . 0.0 113.643 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 71.2 4.16 4.95 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 126.803 2.041 . . . . 0.0 111.182 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.0 111.44 22.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -146.37 25.75 1.21 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -137.48 114.46 10.69 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 119.729 1.15 . . . . 0.0 111.548 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.525 ' H ' HD13 ' A' ' 75' ' ' ILE . 21.9 ttt -84.49 113.88 21.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 169.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.98 96.92 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -104.19 141.2 36.68 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.674 0.79 . . . . 0.0 109.855 -159.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.358 0 C-N-CA 123.374 0.512 . . . . 0.0 111.83 -169.126 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 mttm . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -46.94 157.61 0.15 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.845 1.658 . . . . 0.0 112.492 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.68 134.41 12.2 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 106.999 -2.44 . . . . 0.0 106.999 166.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.1 m -133.37 155.42 49.5 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.62 149.6 39.17 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.666 0.604 . . . . 0.0 111.36 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.0 m -84.5 126.41 33.26 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 159.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.2 mt -121.2 128.35 75.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -172.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 9.1 m-90 -111.13 153.68 25.38 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.739 1.615 . . . . 0.0 113.262 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.78 -45.68 74.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.409 2.284 . . . . 0.0 111.181 172.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.81 157.45 48.9 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 m -78.2 122.48 25.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 163.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.52 41.88 9.61 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 124.761 1.172 . . . . 0.0 111.058 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.5 p 45.79 57.04 5.37 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.454 1.902 . . . . 0.0 113.137 166.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 m -124.63 176.03 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 126.203 1.801 . . . . 0.0 106.95 164.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.54 -160.94 28.22 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -72.86 160.69 31.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 8.8 p -145.13 160.55 41.25 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.898 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.1 t -110.27 159.47 17.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 162.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -110.11 111.51 22.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 160.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.03 122.5 41.25 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.876 0.735 . . . . 0.0 110.767 -171.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.5 m -105.74 152.76 22.78 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.937 1.295 . . . . 0.0 111.967 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.417 ' SG ' ' HD2' ' A' ' 68' ' ' PRO . 1.7 t -151.93 143.73 16.18 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.258 169.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 23.3 Cg_endo -64.81 172.24 7.35 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.837 1.691 . . . . 0.0 113.084 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.99 135.84 33.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.875 1.27 . . . . 0.0 110.97 -172.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 56.25 64.74 1.61 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -165.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 m -145.26 126.67 14.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.34 120.64 28.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.36 1.464 . . . . 0.0 108.725 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.5 m -130.73 105.44 7.8 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -162.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -68.24 112.95 5.45 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.003 0.521 . . . . 0.0 110.785 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -74.09 107.67 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -136.99 129.75 30.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 162.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -126.48 -169.72 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.677 1.126 . . . . 0.0 110.161 -172.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.71 11.69 67.86 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.34 174.87 10.97 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 125.098 1.359 . . . . 0.0 109.284 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -74.3 148.15 41.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 163.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -113.62 142.4 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -134.14 -66.75 0.61 Allowed 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.9 m -93.77 173.48 7.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 116.431 -2.108 . . . . 0.0 112.062 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -155.82 168.22 27.9 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.238 165.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.97 136.37 19.0 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 163.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.418 ' HG3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -68.41 166.4 16.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.942 -171.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.64 -32.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 116.924 -1.513 . . . . 0.0 113.095 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 N--CA 1.466 0.341 0 C-N-CA 124.869 1.268 . . . . 0.0 108.581 -174.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.6 p90 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.522 HD13 HH21 ' A' ' 86' ' ' ARG . 5.1 tt -144.16 126.23 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 161.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.78 170.95 12.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.3 ptm -117.35 168.49 10.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.876 0.846 . . . . 0.0 110.023 158.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 73.2 m -156.05 166.25 34.02 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.319 1.448 . . . . 0.0 108.374 -158.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -85.95 -20.52 28.84 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 170.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.2 p30 -136.9 -175.37 4.01 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.849 172.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 40.7 t -89.05 3.82 50.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.347 -170.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -138.02 94.42 11.28 Favored Pre-proline 0 N--CA 1.456 -0.141 0 C-N-CA 123.651 0.78 . . . . 0.0 110.984 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.08 -23.06 2.5 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.52 2.813 . . . . 0.0 114.679 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -63.65 -41.24 98.24 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 119.801 1.182 . . . . 0.0 110.123 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -111.41 14.12 21.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.677 0.791 . . . . 0.0 110.824 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.38 121.02 5.79 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 125.08 1.324 . . . . 0.0 109.85 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.0 m -65.32 123.26 19.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 159.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 96.4 m -135.93 159.1 42.71 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -172.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.86 92.99 8.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.677 1.227 . . . . 0.0 109.65 169.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -84.51 42.7 0.91 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.243 162.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 167.34 10.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 164.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -64.09 144.08 57.38 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.418 0.627 . . . . 0.0 109.327 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -122.25 -8.3 8.71 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.577 2.351 . . . . 0.0 110.015 167.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -58.78 94.13 0.02 OUTLIER 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.091 0.957 . . . . 0.0 110.093 169.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 41.46 55.79 3.37 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.413 1.485 . . . . 0.0 111.379 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.2 p -138.18 124.35 20.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 102.492 -3.151 . . . . 0.0 102.492 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.4 t -75.3 84.43 2.45 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.681 1.193 . . . . 0.0 109.343 -166.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.7 t -83.63 121.79 36.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -170.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.36 154.51 49.24 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.418 1.009 . . . . 0.0 111.222 174.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -128.27 142.21 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.577 1.951 . . . . 0.0 107.115 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.79 168.81 33.84 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 168.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 61.01 72.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 68.94 2.87 3.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 128.21 2.604 . . . . 0.0 111.259 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -83.71 97.56 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -146.35 34.38 0.97 Allowed 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -135.42 113.98 11.71 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 121.789 -0.569 . . . . 0.0 109.623 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.471 ' H ' HD13 ' A' ' 75' ' ' ILE . 25.4 ttp -85.95 132.61 34.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.72 129.38 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.501 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -144.23 128.19 17.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -159.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 172.875 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.4 mttp . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.369 0.128 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -51.75 143.46 12.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.004 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.96 133.17 11.51 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 107.484 -2.247 . . . . 0.0 107.484 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 74.6 m -119.3 147.33 44.42 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 117.749 0.775 . . . . 0.0 109.164 172.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.13 140.71 26.89 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 114.711 -1.132 . . . . 0.0 108.86 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.7 m -91.0 113.0 25.14 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.8 mt -95.7 143.79 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 22.7 m-90 -125.09 152.63 44.11 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.201 1.4 . . . . 0.0 113.076 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -81.15 -38.77 26.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.702 2.401 . . . . 0.0 109.787 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.38 136.66 23.82 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m -60.45 119.89 8.88 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 168.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.15 46.12 7.18 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 124.183 0.897 . . . . 0.0 111.619 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.6 p 44.67 51.69 8.09 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.268 1.827 . . . . 0.0 113.206 169.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 m -125.88 176.86 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 128.588 2.755 . . . . 0.0 106.452 171.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.37 -156.84 34.11 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.3 ttt85 -67.96 153.82 42.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.408 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.2 p -141.47 165.85 26.36 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 174.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.0 t -137.31 138.87 40.46 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -88.43 94.95 10.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 40.6 tpp -86.38 104.7 16.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 98.8 m -93.08 138.14 31.79 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 166.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.5 t -153.52 132.08 6.67 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.176 1.391 . . . . 0.0 109.801 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -63.18 163.6 22.51 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.404 2.069 . . . . 0.0 115.579 -167.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.07 122.97 25.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 83.11 62.72 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 128.011 2.524 . . . . 0.0 107.402 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.72 -176.91 6.2 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.343 1.068 . . . . 0.0 109.778 158.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.29 122.78 25.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 128.907 2.883 . . . . 0.0 106.42 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.23 113.28 24.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.633 1.973 . . . . 0.0 107.061 -171.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -66.47 115.12 6.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 167.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -77.21 120.62 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 165.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -150.47 66.95 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 170.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 p -78.2 161.56 27.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.581 -167.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -52.84 -30.17 35.82 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.021 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -111.12 159.89 17.41 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 124.575 1.15 . . . . 0.0 109.947 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -72.56 139.26 47.4 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.945 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.32 133.69 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.289 1.036 . . . . 0.0 110.252 -164.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -122.61 -41.05 2.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.906 0.882 . . . . 0.0 111.544 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.94 167.27 22.53 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -154.88 161.44 41.44 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.237 0.615 . . . . 0.0 111.852 163.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -138.29 145.62 41.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.829 2.052 . . . . 0.0 108.395 164.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.522 HH21 HD13 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -76.98 153.54 34.45 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.875 166.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.35 -17.84 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.811 1.644 . . . . 0.0 110.455 164.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 164.537 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 p90 . . . . . 0 N--CA 1.446 -0.628 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 tt -139.18 103.76 4.84 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 159.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.405 HD13 ' CE2' ' A' ' 20' ' ' TRP . 2.5 pt -124.42 171.54 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.0 ptp -136.58 140.11 42.65 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.352 1.061 . . . . 0.0 111.181 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.4 m -125.04 168.8 12.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.108 1.363 . . . . 0.0 109.965 -159.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -79.55 -34.8 40.67 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.928 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -132.47 -168.68 2.1 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 128.033 2.533 . . . . 0.0 107.31 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -94.96 3.46 54.92 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.31 114.55 23.51 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 124.971 1.309 . . . . 0.0 111.229 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.76 -24.4 74.62 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.309 2.006 . . . . 0.0 111.838 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -44.95 91.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.617 1.099 . . . . 0.0 109.44 -177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.2 p -103.95 13.66 32.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.934 0.894 . . . . 0.0 112.346 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.97 114.65 2.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 124.993 1.282 . . . . 0.0 111.408 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.53 94.21 1.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.0 m -87.72 173.15 9.18 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.563 0.745 . . . . 0.0 109.175 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 162.1 27.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 158.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.405 ' CE2' HD13 ' A' ' 6' ' ' ILE . 93.5 m95 -151.5 54.87 0.85 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 168.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -114.89 176.27 5.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.839 1.656 . . . . 0.0 108.259 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -63.98 153.4 37.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.215 0.606 . . . . 0.0 109.456 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -146.5 -23.45 0.43 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -103.07 33.67 3.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.565 -1.334 . . . . 0.0 109.67 -173.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -141.72 43.84 1.72 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.599 -167.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 89.98 177.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 173.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.3 t -47.44 109.89 0.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.515 1.526 . . . . 0.0 112.273 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.03 145.02 12.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 127.005 2.122 . . . . 0.0 107.241 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.74 134.94 14.29 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.7 mm -133.15 166.52 29.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 127.093 2.157 . . . . 0.0 108.613 -169.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.62 -166.98 21.65 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 106.598 -2.601 . . . . 0.0 106.598 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 48.72 89.45 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 164.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.4 m120 64.8 22.25 12.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 126.59 1.956 . . . . 0.0 111.517 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.3 t -133.91 101.14 3.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -146.53 25.8 1.19 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.713 1.205 . . . . 0.0 112.335 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -129.81 143.23 50.71 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 166.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 48.5 ttm -107.15 125.3 50.9 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 167.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.98 93.37 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -99.59 155.13 17.76 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.959 1.304 . . . . 0.0 109.002 -167.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.422 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 175.123 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.63 167.58 3.42 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.237 1.015 . . . . 0.0 110.675 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.21 140.57 9.47 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 162.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 m -126.27 166.6 16.81 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.3 147.03 26.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.296 1.438 . . . . 0.0 110.118 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 m -83.5 123.06 29.35 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 161.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 mt -110.12 150.98 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.446 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 24.6 m-90 -129.65 156.77 43.69 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.855 1.662 . . . . 0.0 110.295 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -83.73 -36.01 23.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.35 1.06 . . . . 0.0 111.271 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.88 148.19 50.85 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.119 -0.988 . . . . 0.0 110.746 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m -78.27 53.98 1.32 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.099 0.96 . . . . 0.0 110.35 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.4 55.4 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -171.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 54.42 34.4 20.78 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 162.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 m -125.93 176.55 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 126.932 2.093 . . . . 0.0 109.763 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.52 -152.7 29.39 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -73.66 142.28 46.45 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.3 p -136.72 168.26 19.86 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.924 0.765 . . . . 0.0 111.411 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.1 t -152.91 140.9 20.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.803 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.8 m -72.67 100.46 2.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 158.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.87 119.39 24.81 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 166.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.7 m -101.46 153.81 19.37 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.7 t -142.61 119.71 7.05 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 123.718 0.807 . . . . 0.0 109.008 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.77 179.89 2.42 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.957 1.771 . . . . 0.0 110.545 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.72 151.54 40.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.831 -161.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.7 m120 50.91 53.34 13.2 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.231 161.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 t -156.08 179.97 8.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.296 0.57 . . . . 0.0 109.804 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 141.75 46.07 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.582 2.753 . . . . 0.0 108.754 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.0 m -143.32 117.69 9.65 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.617 1.167 . . . . 0.0 107.879 -168.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.94 103.96 5.35 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.454 0.57 . . . . 0.0 110.32 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.11 132.96 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t30 141.66 112.82 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 129.111 2.964 . . . . 0.0 104.254 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.45 9.13 19.63 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -174.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.07 -60.91 0.51 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 -159.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -82.73 156.97 23.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -168.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -73.94 133.81 43.09 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.332 -1.304 . . . . 0.0 107.746 172.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.6 128.23 55.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -166.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -136.71 -19.62 1.36 Allowed 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -166.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -142.6 163.24 33.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 119.631 1.105 . . . . 0.0 108.575 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.04 161.48 41.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.958 0.799 . . . . 0.0 112.918 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.37 129.08 12.35 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 171.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.4 mmm-85 -57.41 142.69 42.93 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.17 -3.07 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.193 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 CA--C 1.52 -0.2 0 C-N-CA 126.202 1.801 . . . . 0.0 107.493 177.403 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.3 p90 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.506 HD11 ' SD ' ' A' ' 37' ' ' MET . 0.8 OUTLIER -141.38 119.45 12.03 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 175.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.43 151.98 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 126.552 1.941 . . . . 0.0 106.301 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.1 ptp -110.96 159.3 17.85 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.876 0.846 . . . . 0.0 112.187 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.5 m -145.31 154.56 42.47 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 122.753 1.263 . . . . 0.0 110.133 -159.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -86.14 -13.37 47.32 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 112.679 -2.055 . . . . 0.0 110.741 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -150.77 -179.93 7.68 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.849 1.66 . . . . 0.0 107.84 164.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 t -77.28 3.67 12.42 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -128.57 106.11 19.01 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -59.97 -21.12 63.54 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.618 1.545 . . . . 0.0 112.684 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.9 -33.46 75.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.538 0.608 . . . . 0.0 110.64 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 t -142.37 29.5 1.6 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.221 0.464 . . . . 0.0 111.592 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.22 139.19 10.75 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.11 126.58 28.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 164.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.2 m -135.61 137.14 41.62 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -96.28 103.38 15.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 111.559 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -103.71 56.45 0.73 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 129.266 3.027 . . . . 0.0 109.619 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -99.67 -175.76 3.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 159.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -64.01 147.06 52.99 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -143.52 -8.17 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.742 0.817 . . . . 0.0 112.641 -164.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -101.78 143.59 31.51 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 54.94 47.68 21.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.454 1.101 . . . . 0.0 111.991 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 t -144.05 -173.44 4.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.241 1.416 . . . . 0.0 109.322 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.7 t -151.52 66.79 0.88 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.622 1.969 . . . . 0.0 109.405 -173.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.3 t -104.05 120.62 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.47 1.108 . . . . 0.0 109.659 -167.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.8 128.31 8.38 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.147 0.879 . . . . 0.0 112.639 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.439 HG22 HG21 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -125.31 166.35 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 127.855 2.462 . . . . 0.0 106.09 178.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.63 -178.92 41.85 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.99 99.38 0.05 Allowed 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 127.537 2.335 . . . . 0.0 110.64 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 73.08 8.36 5.37 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.396 1.878 . . . . 0.0 110.98 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 30' ' ' ILE . 62.7 t -84.57 97.62 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -143.25 28.96 1.48 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -143.63 127.41 17.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.506 ' SD ' HD11 ' A' ' 5' ' ' LEU . 43.6 ttm -104.9 132.93 50.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 162.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 t -125.16 81.29 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -94.66 151.65 19.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -168.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.523 ' CA ' ' H ' ' A' ' 70' ' ' ASN . . . . . . . . 0 C--O 1.219 -0.796 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.295 0.569 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.92 159.66 33.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.844 168.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.32 173.04 31.5 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 164.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.2 m -129.86 159.82 35.42 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -163.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.18 140.53 35.92 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.8 m -83.23 124.45 30.57 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 159.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.2 mt -102.93 146.8 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -123.01 160.98 25.16 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.715 1.606 . . . . 0.0 110.936 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -79.54 -50.16 11.15 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.418 1.487 . . . . 0.0 110.919 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.27 121.05 5.3 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -169.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.71 108.87 0.23 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.05 2.14 . . . . 0.0 108.66 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 129.87 -74.75 0.44 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -172.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.1 p 163.03 55.1 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 129.298 3.039 . . . . 0.0 110.462 165.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.63 176.61 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.566 1.546 . . . . 0.0 107.908 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.78 -158.75 37.31 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -80.4 151.55 29.31 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -172.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.73 164.37 30.65 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.11 -169.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.57 128.88 10.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -170.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.0 p -82.3 92.74 7.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 41.2 tpp -83.73 129.78 34.95 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 96.7 m -130.58 134.3 46.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.925 0.784 . . . . 0.0 109.333 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 t -150.16 143.67 16.8 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.653 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -66.98 170.12 13.59 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.539 2.159 . . . . 0.0 113.93 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.61 148.75 42.6 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.523 ' H ' ' CA ' ' A' ' 40' ' ' GLY . 20.1 m120 59.81 41.45 18.09 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.111 1.364 . . . . 0.0 109.007 172.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.4 m -127.9 131.41 49.39 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.2 t -88.49 124.82 34.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 170.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.4 m -121.18 105.79 10.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -160.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -78.04 104.84 8.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.624 0.647 . . . . 0.0 109.671 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.477 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -76.64 116.0 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -139.84 83.23 1.91 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 p -74.47 -174.87 2.18 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.965 -1.084 . . . . 0.0 108.966 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.65 -20.22 71.85 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.321 -0.862 . . . . 0.0 111.573 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -131.02 177.23 7.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.977 1.311 . . . . 0.0 109.838 -172.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -83.35 135.28 34.77 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.32 146.36 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.461 1.504 . . . . 0.0 110.522 -169.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.1 mtt85 -136.25 -85.78 0.35 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.172 0.989 . . . . 0.0 110.024 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.12 168.33 17.84 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.272 -159.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -157.93 165.15 35.91 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.76 123.65 6.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.393 1.477 . . . . 0.0 107.347 170.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -59.9 129.9 44.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -36.9 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 C-N-CA 126.571 1.948 . . . . 0.0 110.472 -167.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 177.528 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.3 p90 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.585 HD21 ' SD ' ' A' ' 37' ' ' MET . 9.4 tt -149.91 91.67 1.81 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 171.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 pt -108.29 144.59 16.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.5 ptp -78.16 131.26 37.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 159.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 66.5 m -103.09 156.41 17.71 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 14.5 pttt -66.46 -39.84 89.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 117.414 -1.715 . . . . 0.0 108.688 178.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.423 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 39.8 p-10 -131.94 -165.9 1.65 Allowed 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 127.123 2.169 . . . . 0.0 108.53 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.0 t -82.99 3.82 28.55 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.397 -0.815 . . . . 0.0 112.609 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -106.84 114.29 61.82 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 123.267 0.627 . . . . 0.0 110.181 -170.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.39 -32.44 89.21 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.653 1.569 . . . . 0.0 111.504 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -100.56 -51.53 3.58 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.599 1.559 . . . . 0.0 111.757 -161.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -103.92 13.78 32.08 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.679 0.672 . . . . 0.0 112.148 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.45 -69.47 1.39 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 106.855 -2.498 . . . . 0.0 106.855 164.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t 94.22 122.05 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.282 2.633 . . . . 0.0 106.314 -163.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.2 m -136.46 159.75 40.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 126.671 1.989 . . . . 0.0 108.881 -165.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -89.25 94.37 9.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.464 2.078 . . . . 0.0 112.584 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -83.64 51.09 1.93 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.37 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -110.43 -176.65 3.03 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.929 2.492 . . . . 0.0 106.834 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 144.36 49.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 167.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -134.91 2.82 3.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 123.69 0.619 . . . . 0.0 110.016 171.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -93.51 125.66 38.23 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 -172.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 53.74 37.45 26.27 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.78 0.832 . . . . 0.0 111.88 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -133.9 151.44 51.51 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.322 1.849 . . . . 0.0 106.613 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -89.32 85.66 6.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -83.85 124.87 40.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -167.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.69 121.44 5.67 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 118.404 0.547 . . . . 0.0 112.04 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.2 mt -93.46 159.43 2.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 126.577 1.951 . . . . 0.0 108.405 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.91 166.13 28.06 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 169.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.23 74.05 0.21 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.768 2.427 . . . . 0.0 112.342 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 68.21 14.9 9.33 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.886 2.074 . . . . 0.0 110.821 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 97.1 t -133.53 99.49 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -145.8 39.9 1.15 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.725 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CD1' ' HA ' ' A' ' 10' ' ' ASN . 60.2 m95 -135.16 132.11 37.6 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.585 ' SD ' HD21 ' A' ' 5' ' ' LEU . 19.5 ttp -106.58 123.23 47.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 165.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -124.03 117.09 49.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -99.47 -177.03 3.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -168.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.96 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 173.712 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.2 mttp . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 122.322 1.058 . . . . 0.0 108.522 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -66.78 150.99 48.33 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.329 165.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.76 147.91 18.68 Favored Glycine 0 C--O 1.238 0.402 0 N-CA-C 105.791 -2.924 . . . . 0.0 105.791 166.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.9 m -132.96 151.33 52.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.147 1.474 . . . . 0.0 108.721 -172.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.79 144.47 49.03 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.924 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.2 m -83.3 115.53 22.03 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 162.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.84 148.47 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -127.94 151.8 48.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.109 1.364 . . . . 0.0 111.504 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -87.91 -33.67 18.41 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.476 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.87 138.44 31.44 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 173.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.6 m -61.83 135.28 57.52 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 159.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.11 32.45 39.4 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 124.727 1.156 . . . . 0.0 111.006 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 12.1 p 45.39 52.29 9.03 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.643 2.377 . . . . 0.0 112.174 169.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.76 175.73 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 125.703 1.601 . . . . 0.0 107.711 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.71 -151.35 26.29 Favored Glycine 0 CA--C 1.523 0.549 0 O-C-N 121.368 -0.832 . . . . 0.0 111.992 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.2 142.85 49.02 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -170.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.99 147.58 28.03 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -167.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p -128.19 115.84 18.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.4 1.48 . . . . 0.0 108.204 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.8 88.33 0.25 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.054 1.342 . . . . 0.0 108.892 171.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -90.52 132.48 35.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.955 1.302 . . . . 0.0 107.984 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 64.5 m -118.51 143.19 46.9 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.1 t -134.2 114.26 12.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 123.729 0.812 . . . . 0.0 109.362 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -72.01 166.48 29.49 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.354 1.369 . . . . 0.0 113.516 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.3 154.25 40.21 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 45.9 53.5 8.89 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.223 1.009 . . . . 0.0 108.718 -164.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 m -144.4 106.64 4.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -73.93 126.08 29.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 169.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 86.4 m -121.57 139.73 53.14 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.942 1.297 . . . . 0.0 108.592 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -108.46 113.84 27.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 109.546 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.5 mp -93.4 71.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -168.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -123.98 84.04 2.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 p -73.97 170.83 14.6 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.01 -36.86 93.49 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -85.07 162.67 19.21 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 122.121 -0.635 . . . . 0.0 109.395 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -84.44 133.7 34.48 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.079 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.75 132.29 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.025 1.33 . . . . 0.0 109.769 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -118.58 -37.39 3.3 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 118.511 -0.757 . . . . 0.0 111.982 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 p -152.72 167.33 29.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -139.18 167.13 22.74 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.32 1.048 . . . . 0.0 112.036 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.8 139.68 40.15 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.013 1.725 . . . . 0.0 109.035 162.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.491 ' HD3' HD22 ' A' ' 5' ' ' LEU . 49.3 mmm-85 -54.54 154.62 4.64 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.649 0.659 . . . . 0.0 112.095 170.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.67 -31.19 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 123.215 0.606 . . . . 0.0 110.985 165.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.597 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.3 p90 . . . . . 0 N--CA 1.443 -0.78 0 CA-C-O 122.163 0.982 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.409 HD13 ' HG2' ' A' ' 86' ' ' ARG . 10.2 tt -141.25 110.57 6.31 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 159.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.52 111.23 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -169.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptm -72.38 148.6 45.11 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.686 -1.206 . . . . 0.0 108.478 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 71.4 m -129.78 157.05 43.27 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -172.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 19.1 pttt -72.65 -30.78 64.58 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 117.544 -1.662 . . . . 0.0 112.359 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -125.59 -166.55 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.589 1.955 . . . . 0.0 109.528 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 t -99.8 25.66 7.04 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.275 1.03 . . . . 0.0 111.909 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -119.63 101.74 48.17 Favored Pre-proline 0 C--N 1.327 -0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 111.81 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -58.27 -24.07 65.72 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 120.858 1.039 . . . . 0.0 113.028 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -66.61 -73.68 0.13 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.112 0.869 . . . . 0.0 111.052 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 t -122.28 37.56 4.36 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.159 0.983 . . . . 0.0 110.413 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.2 -37.37 71.85 Favored Glycine 0 N--CA 1.448 -0.557 0 O-C-N 120.925 -1.109 . . . . 0.0 110.928 161.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.98 114.37 0.05 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -159.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 80.2 m -136.04 137.26 40.97 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 112.46 -2.155 . . . . 0.0 106.663 -166.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -80.61 93.37 6.1 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 122.707 1.241 . . . . 0.0 109.974 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -83.25 41.95 0.79 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.473 1.909 . . . . 0.0 108.309 165.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -96.67 168.43 10.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 166.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -63.74 143.81 57.54 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 118.429 -1.309 . . . . 0.0 109.014 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -129.82 -44.37 1.2 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 126.807 2.043 . . . . 0.0 108.162 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . 0.3 6.4 t-105 -86.19 59.09 5.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.834 1.254 . . . . 0.0 108.212 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.13 -0.01 0.01 OUTLIER 'General case' 0 N--CA 1.46 0.067 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 173.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 t -167.15 142.06 3.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 120.292 1.405 . . . . 0.0 110.382 -158.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.9 t -65.75 75.42 0.07 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.995 2.518 . . . . 0.0 111.625 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 t -83.64 148.33 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 O-C-N 120.882 -1.136 . . . . 0.0 108.646 -167.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.88 144.7 19.62 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 124.337 0.97 . . . . 0.0 111.013 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -101.22 156.63 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 166.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.81 154.58 10.84 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 66.85 83.07 0.17 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.052 1.741 . . . . 0.0 114.323 165.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 67.67 3.76 3.57 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.395 1.478 . . . . 0.0 111.723 171.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 53.3 t -75.29 126.48 36.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 122.486 0.314 . . . . 0.0 110.256 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 30.25 1.02 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 169.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.516 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 68.0 m95 -138.35 127.3 23.95 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.986 0.812 . . . . 0.0 112.728 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.56 ' H ' HD13 ' A' ' 75' ' ' ILE . 64.1 ttp -90.63 135.58 33.61 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 161.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.9 137.55 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 t -146.07 153.4 40.68 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 121.691 -0.63 . . . . 0.0 110.378 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' HA2' ' H ' ' A' ' 70' ' ' ASN . . . . . . . . 0 C--N 1.336 0.547 0 CA-C-N 118.373 0.533 . . . . 0.0 112.143 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.2 mttm . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 122.851 1.31 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -44.13 143.63 1.13 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 126.538 1.935 . . . . 0.0 110.665 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.79 137.38 12.38 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.7 m -125.24 153.74 42.7 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.46 143.69 46.01 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.855 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -88.25 130.88 34.97 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 159.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 mt -116.76 144.43 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -130.43 143.72 50.94 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.1 1.36 . . . . 0.0 110.475 -171.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -61.39 -51.96 66.62 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.32 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.46 145.99 36.68 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 124.392 0.996 . . . . 0.0 113.296 -163.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 m -55.13 116.98 3.1 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 162.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.13 51.14 5.9 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.4 p 43.29 53.17 5.56 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.73 1.612 . . . . 0.0 113.342 163.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -125.76 176.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 128.129 2.572 . . . . 0.0 106.35 167.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.91 -168.24 39.07 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 119.421 1.01 . . . . 0.0 110.814 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -69.41 128.36 36.28 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -170.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.92 165.06 15.74 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.811 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -150.66 151.29 32.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 m -87.02 111.07 20.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 164.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 34.9 tpp -87.02 144.06 27.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 167.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 55.4 m -147.37 136.14 22.05 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.3 t -135.03 137.71 27.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 124.78 1.232 . . . . 0.0 108.406 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.05 168.31 7.63 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.185 1.257 . . . . 0.0 110.759 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.8 150.33 41.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.308 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.451 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 65.5 m-80 54.51 48.47 20.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.942 1.297 . . . . 0.0 107.918 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.9 m -145.32 148.07 33.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.462 1.105 . . . . 0.0 108.181 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.516 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -101.17 137.17 39.88 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 128.559 2.744 . . . . 0.0 108.338 172.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 54.3 m -140.84 128.17 21.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.968 0.804 . . . . 0.0 110.398 -175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -73.36 135.84 44.33 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.186 0.994 . . . . 0.0 111.599 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 37' ' ' MET . 1.3 mp -102.23 112.86 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 126.573 1.949 . . . . 0.0 106.233 173.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -150.71 77.35 1.28 Allowed 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.843 -0.535 . . . . 0.0 109.944 169.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.32 165.67 24.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.829 0.851 . . . . 0.0 109.28 172.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.99 -51.5 56.92 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -77.33 154.33 32.93 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.551 0.691 . . . . 0.0 110.096 171.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -86.2 137.12 32.87 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.384 -1.734 . . . . 0.0 109.918 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.416 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -100.48 127.76 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 124.665 1.186 . . . . 0.0 109.892 -170.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -109.01 -17.82 13.82 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.982 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -139.13 166.63 24.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -153.65 162.3 41.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.615 1.166 . . . . 0.0 111.651 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -137.59 143.96 41.76 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.108 1.763 . . . . 0.0 107.837 159.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG2' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -64.16 154.37 34.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 163.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 m -131.62 -22.99 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 165.855 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.2 p90 . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.525 HD21 ' SD ' ' A' ' 37' ' ' MET . 5.2 tt -147.55 121.17 9.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 18' ' ' CYS . 24.3 pt -132.01 168.89 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 126.851 2.06 . . . . 0.0 106.537 -177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.2 ptp -120.57 144.34 48.14 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 158.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 70.9 m -117.29 156.06 28.44 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 28.5 pttt -60.87 -44.45 97.04 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 116.827 -1.949 . . . . 0.0 109.029 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -126.82 167.73 15.4 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.812 1.645 . . . . 0.0 109.191 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.9 t -72.72 3.88 4.63 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -101.87 100.65 15.26 Favored Pre-proline 0 N--CA 1.467 0.397 0 O-C-N 121.061 -1.024 . . . . 0.0 110.121 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.45 -27.91 83.5 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.958 1.772 . . . . 0.0 112.256 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -63.47 -60.11 3.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.378 0.535 . . . . 0.0 109.688 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.4 p -103.81 13.36 33.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.75 132.75 11.34 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 p -64.42 114.97 4.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 158.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB3' HD12 ' A' ' 6' ' ' ILE . 74.2 m -126.37 138.23 53.54 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -172.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 6' ' ' ILE . 6.0 p30 -76.07 92.69 3.21 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.218 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.472 ' CZ2' HD13 ' A' ' 6' ' ' ILE . 98.7 m95 -90.23 59.57 4.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 128.56 2.744 . . . . 0.0 104.489 166.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -127.53 168.92 14.28 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 170.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -64.3 143.86 57.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -134.22 -39.88 0.83 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.022 0.529 . . . . 0.0 109.813 -170.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.427 ' HA ' ' HB2' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -77.62 33.57 0.17 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.443 1.116 . . . . 0.0 111.805 -175.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.83 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 119.182 -2.199 . . . . 0.0 111.838 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.26 146.83 23.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.958 0.409 . . . . 0.0 111.191 -170.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.7 t -77.78 81.87 4.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.614 1.166 . . . . 0.0 108.579 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.43 145.62 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 O-C-N 121.223 -0.923 . . . . 0.0 109.968 -173.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.75 169.24 44.5 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.597 1.094 . . . . 0.0 112.998 -175.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.22 135.72 56.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 126.321 1.848 . . . . 0.0 106.123 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.59 178.1 35.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 167.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 57.82 79.35 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.075 1.75 . . . . 0.0 113.349 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.7 m120 70.3 4.49 4.91 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.25 1.42 . . . . 0.0 111.669 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 98.7 t -100.23 117.25 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 119.111 0.869 . . . . 0.0 110.87 -175.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -145.96 29.39 1.1 Allowed 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.46 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 79.9 m95 -137.6 121.71 17.93 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 119.377 0.989 . . . . 0.0 112.213 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.644 ' H ' HD13 ' A' ' 75' ' ' ILE . 23.2 tpp -84.3 135.4 34.33 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 163.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.78 128.79 54.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -137.77 155.72 48.75 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.193 -0.942 . . . . 0.0 109.409 -171.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.02 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 178.803 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -48.91 152.03 1.12 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.164 1.386 . . . . 0.0 111.628 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.95 153.11 17.3 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.3 m -139.33 153.81 47.78 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 86' ' ' ARG . . . -130.16 149.84 51.68 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 124.076 0.86 . . . . 0.0 110.695 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 m -83.62 126.3 32.71 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 158.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.6 mm -101.35 146.67 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -129.02 156.92 43.05 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.017 0.913 . . . . 0.0 111.859 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -97.9 -33.79 11.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 127.441 2.296 . . . . 0.0 108.829 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 143.61 47.41 Favored Glycine 0 CA--C 1.521 0.421 0 O-C-N 120.991 -1.068 . . . . 0.0 110.904 170.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.1 m -77.35 59.09 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.062 0.931 . . . . 0.0 111.688 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.42 50.75 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.1 p 44.07 42.77 5.09 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.825 1.25 . . . . 0.0 112.925 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.2 176.41 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 171.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.68 -154.25 37.72 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -73.63 154.36 39.77 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.99 168.37 23.3 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.4 144.84 30.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.55 1.54 . . . . 0.0 107.85 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.76 123.35 28.69 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.06 108.35 15.62 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.595 1.558 . . . . 0.0 108.794 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.5 m -110.02 144.75 38.13 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.085 0.954 . . . . 0.0 111.274 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.7 t -152.47 136.86 10.45 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -67.49 159.52 52.1 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.9 2.4 . . . . 0.0 113.088 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.17 53.39 2.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.443 -159.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 156.73 50.49 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -163.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -156.04 167.38 30.59 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 165.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.46 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 13.0 t -103.08 127.28 50.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.261 1.825 . . . . 0.0 107.482 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.18 119.23 31.75 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.173 1.789 . . . . 0.0 107.25 -164.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -82.05 122.55 27.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.118 0.872 . . . . 0.0 110.685 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -92.28 86.46 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.26 83.84 2.16 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 166.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 p -73.66 179.36 4.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.678 1.191 . . . . 0.0 108.785 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.21 -30.12 63.77 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 121.65 -0.656 . . . . 0.0 112.419 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -119.28 171.23 8.45 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 127.1 2.16 . . . . 0.0 109.525 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -74.64 133.34 42.16 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.93 157.98 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.527 0.731 . . . . 0.0 110.734 -173.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.91 -40.65 0.6 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 167.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 p -147.69 170.09 18.28 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -156.68 158.01 36.2 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.311 0.959 . . . . 0.0 112.816 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.84 135.55 11.63 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 166.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 1.5 mtm180 -60.74 146.84 44.5 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.307 0.503 . . . . 0.0 112.228 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 m -107.76 -9.97 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.815 1.246 . . . . 0.0 111.915 171.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.175 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.2 p90 . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 tt -127.76 122.65 33.34 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 103.9 -2.63 . . . . 0.0 103.9 164.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 pt -140.74 168.21 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.21 169.0 9.02 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 122.729 1.252 . . . . 0.0 112.092 159.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 88.1 m -155.7 157.91 37.38 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.958 -159.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -64.02 -32.25 73.72 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.017 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -159.43 175.84 12.82 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.365 0.666 . . . . 0.0 109.742 -165.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.0 t -79.92 20.52 0.62 Allowed 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.024 1.73 . . . . 0.0 113.082 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -141.82 118.58 7.31 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.877 1.271 . . . . 0.0 110.714 171.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.19 -25.34 10.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.109 2.539 . . . . 0.0 111.463 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -63.94 -42.64 97.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.9 p -108.04 13.88 25.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.933 1.293 . . . . 0.0 112.124 177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.0 118.51 3.71 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 125.355 1.455 . . . . 0.0 109.901 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.21 120.82 15.64 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.2 m -122.18 158.96 28.23 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.708 0.803 . . . . 0.0 109.35 -169.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -95.76 93.77 7.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 125.394 2.521 . . . . 0.0 112.729 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -83.98 47.35 1.3 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.052 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.46 -178.03 1.04 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.135 1.774 . . . . 0.0 108.938 173.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -69.73 143.4 53.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 158.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -125.27 -24.44 3.97 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.226 0.61 . . . . 0.0 110.464 -166.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.23 -162.95 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 131.068 3.747 . . . . 0.0 115.948 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -45.57 62.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 130.886 3.675 . . . . 0.0 110.547 158.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 t -140.02 175.35 9.66 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 128.113 2.565 . . . . 0.0 109.555 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.4 t -139.65 67.19 1.38 Allowed 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.249 1.82 . . . . 0.0 107.701 -165.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.4 t -83.64 144.84 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 124.528 1.131 . . . . 0.0 108.323 -163.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.04 133.68 12.14 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mm -136.61 162.33 35.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 123.817 0.847 . . . . 0.0 110.825 -165.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.22 -148.8 19.73 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 52.19 88.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.774 2.03 . . . . 0.0 116.229 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.279 0.0 OUTLIER 53.68 16.31 0.96 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.156 2.183 . . . . 0.0 113.41 175.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.1 t -115.46 120.16 63.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.948 1.299 . . . . 0.0 107.895 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.4 24.28 1.27 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.771 0.828 . . . . 0.0 112.705 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CZ3' ' HB2' ' A' ' 74' ' ' ASN . 60.7 m95 -130.75 117.11 18.92 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.472 ' H ' HD13 ' A' ' 75' ' ' ILE . 46.0 ttm -83.54 146.57 28.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 165.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 t -141.12 135.02 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -146.32 154.35 41.58 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 C-N-CA 128.363 2.887 . . . . 0.0 112.737 173.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? . . . . . 0 N--CA 1.441 -0.915 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -60.66 144.01 52.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -164.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.72 143.56 16.31 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 106.186 -2.765 . . . . 0.0 106.186 167.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.2 m -133.23 156.07 48.21 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 118.355 1.077 . . . . 0.0 108.335 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.06 147.6 47.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.126 0.97 . . . . 0.0 109.379 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.3 m -83.93 111.1 18.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 158.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.6 mt -83.04 151.8 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 166.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.451 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 13.7 m-90 -126.41 150.36 48.68 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.06 0.933 . . . . 0.0 110.567 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -63.21 -60.9 2.79 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.238 -1.346 . . . . 0.0 107.535 163.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.74 148.81 47.2 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-O 122.408 1.004 . . . . 0.0 112.74 -159.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.33 72.0 8.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.173 0.989 . . . . 0.0 109.747 -168.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.48 46.61 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 125.259 1.409 . . . . 0.0 110.908 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.3 p 44.09 49.97 7.45 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 125.973 1.709 . . . . 0.0 111.376 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.16 176.85 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 126.716 2.006 . . . . 0.0 107.708 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.87 -155.24 38.64 Favored Glycine 0 CA--C 1.518 0.233 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -75.34 159.62 31.24 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.451 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.6 p -127.87 156.23 42.9 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 124.725 1.266 . . . . 0.0 111.663 173.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.46 110.36 8.77 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.153 1.781 . . . . 0.0 106.92 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.3 t -68.25 108.45 3.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 174.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.2 tpt -113.65 106.48 14.56 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.019 0.927 . . . . 0.0 110.134 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.0 m -93.19 154.65 17.93 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.779 0.832 . . . . 0.0 109.353 171.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.5 t -155.13 132.36 6.29 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.453 0.701 . . . . 0.0 110.505 167.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.27 169.11 16.01 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.3 2.0 . . . . 0.0 113.212 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.67 147.4 43.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 59.07 51.65 6.93 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.492 1.117 . . . . 0.0 108.578 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -140.23 130.94 25.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.243 0.544 . . . . 0.0 110.102 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.5 137.04 32.69 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.874 1.67 . . . . 0.0 109.451 165.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 m -138.9 93.57 2.72 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.957 1.303 . . . . 0.0 109.238 -159.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HB2' ' CZ3' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -70.23 122.7 20.0 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 119.906 -1.746 . . . . 0.0 110.268 -178.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 37' ' ' MET . 1.5 mp -79.06 114.84 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.72 1.208 . . . . 0.0 109.644 176.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.16 108.52 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.58 -5.81 3.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.899 0.88 . . . . 0.0 110.439 -171.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.3 13.14 82.3 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 121.242 -0.911 . . . . 0.0 112.538 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -139.9 156.42 46.7 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 119.33 1.565 . . . . 0.0 108.411 159.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.82 133.24 43.19 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.33 131.71 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 125.225 1.41 . . . . 0.0 108.412 -169.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.47 -1.52 8.06 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.5 p -156.43 168.98 25.66 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 166.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -153.73 166.84 31.57 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.989 1.316 . . . . 0.0 111.102 165.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -137.01 124.51 22.14 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 128.082 2.553 . . . . 0.0 106.467 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HE ' ' C ' ' A' ' 88' ' ' GLU . 48.9 ttt180 -69.89 130.63 42.76 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 120.746 1.612 . . . . 0.0 107.522 169.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 m -98.26 -33.64 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.106 0.962 . . . . 0.0 111.098 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.402 ' C ' ' HE ' ' A' ' 86' ' ' ARG . 2.9 pt-20 . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.2 p90 . . . . . 0 C--O 1.236 0.376 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.418 HD22 ' HD3' ' A' ' 86' ' ' ARG . 4.8 tt -156.61 82.28 0.96 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.612 2.365 . . . . 0.0 108.081 171.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 pt -108.64 175.98 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 125.477 1.511 . . . . 0.0 107.642 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.3 ptm -124.37 169.53 11.72 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.521 0.677 . . . . 0.0 111.01 158.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.6 m -155.49 163.43 40.03 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.146 1.378 . . . . 0.0 109.14 -158.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER -83.06 -28.97 29.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -121.37 177.95 4.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 169.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.47 3.46 11.2 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.218 1.007 . . . . 0.0 112.904 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -129.83 96.11 27.16 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.017 0.527 . . . . 0.0 110.687 -161.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -68.94 -12.37 34.21 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.56 1.507 . . . . 0.0 113.455 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -70.28 -50.69 36.88 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.196 -0.94 . . . . 0.0 109.678 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.9 p -111.72 22.81 14.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.194 0.998 . . . . 0.0 111.928 -170.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.03 137.24 9.15 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 124.394 0.997 . . . . 0.0 110.7 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.16 129.77 41.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 168.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.0 m -135.8 151.08 49.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.239 1.015 . . . . 0.0 108.672 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -86.16 95.46 9.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.562 1.172 . . . . 0.0 110.879 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -83.53 58.01 4.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.184 2.193 . . . . 0.0 106.877 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -124.36 161.29 26.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.042 1.337 . . . . 0.0 108.271 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -64.09 146.41 54.25 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.693 0.759 . . . . 0.0 109.049 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -145.98 7.76 1.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.763 1.625 . . . . 0.0 111.007 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -88.33 121.83 31.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 54.45 38.0 28.81 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.384 1.073 . . . . 0.0 111.452 167.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 t -135.82 148.3 48.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.99 1.716 . . . . 0.0 107.457 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.2 t -84.38 100.98 11.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.03 126.65 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 120.101 1.319 . . . . 0.0 109.765 -171.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.59 140.72 15.2 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 127.061 2.267 . . . . 0.0 111.632 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.2 152.52 20.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 128.43 2.692 . . . . 0.0 108.943 -163.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.02 -167.01 34.28 Favored Glycine 0 CA--C 1.525 0.656 0 O-C-N 121.468 -0.77 . . . . 0.0 111.329 168.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.263 . . 59.28 64.8 1.29 Allowed 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 126.884 2.074 . . . . 0.0 115.235 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 m120 64.7 3.58 2.04 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.581 2.352 . . . . 0.0 110.886 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 75.6 t -77.02 106.31 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.629 0.649 . . . . 0.0 109.696 -173.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -146.13 29.86 1.06 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -136.43 113.51 10.54 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 121.766 -0.584 . . . . 0.0 109.962 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.457 ' H ' HD13 ' A' ' 75' ' ' ILE . 59.9 ttp -84.43 142.46 30.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.09 118.41 21.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.3 118.28 36.23 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.474 0 CA-C-O 123.157 1.421 . . . . 0.0 115.743 169.792 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.6 pttt . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -60.85 162.21 7.12 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 120.923 -1.111 . . . . 0.0 110.364 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.06 159.01 25.46 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 166.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.5 m -143.21 164.62 29.69 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 119.577 1.689 . . . . 0.0 111.293 -167.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' HB2' ' HE ' ' A' ' 86' ' ' ARG . . . -138.71 159.47 42.03 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 124.324 1.05 . . . . 0.0 109.998 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -84.47 130.46 34.76 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 158.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.62 150.3 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 20.8 m-90 -125.98 156.09 40.38 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 173.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -84.13 -34.01 24.16 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.728 1.611 . . . . 0.0 109.87 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.18 145.35 24.3 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 121.503 0.502 . . . . 0.0 112.312 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -76.17 85.41 3.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.783 1.633 . . . . 0.0 112.627 -161.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.59 -50.44 0.54 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.6 p 159.34 45.53 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 131.613 3.965 . . . . 0.0 107.622 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.52 176.32 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -171.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.37 -147.74 37.91 Favored Glycine 0 CA--C 1.521 0.466 0 O-C-N 121.328 -0.857 . . . . 0.0 111.053 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -71.28 151.74 43.94 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.681 1.192 . . . . 0.0 108.132 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.467 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.7 p -146.71 159.2 43.78 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.573 1.17 . . . . 0.0 112.22 171.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -139.26 155.58 47.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 170.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 m -83.99 121.4 27.34 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 38.7 tpp -104.06 118.86 37.66 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 20.3 m -108.84 152.91 24.25 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.866 0.866 . . . . 0.0 108.859 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.6 t -151.86 143.24 15.78 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 117.688 -1.148 . . . . 0.0 109.684 171.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.6 168.02 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.196 2.597 . . . . 0.0 111.689 169.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.5 166.76 16.04 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 56.7 47.19 18.74 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.727 0.811 . . . . 0.0 109.215 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -156.28 173.01 17.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.874 0.845 . . . . 0.0 111.438 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -109.14 144.21 37.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.962 2.905 . . . . 0.0 107.942 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.2 m -141.94 99.13 3.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.597 1.159 . . . . 0.0 107.917 -162.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -60.45 105.3 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.167 -0.958 . . . . 0.0 110.22 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -74.07 121.72 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 164.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -168.05 79.12 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 p -73.53 166.99 22.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.5 -37.02 91.52 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -81.18 158.71 24.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 123.452 0.701 . . . . 0.0 110.831 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.74 134.0 43.41 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.85 140.99 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 123.668 0.787 . . . . 0.0 109.531 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -129.65 -23.22 2.89 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 117.216 -1.374 . . . . 0.0 114.126 168.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -150.52 166.12 31.18 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 120.976 1.716 . . . . 0.0 111.877 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -157.79 157.68 33.82 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.399 0.545 . . . . 0.0 111.857 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -146.29 124.23 12.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.022 1.729 . . . . 0.0 108.407 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' HE ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -59.25 153.69 18.01 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.508 0.595 . . . . 0.0 110.842 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.2 m -124.89 -37.51 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.32 0.648 . . . . 0.0 110.87 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.03 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.4 p90 . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.22 114.95 12.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 170.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.0 pt -129.72 174.9 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.771 1.628 . . . . 0.0 107.129 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.5 ptp -129.32 164.53 23.35 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 160.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.4 m -144.44 160.91 40.28 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.836 1.654 . . . . 0.0 107.777 -161.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -52.99 -53.57 47.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.637 0.732 . . . . 0.0 111.031 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -132.56 -173.36 3.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.413 1.885 . . . . 0.0 107.777 -169.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 t -72.99 4.03 4.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -100.02 105.22 33.94 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 123.201 0.601 . . . . 0.0 111.84 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.25 -34.51 55.78 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 120.864 1.043 . . . . 0.0 112.091 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -74.21 -47.8 33.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.932 -0.48 . . . . 0.0 110.77 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.8 t -125.89 17.9 7.92 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.37 -36.26 45.21 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 120.475 -1.39 . . . . 0.0 111.642 170.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m 73.25 115.53 0.06 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.906 1.683 . . . . 0.0 106.793 -158.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -136.26 152.72 51.02 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.072 0.949 . . . . 0.0 108.584 -166.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.93 93.21 9.27 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.849 1.309 . . . . 0.0 109.725 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -84.03 56.84 3.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.943 2.497 . . . . 0.0 105.591 162.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -117.31 -175.06 2.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.376 1.871 . . . . 0.0 107.734 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -64.39 143.05 58.18 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 171.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -146.62 -15.52 0.43 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.327 1.851 . . . . 0.0 111.296 -159.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -119.15 163.43 17.06 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 129.139 2.976 . . . . 0.0 104.629 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 m120 33.93 58.68 0.58 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.32 1.848 . . . . 0.0 114.285 170.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.35 -173.89 2.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.511 1.924 . . . . 0.0 107.261 166.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.5 t -121.72 136.19 54.94 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.571 1.948 . . . . 0.0 108.335 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -147.46 142.49 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.99 1.268 . . . . 0.0 107.842 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.51 137.96 13.66 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.779 2.133 . . . . 0.0 112.235 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.653 ' CD1' ' HA ' ' A' ' 83' ' ' SER . 4.7 mp -126.71 165.73 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 128.201 2.6 . . . . 0.0 107.135 -166.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.03 -178.98 34.06 Favored Glycine 0 N--CA 1.451 -0.353 0 O-C-N 121.25 -0.906 . . . . 0.0 111.518 159.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 60.31 94.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.894 2.078 . . . . 0.0 112.35 169.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.28 0.0 OUTLIER 56.28 26.12 10.11 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.593 1.557 . . . . 0.0 111.922 -176.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.53 103.71 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -146.32 38.16 1.04 Allowed 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 170.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -138.25 114.24 10.02 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 118.801 0.728 . . . . 0.0 110.245 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.419 ' H ' HD13 ' A' ' 75' ' ' ILE . 6.7 ttm -84.01 142.63 30.33 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 170.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.44 130.88 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 68' ' ' PRO . 1.3 t -146.35 146.49 30.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -173.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.1 mttm . . . . . 0 N--CA 1.444 -0.757 0 CA-C-O 121.134 0.492 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.488 ' CB ' ' HA ' ' A' ' 68' ' ' PRO . 28.0 pt20 -64.23 143.43 57.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.182 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.46 152.11 17.19 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.5 m -127.5 154.56 44.97 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.36 133.58 24.49 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.525 1.13 . . . . 0.0 109.08 -174.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -83.63 117.74 23.37 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 mt -95.0 146.55 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -124.11 148.24 47.3 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.521 1.529 . . . . 0.0 110.648 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -74.61 -46.08 40.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.179 1.392 . . . . 0.0 108.193 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.1 144.54 42.08 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 121.619 0.566 . . . . 0.0 112.434 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.2 m -66.43 108.64 2.45 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 165.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.55 52.18 2.9 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 19.2 p 46.98 44.23 14.57 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.251 1.82 . . . . 0.0 113.34 165.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.57 176.41 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.053 1.341 . . . . 0.0 107.385 171.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.73 -146.02 25.38 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 173.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -79.89 147.58 31.63 Favored 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 125.905 1.682 . . . . 0.0 107.792 -170.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -138.76 166.94 23.09 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 123.882 0.739 . . . . 0.0 112.017 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -160.56 119.03 2.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -71.45 117.49 13.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.9 ttp -106.18 137.84 43.41 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 167.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 93.2 m -113.39 149.74 33.67 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.469 1.107 . . . . 0.0 108.75 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.2 t -153.06 123.53 3.46 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.15 0.58 . . . . 0.0 112.288 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HA ' ' CB ' ' A' ' 47' ' ' GLN . 12.1 Cg_endo -71.82 149.18 53.58 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 N-CA-C 116.951 1.866 . . . . 0.0 116.951 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.73 108.47 6.58 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 107.47 44.06 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 130.13 3.372 . . . . 0.0 109.112 -174.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -150.57 156.88 42.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.647 1.213 . . . . 0.0 110.511 165.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -92.7 138.11 31.78 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.352 160.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 m -131.59 99.31 4.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 126.514 1.926 . . . . 0.0 108.369 -170.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -56.67 120.83 8.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 119.098 -0.477 . . . . 0.0 109.846 168.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 37' ' ' MET . 1.6 mp -78.57 128.7 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 164.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -176.93 98.63 0.05 OUTLIER 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 164.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 p -89.16 -174.57 4.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.456 1.102 . . . . 0.0 108.915 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.69 -4.1 30.95 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.688 -0.633 . . . . 0.0 113.338 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -143.17 159.1 42.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.841 1.656 . . . . 0.0 107.159 174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -69.52 142.4 53.68 Favored 'General case' 0 N--CA 1.441 -0.885 0 O-C-N 124.765 1.291 . . . . 0.0 108.204 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -116.61 142.79 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 124.126 0.97 . . . . 0.0 109.249 -171.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -129.51 -19.18 3.44 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.653 ' HA ' ' CD1' ' A' ' 30' ' ' ILE . 1.7 m -134.12 168.76 18.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.458 1.481 . . . . 0.0 109.862 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -163.07 167.84 21.78 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.579 0.627 . . . . 0.0 109.887 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -157.27 144.46 18.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 123.91 0.756 . . . . 0.0 109.579 158.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.09 137.43 57.05 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 m -106.47 -13.51 9.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.053 1.341 . . . . 0.0 111.752 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 158.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.6 p90 . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.701 0.286 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 tt -125.46 111.11 14.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 162.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' A' ' 20' ' ' TRP . 13.5 pt -119.8 168.63 11.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 169.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.9 ptp -118.91 152.88 35.51 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.022 0.439 . . . . 0.0 110.273 165.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.6 m -138.29 154.04 49.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.538 -158.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -72.26 -6.36 42.49 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.25 1.42 . . . . 0.0 112.6 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.7 p30 -164.15 -177.54 5.05 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.048 1.739 . . . . 0.0 107.297 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.6 t -81.8 4.0 23.8 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.087 0.955 . . . . 0.0 112.576 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.556 ' CG ' HG22 ' A' ' 15' ' ' THR . 46.0 t0 -125.95 90.53 50.1 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.686 1.194 . . . . 0.0 110.081 -162.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.55 -20.29 69.26 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.901 1.734 . . . . 0.0 112.264 -172.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -66.9 -24.14 66.07 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.369 -0.832 . . . . 0.0 111.204 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.556 HG22 ' CG ' ' A' ' 12' ' ' ASP . 10.9 t -144.48 13.89 1.58 Allowed 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -167.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.43 138.54 14.85 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 165.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 p -75.19 93.44 2.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.948 1.374 . . . . 0.0 107.576 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.3 m -94.66 152.59 18.36 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -170.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.84 107.3 19.53 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.924 1.345 . . . . 0.0 111.112 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.406 ' HA ' HG22 ' A' ' 6' ' ' ILE . 59.9 m95 -83.8 35.78 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.358 2.263 . . . . 0.0 108.806 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -87.23 157.98 19.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.837 1.255 . . . . 0.0 107.994 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -63.38 144.72 56.72 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 166.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -145.88 20.78 1.45 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.007 0.523 . . . . 0.0 112.27 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -115.91 141.75 47.69 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.86 20.4 10.63 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.066 0.546 . . . . 0.0 112.399 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.6 p -141.35 133.08 27.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -171.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.9 t -85.53 75.91 10.1 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.81 144.62 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -166.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.38 160.86 42.42 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.569 1.081 . . . . 0.0 111.15 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 mt -122.14 135.44 62.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 171.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.89 143.69 9.9 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 119.571 1.078 . . . . 0.0 113.175 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 69.46 73.77 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.957 2.103 . . . . 0.0 114.881 161.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.8 9.86 6.36 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.564 1.546 . . . . 0.0 110.355 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.75 97.32 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 170.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -135.07 39.73 2.93 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.765 0.826 . . . . 0.0 110.722 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -145.42 134.84 23.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.414 ' H ' HD13 ' A' ' 75' ' ' ILE . 49.0 ttm -114.96 132.88 56.43 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 165.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.94 111.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -170.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.94 72.67 3.0 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.335 1.064 . . . . 0.0 109.526 -170.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.873 0 CA-C-O 123.028 1.349 . . . . 0.0 112.438 167.142 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -53.92 143.26 22.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 160.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.66 131.6 10.73 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 107.007 -2.437 . . . . 0.0 107.007 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 47.2 m -130.62 149.36 52.31 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -162.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.17 140.06 27.69 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.548 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.3 m -83.84 114.74 21.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 162.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 mt -100.99 136.98 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.467 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 4.9 m-90 -119.96 158.87 25.84 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.032 0.933 . . . . 0.0 110.029 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.86 -47.51 70.95 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.218 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.5 -179.4 48.86 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 114.119 -3.896 . . . . 0.0 121.365 175.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m 33.61 82.42 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.63 2.772 . . . . 0.0 114.372 161.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.41 25.32 59.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.467 ' HB2' ' CD2' ' A' ' 53' ' ' TRP . 2.9 p 44.73 65.11 1.15 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.729 1.212 . . . . 0.0 111.609 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.1 176.03 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 126.406 1.882 . . . . 0.0 107.638 172.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.04 -152.73 23.97 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.1 ttm-85 -74.5 159.51 32.14 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.456 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 5.9 p -145.66 167.96 21.84 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.208 0.528 . . . . 0.0 111.235 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.551 HG21 HG21 ' A' ' 77' ' ' THR . 6.5 t -154.75 135.97 13.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 m -85.15 105.72 16.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.0 tpp -83.58 144.81 29.23 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.8 m -124.36 145.53 49.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 159.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.7 t -131.6 109.61 14.66 Favored Pre-proline 0 C--N 1.325 -0.461 0 C-N-CA 124.384 1.074 . . . . 0.0 108.253 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -50.01 146.93 15.92 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.979 2.452 . . . . 0.0 112.223 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.0 160.68 30.98 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.306 0.574 . . . . 0.0 110.571 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.16 39.79 9.51 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.31 160.18 39.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.923 0.868 . . . . 0.0 111.201 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.56 134.69 52.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 128.647 2.779 . . . . 0.0 108.079 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 99.3 m -127.06 136.65 52.47 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.456 1.102 . . . . 0.0 109.827 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -82.61 126.73 32.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.581 0.752 . . . . 0.0 111.569 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.414 HD13 ' H ' ' A' ' 37' ' ' MET . 1.5 mp -95.1 88.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 127.297 2.239 . . . . 0.0 106.721 178.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -154.0 67.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.551 HG21 HG21 ' A' ' 63' ' ' THR . 1.2 p -73.61 176.27 6.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.194 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -46.96 -50.34 15.62 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -90.85 161.34 15.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 125.057 1.343 . . . . 0.0 110.891 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -75.06 138.9 42.45 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.731 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -114.44 135.66 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.193 0.997 . . . . 0.0 109.714 -170.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.9 ttt85 -136.36 -20.19 1.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.3 m -132.46 174.05 10.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 121.068 1.758 . . . . 0.0 112.456 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -167.08 172.87 9.68 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 124.903 1.281 . . . . 0.0 110.884 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -149.33 124.07 9.86 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -67.12 138.74 57.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.801 1.182 . . . . 0.0 108.674 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 m -121.1 -28.23 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 175.721 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.5 p90 . . . . . 0 C--O 1.235 0.303 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.8 136.56 52.86 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.933 1.693 . . . . 0.0 106.736 166.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 20' ' ' TRP . 9.2 pt -144.39 148.65 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 168.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.4 ptp -96.8 138.25 34.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.5 m -129.43 164.71 23.08 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.659 0.784 . . . . 0.0 109.533 -170.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -75.49 -32.08 60.43 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.469 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -143.18 -177.24 5.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.6 t -84.1 7.62 18.14 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.312 1.045 . . . . 0.0 111.442 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -126.84 93.37 42.34 Favored Pre-proline 0 N--CA 1.447 -0.581 0 C-N-CA 125.317 1.447 . . . . 0.0 111.164 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.18 -14.25 40.67 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.629 1.553 . . . . 0.0 113.271 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -68.2 -40.57 82.15 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 119.146 0.885 . . . . 0.0 110.612 172.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -120.47 13.96 11.87 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.63 129.28 9.47 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 163.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.64 93.15 5.45 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 176.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.1 m -80.21 157.68 26.45 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.339 0.7 OUTLIER -96.16 102.6 14.42 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 122.99 1.376 . . . . 0.0 111.683 170.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.488 ' HA ' HG22 ' A' ' 6' ' ' ILE . 71.7 m95 -83.7 50.27 1.77 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 129.688 3.195 . . . . 0.0 107.329 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -117.45 176.52 5.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -166.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -63.8 143.71 57.63 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -164.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -131.04 -29.45 1.86 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.873 2.869 . . . . 0.0 111.38 -162.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -99.62 -163.95 1.08 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -172.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t30 85.27 -57.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.207 1.803 . . . . 0.0 113.669 161.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.65 156.63 4.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.238 0.472 . . . . 0.0 111.433 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -31.44 116.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 129.002 2.921 . . . . 0.0 113.849 169.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.46 150.29 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 126.354 1.861 . . . . 0.0 108.378 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.32 145.0 20.22 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.882 1.706 . . . . 0.0 111.498 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -131.81 157.26 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.662 1.585 . . . . 0.0 109.047 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.53 -166.73 39.92 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 165.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 72.0 78.37 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.078 2.151 . . . . 0.0 115.104 164.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 68.26 4.49 4.2 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.439 1.896 . . . . 0.0 110.671 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.8 t -82.42 115.54 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -146.66 38.62 1.03 Allowed 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 122.857 0.463 . . . . 0.0 111.805 163.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -144.81 138.68 27.25 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -116.83 130.12 56.51 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 168.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.78 120.08 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.16 148.72 31.26 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.385 1.074 . . . . 0.0 108.745 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.532 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.626 162.053 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 mttp . . . . . 0 C--O 1.235 0.309 0 CA-C-O 123.119 1.438 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -50.18 155.87 0.9 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.497 170.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.97 -178.51 30.23 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 106.727 -2.549 . . . . 0.0 106.727 165.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.6 m -137.76 147.99 45.19 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.259 1.023 . . . . 0.0 110.404 -171.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.54 135.79 51.62 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.681 168.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.4 m -83.51 109.2 17.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 162.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.8 mt -95.06 143.78 11.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.484 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 22.0 m-90 -126.11 156.33 40.23 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.529 1.132 . . . . 0.0 112.799 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.98 -47.69 28.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.907 1.683 . . . . 0.0 111.281 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.54 159.48 30.26 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -82.05 54.45 2.5 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.288 -1.125 . . . . 0.0 111.174 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.46 75.35 0.22 Allowed Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -167.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.437 ' HA ' ' CG ' ' A' ' 53' ' ' TRP . 26.0 p 50.46 38.54 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 159.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.13 176.21 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 125.067 1.347 . . . . 0.0 107.588 163.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.48 -156.7 32.2 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -68.24 153.25 44.12 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.484 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 10.5 p -129.87 166.49 19.87 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 124.468 1.105 . . . . 0.0 111.52 161.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.45 156.77 47.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 159.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.8 p -103.35 80.37 1.81 Allowed 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 135.09 34.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -169.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.4 m -128.1 134.27 49.12 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -173.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.79 114.26 11.03 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.626 -170.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -62.86 165.28 16.64 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.661 2.241 . . . . 0.0 114.748 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.74 53.67 1.67 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.933 1.293 . . . . 0.0 113.713 -162.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.416 ' H ' ' H ' ' A' ' 71' ' ' THR . 6.4 p30 157.54 14.24 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.606 2.762 . . . . 0.0 110.434 -167.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.416 ' H ' ' H ' ' A' ' 70' ' ' ASN . 95.1 m -104.98 136.45 44.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.04 127.14 37.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 160.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.7 m -121.63 136.68 54.94 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.918 1.687 . . . . 0.0 107.59 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -90.29 113.89 25.83 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.793 0.837 . . . . 0.0 111.408 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 75' ' ' ILE . 1.3 mp -84.84 66.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 124.609 1.163 . . . . 0.0 108.535 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -130.86 73.82 1.56 Allowed 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 163.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.43 177.48 5.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 176.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.26 -30.66 71.55 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -80.68 155.74 26.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 163.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.29 158.45 34.0 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.66 123.98 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -169.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -136.89 -13.14 1.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 p -154.55 171.14 19.91 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.512 -0.742 . . . . 0.0 110.459 166.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -164.52 170.27 16.08 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 6.1 tpt180 -153.23 144.64 23.23 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 158.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -67.94 134.1 50.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 123.623 0.577 . . . . 0.0 109.772 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.39 -30.97 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.052 0.941 . . . . 0.0 111.668 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 p90 . . . . . 0 C--O 1.234 0.258 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.6 tt -158.41 111.6 2.38 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.199 0.999 . . . . 0.0 109.046 168.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.41 HG22 ' HA ' ' A' ' 20' ' ' TRP . 27.9 pt -120.3 163.08 18.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 124.207 1.003 . . . . 0.0 111.248 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.09 152.3 18.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.238 1.415 . . . . 0.0 107.803 164.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.0 m -143.23 165.49 27.32 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.256 0.622 . . . . 0.0 109.757 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -79.07 -21.84 46.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.787 0.835 . . . . 0.0 112.476 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.49 172.25 18.87 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.34 3.86 1.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.882 1.273 . . . . 0.0 113.123 -175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -104.86 99.77 20.58 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.504 1.522 . . . . 0.0 109.961 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.12 -19.36 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.551 2.167 . . . . 0.0 112.275 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -70.72 -49.21 49.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.189 0.595 . . . . 0.0 109.566 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -127.69 16.4 6.95 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.7 -28.17 72.16 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 119.219 -2.176 . . . . 0.0 112.368 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 m 55.12 93.21 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -159.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.0 m -126.53 141.65 51.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -160.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.255 1.3 p-10 -85.15 102.71 13.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.475 1.131 . . . . 0.0 110.577 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.41 ' HA ' HG22 ' A' ' 6' ' ' ILE . 83.5 m95 -83.04 47.68 1.26 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.816 2.446 . . . . 0.0 107.375 171.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -96.71 172.14 8.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.96 1.704 . . . . 0.0 109.031 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.01 144.34 34.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -146.58 27.25 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.555 0.742 . . . . 0.0 112.345 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -100.16 114.5 27.95 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.098 0.959 . . . . 0.0 109.544 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 50.31 53.92 12.04 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.726 0.774 . . . . 0.0 110.127 174.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.9 t -148.23 138.67 22.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.0 t -67.23 99.49 0.7 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.315 1.446 . . . . 0.0 108.205 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.9 t -128.99 118.96 48.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.417 0.687 . . . . 0.0 109.456 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.2 135.19 23.8 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 125.683 1.611 . . . . 0.0 111.235 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.2 mt -84.14 159.82 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.796 2.038 . . . . 0.0 106.903 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 179.2 164.59 32.06 Favored Glycine 0 N--CA 1.449 -0.451 0 O-C-N 121.403 -0.811 . . . . 0.0 113.35 164.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.1 74.7 0.22 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.161 2.185 . . . . 0.0 113.983 166.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 67.71 3.58 3.51 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.631 2.372 . . . . 0.0 110.902 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.5 t -79.21 99.58 3.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 O-C-N 121.153 -0.967 . . . . 0.0 109.681 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -143.87 43.01 1.46 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.797 1.639 . . . . 0.0 109.226 170.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -139.34 139.26 37.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.421 ' H ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -107.05 136.99 45.98 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 164.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.34 117.51 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.2 p -94.74 160.98 14.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.687 0 C-N-CA 124.483 1.04 . . . . 0.0 113.597 -178.497 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.1 mttt . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -63.24 143.61 57.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.297 159.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.05 157.12 15.24 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-O 117.167 -1.907 . . . . 0.0 108.685 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 38.2 m -139.47 151.33 46.11 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 121.136 2.468 . . . . 0.0 108.561 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.26 140.16 52.04 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 124.642 1.177 . . . . 0.0 108.479 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.2 m -83.9 119.9 25.43 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 159.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 mt -97.19 147.87 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 126.398 1.879 . . . . 0.0 106.082 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 3.1 m-90 -125.27 158.2 34.72 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.105 1.762 . . . . 0.0 111.096 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -93.43 -34.02 13.6 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 125.086 1.354 . . . . 0.0 111.581 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.07 138.77 37.33 Favored Glycine 0 CA--C 1.523 0.57 0 O-C-N 120.454 -1.404 . . . . 0.0 110.074 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -70.57 75.44 0.58 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.746 1.219 . . . . 0.0 110.325 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.57 -65.14 0.16 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 21.2 p 156.66 41.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 129.824 3.249 . . . . 0.0 110.792 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 m -125.8 176.4 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.967 1.307 . . . . 0.0 108.023 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.87 -151.53 27.65 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -77.01 152.37 35.19 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.988 1.315 . . . . 0.0 108.011 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -152.84 151.45 30.43 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.622 0.576 . . . . 0.0 112.47 -167.166 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -145.06 138.69 26.87 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -85.02 99.85 11.29 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.333 0.653 . . . . 0.0 110.273 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -88.37 124.95 34.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 99.3 m -110.02 139.47 45.1 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.9 t -132.47 136.22 27.58 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.15 -0.929 . . . . 0.0 109.768 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.53 -179.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.334 2.689 . . . . 0.0 114.484 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.23 155.84 37.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.22 167.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 33.95 57.6 0.6 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.783 2.033 . . . . 0.0 114.134 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 t -154.71 165.73 35.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.883 0.849 . . . . 0.0 110.75 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.84 139.22 34.83 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.814 2.446 . . . . 0.0 109.478 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.9 m -131.77 135.96 47.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.613 1.565 . . . . 0.0 107.127 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -85.62 114.8 22.89 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.254 0.934 . . . . 0.0 110.731 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.456 HG22 HG13 ' A' ' 81' ' ' ILE . 1.7 mp -86.77 72.74 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 108.817 -174.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -110.57 152.43 26.44 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 158.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.2 p -144.66 -159.73 1.04 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.074 0.852 . . . . 0.0 108.822 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.49 -15.56 79.1 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.434 -0.648 . . . . 0.0 112.882 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -136.39 163.22 30.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 118.859 1.33 . . . . 0.0 108.687 173.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -69.21 133.82 48.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.456 HG13 HG22 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -103.37 129.78 54.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.04 0.936 . . . . 0.0 109.471 -162.298 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -123.96 -29.01 3.7 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -162.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.1 169.71 20.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 117.789 -1.1 . . . . 0.0 110.439 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -157.61 163.62 38.1 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 120.132 1.333 . . . . 0.0 112.906 169.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -125.25 128.65 48.62 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.608 1.963 . . . . 0.0 108.158 161.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.9 mmm-85 -58.86 134.23 56.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 161.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.42 -50.6 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -170.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . 0.357 15.9 pt-20 . . . . . 0 N--CA 1.429 -1.475 1 C-N-CA 132.926 4.491 . . . . 0.0 111.433 158.297 . . . . . . . . 2 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.0 p90 . . . . . 0 CA--C 1.516 -0.344 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 tt -140.34 131.49 26.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 20' ' ' TRP . 12.7 pt -147.59 146.46 18.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.393 1.077 . . . . 0.0 109.426 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -95.02 141.85 28.19 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.24 0.616 . . . . 0.0 110.005 167.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.9 m -134.56 152.45 51.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.599 1.16 . . . . 0.0 108.555 -172.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -78.66 -16.65 57.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -143.82 -167.93 2.72 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.622 1.169 . . . . 0.0 109.331 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 40.2 t -90.27 4.01 51.93 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.666 0.786 . . . . 0.0 112.887 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -105.0 106.79 56.87 Favored Pre-proline 0 C--N 1.331 -0.217 0 C-N-CA 123.989 0.916 . . . . 0.0 109.319 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.38 -23.86 75.37 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 CA-C-N 120.009 1.039 . . . . 0.0 111.946 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -71.2 -63.93 1.01 Allowed 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 122.045 -0.409 . . . . 0.0 110.343 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -109.99 13.22 23.44 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.94 -30.5 59.26 Favored Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m 70.15 110.75 0.05 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -159.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.5 m -122.5 146.04 47.76 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.35 107.82 20.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.614 1.197 . . . . 0.0 110.806 169.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.411 ' HA ' HG22 ' A' ' 6' ' ' ILE . 63.7 m95 -83.72 48.32 1.42 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.669 2.388 . . . . 0.0 107.276 174.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -92.83 153.91 18.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.81 142.94 57.18 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 173.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -146.88 19.49 1.28 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.376 1.071 . . . . 0.0 112.307 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -95.13 129.43 42.23 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -166.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 53.31 43.94 30.78 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.129 0.572 . . . . 0.0 110.099 172.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 t -159.87 163.69 34.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.171 -0.956 . . . . 0.0 110.631 -170.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 54.1 t -92.79 96.0 9.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.97 2.108 . . . . 0.0 110.07 -166.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -111.99 104.12 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 119.373 0.988 . . . . 0.0 111.072 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.48 127.76 37.61 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 167.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.2 mt -84.05 156.86 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.327 2.251 . . . . 0.0 106.013 166.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.66 -166.29 22.27 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.281 . . 34.02 75.13 0.05 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 47.41 22.5 0.28 Allowed 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 125.099 1.359 . . . . 0.0 112.282 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.76 118.06 18.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 119.391 -0.924 . . . . 0.0 108.963 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.28 37.45 1.25 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.743 0.817 . . . . 0.0 111.025 171.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -142.88 134.24 26.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 45.4 ttm -113.47 127.34 56.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 165.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -123.64 91.11 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 t -108.3 155.46 20.48 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.603 0.716 . . . . 0.0 111.473 -158.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.623 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.389 0 C-N-CA 125.845 1.688 . . . . 0.0 112.764 -175.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -57.28 169.69 0.57 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.018 1.327 . . . . 0.0 113.018 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -129.88 158.67 22.37 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 62.2 m -143.69 155.67 44.29 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 117.88 0.84 . . . . 0.0 109.118 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.43 148.14 40.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.875 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -84.03 144.54 29.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 162.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -127.19 152.11 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.445 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 21.8 m-90 -133.6 149.98 51.61 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.218 1.372 . . . . 0.0 112.916 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.69 -54.39 23.61 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.658 1.183 . . . . 0.0 109.067 164.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.38 124.63 11.15 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -168.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.54 67.49 0.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.448 3.099 . . . . 0.0 112.552 -162.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.69 -55.12 0.08 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 127.391 2.424 . . . . 0.0 107.919 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 20.0 p 163.65 50.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 130.544 3.538 . . . . 0.0 108.641 166.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.99 176.65 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.979 1.712 . . . . 0.0 108.281 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.79 -157.41 51.54 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.69 132.37 34.87 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 117.691 0.745 . . . . 0.0 109.017 -166.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 10.1 p -113.64 157.23 22.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 123.598 0.561 . . . . 0.0 112.428 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.83 -177.76 4.58 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 127.352 2.261 . . . . 0.0 106.856 174.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 t -135.15 136.86 42.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -142.32 114.78 8.44 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.044 0.538 . . . . 0.0 110.013 -173.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.7 m -96.05 143.22 27.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.819 1.248 . . . . 0.0 109.557 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.7 t -141.9 123.97 9.1 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.259 1.423 . . . . 0.0 110.511 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.87 145.6 72.15 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.225 1.95 . . . . 0.0 111.506 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.623 ' HB1' ' HA3' ' A' ' 40' ' ' GLY . . . -73.31 140.04 46.48 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 161.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 74.11 45.21 0.22 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -170.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -154.62 144.38 21.6 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 171.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.89 125.19 36.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.424 1.49 . . . . 0.0 108.086 164.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 55.6 m -116.21 136.8 52.69 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 124.905 1.282 . . . . 0.0 109.179 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -98.69 110.83 23.36 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.156 0.982 . . . . 0.0 109.55 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -82.75 96.29 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 122.167 0.984 . . . . 0.0 108.767 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.52 158.08 44.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 163.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.3 p -132.77 -150.1 0.4 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 167.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.31 -28.73 67.48 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 164.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -125.89 165.05 19.44 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.297 1.039 . . . . 0.0 110.082 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -80.58 137.39 36.38 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.558 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -113.64 148.89 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.107 0.963 . . . . 0.0 109.957 -170.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -134.97 -3.67 2.49 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 124.364 1.065 . . . . 0.0 113.333 -170.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.85 164.1 31.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 164.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -144.32 171.79 13.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.104 0.961 . . . . 0.0 112.267 166.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.46 123.88 10.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.52 1.928 . . . . 0.0 106.027 169.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -70.28 138.74 51.83 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 119.199 0.909 . . . . 0.0 109.01 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -104.69 -42.08 7.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 125.04 1.336 . . . . 0.0 110.873 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -177.615 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.52 -0.194 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tt -141.57 103.14 4.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.71 161.13 39.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.4 ptp -125.61 154.46 42.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 122.619 1.2 . . . . 0.0 111.284 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 1.3 m -135.78 169.56 17.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.108 1.763 . . . . 0.0 107.261 -163.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -79.45 -24.61 42.31 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 166.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -139.19 -176.63 4.58 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 172.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.8 t -83.28 3.61 30.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.869 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -113.11 113.95 48.92 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.942 0.897 . . . . 0.0 109.304 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.73 -39.23 21.17 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 120.997 1.392 . . . . 0.0 110.806 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -69.96 -34.01 72.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.482 1.913 . . . . 0.0 111.09 -165.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.8 t -135.46 15.03 3.45 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.37 -46.65 5.18 Favored Glycine 0 CA--C 1.519 0.309 0 O-C-N 120.463 -1.398 . . . . 0.0 110.755 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t 82.04 124.79 0.04 OUTLIER 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.605 1.562 . . . . 0.0 108.552 -166.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 1.2 m -125.85 170.75 11.32 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.059 1.743 . . . . 0.0 110.448 -177.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -90.31 94.02 9.57 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 123.164 1.459 . . . . 0.0 113.122 165.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -83.43 45.68 1.07 Allowed 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.724 -1.235 . . . . 0.0 108.428 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -85.77 163.96 17.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.74 1.616 . . . . 0.0 109.592 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -70.98 143.34 50.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 161.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -137.3 -44.44 0.55 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -167.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -48.21 113.94 0.84 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.592 1.557 . . . . 0.0 109.614 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 55.85 19.51 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.403 1.481 . . . . 0.0 112.667 174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -114.34 179.76 3.86 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -175.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.0 t -149.36 74.85 1.26 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 121.183 1.811 . . . . 0.0 109.96 -166.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 t -83.81 163.94 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -166.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.73 115.81 5.21 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 124.631 1.11 . . . . 0.0 111.103 163.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.11 152.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 126.36 1.864 . . . . 0.0 107.551 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.92 -165.52 38.98 Favored Glycine 0 N--CA 1.444 -0.801 0 O-C-N 121.649 -0.657 . . . . 0.0 111.84 167.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 71.09 73.15 0.19 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.687 2.395 . . . . 0.0 113.548 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 61.11 11.27 3.35 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.568 1.547 . . . . 0.0 110.777 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 24.6 t -73.6 108.84 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -173.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -146.63 34.61 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 170.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -140.71 113.62 8.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.309 0.959 . . . . 0.0 111.756 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.472 ' HB2' HD11 ' A' ' 75' ' ' ILE . 44.3 ttp -84.07 138.92 32.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.06 101.54 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.2 p -93.6 49.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.429 -0.794 . . . . 0.0 111.595 -159.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.391 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -171.209 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -59.51 164.78 3.24 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.0 132.68 8.73 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 170.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 86.0 m -132.99 149.14 52.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.9 140.5 16.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.67 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.8 m -86.66 117.3 25.33 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 166.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 mm -99.47 149.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -130.57 160.34 34.47 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.315 1.446 . . . . 0.0 112.002 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -89.49 -35.34 16.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.087 2.155 . . . . 0.0 111.322 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.75 144.48 38.49 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -76.75 64.02 2.26 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.93 33.73 0.02 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.26 27.9 p 44.65 42.4 5.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.557 1.543 . . . . 0.0 112.226 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -126.18 176.34 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 126.729 2.012 . . . . 0.0 107.695 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.17 -156.93 32.93 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -69.46 153.16 43.95 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.53 168.81 22.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.21 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.93 149.73 26.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.45 106.54 17.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -91.34 83.92 5.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.0 m -84.0 139.42 32.55 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 18.9 t -145.16 142.11 17.99 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 125.122 1.369 . . . . 0.0 109.446 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.33 177.27 2.16 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.974 1.782 . . . . 0.0 111.384 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.55 149.11 42.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.168 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 50.67 38.53 19.37 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.038 1.335 . . . . 0.0 110.094 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.4 m -115.52 137.3 52.21 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -98.17 114.09 26.2 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.26 106.01 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.84 2.056 . . . . 0.0 107.823 -162.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -64.42 136.15 56.81 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.887 0.851 . . . . 0.0 110.637 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 37' ' ' MET . 12.5 mm -101.86 117.45 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.79 65.57 1.05 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.5 p -73.94 161.79 29.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.269 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -54.14 -52.88 40.78 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -80.64 157.55 25.93 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.527 0.68 . . . . 0.0 110.62 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -76.15 134.43 39.95 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.893 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.09 132.79 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -168.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -135.93 -27.81 1.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -173.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 p -152.69 171.87 17.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.563 0.619 . . . . 0.0 111.251 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -156.32 170.06 23.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.633 0.651 . . . . 0.0 111.157 176.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 26' ' ' THR . 14.5 mtt180 -140.2 147.1 39.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.496 1.918 . . . . 0.0 109.31 159.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -63.58 163.53 11.04 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.624 0.769 . . . . 0.0 110.607 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.09 -36.51 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 117.809 0.277 . . . . 0.0 110.458 159.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 163.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.9 p90 . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.94 88.59 2.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 159.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pt -108.3 162.47 6.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 169.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 ptm -108.24 167.94 9.66 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.493 1.139 . . . . 0.0 110.118 161.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 82.2 m -153.58 163.22 40.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 124.5 1.12 . . . . 0.0 108.496 -158.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -85.58 -21.37 28.54 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -133.58 -175.15 3.73 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.811 0.444 . . . . 0.0 111.267 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.1 t -92.13 3.46 55.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.307 1.043 . . . . 0.0 111.811 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -132.98 88.71 36.2 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 126.011 1.725 . . . . 0.0 110.088 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -48.76 -26.77 10.06 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.203 3.268 . . . . 0.0 113.293 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -64.3 -44.32 91.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.46 -0.775 . . . . 0.0 111.495 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.7 p -104.13 13.83 31.65 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.65 135.3 7.48 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 123.966 0.793 . . . . 0.0 112.898 172.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -63.75 137.78 58.21 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.086 -0.655 . . . . 0.0 109.821 169.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 89.3 m -130.39 157.21 43.22 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 125.372 1.469 . . . . 0.0 107.317 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -85.07 93.43 8.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 123.677 1.704 . . . . 0.0 110.821 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -83.87 50.93 1.92 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.658 1.983 . . . . 0.0 107.122 169.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -119.23 -174.1 2.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.88 1.672 . . . . 0.0 108.255 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.11 143.12 50.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 167.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -146.5 5.69 0.93 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.693 -166.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.411 ' CG ' ' N ' ' A' ' 25' ' ' ASN . 19.8 t-105 -78.07 -163.63 0.45 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -165.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' N ' ' CG ' ' A' ' 24' ' ' TRP . 15.0 t-20 -68.31 61.55 0.09 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.526 2.731 . . . . 0.0 110.411 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 t -141.93 149.79 40.61 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 127.477 2.311 . . . . 0.0 105.692 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.2 t -72.56 69.8 0.89 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.433 1.493 . . . . 0.0 111.706 -164.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.3 t -93.42 124.84 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.125 0.97 . . . . 0.0 109.53 -165.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.77 132.39 11.34 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -83.71 153.3 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 169.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.13 158.52 29.86 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 68.87 69.38 0.28 Allowed 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 127.343 2.257 . . . . 0.0 115.835 169.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 49.84 19.26 0.42 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.596 1.159 . . . . 0.0 112.304 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.45 110.86 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -146.26 26.42 1.19 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.939 0.895 . . . . 0.0 112.771 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -138.56 121.45 16.58 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.295 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.587 ' H ' HD13 ' A' ' 75' ' ' ILE . 53.1 tpp -83.62 134.7 34.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -131.05 120.21 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.1 p -104.14 45.37 0.96 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.184 0.993 . . . . 0.0 109.975 -159.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -175.465 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.274 0.559 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -53.96 146.19 14.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.564 1.146 . . . . 0.0 111.739 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.43 136.21 10.3 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 59.0 m -122.8 149.76 43.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.01 136.83 21.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.633 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.6 m -89.45 117.38 28.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 170.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.1 mt -106.53 137.92 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.028 1.731 . . . . 0.0 107.049 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.451 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 5.0 m-90 -122.14 160.63 24.69 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.54 1.536 . . . . 0.0 112.7 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -91.79 -33.89 14.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.494 2.318 . . . . 0.0 111.236 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.41 128.02 9.44 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 124.668 1.128 . . . . 0.0 111.736 -169.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -44.29 121.31 2.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.814 2.046 . . . . 0.0 112.087 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.38 -60.56 0.59 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 126.574 2.035 . . . . 0.0 109.593 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 30.6 p 168.94 43.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.385 1.874 . . . . 0.0 111.472 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 m -120.41 176.75 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.36 -157.93 28.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -73.59 158.57 34.55 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 126.246 1.818 . . . . 0.0 108.161 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.451 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.4 p -159.18 160.68 35.75 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.987 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.0 p -142.67 149.9 39.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.1 t -91.17 128.24 36.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -119.95 116.04 24.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.924 1.69 . . . . 0.0 108.491 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 11.5 m -98.09 146.73 25.26 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.516 0.726 . . . . 0.0 109.77 173.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.2 t -149.41 136.85 11.24 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.405 1.082 . . . . 0.0 111.01 173.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.88 177.75 3.32 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.912 1.741 . . . . 0.0 112.213 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.4 175.24 7.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 37.73 54.1 1.51 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 126.071 1.748 . . . . 0.0 112.265 171.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.24 168.44 25.98 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.923 0.868 . . . . 0.0 108.948 175.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.18 134.34 52.85 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.705 2.002 . . . . 0.0 107.244 172.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.83 118.16 20.38 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -169.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -78.55 122.94 26.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.951 -0.468 . . . . 0.0 110.013 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.587 HD13 ' H ' ' A' ' 37' ' ' MET . 1.9 mp -102.42 104.19 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 169.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.05 69.86 1.26 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 169.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 p -74.01 176.01 6.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.238 1.815 . . . . 0.0 110.58 -162.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.99 -41.59 92.42 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -93.72 164.18 13.24 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.768 0.827 . . . . 0.0 110.545 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -80.93 133.82 35.61 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.85 129.89 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.086 0.554 . . . . 0.0 110.039 -169.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ttt85 -136.54 -13.2 1.76 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -172.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.84 169.32 16.76 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.454 -0.779 . . . . 0.0 111.708 -173.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -166.9 171.79 10.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.463 0.649 . . . . 0.0 112.46 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . 0.295 0.0 OUTLIER -137.56 135.83 37.04 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 129.281 3.033 . . . . 0.0 105.227 170.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -64.5 159.19 22.09 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 158.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.09 -41.54 3.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 119.351 0.978 . . . . 0.0 111.171 163.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 172.988 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.8 p90 . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -150.01 103.98 3.25 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 pt -153.1 159.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.335 1.854 . . . . 0.0 107.843 -167.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.7 ptm -106.55 147.2 29.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.946 0.898 . . . . 0.0 110.088 166.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 1.3 m -117.87 162.31 18.32 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 10.8 pttt -62.86 -37.47 86.97 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 116.347 -2.141 . . . . 0.0 109.936 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -122.15 -171.25 2.21 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 126.831 2.053 . . . . 0.0 109.143 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 50.8 t -78.47 3.23 16.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -118.3 114.52 36.54 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 121.269 -0.894 . . . . 0.0 113.166 -164.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.67 -23.48 56.36 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 120.932 1.088 . . . . 0.0 111.834 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -64.54 -63.11 1.21 Allowed 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.448 1.022 . . . . 0.0 110.221 -176.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -118.92 13.76 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.9 -19.38 78.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.456 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.9 m 58.33 93.22 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -160.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 1.2 m -98.04 145.31 26.65 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -91.61 98.88 11.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.536 1.16 . . . . 0.0 109.474 172.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -83.38 45.56 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.801 2.04 . . . . 0.0 107.995 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.54 -177.68 6.79 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.373 1.469 . . . . 0.0 110.198 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -63.71 150.36 44.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 163.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -139.86 -15.7 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.029 0.932 . . . . 0.0 111.894 176.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -91.08 112.98 25.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 48.72 64.52 1.67 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.709 1.203 . . . . 0.0 110.044 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.21 -178.61 4.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.81 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.3 t -154.41 54.61 0.69 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -94.7 129.98 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 125.395 1.478 . . . . 0.0 109.384 -170.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.15 126.58 7.77 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.783 0.706 . . . . 0.0 112.41 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 mm -107.14 166.24 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 130.406 3.482 . . . . 0.0 108.426 -174.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.85 175.88 25.62 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 165.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 91.32 79.89 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 129.763 3.225 . . . . 0.0 112.343 174.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 80.61 6.96 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 129.34 3.056 . . . . 0.0 110.819 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 62.1 t -83.99 118.49 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 CA-C-N 118.912 0.778 . . . . 0.0 112.467 -164.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.414 ' CE1' ' HE1' ' A' ' 36' ' ' TRP . 4.4 p80 -146.55 35.53 0.96 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 163.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.414 ' HE1' ' CE1' ' A' ' 35' ' ' HIS . 74.6 m95 -140.67 124.47 17.16 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.148 1.34 . . . . 0.0 112.224 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.567 ' H ' HD13 ' A' ' 75' ' ' ILE . 14.1 tpt -84.89 131.14 34.54 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 161.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.47 85.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -172.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 t -93.95 143.89 25.94 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 C-N-CA 124.493 1.044 . . . . 0.0 111.286 -178.016 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -53.03 144.46 15.12 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.56 153.6 16.9 Favored Glycine 0 C--O 1.239 0.442 0 N-CA-C 107.078 -2.409 . . . . 0.0 107.078 167.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.6 m -126.52 144.23 50.94 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.93 126.68 49.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.0 m -83.59 118.88 24.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 168.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 mt -96.65 150.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 -129.08 157.85 40.59 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.984 1.714 . . . . 0.0 111.549 -175.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -82.42 -44.28 16.26 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.09 2.156 . . . . 0.0 111.636 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.81 135.15 21.33 Favored Glycine 0 N--CA 1.449 -0.494 0 O-C-N 120.999 -1.063 . . . . 0.0 111.098 -173.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.1 m -54.48 102.54 0.06 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.587 0.755 . . . . 0.0 109.979 171.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.53 -75.92 0.4 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 24.0 p 158.69 42.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 128.692 2.797 . . . . 0.0 110.397 -174.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.38 176.28 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.33 -167.19 44.81 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 119.615 1.098 . . . . 0.0 110.592 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -73.84 149.57 41.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.497 -1.002 . . . . 0.0 108.874 -170.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.9 161.34 40.94 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.103 -163.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.53 117.05 4.66 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -167.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.5 m -71.55 100.25 2.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.317 0.647 . . . . 0.0 109.51 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.8 tpp -84.04 103.56 13.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.655 1.182 . . . . 0.0 107.836 172.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 50.7 m -84.7 146.45 27.43 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.3 t -155.53 108.31 2.2 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.447 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.2 162.13 14.82 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.844 2.363 . . . . 0.0 113.297 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.53 137.94 44.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 58.76 48.56 11.23 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.348 1.859 . . . . 0.0 110.853 -166.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m -124.44 116.81 23.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.314 0.578 . . . . 0.0 109.99 170.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.406 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -74.35 114.11 12.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 158.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.2 m -116.2 123.84 48.78 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.286 1.834 . . . . 0.0 107.922 -172.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -78.24 132.49 37.56 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 118.454 0.57 . . . . 0.0 110.364 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 37' ' ' MET . 1.2 mp -98.35 107.54 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -123.52 144.63 49.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 p -142.35 -161.93 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 175.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.39 15.58 57.41 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.073 168.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.7 169.97 17.42 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 119.075 1.437 . . . . 0.0 109.425 -173.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -70.51 133.98 47.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 170.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.61 128.75 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.19 -46.97 0.64 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.559 -158.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -133.06 175.89 8.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 119.758 1.163 . . . . 0.0 110.424 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -160.64 163.86 32.25 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 119.779 1.172 . . . . 0.0 113.34 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.06 127.77 10.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 169.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -66.1 115.87 6.59 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.53 -39.33 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 C-N-CA 124.612 1.165 . . . . 0.0 110.047 -168.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.92 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 p90 . . . . . 0 C--O 1.235 0.297 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 tt -140.98 117.71 11.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.211 1.404 . . . . 0.0 108.266 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.27 165.95 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 123.783 0.833 . . . . 0.0 110.077 174.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.6 ptm -105.51 142.39 35.34 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 108.541 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -138.46 158.53 44.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.651 1.181 . . . . 0.0 108.935 -165.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -82.57 -5.88 59.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.63 -172.44 3.12 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.219 1.408 . . . . 0.0 108.149 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.7 t -86.43 3.57 43.26 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.594 0.757 . . . . 0.0 112.081 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -128.43 105.71 19.35 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 118.754 -0.641 . . . . 0.0 111.574 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -58.14 -24.89 68.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.513 1.476 . . . . 0.0 111.581 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -63.83 -27.69 69.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.223 -0.923 . . . . 0.0 110.953 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.0 t -138.79 23.23 2.65 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.352 0.661 . . . . 0.0 111.338 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.05 123.7 5.98 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 164.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.14 94.59 4.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 171.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.5 m -92.44 149.77 21.19 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -171.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -96.29 98.9 10.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.798 0.808 . . . . 0.0 111.462 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -83.77 44.83 1.02 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 130.028 3.331 . . . . 0.0 111.304 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -101.28 174.13 6.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.748 1.219 . . . . 0.0 110.057 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -65.04 143.82 57.68 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.496 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.27 -27.35 8.71 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.931 1.292 . . . . 0.0 109.913 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -84.52 143.28 29.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.785 1.634 . . . . 0.0 106.812 -177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 44.92 43.57 7.23 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.818 1.647 . . . . 0.0 111.527 171.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 t -162.98 149.31 12.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 167.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.4 t -115.97 84.17 2.07 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.581 1.152 . . . . 0.0 111.282 -165.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.5 t -84.8 153.63 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.119 -165.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.02 154.21 31.7 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.448 1.023 . . . . 0.0 111.63 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.4 166.15 8.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 128.103 2.561 . . . . 0.0 105.831 172.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.02 162.22 12.57 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-O 121.439 0.466 . . . . 0.0 113.117 164.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 62.51 81.48 0.2 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.466 2.307 . . . . 0.0 111.185 -175.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 66.24 3.66 2.83 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 125.919 1.687 . . . . 0.0 111.339 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.0 t -102.56 99.31 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -145.99 33.4 1.01 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.168 0.987 . . . . 0.0 111.08 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -144.45 121.84 11.65 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.598 ' H ' HD13 ' A' ' 75' ' ' ILE . 43.0 ttm -85.4 138.77 32.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 158.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 t -134.08 150.31 31.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.6 p -129.06 -173.92 3.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.445 0.698 . . . . 0.0 109.343 -170.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.672 0 CA-C-O 118.611 -1.105 . . . . 0.0 112.445 161.544 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -43.61 143.76 0.92 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.87 0.868 . . . . 0.0 111.601 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -146.86 157.62 27.47 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -171.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.4 m -136.65 154.6 50.6 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.888 0.875 . . . . 0.0 108.869 -172.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.29 141.61 49.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.795 1.238 . . . . 0.0 109.023 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 m -83.61 116.96 22.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 159.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -94.46 145.54 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -126.28 151.61 47.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.71 1.604 . . . . 0.0 109.722 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -58.65 -40.81 84.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 124.384 1.074 . . . . 0.0 109.766 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 82' ' ' ARG . . . -163.2 175.85 39.47 Favored Glycine 0 C--O 1.221 -0.71 0 C-N-CA 116.097 -2.954 . . . . 0.0 120.434 175.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.9 m 32.29 80.84 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.875 2.87 . . . . 0.0 116.314 159.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.3 43.53 95.02 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 52.55 69.25 0.71 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.062 1.345 . . . . 0.0 111.902 171.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.12 175.93 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 C-N-CA 126.743 2.017 . . . . 0.0 107.921 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.6 -160.0 53.41 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ttp-105 -76.82 156.6 32.14 Favored 'General case' 0 CA--C 1.5 -0.956 0 O-C-N 121.934 -0.744 . . . . 0.0 109.585 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.42 144.24 34.35 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.864 -172.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 p -139.93 147.24 40.25 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.065 1.346 . . . . 0.0 108.466 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 t -85.57 113.06 21.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.4 tpt -86.14 139.41 31.12 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 165.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 50.8 m -139.06 143.04 38.2 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.2 t -150.77 123.53 4.17 Favored Pre-proline 0 CA--C 1.535 0.365 0 C-N-CA 124.134 0.974 . . . . 0.0 110.026 -170.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -52.99 157.35 8.25 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.943 2.428 . . . . 0.0 110.646 168.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.8 138.57 32.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.034 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 77.04 44.47 0.1 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 125.748 1.619 . . . . 0.0 109.192 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -149.9 169.3 21.48 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 164.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.6 t -113.15 139.14 48.99 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.018 1.727 . . . . 0.0 107.751 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 24.7 m -140.96 101.63 4.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -163.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -67.67 130.39 42.87 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.795 -0.566 . . . . 0.0 110.25 176.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.598 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -94.13 106.88 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.302 1.841 . . . . 0.0 106.954 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -166.39 71.02 0.13 Allowed 'General case' 0 N--CA 1.461 0.107 0 O-C-N 121.7 -0.625 . . . . 0.0 109.681 176.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 p -74.4 -160.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.124 0.488 . . . . 0.0 110.471 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.8 -24.66 60.41 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 121.374 -0.829 . . . . 0.0 111.783 168.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -118.26 153.89 33.18 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.525 1.163 . . . . 0.0 109.317 169.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -73.87 141.5 46.07 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 125.806 1.942 . . . . 0.0 107.093 163.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.06 136.21 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 124.137 0.975 . . . . 0.0 109.047 -168.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.412 ' HB3' ' HA2' ' A' ' 55' ' ' GLY . 46.6 ttt180 -106.76 -22.27 12.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 116.975 -1.488 . . . . 0.0 112.803 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -137.16 170.7 15.65 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 122.909 2.595 . . . . 0.0 113.316 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -160.11 166.84 29.06 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.069 0.548 . . . . 0.0 109.999 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.11 145.48 28.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -71.34 149.91 45.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.085 0.954 . . . . 0.0 112.312 -170.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.6 m -137.42 -7.4 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-N 120.814 1.643 . . . . 0.0 109.299 158.66 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.5 p90 . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.517 HD21 ' SD ' ' A' ' 37' ' ' MET . 1.3 tt -136.22 91.51 2.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.394 1.478 . . . . 0.0 107.248 176.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.07 159.31 11.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.409 1.084 . . . . 0.0 109.568 174.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.469 ' HB2' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -111.72 166.85 10.82 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 126.169 1.788 . . . . 0.0 114.6 166.117 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 64.0 m -151.12 160.27 43.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.275 1.83 . . . . 0.0 109.555 -159.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.3 -39.42 78.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.572 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -138.98 -170.16 2.8 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 125.875 1.67 . . . . 0.0 108.056 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 t -76.05 3.59 10.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -107.04 104.32 51.5 Favored Pre-proline 0 CA--C 1.539 0.524 0 O-C-N 121.644 -0.66 . . . . 0.0 112.191 -164.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.39 -23.51 51.04 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.99 1.793 . . . . 0.0 112.27 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.52 -56.28 5.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.705 1.202 . . . . 0.0 109.648 -172.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.2 t -132.82 13.85 4.37 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 112.702 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.39 -45.91 58.57 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 168.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 t 76.9 124.63 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.264 1.426 . . . . 0.0 107.848 -164.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 83.4 m -136.58 140.12 42.65 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 125.633 1.573 . . . . 0.0 107.882 -164.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.254 7.5 p-10 -82.78 97.51 8.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 120.566 1.53 . . . . 0.0 110.363 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -82.74 53.23 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.901 2.08 . . . . 0.0 108.484 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -84.92 156.25 21.31 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 158.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.09 144.12 30.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 165.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -143.15 41.02 1.5 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.469 0.708 . . . . 0.0 109.347 -165.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -124.99 130.44 52.36 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -169.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 t30 51.13 55.71 9.11 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.448 0.699 . . . . 0.0 110.117 -172.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 t -160.39 146.88 15.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.761 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -79.57 71.88 6.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 128.8 2.84 . . . . 0.0 108.097 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.5 t -84.21 139.06 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 O-C-N 121.712 -0.617 . . . . 0.0 109.397 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.59 139.29 24.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 31' ' ' GLY . 45.7 mm -98.19 166.22 2.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 125.315 1.446 . . . . 0.0 107.238 168.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.427 ' N ' HG22 ' A' ' 30' ' ' ILE . . . 96.27 170.07 34.77 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 57.65 100.9 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.865 2.066 . . . . 0.0 112.615 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.42 10.68 4.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.383 1.073 . . . . 0.0 112.566 169.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.469 HG13 ' HB2' ' A' ' 7' ' ' MET . 1.6 t -136.19 113.1 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -146.75 18.12 1.29 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -138.31 114.14 9.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.517 ' SD ' HD21 ' A' ' 5' ' ' LEU . 48.1 ttp -85.4 124.75 32.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.43 94.86 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -93.97 127.49 39.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -171.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.833 0 CA-C-O 125.938 2.966 . . . . 0.0 110.024 168.958 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? . . . . . 0 N--CA 1.442 -0.834 0 CA-C-O 121.258 0.551 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -44.07 143.51 1.14 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.064 0.946 . . . . 0.0 110.549 164.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.89 144.0 16.85 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 170.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.7 m -138.85 152.27 47.68 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 119.382 1.591 . . . . 0.0 109.5 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.4 140.5 35.5 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.721 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.2 m -83.86 135.19 34.6 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 168.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 mt -122.82 152.7 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.402 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 27.2 m-90 -139.8 152.99 46.99 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.824 1.25 . . . . 0.0 113.997 -173.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -82.84 -39.8 21.17 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 126.591 1.956 . . . . 0.0 108.898 167.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.77 125.13 36.07 Favored Glycine 0 CA--C 1.522 0.488 0 O-C-N 119.36 -2.087 . . . . 0.0 108.987 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -67.8 107.1 2.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.71 42.21 2.35 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 125.789 1.661 . . . . 0.0 111.971 -169.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 25.6 p 45.4 46.99 10.75 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.448 1.899 . . . . 0.0 114.714 166.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 m -126.27 176.58 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 127.437 2.295 . . . . 0.0 107.843 166.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.46 -157.74 23.26 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 120.841 -1.162 . . . . 0.0 112.332 167.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -70.19 150.73 46.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.402 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 5.8 p -141.75 172.61 12.46 Favored 'General case' 0 N--CA 1.436 -1.158 0 O-C-N 124.023 0.827 . . . . 0.0 111.483 -166.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -144.01 -175.41 4.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 159.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 t -127.96 122.43 32.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 168.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.0 tpt -121.64 118.66 29.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 96.9 m -113.78 146.74 39.47 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.8 t -138.1 121.95 11.58 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 124.432 1.093 . . . . 0.0 108.382 -178.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.32 151.27 9.85 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.111 2.541 . . . . 0.0 112.347 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.02 143.59 47.49 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 54.84 61.63 2.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.003 1.721 . . . . 0.0 109.067 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -154.48 157.41 38.36 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.39 124.44 49.6 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 126.891 2.076 . . . . 0.0 108.957 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.4 m -129.36 113.8 15.41 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.667 1.587 . . . . 0.0 108.717 -168.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -71.2 127.24 31.93 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.551 -0.718 . . . . 0.0 110.037 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.509 HD13 ' H ' ' A' ' 37' ' ' MET . 1.6 mp -85.96 111.59 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 123.978 0.911 . . . . 0.0 108.644 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -163.71 98.77 0.88 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 162.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.2 p -74.35 -157.53 0.06 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.03 -2.04 86.31 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.786 -1.196 . . . . 0.0 112.27 168.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -140.63 174.29 10.66 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 118.91 1.355 . . . . 0.0 108.953 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -79.78 133.65 36.32 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.408 ' HB ' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -95.89 133.3 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -167.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.7 mtt-85 -126.21 -36.31 2.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 118.328 -0.844 . . . . 0.0 113.095 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.93 163.21 33.5 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 119.482 1.037 . . . . 0.0 110.971 171.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.417 ' CD1' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -151.16 169.21 22.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.069 0.548 . . . . 0.0 111.258 165.567 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -157.09 126.0 5.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.183 172.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.465 HH21 ' C ' ' A' ' 88' ' ' GLU . 31.3 mtp180 -55.44 141.94 34.64 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.854 0.462 . . . . 0.0 110.763 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.4 m -96.95 -43.74 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 123.836 0.71 . . . . 0.0 109.295 163.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.465 ' C ' HH21 ' A' ' 86' ' ' ARG . 1.9 tt0 . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.063 0.945 . . . . 0.0 108.569 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 tt -138.75 116.09 11.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 162.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.83 158.84 23.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 126.613 1.965 . . . . 0.0 106.134 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -121.62 175.7 6.09 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.579 0.704 . . . . 0.0 110.427 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 93.7 m -153.16 154.58 35.05 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -159.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -77.6 1.95 18.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 115.095 1.516 . . . . 0.0 115.095 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -158.97 -172.79 3.94 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 125.537 1.535 . . . . 0.0 109.416 169.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.98 3.77 32.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.698 0.761 . . . . 0.0 112.504 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -113.27 130.12 23.93 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 124.07 0.948 . . . . 0.0 110.87 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.09 -46.77 7.52 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 119.85 0.982 . . . . 0.0 109.995 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -64.01 -50.66 67.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.704 0.802 . . . . 0.0 111.069 -161.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 t -110.65 14.34 22.36 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.695 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.79 -50.04 15.54 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t 71.11 116.29 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -158.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.9 m -136.13 148.56 48.28 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.069 -158.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -93.71 93.14 7.84 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 123.704 1.716 . . . . 0.0 110.833 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -83.66 58.04 4.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 111.359 -2.655 . . . . 0.0 103.929 158.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.26 177.51 4.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 127.444 2.298 . . . . 0.0 106.582 172.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -66.98 143.31 56.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 118.557 -1.257 . . . . 0.0 107.722 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -139.99 -12.24 1.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.835 1.254 . . . . 0.0 109.938 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -86.91 173.18 9.52 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.093 1.357 . . . . 0.0 108.57 -165.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -33.46 76.78 0.0 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 131.235 3.814 . . . . 0.0 113.846 -166.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -176.21 178.83 1.34 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 128.605 2.762 . . . . 0.0 108.179 168.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.8 t -72.27 127.36 32.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.752 0.821 . . . . 0.0 109.736 -173.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 t -127.4 133.86 67.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.43 161.79 53.01 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 121.829 -0.544 . . . . 0.0 111.865 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.7 mt -135.41 151.97 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.449 1.9 . . . . 0.0 106.065 165.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.22 156.72 7.96 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.242 0.474 . . . . 0.0 112.003 163.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.48 86.15 0.13 Allowed 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 128.186 2.594 . . . . 0.0 112.517 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 61.35 3.25 0.74 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 128.378 2.671 . . . . 0.0 112.409 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.1 t -86.51 98.76 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -146.04 29.3 1.09 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 89.4 m95 -144.77 113.67 6.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -173.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.459 ' H ' HD13 ' A' ' 75' ' ' ILE . 43.9 ttm -87.59 140.03 29.93 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 168.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.61 95.7 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -174.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 p -93.94 151.7 19.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.994 1.317 . . . . 0.0 114.37 -158.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.747 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -177.942 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -52.73 154.2 2.84 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.793 -0.567 . . . . 0.0 110.669 171.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.75 140.87 12.49 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 106.199 -2.761 . . . . 0.0 106.199 168.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 m -130.73 158.1 41.02 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 117.574 0.687 . . . . 0.0 109.194 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.41 154.42 40.83 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.137 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -99.98 131.63 45.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 167.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 mm -114.88 144.64 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -167.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -132.78 151.7 51.94 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.357 0.98 . . . . 0.0 112.67 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -88.87 -33.62 17.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.07 1.748 . . . . 0.0 109.42 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.14 141.89 42.08 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 m -63.5 151.68 40.62 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 159.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.19 38.75 90.92 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.887 -174.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 30.1 p 44.85 50.97 8.7 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.287 1.835 . . . . 0.0 114.016 170.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -123.88 176.62 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.019 1.328 . . . . 0.0 108.002 169.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.22 -151.42 21.5 Favored Glycine 0 CA--C 1.52 0.377 0 O-C-N 121.313 -0.867 . . . . 0.0 111.592 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -80.2 150.85 29.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 p -147.55 174.46 11.71 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.53 0.681 . . . . 0.0 111.411 -164.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 t -147.31 -176.18 5.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 158.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.89 133.93 42.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 166.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.1 ttt -124.24 144.0 50.21 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.289 1.035 . . . . 0.0 108.849 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.4 m -115.88 151.38 35.41 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 37.5 t -142.45 122.41 8.04 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 123.516 0.726 . . . . 0.0 110.157 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -60.07 165.2 10.91 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.237 1.958 . . . . 0.0 110.061 171.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.1 174.88 8.05 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.621 173.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 p30 47.15 45.93 16.23 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 124.559 1.144 . . . . 0.0 109.977 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.1 m -143.09 139.46 30.47 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.407 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -101.97 113.85 27.45 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 167.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 120.95 41.21 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.07 2.148 . . . . 0.0 106.525 -168.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -84.75 111.22 19.4 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.803 0.841 . . . . 0.0 109.453 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -80.44 93.4 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.18 75.35 0.45 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -6.52 48.86 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -173.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.07 -43.08 1.45 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.47 156.4 29.36 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 117.891 0.845 . . . . 0.0 111.724 175.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -78.93 133.54 36.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 165.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.36 143.74 12.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.193 0.997 . . . . 0.0 108.973 -170.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -126.17 -25.89 3.47 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 171.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.94 165.07 30.91 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.37 179.53 9.05 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.426 1.49 . . . . 0.0 109.883 170.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -148.7 123.75 10.07 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.351 1.86 . . . . 0.0 106.783 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -75.8 139.18 41.63 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.643 1.565 . . . . 0.0 108.546 170.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.1 m -109.6 -35.43 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.749 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 CA--C 1.529 0.149 0 CA-C-N 119.671 1.123 . . . . 0.0 110.629 -174.829 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.8 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 69.12 126.62 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.119 1.767 . . . . 0.0 112.347 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -54.57 153.26 10.5 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.61 167.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -176.73 160.67 1.96 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.621 1.568 . . . . 0.0 108.745 169.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tp -132.94 60.19 1.71 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.478 HD13 ' CE2' ' A' ' 20' ' ' TRP . 4.2 pt -94.22 175.2 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.123 0.969 . . . . 0.0 110.867 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.7 ptm -138.37 166.89 23.09 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.881 1.273 . . . . 0.0 108.887 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 61.0 m -147.44 162.03 39.85 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.766 1.269 . . . . 0.0 110.707 -158.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -85.76 -29.5 23.81 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.07 -1.877 . . . . 0.0 110.28 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -126.07 -166.0 1.51 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.9 t -93.0 3.32 55.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -139.94 105.82 6.81 Favored Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 124.365 1.066 . . . . 0.0 112.824 -164.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.45 -20.89 58.85 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.853 1.702 . . . . 0.0 112.659 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -64.22 -44.12 92.88 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.65 1.114 . . . . 0.0 109.886 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 p -113.97 13.5 18.27 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -174.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.63 133.12 6.08 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 124.571 1.082 . . . . 0.0 110.769 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.14 94.25 1.13 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 174.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 70.9 m -77.53 148.19 35.39 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.35 129.74 36.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.478 ' CE2' HD13 ' A' ' 6' ' ' ILE . 73.3 m95 -111.99 59.84 0.63 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.7 2.8 . . . . 0.0 106.631 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -92.6 165.72 12.85 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 165.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -73.16 143.75 47.14 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 118.199 -1.4 . . . . 0.0 107.525 166.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -130.29 -14.12 3.84 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.726 1.611 . . . . 0.0 109.952 -172.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.418 ' CE3' ' HG3' ' A' ' 86' ' ' ARG . 21.7 m95 -79.04 112.82 16.63 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -172.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.6 t30 64.11 44.75 4.39 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.036 0.935 . . . . 0.0 111.36 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.32 141.37 30.94 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.947 0.899 . . . . 0.0 109.093 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.32 77.76 5.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.904 2.081 . . . . 0.0 109.127 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 t -92.64 127.64 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.51 139.68 16.14 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.948 1.261 . . . . 0.0 111.365 172.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 mm -134.5 165.84 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 126.73 2.012 . . . . 0.0 108.891 -174.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.98 -170.71 40.83 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 163.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.77 80.54 0.2 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.599 1.96 . . . . 0.0 113.643 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 71.2 4.16 4.95 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 126.803 2.041 . . . . 0.0 111.182 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.2 t -89.0 111.44 22.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -146.37 25.75 1.21 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -137.48 114.46 10.69 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 119.729 1.15 . . . . 0.0 111.548 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.525 ' H ' HD13 ' A' ' 75' ' ' ILE . 21.9 ttt -84.49 113.88 21.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 169.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.98 96.92 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -104.19 141.2 36.68 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.674 0.79 . . . . 0.0 109.855 -159.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.56 -173.71 43.01 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 123.374 0.512 . . . . 0.0 111.83 -169.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.39 35.63 4.19 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 124.752 1.168 . . . . 0.0 111.392 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.4 m -31.78 -61.22 0.23 Allowed 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 129.289 3.036 . . . . 0.0 112.593 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.36 45.35 2.77 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -19.62 104.65 0.02 OUTLIER 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.963 2.505 . . . . 0.0 113.07 -175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.61 -56.37 0.74 Allowed Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 105.853 -2.899 . . . . 0.0 105.853 -171.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -74.15 107.06 6.11 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.33 1.052 . . . . 0.0 108.79 -175.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -46.94 157.61 0.15 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.845 1.658 . . . . 0.0 112.492 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.68 134.41 12.2 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 106.999 -2.44 . . . . 0.0 106.999 166.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.1 m -133.37 155.42 49.5 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.62 149.6 39.17 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.666 0.604 . . . . 0.0 111.36 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.0 m -84.5 126.41 33.26 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 159.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.2 mt -121.2 128.35 75.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -172.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 9.1 m-90 -111.13 153.68 25.38 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.739 1.615 . . . . 0.0 113.262 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.78 -45.68 74.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.409 2.284 . . . . 0.0 111.181 172.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.81 157.45 48.9 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 m -78.2 122.48 25.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 163.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.52 41.88 9.61 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 124.761 1.172 . . . . 0.0 111.058 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.5 p 45.79 57.04 5.37 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.454 1.902 . . . . 0.0 113.137 166.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 m -124.63 176.03 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 126.203 1.801 . . . . 0.0 106.95 164.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.54 -160.94 28.22 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -72.86 160.69 31.74 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 8.8 p -145.13 160.55 41.25 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.898 173.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.1 t -110.27 159.47 17.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 162.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -110.11 111.51 22.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 160.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.03 122.5 41.25 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.876 0.735 . . . . 0.0 110.767 -171.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 23.5 m -105.74 152.76 22.78 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.937 1.295 . . . . 0.0 111.967 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.417 ' SG ' ' HD2' ' A' ' 68' ' ' PRO . 1.7 t -151.93 143.73 16.18 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.258 169.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD2' ' SG ' ' A' ' 67' ' ' CYS . 23.3 Cg_endo -64.81 172.24 7.35 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.837 1.691 . . . . 0.0 113.084 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.99 135.84 33.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.875 1.27 . . . . 0.0 110.97 -172.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 56.25 64.74 1.61 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -165.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 m -145.26 126.67 14.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.34 120.64 28.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.36 1.464 . . . . 0.0 108.725 172.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.5 m -130.73 105.44 7.8 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -162.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -68.24 112.95 5.45 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.003 0.521 . . . . 0.0 110.785 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -74.09 107.67 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -136.99 129.75 30.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 162.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -126.48 -169.72 2.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.677 1.126 . . . . 0.0 110.161 -172.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.71 11.69 67.86 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.34 174.87 10.97 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 125.098 1.359 . . . . 0.0 109.284 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -74.3 148.15 41.66 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 163.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -113.62 142.4 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -134.14 -66.75 0.61 Allowed 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.9 m -93.77 173.48 7.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 116.431 -2.108 . . . . 0.0 112.062 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -155.82 168.22 27.9 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.238 165.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.97 136.37 19.0 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 163.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.418 ' HG3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -68.41 166.4 16.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.942 -171.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.64 -32.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 116.924 -1.513 . . . . 0.0 113.095 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 N--CA 1.466 0.341 0 C-N-CA 124.869 1.268 . . . . 0.0 108.581 -174.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.148 0 CA-C-O 119.4 -0.667 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 t70 68.21 -59.1 0.45 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.876 2.47 . . . . 0.0 109.503 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.3 148.44 42.41 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 159.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -128.04 171.95 11.39 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.772 1.629 . . . . 0.0 107.952 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.522 HD13 HH21 ' A' ' 86' ' ' ARG . 5.1 tt -144.16 126.23 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 161.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.78 170.95 12.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.3 ptm -117.35 168.49 10.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.876 0.846 . . . . 0.0 110.023 158.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 73.2 m -156.05 166.25 34.02 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.319 1.448 . . . . 0.0 108.374 -158.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -85.95 -20.52 28.84 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 170.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.2 p30 -136.9 -175.37 4.01 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.849 172.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 40.7 t -89.05 3.82 50.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.347 -170.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -138.02 94.42 11.28 Favored Pre-proline 0 N--CA 1.456 -0.141 0 C-N-CA 123.651 0.78 . . . . 0.0 110.984 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.08 -23.06 2.5 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.52 2.813 . . . . 0.0 114.679 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -63.65 -41.24 98.24 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 119.801 1.182 . . . . 0.0 110.123 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -111.41 14.12 21.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.677 0.791 . . . . 0.0 110.824 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.38 121.02 5.79 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 125.08 1.324 . . . . 0.0 109.85 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.0 m -65.32 123.26 19.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 159.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 96.4 m -135.93 159.1 42.71 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -172.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.86 92.99 8.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.677 1.227 . . . . 0.0 109.65 169.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -84.51 42.7 0.91 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.243 162.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 167.34 10.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 164.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -64.09 144.08 57.38 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.418 0.627 . . . . 0.0 109.327 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -122.25 -8.3 8.71 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.577 2.351 . . . . 0.0 110.015 167.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -58.78 94.13 0.02 OUTLIER 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.091 0.957 . . . . 0.0 110.093 169.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 41.46 55.79 3.37 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.413 1.485 . . . . 0.0 111.379 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.2 p -138.18 124.35 20.35 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 102.492 -3.151 . . . . 0.0 102.492 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.4 t -75.3 84.43 2.45 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.681 1.193 . . . . 0.0 109.343 -166.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.7 t -83.63 121.79 36.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -170.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.36 154.51 49.24 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.418 1.009 . . . . 0.0 111.222 174.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.6 mt -128.27 142.21 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.577 1.951 . . . . 0.0 107.115 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.79 168.81 33.84 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 168.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 61.01 72.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 68.94 2.87 3.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 128.21 2.604 . . . . 0.0 111.259 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -83.71 97.56 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -146.35 34.38 0.97 Allowed 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -135.42 113.98 11.71 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 121.789 -0.569 . . . . 0.0 109.623 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.471 ' H ' HD13 ' A' ' 75' ' ' ILE . 25.4 ttp -85.95 132.61 34.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 t -129.72 129.38 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.501 ' HB ' HD12 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -144.23 128.19 17.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -159.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.31 -160.48 24.42 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 172.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.35 -66.4 0.57 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 105.447 -3.061 . . . . 0.0 105.447 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 p -68.11 149.97 48.95 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.491 1.116 . . . . 0.0 109.29 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -42.88 59.5 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -99.75 96.3 7.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.03 -26.92 2.61 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.144 0.878 . . . . 0.0 113.875 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.4 mttp 61.93 137.04 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 127.461 2.305 . . . . 0.0 110.776 -160.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -51.75 143.46 12.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.004 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.96 133.17 11.51 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 107.484 -2.247 . . . . 0.0 107.484 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 74.6 m -119.3 147.33 44.42 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 117.749 0.775 . . . . 0.0 109.164 172.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.13 140.71 26.89 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 114.711 -1.132 . . . . 0.0 108.86 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.7 m -91.0 113.0 25.14 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 166.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.8 mt -95.7 143.79 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 22.7 m-90 -125.09 152.63 44.11 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.201 1.4 . . . . 0.0 113.076 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -81.15 -38.77 26.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.702 2.401 . . . . 0.0 109.787 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.38 136.66 23.82 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m -60.45 119.89 8.88 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 168.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.15 46.12 7.18 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 124.183 0.897 . . . . 0.0 111.619 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.6 p 44.67 51.69 8.09 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.268 1.827 . . . . 0.0 113.206 169.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 m -125.88 176.86 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 128.588 2.755 . . . . 0.0 106.452 171.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.37 -156.84 34.11 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.3 ttt85 -67.96 153.82 42.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.408 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.2 p -141.47 165.85 26.36 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 174.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.0 t -137.31 138.87 40.46 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 170.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -88.43 94.95 10.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 40.6 tpp -86.38 104.7 16.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 98.8 m -93.08 138.14 31.79 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 166.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.5 t -153.52 132.08 6.67 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.176 1.391 . . . . 0.0 109.801 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -63.18 163.6 22.51 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.404 2.069 . . . . 0.0 115.579 -167.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.07 122.97 25.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 83.11 62.72 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 128.011 2.524 . . . . 0.0 107.402 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.72 -176.91 6.2 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.343 1.068 . . . . 0.0 109.778 158.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.29 122.78 25.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 128.907 2.883 . . . . 0.0 106.42 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.23 113.28 24.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.633 1.973 . . . . 0.0 107.061 -171.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -66.47 115.12 6.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 167.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -77.21 120.62 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 165.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -150.47 66.95 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 170.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 p -78.2 161.56 27.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.581 -167.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -52.84 -30.17 35.82 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.021 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -111.12 159.89 17.41 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 124.575 1.15 . . . . 0.0 109.947 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -72.56 139.26 47.4 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.945 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.32 133.69 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.289 1.036 . . . . 0.0 110.252 -164.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -122.61 -41.05 2.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.906 0.882 . . . . 0.0 111.544 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.94 167.27 22.53 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -154.88 161.44 41.44 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.237 0.615 . . . . 0.0 111.852 163.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -138.29 145.62 41.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.829 2.052 . . . . 0.0 108.395 164.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.522 HH21 HD13 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -76.98 153.54 34.45 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.875 166.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.35 -17.84 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.811 1.644 . . . . 0.0 110.455 164.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 164.537 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.886 0 CA-C-O 118.16 -1.356 . . . . 0.0 115.2 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -76.83 61.11 1.85 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 120.081 1.94 . . . . 0.0 111.093 -170.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.38 133.24 12.53 Favored Glycine 0 N--CA 1.443 -0.857 0 O-C-N 121.179 -0.951 . . . . 0.0 110.826 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -113.18 159.4 19.32 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.866 1.267 . . . . 0.0 108.087 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 tt -139.18 103.76 4.84 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 159.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.405 HD13 ' CE2' ' A' ' 20' ' ' TRP . 2.5 pt -124.42 171.54 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.0 ptp -136.58 140.11 42.65 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.352 1.061 . . . . 0.0 111.181 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.4 m -125.04 168.8 12.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.108 1.363 . . . . 0.0 109.965 -159.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -79.55 -34.8 40.67 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.086 -1.415 . . . . 0.0 108.928 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -132.47 -168.68 2.1 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 128.033 2.533 . . . . 0.0 107.31 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -94.96 3.46 54.92 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -126.31 114.55 23.51 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 124.971 1.309 . . . . 0.0 111.229 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.76 -24.4 74.62 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.309 2.006 . . . . 0.0 111.838 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -44.95 91.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 119.617 1.099 . . . . 0.0 109.44 -177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.2 p -103.95 13.66 32.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.934 0.894 . . . . 0.0 112.346 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.97 114.65 2.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 124.993 1.282 . . . . 0.0 111.408 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.53 94.21 1.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 172.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.0 m -87.72 173.15 9.18 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.563 0.745 . . . . 0.0 109.175 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 162.1 27.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 158.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.405 ' CE2' HD13 ' A' ' 6' ' ' ILE . 93.5 m95 -151.5 54.87 0.85 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 168.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -114.89 176.27 5.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.839 1.656 . . . . 0.0 108.259 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -63.98 153.4 37.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.215 0.606 . . . . 0.0 109.456 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -146.5 -23.45 0.43 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -103.07 33.67 3.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.565 -1.334 . . . . 0.0 109.67 -173.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -141.72 43.84 1.72 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.599 -167.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 89.98 177.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 173.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.3 t -47.44 109.89 0.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.515 1.526 . . . . 0.0 112.273 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.03 145.02 12.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 127.005 2.122 . . . . 0.0 107.241 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.74 134.94 14.29 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.7 mm -133.15 166.52 29.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 127.093 2.157 . . . . 0.0 108.613 -169.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.62 -166.98 21.65 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 106.598 -2.601 . . . . 0.0 106.598 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 48.72 89.45 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 164.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.4 m120 64.8 22.25 12.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 126.59 1.956 . . . . 0.0 111.517 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.3 t -133.91 101.14 3.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -146.53 25.8 1.19 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.713 1.205 . . . . 0.0 112.335 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -129.81 143.23 50.71 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 166.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 48.5 ttm -107.15 125.3 50.9 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 104.068 -2.567 . . . . 0.0 104.068 167.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.98 93.37 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -99.59 155.13 17.76 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.959 1.304 . . . . 0.0 109.002 -167.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.74 -161.56 35.33 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 175.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.24 -15.51 59.61 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 124.139 0.875 . . . . 0.0 114.06 164.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.07 -68.88 0.29 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.877 1.339 . . . . 0.0 109.855 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -163.44 -86.93 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 -164.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -167.95 146.29 4.52 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.365 3.066 . . . . 0.0 106.518 159.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.09 23.44 68.81 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 118.342 0.519 . . . . 0.0 112.214 167.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -105.68 104.48 14.21 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.944 0.498 . . . . 0.0 110.012 166.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.63 167.58 3.42 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.237 1.015 . . . . 0.0 110.675 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.21 140.57 9.47 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 162.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.5 m -126.27 166.6 16.81 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.3 147.03 26.46 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.296 1.438 . . . . 0.0 110.118 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 m -83.5 123.06 29.35 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 161.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 mt -110.12 150.98 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.446 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 24.6 m-90 -129.65 156.77 43.69 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.855 1.662 . . . . 0.0 110.295 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -83.73 -36.01 23.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.35 1.06 . . . . 0.0 111.271 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.88 148.19 50.85 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.119 -0.988 . . . . 0.0 110.746 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m -78.27 53.98 1.32 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.099 0.96 . . . . 0.0 110.35 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.4 55.4 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -171.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 54.42 34.4 20.78 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 162.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 m -125.93 176.55 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 126.932 2.093 . . . . 0.0 109.763 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.52 -152.7 29.39 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -73.66 142.28 46.45 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 1.3 p -136.72 168.26 19.86 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.924 0.765 . . . . 0.0 111.411 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.1 t -152.91 140.9 20.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.803 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.8 m -72.67 100.46 2.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 158.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.87 119.39 24.81 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 166.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.7 m -101.46 153.81 19.37 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.7 t -142.61 119.71 7.05 Favored Pre-proline 0 N--CA 1.449 -0.513 0 C-N-CA 123.718 0.807 . . . . 0.0 109.008 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.77 179.89 2.42 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.957 1.771 . . . . 0.0 110.545 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.72 151.54 40.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.831 -161.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.7 m120 50.91 53.34 13.2 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.231 161.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 t -156.08 179.97 8.72 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.296 0.57 . . . . 0.0 109.804 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 141.75 46.07 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.582 2.753 . . . . 0.0 108.754 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.0 m -143.32 117.69 9.65 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.617 1.167 . . . . 0.0 107.879 -168.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.94 103.96 5.35 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.454 0.57 . . . . 0.0 110.32 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.11 132.96 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t30 141.66 112.82 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 129.111 2.964 . . . . 0.0 104.254 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.45 9.13 19.63 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -174.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.07 -60.91 0.51 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 -159.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -82.73 156.97 23.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -168.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -73.94 133.81 43.09 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.332 -1.304 . . . . 0.0 107.746 172.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.6 128.23 55.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -166.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -136.71 -19.62 1.36 Allowed 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -166.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -142.6 163.24 33.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 119.631 1.105 . . . . 0.0 108.575 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.04 161.48 41.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.958 0.799 . . . . 0.0 112.918 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.37 129.08 12.35 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 171.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.4 mmm-85 -57.41 142.69 42.93 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.17 -3.07 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 117.618 -1.182 . . . . 0.0 113.193 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 CA--C 1.52 -0.2 0 C-N-CA 126.202 1.801 . . . . 0.0 107.493 177.403 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.604 0 N-CA-C 106.492 -2.643 . . . . 0.0 106.492 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 t70 63.83 -71.66 0.06 Allowed 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 128.134 2.574 . . . . 0.0 111.135 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.7 163.7 9.61 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 -161.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -168.92 172.73 7.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.506 HD11 ' SD ' ' A' ' 37' ' ' MET . 0.8 OUTLIER -141.38 119.45 12.03 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 175.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.43 151.98 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 126.552 1.941 . . . . 0.0 106.301 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.1 ptp -110.96 159.3 17.85 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.876 0.846 . . . . 0.0 112.187 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.5 m -145.31 154.56 42.47 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 122.753 1.263 . . . . 0.0 110.133 -159.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -86.14 -13.37 47.32 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 112.679 -2.055 . . . . 0.0 110.741 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -150.77 -179.93 7.68 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.849 1.66 . . . . 0.0 107.84 164.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 t -77.28 3.67 12.42 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -128.57 106.11 19.01 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -59.97 -21.12 63.54 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.618 1.545 . . . . 0.0 112.684 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.9 -33.46 75.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.538 0.608 . . . . 0.0 110.64 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 t -142.37 29.5 1.6 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.221 0.464 . . . . 0.0 111.592 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.22 139.19 10.75 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.11 126.58 28.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 164.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.2 m -135.61 137.14 41.62 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -96.28 103.38 15.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 111.559 -175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -103.71 56.45 0.73 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 129.266 3.027 . . . . 0.0 109.619 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -99.67 -175.76 3.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 159.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -64.01 147.06 52.99 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -143.52 -8.17 0.76 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.742 0.817 . . . . 0.0 112.641 -164.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -101.78 143.59 31.51 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 54.94 47.68 21.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.454 1.101 . . . . 0.0 111.991 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 t -144.05 -173.44 4.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.241 1.416 . . . . 0.0 109.322 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.7 t -151.52 66.79 0.88 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.622 1.969 . . . . 0.0 109.405 -173.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.3 t -104.05 120.62 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.47 1.108 . . . . 0.0 109.659 -167.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.8 128.31 8.38 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.147 0.879 . . . . 0.0 112.639 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.439 HG22 HG21 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -125.31 166.35 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 127.855 2.462 . . . . 0.0 106.09 178.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.63 -178.92 41.85 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.99 99.38 0.05 Allowed 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 127.537 2.335 . . . . 0.0 110.64 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 73.08 8.36 5.37 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.396 1.878 . . . . 0.0 110.98 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 30' ' ' ILE . 62.7 t -84.57 97.62 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -143.25 28.96 1.48 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -143.63 127.41 17.2 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.506 ' SD ' HD11 ' A' ' 5' ' ' LEU . 43.6 ttm -104.9 132.93 50.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 162.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 t -125.16 81.29 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -94.66 151.65 19.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -168.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.523 ' CA ' ' H ' ' A' ' 70' ' ' ASN . . . 141.86 -172.68 23.95 Favored Glycine 0 C--O 1.219 -0.796 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.25 -34.79 0.24 Allowed Glycine 0 CA--C 1.521 0.463 0 CA-C-N 119.097 1.448 . . . . 0.0 112.462 172.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -107.06 -96.14 0.36 Allowed 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 165.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -156.85 -63.13 0.1 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.03 50.09 1.77 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.637 2.375 . . . . 0.0 108.472 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.06 1.96 77.61 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.421 -0.655 . . . . 0.0 112.279 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt 60.81 163.33 0.07 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.832 2.053 . . . . 0.0 111.333 -169.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -69.92 159.66 33.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.844 168.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.32 173.04 31.5 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 164.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.2 m -129.86 159.82 35.42 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -163.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.18 140.53 35.92 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.8 m -83.23 124.45 30.57 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 159.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.2 mt -102.93 146.8 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -123.01 160.98 25.16 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.715 1.606 . . . . 0.0 110.936 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -79.54 -50.16 11.15 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.418 1.487 . . . . 0.0 110.919 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.27 121.05 5.3 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -169.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.71 108.87 0.23 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.05 2.14 . . . . 0.0 108.66 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 129.87 -74.75 0.44 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -172.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 14.1 p 163.03 55.1 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 129.298 3.039 . . . . 0.0 110.462 165.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.63 176.61 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.566 1.546 . . . . 0.0 107.908 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.78 -158.75 37.31 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -80.4 151.55 29.31 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -172.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.73 164.37 30.65 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.11 -169.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.57 128.88 10.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -170.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.0 p -82.3 92.74 7.01 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 41.2 tpp -83.73 129.78 34.95 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 96.7 m -130.58 134.3 46.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.925 0.784 . . . . 0.0 109.333 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 t -150.16 143.67 16.8 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.653 -173.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -66.98 170.12 13.59 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.539 2.159 . . . . 0.0 113.93 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.61 148.75 42.6 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.523 ' H ' ' CA ' ' A' ' 40' ' ' GLY . 20.1 m120 59.81 41.45 18.09 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.111 1.364 . . . . 0.0 109.007 172.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.4 m -127.9 131.41 49.39 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.2 t -88.49 124.82 34.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 170.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.4 m -121.18 105.79 10.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -160.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -78.04 104.84 8.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.624 0.647 . . . . 0.0 109.671 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.477 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -76.64 116.0 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -139.84 83.23 1.91 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 170.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 p -74.47 -174.87 2.18 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.965 -1.084 . . . . 0.0 108.966 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.65 -20.22 71.85 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.321 -0.862 . . . . 0.0 111.573 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -131.02 177.23 7.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.977 1.311 . . . . 0.0 109.838 -172.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -83.35 135.28 34.77 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.32 146.36 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.461 1.504 . . . . 0.0 110.522 -169.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.1 mtt85 -136.25 -85.78 0.35 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.172 0.989 . . . . 0.0 110.024 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.12 168.33 17.84 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.272 -159.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -157.93 165.15 35.91 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.76 123.65 6.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.393 1.477 . . . . 0.0 107.347 170.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -59.9 129.9 44.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.12 -36.9 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 C-N-CA 126.571 1.948 . . . . 0.0 110.472 -167.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 177.528 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.816 0 CA-C-O 118.485 -1.175 . . . . 0.0 113.829 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 64.05 109.95 0.03 OUTLIER 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.108 1.763 . . . . 0.0 110.297 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.71 172.84 7.86 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -167.24 179.1 5.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.753 1.221 . . . . 0.0 108.157 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.585 HD21 ' SD ' ' A' ' 37' ' ' MET . 9.4 tt -149.91 91.67 1.81 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 171.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 pt -108.29 144.59 16.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.5 ptp -78.16 131.26 37.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 159.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 66.5 m -103.09 156.41 17.71 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 14.5 pttt -66.46 -39.84 89.05 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 117.414 -1.715 . . . . 0.0 108.688 178.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.423 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 39.8 p-10 -131.94 -165.9 1.65 Allowed 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 127.123 2.169 . . . . 0.0 108.53 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.0 t -82.99 3.82 28.55 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.397 -0.815 . . . . 0.0 112.609 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -106.84 114.29 61.82 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 123.267 0.627 . . . . 0.0 110.181 -170.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.39 -32.44 89.21 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.653 1.569 . . . . 0.0 111.504 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -100.56 -51.53 3.58 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.599 1.559 . . . . 0.0 111.757 -161.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 p -103.92 13.78 32.08 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.679 0.672 . . . . 0.0 112.148 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.45 -69.47 1.39 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 106.855 -2.498 . . . . 0.0 106.855 164.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t 94.22 122.05 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 128.282 2.633 . . . . 0.0 106.314 -163.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.2 m -136.46 159.75 40.84 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 126.671 1.989 . . . . 0.0 108.881 -165.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -89.25 94.37 9.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.464 2.078 . . . . 0.0 112.584 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -83.64 51.09 1.93 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.939 -1.482 . . . . 0.0 107.37 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -110.43 -176.65 3.03 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.929 2.492 . . . . 0.0 106.834 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 144.36 49.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 167.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -134.91 2.82 3.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 123.69 0.619 . . . . 0.0 110.016 171.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -93.51 125.66 38.23 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 -172.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 53.74 37.45 26.27 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.78 0.832 . . . . 0.0 111.88 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -133.9 151.44 51.51 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.322 1.849 . . . . 0.0 106.613 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -89.32 85.66 6.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -83.85 124.87 40.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -167.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.69 121.44 5.67 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 118.404 0.547 . . . . 0.0 112.04 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.2 mt -93.46 159.43 2.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 126.577 1.951 . . . . 0.0 108.405 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.91 166.13 28.06 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 169.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.23 74.05 0.21 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.768 2.427 . . . . 0.0 112.342 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 68.21 14.9 9.33 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.886 2.074 . . . . 0.0 110.821 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 97.1 t -133.53 99.49 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -145.8 39.9 1.15 Allowed 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.725 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CD1' ' HA ' ' A' ' 10' ' ' ASN . 60.2 m95 -135.16 132.11 37.6 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.585 ' SD ' HD21 ' A' ' 5' ' ' LEU . 19.5 ttp -106.58 123.23 47.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 165.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -124.03 117.09 49.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -99.47 -177.03 3.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -168.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -44.18 139.26 4.21 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.16 -51.24 5.84 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 106.052 -2.819 . . . . 0.0 106.052 165.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 m -62.92 170.97 2.38 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.559 -0.82 . . . . 0.0 111.939 174.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.14 46.15 22.05 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -168.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -59.97 72.88 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.116 2.166 . . . . 0.0 111.795 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.35 -26.81 0.87 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.975 1.274 . . . . 0.0 112.106 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -77.41 96.32 4.64 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.322 1.058 . . . . 0.0 108.522 167.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -66.78 150.99 48.33 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.329 165.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.76 147.91 18.68 Favored Glycine 0 C--O 1.238 0.402 0 N-CA-C 105.791 -2.924 . . . . 0.0 105.791 166.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 58.9 m -132.96 151.33 52.07 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.147 1.474 . . . . 0.0 108.721 -172.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.79 144.47 49.03 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.924 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.2 m -83.3 115.53 22.03 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 162.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.84 148.47 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -127.94 151.8 48.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.109 1.364 . . . . 0.0 111.504 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -87.91 -33.67 18.41 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.476 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.87 138.44 31.44 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 173.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.6 m -61.83 135.28 57.52 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 159.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.11 32.45 39.4 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 124.727 1.156 . . . . 0.0 111.006 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 12.1 p 45.39 52.29 9.03 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.643 2.377 . . . . 0.0 112.174 169.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.76 175.73 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 C-N-CA 125.703 1.601 . . . . 0.0 107.711 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.71 -151.35 26.29 Favored Glycine 0 CA--C 1.523 0.549 0 O-C-N 121.368 -0.832 . . . . 0.0 111.992 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.2 142.85 49.02 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -170.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.99 147.58 28.03 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -167.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p -128.19 115.84 18.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.4 1.48 . . . . 0.0 108.204 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.8 88.33 0.25 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.054 1.342 . . . . 0.0 108.892 171.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -90.52 132.48 35.66 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.955 1.302 . . . . 0.0 107.984 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 64.5 m -118.51 143.19 46.9 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.1 t -134.2 114.26 12.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 123.729 0.812 . . . . 0.0 109.362 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -72.01 166.48 29.49 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.354 1.369 . . . . 0.0 113.516 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.3 154.25 40.21 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 45.9 53.5 8.89 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.223 1.009 . . . . 0.0 108.718 -164.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 m -144.4 106.64 4.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -73.93 126.08 29.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 169.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 86.4 m -121.57 139.73 53.14 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.942 1.297 . . . . 0.0 108.592 -172.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -108.46 113.84 27.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 109.546 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 75' ' ' ILE . 1.5 mp -93.4 71.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -168.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -123.98 84.04 2.22 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 172.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.2 p -73.97 170.83 14.6 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.01 -36.86 93.49 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -85.07 162.67 19.21 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 122.121 -0.635 . . . . 0.0 109.395 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -84.44 133.7 34.48 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.079 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.75 132.29 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.025 1.33 . . . . 0.0 109.769 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -118.58 -37.39 3.3 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 118.511 -0.757 . . . . 0.0 111.982 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 p -152.72 167.33 29.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -139.18 167.13 22.74 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.32 1.048 . . . . 0.0 112.036 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.8 139.68 40.15 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.013 1.725 . . . . 0.0 109.035 162.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.491 ' HD3' HD22 ' A' ' 5' ' ' LEU . 49.3 mmm-85 -54.54 154.62 4.64 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.649 0.659 . . . . 0.0 112.095 170.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.67 -31.19 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 123.215 0.606 . . . . 0.0 110.985 165.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.597 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 CA-C-O 118.803 -0.998 . . . . 0.0 113.054 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.1 123.89 0.03 OUTLIER 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.451 1.626 . . . . 0.0 109.358 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.72 147.56 16.71 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 123.386 0.517 . . . . 0.0 112.23 -171.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -84.28 155.87 22.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.163 0.982 . . . . 0.0 110.419 173.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.409 HD13 ' HG2' ' A' ' 86' ' ' ARG . 10.2 tt -141.25 110.57 6.31 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 159.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.52 111.23 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -169.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptm -72.38 148.6 45.11 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.686 -1.206 . . . . 0.0 108.478 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 71.4 m -129.78 157.05 43.27 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -172.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 19.1 pttt -72.65 -30.78 64.58 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 117.544 -1.662 . . . . 0.0 112.359 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -125.59 -166.55 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.589 1.955 . . . . 0.0 109.528 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 t -99.8 25.66 7.04 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.275 1.03 . . . . 0.0 111.909 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -119.63 101.74 48.17 Favored Pre-proline 0 C--N 1.327 -0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 111.81 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -58.27 -24.07 65.72 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 120.858 1.039 . . . . 0.0 113.028 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -66.61 -73.68 0.13 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.112 0.869 . . . . 0.0 111.052 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.2 t -122.28 37.56 4.36 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.159 0.983 . . . . 0.0 110.413 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.2 -37.37 71.85 Favored Glycine 0 N--CA 1.448 -0.557 0 O-C-N 120.925 -1.109 . . . . 0.0 110.928 161.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.98 114.37 0.05 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -159.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 80.2 m -136.04 137.26 40.97 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 112.46 -2.155 . . . . 0.0 106.663 -166.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -80.61 93.37 6.1 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 122.707 1.241 . . . . 0.0 109.974 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -83.25 41.95 0.79 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.473 1.909 . . . . 0.0 108.309 165.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -96.67 168.43 10.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 166.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -63.74 143.81 57.54 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 118.429 -1.309 . . . . 0.0 109.014 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -129.82 -44.37 1.2 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 126.807 2.043 . . . . 0.0 108.162 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . 0.3 6.4 t-105 -86.19 59.09 5.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.834 1.254 . . . . 0.0 108.212 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.13 -0.01 0.01 OUTLIER 'General case' 0 N--CA 1.46 0.067 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 173.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 t -167.15 142.06 3.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 120.292 1.405 . . . . 0.0 110.382 -158.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.9 t -65.75 75.42 0.07 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.995 2.518 . . . . 0.0 111.625 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 t -83.64 148.33 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 O-C-N 120.882 -1.136 . . . . 0.0 108.646 -167.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.88 144.7 19.62 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 124.337 0.97 . . . . 0.0 111.013 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -101.22 156.63 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 166.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.81 154.58 10.84 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 66.85 83.07 0.17 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.052 1.741 . . . . 0.0 114.323 165.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 67.67 3.76 3.57 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.395 1.478 . . . . 0.0 111.723 171.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 53.3 t -75.29 126.48 36.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 122.486 0.314 . . . . 0.0 110.256 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 30.25 1.02 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 169.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.516 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 68.0 m95 -138.35 127.3 23.95 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.986 0.812 . . . . 0.0 112.728 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.56 ' H ' HD13 ' A' ' 75' ' ' ILE . 64.1 ttp -90.63 135.58 33.61 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 161.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.9 137.55 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 t -146.07 153.4 40.68 Favored 'General case' 0 C--N 1.332 -0.155 0 O-C-N 121.691 -0.63 . . . . 0.0 110.378 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' HA2' ' H ' ' A' ' 70' ' ' ASN . . . 164.77 -156.14 27.93 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 118.373 0.533 . . . . 0.0 112.143 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.02 -53.94 3.97 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -39.18 -58.55 1.15 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.076 1.351 . . . . 0.0 112.209 -162.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.9 -87.55 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.803 1 N-CA-C 100.017 -4.068 . . . . 0.0 100.017 172.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -171.06 168.19 6.96 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.308 2.243 . . . . 0.0 108.642 158.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.34 -23.94 22.05 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.994 1.759 . . . . 0.0 109.877 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -86.27 69.26 10.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 122.851 1.31 . . . . 0.0 110.95 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -44.13 143.63 1.13 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 126.538 1.935 . . . . 0.0 110.665 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.79 137.38 12.38 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.7 m -125.24 153.74 42.7 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.46 143.69 46.01 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.855 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -88.25 130.88 34.97 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 159.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 mt -116.76 144.43 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -130.43 143.72 50.94 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.1 1.36 . . . . 0.0 110.475 -171.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -61.39 -51.96 66.62 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.32 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -73.46 145.99 36.68 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 124.392 0.996 . . . . 0.0 113.296 -163.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.3 m -55.13 116.98 3.1 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 162.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.13 51.14 5.9 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.4 p 43.29 53.17 5.56 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.73 1.612 . . . . 0.0 113.342 163.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -125.76 176.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 128.129 2.572 . . . . 0.0 106.35 167.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.91 -168.24 39.07 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 119.421 1.01 . . . . 0.0 110.814 172.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -69.41 128.36 36.28 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -170.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.92 165.06 15.74 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.811 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -150.66 151.29 32.26 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 m -87.02 111.07 20.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 164.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 34.9 tpp -87.02 144.06 27.06 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 167.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 55.4 m -147.37 136.14 22.05 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.3 t -135.03 137.71 27.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 124.78 1.232 . . . . 0.0 108.406 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.05 168.31 7.63 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.185 1.257 . . . . 0.0 110.759 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.8 150.33 41.12 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.308 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.451 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 65.5 m-80 54.51 48.47 20.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.942 1.297 . . . . 0.0 107.918 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.9 m -145.32 148.07 33.01 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.462 1.105 . . . . 0.0 108.181 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.516 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -101.17 137.17 39.88 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 128.559 2.744 . . . . 0.0 108.338 172.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 54.3 m -140.84 128.17 21.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.968 0.804 . . . . 0.0 110.398 -175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -73.36 135.84 44.33 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.186 0.994 . . . . 0.0 111.599 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 37' ' ' MET . 1.3 mp -102.23 112.86 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 126.573 1.949 . . . . 0.0 106.233 173.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -150.71 77.35 1.28 Allowed 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.843 -0.535 . . . . 0.0 109.944 169.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.32 165.67 24.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.829 0.851 . . . . 0.0 109.28 172.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.99 -51.5 56.92 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -77.33 154.33 32.93 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.551 0.691 . . . . 0.0 110.096 171.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -86.2 137.12 32.87 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.384 -1.734 . . . . 0.0 109.918 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.416 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -100.48 127.76 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 124.665 1.186 . . . . 0.0 109.892 -170.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -109.01 -17.82 13.82 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.982 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -139.13 166.63 24.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -153.65 162.3 41.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.615 1.166 . . . . 0.0 111.651 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -137.59 143.96 41.76 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.108 1.763 . . . . 0.0 107.837 159.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG2' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -64.16 154.37 34.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 163.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 m -131.62 -22.99 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 165.855 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.621 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.56 95.78 2.8 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -172.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.31 124.36 0.2 Allowed Glycine 0 CA--C 1.512 -0.132 0 CA-C-O 122.838 1.243 . . . . 0.0 111.122 -163.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.2 p90 178.4 167.52 0.82 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 127.755 2.422 . . . . 0.0 107.92 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.525 HD21 ' SD ' ' A' ' 37' ' ' MET . 5.2 tt -147.55 121.17 9.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 167.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 18' ' ' CYS . 24.3 pt -132.01 168.89 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 126.851 2.06 . . . . 0.0 106.537 -177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.2 ptp -120.57 144.34 48.14 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 158.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 70.9 m -117.29 156.06 28.44 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 28.5 pttt -60.87 -44.45 97.04 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 116.827 -1.949 . . . . 0.0 109.029 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -126.82 167.73 15.4 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.812 1.645 . . . . 0.0 109.191 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.9 t -72.72 3.88 4.63 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -101.87 100.65 15.26 Favored Pre-proline 0 N--CA 1.467 0.397 0 O-C-N 121.061 -1.024 . . . . 0.0 110.121 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.45 -27.91 83.5 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.958 1.772 . . . . 0.0 112.256 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -63.47 -60.11 3.78 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.378 0.535 . . . . 0.0 109.688 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.4 p -103.81 13.36 33.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -173.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.75 132.75 11.34 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 p -64.42 114.97 4.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 158.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB3' HD12 ' A' ' 6' ' ' ILE . 74.2 m -126.37 138.23 53.54 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -172.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 6' ' ' ILE . 6.0 p30 -76.07 92.69 3.21 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.218 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.472 ' CZ2' HD13 ' A' ' 6' ' ' ILE . 98.7 m95 -90.23 59.57 4.47 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 128.56 2.744 . . . . 0.0 104.489 166.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -127.53 168.92 14.28 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 170.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -64.3 143.86 57.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -134.22 -39.88 0.83 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.022 0.529 . . . . 0.0 109.813 -170.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.427 ' HA ' ' HB2' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -77.62 33.57 0.17 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.443 1.116 . . . . 0.0 111.805 -175.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.83 24.23 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 119.182 -2.199 . . . . 0.0 111.838 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.26 146.83 23.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.958 0.409 . . . . 0.0 111.191 -170.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.7 t -77.78 81.87 4.19 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.614 1.166 . . . . 0.0 108.579 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.43 145.62 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 O-C-N 121.223 -0.923 . . . . 0.0 109.968 -173.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.75 169.24 44.5 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.597 1.094 . . . . 0.0 112.998 -175.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.22 135.72 56.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 126.321 1.848 . . . . 0.0 106.123 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.59 178.1 35.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 167.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 57.82 79.35 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.075 1.75 . . . . 0.0 113.349 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.7 m120 70.3 4.49 4.91 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.25 1.42 . . . . 0.0 111.669 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 98.7 t -100.23 117.25 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 119.111 0.869 . . . . 0.0 110.87 -175.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -145.96 29.39 1.1 Allowed 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.46 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 79.9 m95 -137.6 121.71 17.93 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 119.377 0.989 . . . . 0.0 112.213 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.644 ' H ' HD13 ' A' ' 75' ' ' ILE . 23.2 tpp -84.3 135.4 34.33 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 163.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 t -133.78 128.79 54.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 t -137.77 155.72 48.75 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 121.193 -0.942 . . . . 0.0 109.409 -171.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.94 -179.6 16.56 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.55 -21.93 4.45 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -159.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 t 66.56 -62.22 0.29 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 129.073 2.949 . . . . 0.0 113.398 158.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.7 p -129.82 -73.86 0.56 Allowed 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 158.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.55 33.18 1.28 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.447 0.641 . . . . 0.0 111.744 -159.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.43 -28.16 37.1 Favored Glycine 0 CA--C 1.524 0.631 0 O-C-N 121.128 -0.982 . . . . 0.0 110.963 168.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 73.7 134.66 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.586 2.354 . . . . 0.0 111.013 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -48.91 152.03 1.12 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.164 1.386 . . . . 0.0 111.628 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.95 153.11 17.3 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 175.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.3 m -139.33 153.81 47.78 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 86' ' ' ARG . . . -130.16 149.84 51.68 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 124.076 0.86 . . . . 0.0 110.695 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 m -83.62 126.3 32.71 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 102.787 -3.042 . . . . 0.0 102.787 158.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.6 mm -101.35 146.67 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -129.02 156.92 43.05 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.017 0.913 . . . . 0.0 111.859 -174.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -97.9 -33.79 11.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 127.441 2.296 . . . . 0.0 108.829 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 143.61 47.41 Favored Glycine 0 CA--C 1.521 0.421 0 O-C-N 120.991 -1.068 . . . . 0.0 110.904 170.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.1 m -77.35 59.09 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.062 0.931 . . . . 0.0 111.688 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.42 50.75 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.1 p 44.07 42.77 5.09 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.825 1.25 . . . . 0.0 112.925 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.2 176.41 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 171.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.68 -154.25 37.72 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -73.63 154.36 39.77 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.99 168.37 23.3 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.4 144.84 30.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.55 1.54 . . . . 0.0 107.85 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.76 123.35 28.69 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 168.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.06 108.35 15.62 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.595 1.558 . . . . 0.0 108.794 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.5 m -110.02 144.75 38.13 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.085 0.954 . . . . 0.0 111.274 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.7 t -152.47 136.86 10.45 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -67.49 159.52 52.1 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.9 2.4 . . . . 0.0 113.088 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.17 53.39 2.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.443 -159.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 156.73 50.49 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -163.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -156.04 167.38 30.59 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 165.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.46 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 13.0 t -103.08 127.28 50.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.261 1.825 . . . . 0.0 107.482 173.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.18 119.23 31.75 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.173 1.789 . . . . 0.0 107.25 -164.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -82.05 122.55 27.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.118 0.872 . . . . 0.0 110.685 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -92.28 86.46 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.26 83.84 2.16 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 166.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 p -73.66 179.36 4.19 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 124.678 1.191 . . . . 0.0 108.785 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.21 -30.12 63.77 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 121.65 -0.656 . . . . 0.0 112.419 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -119.28 171.23 8.45 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 127.1 2.16 . . . . 0.0 109.525 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -74.64 133.34 42.16 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.93 157.98 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.527 0.731 . . . . 0.0 110.734 -173.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.91 -40.65 0.6 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 167.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 p -147.69 170.09 18.28 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -156.68 158.01 36.2 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.311 0.959 . . . . 0.0 112.816 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.84 135.55 11.63 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 166.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 1.5 mtm180 -60.74 146.84 44.5 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.307 0.503 . . . . 0.0 112.228 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 m -107.76 -9.97 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.815 1.246 . . . . 0.0 111.915 171.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.175 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.444 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.83 -40.44 96.6 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.14 0.976 . . . . 0.0 108.435 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.1 165.1 48.58 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.676 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -146.8 168.66 20.84 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 128.022 2.529 . . . . 0.0 105.531 -171.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 tt -127.76 122.65 33.34 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 103.9 -2.63 . . . . 0.0 103.9 164.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 pt -140.74 168.21 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.21 169.0 9.02 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 122.729 1.252 . . . . 0.0 112.092 159.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 88.1 m -155.7 157.91 37.38 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.958 -159.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -64.02 -32.25 73.72 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.017 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -159.43 175.84 12.82 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.365 0.666 . . . . 0.0 109.742 -165.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.0 t -79.92 20.52 0.62 Allowed 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.024 1.73 . . . . 0.0 113.082 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -141.82 118.58 7.31 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.877 1.271 . . . . 0.0 110.714 171.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.19 -25.34 10.16 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.109 2.539 . . . . 0.0 111.463 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -63.94 -42.64 97.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.9 p -108.04 13.88 25.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.933 1.293 . . . . 0.0 112.124 177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.0 118.51 3.71 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 125.355 1.455 . . . . 0.0 109.901 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.21 120.82 15.64 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.2 m -122.18 158.96 28.23 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.708 0.803 . . . . 0.0 109.35 -169.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -95.76 93.77 7.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 125.394 2.521 . . . . 0.0 112.729 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -83.98 47.35 1.3 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 111.98 -2.373 . . . . 0.0 108.052 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.46 -178.03 1.04 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.135 1.774 . . . . 0.0 108.938 173.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -69.73 143.4 53.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 158.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -125.27 -24.44 3.97 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.226 0.61 . . . . 0.0 110.464 -166.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.23 -162.95 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 131.068 3.747 . . . . 0.0 115.948 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -45.57 62.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 130.886 3.675 . . . . 0.0 110.547 158.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.7 t -140.02 175.35 9.66 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 128.113 2.565 . . . . 0.0 109.555 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.4 t -139.65 67.19 1.38 Allowed 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.249 1.82 . . . . 0.0 107.701 -165.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.4 t -83.64 144.84 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 124.528 1.131 . . . . 0.0 108.323 -163.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.04 133.68 12.14 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mm -136.61 162.33 35.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 123.817 0.847 . . . . 0.0 110.825 -165.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.22 -148.8 19.73 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 52.19 88.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.774 2.03 . . . . 0.0 116.229 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.279 0.0 OUTLIER 53.68 16.31 0.96 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.156 2.183 . . . . 0.0 113.41 175.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.1 t -115.46 120.16 63.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 124.948 1.299 . . . . 0.0 107.895 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.4 24.28 1.27 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.771 0.828 . . . . 0.0 112.705 176.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CZ3' ' HB2' ' A' ' 74' ' ' ASN . 60.7 m95 -130.75 117.11 18.92 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.472 ' H ' HD13 ' A' ' 75' ' ' ILE . 46.0 ttm -83.54 146.57 28.27 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 165.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 t -141.12 135.02 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -146.32 154.35 41.58 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.3 156.68 13.3 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 128.363 2.887 . . . . 0.0 112.737 173.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.79 -64.25 0.13 Allowed Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 104.34 -3.504 . . . . 0.0 104.34 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.7 t -176.52 -108.6 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.962 2.505 . . . . 0.0 109.266 166.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 52.9 29.5 7.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.154 0.982 . . . . 0.0 109.475 -172.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 16.74 57.71 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 128.357 2.663 . . . . 0.0 113.037 -158.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.65 -43.74 91.3 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 124.923 1.249 . . . . 0.0 110.131 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? 70.45 -173.82 0.18 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 126.081 1.752 . . . . 0.0 108.595 -162.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -60.66 144.01 52.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -164.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.72 143.56 16.31 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 106.186 -2.765 . . . . 0.0 106.186 167.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.2 m -133.23 156.07 48.21 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 118.355 1.077 . . . . 0.0 108.335 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.06 147.6 47.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.126 0.97 . . . . 0.0 109.379 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.3 m -83.93 111.1 18.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 158.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.6 mt -83.04 151.8 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 166.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.451 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 13.7 m-90 -126.41 150.36 48.68 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.06 0.933 . . . . 0.0 110.567 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -63.21 -60.9 2.79 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.238 -1.346 . . . . 0.0 107.535 163.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.74 148.81 47.2 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-O 122.408 1.004 . . . . 0.0 112.74 -159.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.33 72.0 8.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.173 0.989 . . . . 0.0 109.747 -168.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.48 46.61 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 125.259 1.409 . . . . 0.0 110.908 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.3 p 44.09 49.97 7.45 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 125.973 1.709 . . . . 0.0 111.376 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.16 176.85 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 126.716 2.006 . . . . 0.0 107.708 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.87 -155.24 38.64 Favored Glycine 0 CA--C 1.518 0.233 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -75.34 159.62 31.24 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.451 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.6 p -127.87 156.23 42.9 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 124.725 1.266 . . . . 0.0 111.663 173.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.46 110.36 8.77 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.153 1.781 . . . . 0.0 106.92 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.3 t -68.25 108.45 3.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 174.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.2 tpt -113.65 106.48 14.56 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.019 0.927 . . . . 0.0 110.134 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.0 m -93.19 154.65 17.93 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.779 0.832 . . . . 0.0 109.353 171.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.5 t -155.13 132.36 6.29 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.453 0.701 . . . . 0.0 110.505 167.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.27 169.11 16.01 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.3 2.0 . . . . 0.0 113.212 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.67 147.4 43.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 59.07 51.65 6.93 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.492 1.117 . . . . 0.0 108.578 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -140.23 130.94 25.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.243 0.544 . . . . 0.0 110.102 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.5 137.04 32.69 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.874 1.67 . . . . 0.0 109.451 165.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 m -138.9 93.57 2.72 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.957 1.303 . . . . 0.0 109.238 -159.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HB2' ' CZ3' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -70.23 122.7 20.0 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 119.906 -1.746 . . . . 0.0 110.268 -178.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 37' ' ' MET . 1.5 mp -79.06 114.84 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 124.72 1.208 . . . . 0.0 109.644 176.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.16 108.52 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.58 -5.81 3.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.899 0.88 . . . . 0.0 110.439 -171.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.3 13.14 82.3 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 121.242 -0.911 . . . . 0.0 112.538 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -139.9 156.42 46.7 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 119.33 1.565 . . . . 0.0 108.411 159.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -73.82 133.24 43.19 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.33 131.71 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 125.225 1.41 . . . . 0.0 108.412 -169.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.47 -1.52 8.06 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.5 p -156.43 168.98 25.66 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 166.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -153.73 166.84 31.57 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.989 1.316 . . . . 0.0 111.102 165.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -137.01 124.51 22.14 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 128.082 2.553 . . . . 0.0 106.467 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.402 ' HE ' ' C ' ' A' ' 88' ' ' GLU . 48.9 ttt180 -69.89 130.63 42.76 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 120.746 1.612 . . . . 0.0 107.522 169.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 m -98.26 -33.64 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.106 0.962 . . . . 0.0 111.098 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.402 ' C ' ' HE ' ' A' ' 86' ' ' ARG . 2.9 pt-20 . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.686 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 178.78 118.02 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.805 1.642 . . . . 0.0 109.386 -159.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -167.64 -157.66 11.08 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 166.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -121.55 172.5 8.05 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.004 0.902 . . . . 0.0 110.294 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.418 HD22 ' HD3' ' A' ' 86' ' ' ARG . 4.8 tt -156.61 82.28 0.96 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.612 2.365 . . . . 0.0 108.081 171.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 pt -108.64 175.98 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 125.477 1.511 . . . . 0.0 107.642 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.3 ptm -124.37 169.53 11.72 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.521 0.677 . . . . 0.0 111.01 158.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 63.6 m -155.49 163.43 40.03 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 125.146 1.378 . . . . 0.0 109.14 -158.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER -83.06 -28.97 29.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -121.37 177.95 4.98 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 169.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.47 3.46 11.2 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.218 1.007 . . . . 0.0 112.904 -174.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -129.83 96.11 27.16 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 123.017 0.527 . . . . 0.0 110.687 -161.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -68.94 -12.37 34.21 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.56 1.507 . . . . 0.0 113.455 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -70.28 -50.69 36.88 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.196 -0.94 . . . . 0.0 109.678 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.9 p -111.72 22.81 14.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.194 0.998 . . . . 0.0 111.928 -170.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.03 137.24 9.15 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 124.394 0.997 . . . . 0.0 110.7 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.16 129.77 41.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 168.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.0 m -135.8 151.08 49.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.239 1.015 . . . . 0.0 108.672 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -86.16 95.46 9.58 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.562 1.172 . . . . 0.0 110.879 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -83.53 58.01 4.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.184 2.193 . . . . 0.0 106.877 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -124.36 161.29 26.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.042 1.337 . . . . 0.0 108.271 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -64.09 146.41 54.25 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.693 0.759 . . . . 0.0 109.049 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -145.98 7.76 1.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.763 1.625 . . . . 0.0 111.007 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -88.33 121.83 31.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 54.45 38.0 28.81 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.384 1.073 . . . . 0.0 111.452 167.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 t -135.82 148.3 48.64 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.99 1.716 . . . . 0.0 107.457 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.2 t -84.38 100.98 11.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.03 126.65 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 120.101 1.319 . . . . 0.0 109.765 -171.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.59 140.72 15.2 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 127.061 2.267 . . . . 0.0 111.632 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.2 152.52 20.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 128.43 2.692 . . . . 0.0 108.943 -163.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.02 -167.01 34.28 Favored Glycine 0 CA--C 1.525 0.656 0 O-C-N 121.468 -0.77 . . . . 0.0 111.329 168.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.263 . . 59.28 64.8 1.29 Allowed 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 126.884 2.074 . . . . 0.0 115.235 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 m120 64.7 3.58 2.04 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.581 2.352 . . . . 0.0 110.886 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 75.6 t -77.02 106.31 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.629 0.649 . . . . 0.0 109.696 -173.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -146.13 29.86 1.06 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -136.43 113.51 10.54 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 121.766 -0.584 . . . . 0.0 109.962 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.457 ' H ' HD13 ' A' ' 75' ' ' ILE . 59.9 ttp -84.43 142.46 30.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.09 118.41 21.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.3 118.28 36.23 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.05 12.74 35.44 Favored Glycine 0 C--O 1.224 -0.474 0 CA-C-O 123.157 1.421 . . . . 0.0 115.743 169.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.06 45.05 12.18 Favored Glycine 0 C--N 1.308 -1.021 0 C-N-CA 125.777 1.655 . . . . 0.0 110.946 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 t 11.31 -68.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 128.563 2.745 . . . . 0.0 115.562 159.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.2 t -156.23 -56.3 0.09 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.86 143.58 27.05 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.387 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.69 -24.61 58.09 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.312 0.958 . . . . 0.0 112.063 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -70.94 179.23 2.8 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.247 -0.561 . . . . 0.0 110.306 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -60.85 162.21 7.12 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 120.923 -1.111 . . . . 0.0 110.364 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.06 159.01 25.46 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 166.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.5 m -143.21 164.62 29.69 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 119.577 1.689 . . . . 0.0 111.293 -167.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' HB2' ' HE ' ' A' ' 86' ' ' ARG . . . -138.71 159.47 42.03 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 124.324 1.05 . . . . 0.0 109.998 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -84.47 130.46 34.76 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 158.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.62 150.3 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 20.8 m-90 -125.98 156.09 40.38 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 173.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -84.13 -34.01 24.16 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.728 1.611 . . . . 0.0 109.87 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.18 145.35 24.3 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 121.503 0.502 . . . . 0.0 112.312 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -76.17 85.41 3.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.783 1.633 . . . . 0.0 112.627 -161.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.59 -50.44 0.54 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.6 p 159.34 45.53 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 131.613 3.965 . . . . 0.0 107.622 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.52 176.32 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -171.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.37 -147.74 37.91 Favored Glycine 0 CA--C 1.521 0.466 0 O-C-N 121.328 -0.857 . . . . 0.0 111.053 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -71.28 151.74 43.94 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.681 1.192 . . . . 0.0 108.132 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.467 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.7 p -146.71 159.2 43.78 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.573 1.17 . . . . 0.0 112.22 171.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 t -139.26 155.58 47.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 170.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 m -83.99 121.4 27.34 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 38.7 tpp -104.06 118.86 37.66 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 20.3 m -108.84 152.91 24.25 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.866 0.866 . . . . 0.0 108.859 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.6 t -151.86 143.24 15.78 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-O 117.688 -1.148 . . . . 0.0 109.684 171.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.6 168.02 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.196 2.597 . . . . 0.0 111.689 169.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.5 166.76 16.04 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 56.7 47.19 18.74 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.727 0.811 . . . . 0.0 109.215 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -156.28 173.01 17.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.874 0.845 . . . . 0.0 111.438 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -109.14 144.21 37.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.962 2.905 . . . . 0.0 107.942 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.2 m -141.94 99.13 3.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.597 1.159 . . . . 0.0 107.917 -162.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -60.45 105.3 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.167 -0.958 . . . . 0.0 110.22 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -74.07 121.72 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 164.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -168.05 79.12 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 p -73.53 166.99 22.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.5 -37.02 91.52 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -81.18 158.71 24.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 123.452 0.701 . . . . 0.0 110.831 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.74 134.0 43.41 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.85 140.99 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 123.668 0.787 . . . . 0.0 109.531 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.5 mtt85 -129.65 -23.22 2.89 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 117.216 -1.374 . . . . 0.0 114.126 168.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -150.52 166.12 31.18 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 120.976 1.716 . . . . 0.0 111.877 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -157.79 157.68 33.82 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.399 0.545 . . . . 0.0 111.857 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -146.29 124.23 12.03 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.022 1.729 . . . . 0.0 108.407 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' HE ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -59.25 153.69 18.01 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.508 0.595 . . . . 0.0 110.842 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.2 m -124.89 -37.51 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.32 0.648 . . . . 0.0 110.87 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 173.03 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.834 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -59.99 1.73 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 171.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.65 -160.61 21.87 Favored Glycine 0 N--CA 1.451 -0.307 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -159.71 165.79 31.84 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.526 1.131 . . . . 0.0 108.224 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -136.22 114.95 12.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 170.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.0 pt -129.72 174.9 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.771 1.628 . . . . 0.0 107.129 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.5 ptp -129.32 164.53 23.35 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 160.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.4 m -144.44 160.91 40.28 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.836 1.654 . . . . 0.0 107.777 -161.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -52.99 -53.57 47.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.637 0.732 . . . . 0.0 111.031 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -132.56 -173.36 3.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.413 1.885 . . . . 0.0 107.777 -169.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 t -72.99 4.03 4.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -100.02 105.22 33.94 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 123.201 0.601 . . . . 0.0 111.84 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.25 -34.51 55.78 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 120.864 1.043 . . . . 0.0 112.091 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -74.21 -47.8 33.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.932 -0.48 . . . . 0.0 110.77 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.8 t -125.89 17.9 7.92 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.37 -36.26 45.21 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 120.475 -1.39 . . . . 0.0 111.642 170.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m 73.25 115.53 0.06 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.906 1.683 . . . . 0.0 106.793 -158.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -136.26 152.72 51.02 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.072 0.949 . . . . 0.0 108.584 -166.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.93 93.21 9.27 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.849 1.309 . . . . 0.0 109.725 173.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -84.03 56.84 3.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.943 2.497 . . . . 0.0 105.591 162.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -117.31 -175.06 2.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.376 1.871 . . . . 0.0 107.734 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -64.39 143.05 58.18 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 171.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -146.62 -15.52 0.43 Allowed 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.327 1.851 . . . . 0.0 111.296 -159.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -119.15 163.43 17.06 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 129.139 2.976 . . . . 0.0 104.629 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 m120 33.93 58.68 0.58 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.32 1.848 . . . . 0.0 114.285 170.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.35 -173.89 2.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.511 1.924 . . . . 0.0 107.261 166.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.5 t -121.72 136.19 54.94 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.571 1.948 . . . . 0.0 108.335 173.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -147.46 142.49 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 119.99 1.268 . . . . 0.0 107.842 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.51 137.96 13.66 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.779 2.133 . . . . 0.0 112.235 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.653 ' CD1' ' HA ' ' A' ' 83' ' ' SER . 4.7 mp -126.71 165.73 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 128.201 2.6 . . . . 0.0 107.135 -166.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.03 -178.98 34.06 Favored Glycine 0 N--CA 1.451 -0.353 0 O-C-N 121.25 -0.906 . . . . 0.0 111.518 159.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 60.31 94.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.894 2.078 . . . . 0.0 112.35 169.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.28 0.0 OUTLIER 56.28 26.12 10.11 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.593 1.557 . . . . 0.0 111.922 -176.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.53 103.71 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 165.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -146.32 38.16 1.04 Allowed 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 170.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -138.25 114.24 10.02 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 118.801 0.728 . . . . 0.0 110.245 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.419 ' H ' HD13 ' A' ' 75' ' ' ILE . 6.7 ttm -84.01 142.63 30.33 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 170.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.44 130.88 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 68' ' ' PRO . 1.3 t -146.35 146.49 30.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.04 -132.63 5.46 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -173.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.72 -63.28 4.12 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 105.995 -2.842 . . . . 0.0 105.995 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.1 m -98.23 -161.19 0.85 Allowed 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 124.201 1.0 . . . . 0.0 111.654 -163.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.8 p -112.08 -85.44 0.57 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.249 1.819 . . . . 0.0 110.33 -158.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.83 77.49 5.3 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.25 -49.79 1.29 Allowed Glycine 0 C--O 1.227 -0.326 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.1 mttm 70.31 139.26 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.705 2.402 . . . . 0.0 110.207 -167.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.488 ' CB ' ' HA ' ' A' ' 68' ' ' PRO . 28.0 pt20 -64.23 143.43 57.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.182 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.46 152.11 17.19 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.5 m -127.5 154.56 44.97 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.36 133.58 24.49 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.525 1.13 . . . . 0.0 109.08 -174.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m -83.63 117.74 23.37 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 mt -95.0 146.55 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.7 m-90 -124.11 148.24 47.3 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.521 1.529 . . . . 0.0 110.648 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -74.61 -46.08 40.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.179 1.392 . . . . 0.0 108.193 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.1 144.54 42.08 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 121.619 0.566 . . . . 0.0 112.434 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.2 m -66.43 108.64 2.45 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 165.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.55 52.18 2.9 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 19.2 p 46.98 44.23 14.57 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.251 1.82 . . . . 0.0 113.34 165.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 m -123.57 176.41 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 125.053 1.341 . . . . 0.0 107.385 171.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.73 -146.02 25.38 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 173.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -79.89 147.58 31.63 Favored 'General case' 0 CA--C 1.504 -0.819 0 C-N-CA 125.905 1.682 . . . . 0.0 107.792 -170.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 p -138.76 166.94 23.09 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 123.882 0.739 . . . . 0.0 112.017 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -160.56 119.03 2.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -71.45 117.49 13.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.9 ttp -106.18 137.84 43.41 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 167.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 93.2 m -113.39 149.74 33.67 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.469 1.107 . . . . 0.0 108.75 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.2 t -153.06 123.53 3.46 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.15 0.58 . . . . 0.0 112.288 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HA ' ' CB ' ' A' ' 47' ' ' GLN . 12.1 Cg_endo -71.82 149.18 53.58 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 N-CA-C 116.951 1.866 . . . . 0.0 116.951 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.73 108.47 6.58 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 107.47 44.06 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 130.13 3.372 . . . . 0.0 109.112 -174.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -150.57 156.88 42.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.647 1.213 . . . . 0.0 110.511 165.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -92.7 138.11 31.78 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.352 160.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.6 m -131.59 99.31 4.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 126.514 1.926 . . . . 0.0 108.369 -170.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -56.67 120.83 8.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 119.098 -0.477 . . . . 0.0 109.846 168.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 37' ' ' MET . 1.6 mp -78.57 128.7 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 164.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -176.93 98.63 0.05 OUTLIER 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 164.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 p -89.16 -174.57 4.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.456 1.102 . . . . 0.0 108.915 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.69 -4.1 30.95 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.688 -0.633 . . . . 0.0 113.338 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -143.17 159.1 42.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.841 1.656 . . . . 0.0 107.159 174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -69.52 142.4 53.68 Favored 'General case' 0 N--CA 1.441 -0.885 0 O-C-N 124.765 1.291 . . . . 0.0 108.204 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -116.61 142.79 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 124.126 0.97 . . . . 0.0 109.249 -171.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -129.51 -19.18 3.44 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.653 ' HA ' ' CD1' ' A' ' 30' ' ' ILE . 1.7 m -134.12 168.76 18.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.458 1.481 . . . . 0.0 109.862 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -163.07 167.84 21.78 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.579 0.627 . . . . 0.0 109.887 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -157.27 144.46 18.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 123.91 0.756 . . . . 0.0 109.579 158.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.09 137.43 57.05 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.1 m -106.47 -13.51 9.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.053 1.341 . . . . 0.0 111.752 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 158.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.229 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 74.08 -59.34 0.56 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.141 1.776 . . . . 0.0 108.481 -169.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -56.88 170.51 2.93 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 158.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -152.99 171.56 18.17 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 120.861 -1.376 . . . . 0.0 110.324 -163.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 tt -125.46 111.11 14.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 162.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' A' ' 20' ' ' TRP . 13.5 pt -119.8 168.63 11.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 169.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.9 ptp -118.91 152.88 35.51 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.022 0.439 . . . . 0.0 110.273 165.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.6 m -138.29 154.04 49.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.538 -158.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -72.26 -6.36 42.49 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.25 1.42 . . . . 0.0 112.6 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.7 p30 -164.15 -177.54 5.05 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.048 1.739 . . . . 0.0 107.297 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.6 t -81.8 4.0 23.8 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.087 0.955 . . . . 0.0 112.576 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.556 ' CG ' HG22 ' A' ' 15' ' ' THR . 46.0 t0 -125.95 90.53 50.1 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.686 1.194 . . . . 0.0 110.081 -162.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.55 -20.29 69.26 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.901 1.734 . . . . 0.0 112.264 -172.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -66.9 -24.14 66.07 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.369 -0.832 . . . . 0.0 111.204 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.556 HG22 ' CG ' ' A' ' 12' ' ' ASP . 10.9 t -144.48 13.89 1.58 Allowed 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -167.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.43 138.54 14.85 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 165.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 p -75.19 93.44 2.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.948 1.374 . . . . 0.0 107.576 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.3 m -94.66 152.59 18.36 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -170.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.84 107.3 19.53 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.924 1.345 . . . . 0.0 111.112 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.406 ' HA ' HG22 ' A' ' 6' ' ' ILE . 59.9 m95 -83.8 35.78 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.358 2.263 . . . . 0.0 108.806 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -87.23 157.98 19.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.837 1.255 . . . . 0.0 107.994 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -63.38 144.72 56.72 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 166.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -145.88 20.78 1.45 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.007 0.523 . . . . 0.0 112.27 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -115.91 141.75 47.69 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 104.532 -2.395 . . . . 0.0 104.532 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.86 20.4 10.63 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.066 0.546 . . . . 0.0 112.399 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.6 p -141.35 133.08 27.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -171.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.9 t -85.53 75.91 10.1 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.81 144.62 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -166.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.38 160.86 42.42 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.569 1.081 . . . . 0.0 111.15 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 mt -122.14 135.44 62.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 171.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.89 143.69 9.9 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 119.571 1.078 . . . . 0.0 113.175 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 69.46 73.77 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.957 2.103 . . . . 0.0 114.881 161.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.8 9.86 6.36 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.564 1.546 . . . . 0.0 110.355 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.4 t -76.75 97.32 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 170.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -135.07 39.73 2.93 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.765 0.826 . . . . 0.0 110.722 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -145.42 134.84 23.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.414 ' H ' HD13 ' A' ' 75' ' ' ILE . 49.0 ttm -114.96 132.88 56.43 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 165.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.94 111.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -170.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.94 72.67 3.0 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.335 1.064 . . . . 0.0 109.526 -170.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.87 173.62 28.36 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 123.028 1.349 . . . . 0.0 112.438 167.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.85 65.23 0.29 Allowed Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 103.465 -3.854 . . . . 0.0 103.465 171.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.8 t -139.82 -114.36 0.14 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.481 1.112 . . . . 0.0 108.648 -163.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 p -144.91 -71.88 0.27 Allowed 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -159.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -12.62 94.87 0.01 OUTLIER 'General case' 0 C--O 1.232 0.169 0 C-N-CA 128.639 2.776 . . . . 0.0 112.605 160.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.89 7.9 33.55 Favored Glycine 0 CA--C 1.519 0.29 0 O-C-N 123.739 0.65 . . . . 0.0 112.345 -159.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -69.14 131.68 45.35 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 167.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -53.92 143.26 22.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 160.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.66 131.6 10.73 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 107.007 -2.437 . . . . 0.0 107.007 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 47.2 m -130.62 149.36 52.31 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -162.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.17 140.06 27.69 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.548 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.3 m -83.84 114.74 21.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 162.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 mt -100.99 136.98 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.467 ' CD2' ' HB2' ' A' ' 58' ' ' CYS . 4.9 m-90 -119.96 158.87 25.84 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.032 0.933 . . . . 0.0 110.029 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.86 -47.51 70.95 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.218 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.5 -179.4 48.86 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 114.119 -3.896 . . . . 0.0 121.365 175.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 m 33.61 82.42 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.63 2.772 . . . . 0.0 114.372 161.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.41 25.32 59.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.467 ' HB2' ' CD2' ' A' ' 53' ' ' TRP . 2.9 p 44.73 65.11 1.15 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.729 1.212 . . . . 0.0 111.609 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.1 176.03 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 126.406 1.882 . . . . 0.0 107.638 172.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.04 -152.73 23.97 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.1 ttm-85 -74.5 159.51 32.14 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.456 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 5.9 p -145.66 167.96 21.84 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.208 0.528 . . . . 0.0 111.235 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.551 HG21 HG21 ' A' ' 77' ' ' THR . 6.5 t -154.75 135.97 13.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 m -85.15 105.72 16.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.0 tpp -83.58 144.81 29.23 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 30.8 m -124.36 145.53 49.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 159.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.7 t -131.6 109.61 14.66 Favored Pre-proline 0 C--N 1.325 -0.461 0 C-N-CA 124.384 1.074 . . . . 0.0 108.253 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -50.01 146.93 15.92 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.979 2.452 . . . . 0.0 112.223 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.0 160.68 30.98 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.306 0.574 . . . . 0.0 110.571 -176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 63.16 39.79 9.51 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.31 160.18 39.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.923 0.868 . . . . 0.0 111.201 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.56 134.69 52.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 128.647 2.779 . . . . 0.0 108.079 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 99.3 m -127.06 136.65 52.47 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.456 1.102 . . . . 0.0 109.827 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -82.61 126.73 32.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.581 0.752 . . . . 0.0 111.569 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.414 HD13 ' H ' ' A' ' 37' ' ' MET . 1.5 mp -95.1 88.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 127.297 2.239 . . . . 0.0 106.721 178.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -154.0 67.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.551 HG21 HG21 ' A' ' 63' ' ' THR . 1.2 p -73.61 176.27 6.34 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.194 -177.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -46.96 -50.34 15.62 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -176.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -90.85 161.34 15.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 125.057 1.343 . . . . 0.0 110.891 177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -75.06 138.9 42.45 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.731 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -114.44 135.66 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.193 0.997 . . . . 0.0 109.714 -170.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.9 ttt85 -136.36 -20.19 1.41 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.3 m -132.46 174.05 10.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 121.068 1.758 . . . . 0.0 112.456 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -167.08 172.87 9.68 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 124.903 1.281 . . . . 0.0 110.884 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -149.33 124.07 9.86 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -67.12 138.74 57.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.801 1.182 . . . . 0.0 108.674 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 m -121.1 -28.23 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -172.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 175.721 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.716 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.1 t70 64.89 -57.06 0.27 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 129.049 2.94 . . . . 0.0 111.146 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.01 -162.1 23.87 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 125.45 1.5 . . . . 0.0 109.701 172.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -164.57 168.96 17.66 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.372 1.069 . . . . 0.0 108.799 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.8 136.56 52.86 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.933 1.693 . . . . 0.0 106.736 166.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 20' ' ' TRP . 9.2 pt -144.39 148.65 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 168.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.4 ptp -96.8 138.25 34.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.5 m -129.43 164.71 23.08 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.659 0.784 . . . . 0.0 109.533 -170.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -75.49 -32.08 60.43 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.469 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -143.18 -177.24 5.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.6 t -84.1 7.62 18.14 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.312 1.045 . . . . 0.0 111.442 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -126.84 93.37 42.34 Favored Pre-proline 0 N--CA 1.447 -0.581 0 C-N-CA 125.317 1.447 . . . . 0.0 111.164 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.18 -14.25 40.67 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.629 1.553 . . . . 0.0 113.271 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -68.2 -40.57 82.15 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 119.146 0.885 . . . . 0.0 110.612 172.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -120.47 13.96 11.87 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.63 129.28 9.47 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 163.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.64 93.15 5.45 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 176.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.1 m -80.21 157.68 26.45 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.339 0.7 OUTLIER -96.16 102.6 14.42 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 122.99 1.376 . . . . 0.0 111.683 170.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.488 ' HA ' HG22 ' A' ' 6' ' ' ILE . 71.7 m95 -83.7 50.27 1.77 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 129.688 3.195 . . . . 0.0 107.329 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -117.45 176.52 5.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -166.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -63.8 143.71 57.63 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -164.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -131.04 -29.45 1.86 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.873 2.869 . . . . 0.0 111.38 -162.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -99.62 -163.95 1.08 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -172.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 t30 85.27 -57.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.207 1.803 . . . . 0.0 113.669 161.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -171.65 156.63 4.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.238 0.472 . . . . 0.0 111.433 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -31.44 116.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 129.002 2.921 . . . . 0.0 113.849 169.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.46 150.29 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 126.354 1.861 . . . . 0.0 108.378 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.32 145.0 20.22 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.882 1.706 . . . . 0.0 111.498 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -131.81 157.26 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.662 1.585 . . . . 0.0 109.047 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.53 -166.73 39.92 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 165.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 72.0 78.37 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.078 2.151 . . . . 0.0 115.104 164.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 68.26 4.49 4.2 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.439 1.896 . . . . 0.0 110.671 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.8 t -82.42 115.54 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -146.66 38.62 1.03 Allowed 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 122.857 0.463 . . . . 0.0 111.805 163.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -144.81 138.68 27.25 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -116.83 130.12 56.51 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 168.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -128.78 120.08 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.16 148.72 31.26 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.385 1.074 . . . . 0.0 108.745 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.94 -149.79 21.8 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.4 -0.428 . . . . 0.0 113.626 162.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.67 40.6 7.64 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.204 1.383 . . . . 0.0 111.265 -175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 p -124.49 -82.71 0.64 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 119.209 1.504 . . . . 0.0 108.081 174.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 p -150.35 -75.52 0.15 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 160.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.449 ' CG ' HD21 ' A' ' 70' ' ' ASN . 41.2 t0 -155.34 -176.59 6.02 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.137 2.175 . . . . 0.0 107.166 168.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.07 23.91 53.82 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 124.555 1.074 . . . . 0.0 112.972 161.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -135.35 47.96 2.28 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.396 1.479 . . . . 0.0 110.949 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -50.18 155.87 0.9 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.497 170.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.97 -178.51 30.23 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 106.727 -2.549 . . . . 0.0 106.727 165.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.6 m -137.76 147.99 45.19 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.259 1.023 . . . . 0.0 110.404 -171.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.54 135.79 51.62 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.681 168.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.4 m -83.51 109.2 17.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 162.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.8 mt -95.06 143.78 11.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.484 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 22.0 m-90 -126.11 156.33 40.23 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.529 1.132 . . . . 0.0 112.799 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.98 -47.69 28.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.907 1.683 . . . . 0.0 111.281 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.54 159.48 30.26 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 m -82.05 54.45 2.5 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.288 -1.125 . . . . 0.0 111.174 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.46 75.35 0.22 Allowed Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -167.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.437 ' HA ' ' CG ' ' A' ' 53' ' ' TRP . 26.0 p 50.46 38.54 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 159.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.13 176.21 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 125.067 1.347 . . . . 0.0 107.588 163.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.48 -156.7 32.2 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -68.24 153.25 44.12 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.484 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 10.5 p -129.87 166.49 19.87 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 124.468 1.105 . . . . 0.0 111.52 161.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.45 156.77 47.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 159.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.8 p -103.35 80.37 1.81 Allowed 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 135.09 34.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -169.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.4 m -128.1 134.27 49.12 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -173.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.79 114.26 11.03 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.626 -170.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -62.86 165.28 16.64 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.661 2.241 . . . . 0.0 114.748 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.74 53.67 1.67 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.933 1.293 . . . . 0.0 113.713 -162.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.449 HD21 ' CG ' ' A' ' 44' ' ' ASP . 6.4 p30 157.54 14.24 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.606 2.762 . . . . 0.0 110.434 -167.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.416 ' H ' ' H ' ' A' ' 70' ' ' ASN . 95.1 m -104.98 136.45 44.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.04 127.14 37.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 160.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.7 m -121.63 136.68 54.94 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.918 1.687 . . . . 0.0 107.59 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -90.29 113.89 25.83 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.793 0.837 . . . . 0.0 111.408 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 75' ' ' ILE . 1.3 mp -84.84 66.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 124.609 1.163 . . . . 0.0 108.535 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -130.86 73.82 1.56 Allowed 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 163.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.43 177.48 5.23 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 176.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.26 -30.66 71.55 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -80.68 155.74 26.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 163.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.29 158.45 34.0 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.66 123.98 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -169.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -136.89 -13.14 1.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 p -154.55 171.14 19.91 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.512 -0.742 . . . . 0.0 110.459 166.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -164.52 170.27 16.08 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 6.1 tpt180 -153.23 144.64 23.23 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 158.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -67.94 134.1 50.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 123.623 0.577 . . . . 0.0 109.772 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.39 -30.97 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.052 0.941 . . . . 0.0 111.668 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -137.27 81.36 1.87 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 -165.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.77 -173.21 34.75 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.434 1.493 . . . . 0.0 112.811 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -159.28 178.31 10.11 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.6 tt -158.41 111.6 2.38 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.199 0.999 . . . . 0.0 109.046 168.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.41 HG22 ' HA ' ' A' ' 20' ' ' TRP . 27.9 pt -120.3 163.08 18.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 124.207 1.003 . . . . 0.0 111.248 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.09 152.3 18.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.238 1.415 . . . . 0.0 107.803 164.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.0 m -143.23 165.49 27.32 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.256 0.622 . . . . 0.0 109.757 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -79.07 -21.84 46.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.787 0.835 . . . . 0.0 112.476 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.49 172.25 18.87 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.34 3.86 1.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.882 1.273 . . . . 0.0 113.123 -175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -104.86 99.77 20.58 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.504 1.522 . . . . 0.0 109.961 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.12 -19.36 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.551 2.167 . . . . 0.0 112.275 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -70.72 -49.21 49.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.189 0.595 . . . . 0.0 109.566 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -127.69 16.4 6.95 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.7 -28.17 72.16 Favored Glycine 0 CA--C 1.528 0.846 0 O-C-N 119.219 -2.176 . . . . 0.0 112.368 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 m 55.12 93.21 0.02 OUTLIER 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -159.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.0 m -126.53 141.65 51.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -160.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.255 1.3 p-10 -85.15 102.71 13.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.475 1.131 . . . . 0.0 110.577 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.41 ' HA ' HG22 ' A' ' 6' ' ' ILE . 83.5 m95 -83.04 47.68 1.26 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.816 2.446 . . . . 0.0 107.375 171.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -96.71 172.14 8.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.96 1.704 . . . . 0.0 109.031 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.01 144.34 34.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -146.58 27.25 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.555 0.742 . . . . 0.0 112.345 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -100.16 114.5 27.95 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.098 0.959 . . . . 0.0 109.544 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 50.31 53.92 12.04 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.726 0.774 . . . . 0.0 110.127 174.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.9 t -148.23 138.67 22.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.0 t -67.23 99.49 0.7 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.315 1.446 . . . . 0.0 108.205 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.9 t -128.99 118.96 48.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.417 0.687 . . . . 0.0 109.456 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.2 135.19 23.8 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 125.683 1.611 . . . . 0.0 111.235 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.2 mt -84.14 159.82 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.796 2.038 . . . . 0.0 106.903 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 179.2 164.59 32.06 Favored Glycine 0 N--CA 1.449 -0.451 0 O-C-N 121.403 -0.811 . . . . 0.0 113.35 164.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.1 74.7 0.22 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.161 2.185 . . . . 0.0 113.983 166.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 67.71 3.58 3.51 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.631 2.372 . . . . 0.0 110.902 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 82.5 t -79.21 99.58 3.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 O-C-N 121.153 -0.967 . . . . 0.0 109.681 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -143.87 43.01 1.46 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.797 1.639 . . . . 0.0 109.226 170.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.0 m95 -139.34 139.26 37.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.421 ' H ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -107.05 136.99 45.98 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 164.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.34 117.51 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.2 p -94.74 160.98 14.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.24 25.71 1.56 Allowed Glycine 0 C--O 1.221 -0.687 0 C-N-CA 124.483 1.04 . . . . 0.0 113.597 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.11 45.08 2.22 Favored Glycine 0 C--N 1.312 -0.768 0 C-N-CA 129.179 3.276 . . . . 0.0 110.821 -168.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.8 t 50.09 -149.56 0.26 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.703 2.001 . . . . 0.0 109.204 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -90.65 -66.5 0.92 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 163.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.24 50.84 2.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.911 1.684 . . . . 0.0 108.653 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.07 29.1 3.56 Favored Glycine 0 CA--C 1.524 0.613 0 O-C-N 121.295 -0.878 . . . . 0.0 111.637 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.1 mttt 53.48 161.01 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -63.24 143.61 57.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.297 159.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.05 157.12 15.24 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-O 117.167 -1.907 . . . . 0.0 108.685 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 38.2 m -139.47 151.33 46.11 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 121.136 2.468 . . . . 0.0 108.561 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.26 140.16 52.04 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 124.642 1.177 . . . . 0.0 108.479 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.2 m -83.9 119.9 25.43 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 159.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 mt -97.19 147.87 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 126.398 1.879 . . . . 0.0 106.082 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 3.1 m-90 -125.27 158.2 34.72 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.105 1.762 . . . . 0.0 111.096 -177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -93.43 -34.02 13.6 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 125.086 1.354 . . . . 0.0 111.581 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.07 138.77 37.33 Favored Glycine 0 CA--C 1.523 0.57 0 O-C-N 120.454 -1.404 . . . . 0.0 110.074 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -70.57 75.44 0.58 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.746 1.219 . . . . 0.0 110.325 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.57 -65.14 0.16 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 21.2 p 156.66 41.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 129.824 3.249 . . . . 0.0 110.792 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 m -125.8 176.4 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.967 1.307 . . . . 0.0 108.023 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.87 -151.53 27.65 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -77.01 152.37 35.19 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.988 1.315 . . . . 0.0 108.011 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -152.84 151.45 30.43 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.622 0.576 . . . . 0.0 112.47 -167.166 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -145.06 138.69 26.87 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -85.02 99.85 11.29 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.333 0.653 . . . . 0.0 110.273 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -88.37 124.95 34.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 99.3 m -110.02 139.47 45.1 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.9 t -132.47 136.22 27.58 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.15 -0.929 . . . . 0.0 109.768 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.53 -179.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.334 2.689 . . . . 0.0 114.484 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.23 155.84 37.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.22 167.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 33.95 57.6 0.6 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.783 2.033 . . . . 0.0 114.134 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 t -154.71 165.73 35.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.883 0.849 . . . . 0.0 110.75 172.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.84 139.22 34.83 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.814 2.446 . . . . 0.0 109.478 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.9 m -131.77 135.96 47.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.613 1.565 . . . . 0.0 107.127 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -85.62 114.8 22.89 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.254 0.934 . . . . 0.0 110.731 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.456 HG22 HG13 ' A' ' 81' ' ' ILE . 1.7 mp -86.77 72.74 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 108.817 -174.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -110.57 152.43 26.44 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 158.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.2 p -144.66 -159.73 1.04 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.074 0.852 . . . . 0.0 108.822 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.49 -15.56 79.1 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.434 -0.648 . . . . 0.0 112.882 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -136.39 163.22 30.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 118.859 1.33 . . . . 0.0 108.687 173.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -69.21 133.82 48.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.456 HG13 HG22 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -103.37 129.78 54.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.04 0.936 . . . . 0.0 109.471 -162.298 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -123.96 -29.01 3.7 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -162.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.1 169.71 20.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 117.789 -1.1 . . . . 0.0 110.439 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -157.61 163.62 38.1 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-N 120.132 1.333 . . . . 0.0 112.906 169.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -125.25 128.65 48.62 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.608 1.963 . . . . 0.0 108.158 161.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.9 mmm-85 -58.86 134.23 56.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 161.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.42 -50.6 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -170.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . 0.357 15.9 pt-20 . . . . . 0 N--CA 1.429 -1.475 1 C-N-CA 132.926 4.491 . . . . 0.0 111.433 158.297 . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.814 0 CA-C-O 119.637 -0.535 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.46 -64.26 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.705 0.753 . . . . 0.0 111.061 -159.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.93 -168.09 0.43 Allowed Glycine 0 CA--C 1.532 1.096 0 CA-C-O 122.112 0.84 . . . . 0.0 111.022 159.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -176.59 -177.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 -162.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.5 tt -140.34 131.49 26.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 20' ' ' TRP . 12.7 pt -147.59 146.46 18.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.393 1.077 . . . . 0.0 109.426 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -95.02 141.85 28.19 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.24 0.616 . . . . 0.0 110.005 167.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.9 m -134.56 152.45 51.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.599 1.16 . . . . 0.0 108.555 -172.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -78.66 -16.65 57.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -143.82 -167.93 2.72 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.622 1.169 . . . . 0.0 109.331 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 40.2 t -90.27 4.01 51.93 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.666 0.786 . . . . 0.0 112.887 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -105.0 106.79 56.87 Favored Pre-proline 0 C--N 1.331 -0.217 0 C-N-CA 123.989 0.916 . . . . 0.0 109.319 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.38 -23.86 75.37 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 CA-C-N 120.009 1.039 . . . . 0.0 111.946 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -71.2 -63.93 1.01 Allowed 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 122.045 -0.409 . . . . 0.0 110.343 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -109.99 13.22 23.44 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -174.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.94 -30.5 59.26 Favored Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m 70.15 110.75 0.05 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -159.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.5 m -122.5 146.04 47.76 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.35 107.82 20.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 122.614 1.197 . . . . 0.0 110.806 169.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.411 ' HA ' HG22 ' A' ' 6' ' ' ILE . 63.7 m95 -83.72 48.32 1.42 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.669 2.388 . . . . 0.0 107.276 174.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -92.83 153.91 18.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.81 142.94 57.18 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 173.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -146.88 19.49 1.28 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.376 1.071 . . . . 0.0 112.307 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 7.3 t-105 -95.13 129.43 42.23 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -166.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 53.31 43.94 30.78 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.129 0.572 . . . . 0.0 110.099 172.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 t -159.87 163.69 34.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.171 -0.956 . . . . 0.0 110.631 -170.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 54.1 t -92.79 96.0 9.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.97 2.108 . . . . 0.0 110.07 -166.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -111.99 104.12 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 119.373 0.988 . . . . 0.0 111.072 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.48 127.76 37.61 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 167.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.2 mt -84.05 156.86 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.327 2.251 . . . . 0.0 106.013 166.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.66 -166.29 22.27 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . 0.281 . . 34.02 75.13 0.05 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 47.41 22.5 0.28 Allowed 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 125.099 1.359 . . . . 0.0 112.282 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.76 118.06 18.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 119.391 -0.924 . . . . 0.0 108.963 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.28 37.45 1.25 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.743 0.817 . . . . 0.0 111.025 171.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -142.88 134.24 26.17 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 45.4 ttm -113.47 127.34 56.07 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 165.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -123.64 91.11 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 t -108.3 155.46 20.48 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.603 0.716 . . . . 0.0 111.473 -158.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.623 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . 45.46 -153.03 0.73 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 125.845 1.688 . . . . 0.0 112.764 -175.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.05 13.12 0.61 Allowed Glycine 0 CA--C 1.522 0.477 0 CA-C-O 118.815 -0.991 . . . . 0.0 111.999 -175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 44' ' ' ASP 0.267 1.1 t -147.78 92.78 2.11 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.1 1.45 . . . . 0.0 110.027 -170.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 55.5 -10.32 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.84 2.056 . . . . 0.0 112.439 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.758 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -80.59 85.84 5.94 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.538 1.535 . . . . 0.0 107.871 -171.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.14 -0.47 82.85 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.637 158.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -82.41 105.59 13.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.21 -1.171 . . . . 0.0 108.865 169.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -57.28 169.69 0.57 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.018 1.327 . . . . 0.0 113.018 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -129.88 158.67 22.37 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 62.2 m -143.69 155.67 44.29 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 117.88 0.84 . . . . 0.0 109.118 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.43 148.14 40.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.875 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 m -84.03 144.54 29.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 162.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -127.19 152.11 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -172.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.445 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 21.8 m-90 -133.6 149.98 51.61 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.218 1.372 . . . . 0.0 112.916 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.69 -54.39 23.61 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.658 1.183 . . . . 0.0 109.067 164.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.38 124.63 11.15 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -168.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.54 67.49 0.13 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.448 3.099 . . . . 0.0 112.552 -162.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.69 -55.12 0.08 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 127.391 2.424 . . . . 0.0 107.919 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 20.0 p 163.65 50.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 130.544 3.538 . . . . 0.0 108.641 166.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.99 176.65 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.979 1.712 . . . . 0.0 108.281 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.79 -157.41 51.54 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.69 132.37 34.87 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 117.691 0.745 . . . . 0.0 109.017 -166.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 10.1 p -113.64 157.23 22.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 123.598 0.561 . . . . 0.0 112.428 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.83 -177.76 4.58 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 127.352 2.261 . . . . 0.0 106.856 174.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 t -135.15 136.86 42.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.0 tmm? -142.32 114.78 8.44 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.044 0.538 . . . . 0.0 110.013 -173.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 46.7 m -96.05 143.22 27.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.819 1.248 . . . . 0.0 109.557 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.7 t -141.9 123.97 9.1 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.259 1.423 . . . . 0.0 110.511 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.87 145.6 72.15 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.225 1.95 . . . . 0.0 111.506 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 44' ' ' ASP . . . -73.31 140.04 46.48 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 161.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 74.11 45.21 0.22 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -170.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -154.62 144.38 21.6 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 171.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.89 125.19 36.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.424 1.49 . . . . 0.0 108.086 164.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 55.6 m -116.21 136.8 52.69 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 124.905 1.282 . . . . 0.0 109.179 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -98.69 110.83 23.36 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.156 0.982 . . . . 0.0 109.55 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mp -82.75 96.29 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 122.167 0.984 . . . . 0.0 108.767 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.52 158.08 44.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 163.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.3 p -132.77 -150.1 0.4 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 167.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.31 -28.73 67.48 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 164.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -125.89 165.05 19.44 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.297 1.039 . . . . 0.0 110.082 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -80.58 137.39 36.38 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.558 HD13 ' N ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -113.64 148.89 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.107 0.963 . . . . 0.0 109.957 -170.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -134.97 -3.67 2.49 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 124.364 1.065 . . . . 0.0 113.333 -170.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.85 164.1 31.14 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 164.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -144.32 171.79 13.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.104 0.961 . . . . 0.0 112.267 166.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.46 123.88 10.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.52 1.928 . . . . 0.0 106.027 169.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -70.28 138.74 51.83 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 119.199 0.909 . . . . 0.0 109.01 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -104.69 -42.08 7.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 125.04 1.336 . . . . 0.0 110.873 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -177.615 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.299 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -118.92 85.41 2.36 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.658 1.183 . . . . 0.0 108.289 -173.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.34 141.94 48.16 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 160.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -169.03 -174.32 2.01 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.958 1.703 . . . . 0.0 107.448 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tt -141.57 103.14 4.33 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 pt -135.71 161.13 39.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.4 ptp -125.61 154.46 42.23 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 122.619 1.2 . . . . 0.0 111.284 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 1.3 m -135.78 169.56 17.37 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.108 1.763 . . . . 0.0 107.261 -163.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -79.45 -24.61 42.31 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 166.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -139.19 -176.63 4.58 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 172.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.8 t -83.28 3.61 30.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.869 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -113.11 113.95 48.92 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.942 0.897 . . . . 0.0 109.304 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.73 -39.23 21.17 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 120.997 1.392 . . . . 0.0 110.806 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -69.96 -34.01 72.83 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.482 1.913 . . . . 0.0 111.09 -165.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.8 t -135.46 15.03 3.45 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.37 -46.65 5.18 Favored Glycine 0 CA--C 1.519 0.309 0 O-C-N 120.463 -1.398 . . . . 0.0 110.755 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 t 82.04 124.79 0.04 OUTLIER 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.605 1.562 . . . . 0.0 108.552 -166.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 1.2 m -125.85 170.75 11.32 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.059 1.743 . . . . 0.0 110.448 -177.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -90.31 94.02 9.57 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 123.164 1.459 . . . . 0.0 113.122 165.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -83.43 45.68 1.07 Allowed 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.724 -1.235 . . . . 0.0 108.428 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -85.77 163.96 17.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.74 1.616 . . . . 0.0 109.592 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -70.98 143.34 50.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 161.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -137.3 -44.44 0.55 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -167.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -48.21 113.94 0.84 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 125.592 1.557 . . . . 0.0 109.614 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 55.85 19.51 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.403 1.481 . . . . 0.0 112.667 174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -114.34 179.76 3.86 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -175.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.0 t -149.36 74.85 1.26 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 121.183 1.811 . . . . 0.0 109.96 -166.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 t -83.81 163.94 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -166.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.73 115.81 5.21 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 124.631 1.11 . . . . 0.0 111.103 163.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.11 152.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 126.36 1.864 . . . . 0.0 107.551 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.92 -165.52 38.98 Favored Glycine 0 N--CA 1.444 -0.801 0 O-C-N 121.649 -0.657 . . . . 0.0 111.84 167.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 71.09 73.15 0.19 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.687 2.395 . . . . 0.0 113.548 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 61.11 11.27 3.35 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 125.568 1.547 . . . . 0.0 110.777 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 24.6 t -73.6 108.84 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -173.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -146.63 34.61 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 170.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -140.71 113.62 8.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.309 0.959 . . . . 0.0 111.756 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.472 ' HB2' HD11 ' A' ' 75' ' ' ILE . 44.3 ttp -84.07 138.92 32.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.06 101.54 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.2 p -93.6 49.03 1.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.429 -0.794 . . . . 0.0 111.595 -159.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.56 -155.3 16.18 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -171.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.53 -38.53 0.02 OUTLIER Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.395 0.998 . . . . 0.0 111.8 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.1 m -23.83 -92.6 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 128.01 2.524 . . . . 0.0 116.123 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.728 HG23 ' H ' ' A' ' 44' ' ' ASP . 14.5 t -155.94 -89.36 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -173.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.728 ' H ' HG23 ' A' ' 43' ' ' THR 0.255 0.5 OUTLIER -123.7 178.82 5.04 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 101.517 -3.512 . . . . 0.0 101.517 160.643 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.86 -76.22 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 105.867 -2.893 . . . . 0.0 105.867 159.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.42 146.47 10.23 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 127.761 2.425 . . . . 0.0 106.744 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -59.51 164.78 3.24 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.0 132.68 8.73 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 170.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 86.0 m -132.99 149.14 52.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.9 140.5 16.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.67 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.8 m -86.66 117.3 25.33 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 166.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 mm -99.47 149.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -130.57 160.34 34.47 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.315 1.446 . . . . 0.0 112.002 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -89.49 -35.34 16.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.087 2.155 . . . . 0.0 111.322 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.75 144.48 38.49 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -76.75 64.02 2.26 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.93 33.73 0.02 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . 0.26 27.9 p 44.65 42.4 5.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.557 1.543 . . . . 0.0 112.226 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 m -126.18 176.34 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 126.729 2.012 . . . . 0.0 107.695 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.17 -156.93 32.93 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -69.46 153.16 43.95 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.53 168.81 22.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.21 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.93 149.73 26.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.45 106.54 17.54 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -91.34 83.92 5.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 52.0 m -84.0 139.42 32.55 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 18.9 t -145.16 142.11 17.99 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 125.122 1.369 . . . . 0.0 109.446 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.33 177.27 2.16 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.974 1.782 . . . . 0.0 111.384 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.55 149.11 42.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.168 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 50.67 38.53 19.37 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.038 1.335 . . . . 0.0 110.094 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.4 m -115.52 137.3 52.21 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -98.17 114.09 26.2 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.26 106.01 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.84 2.056 . . . . 0.0 107.823 -162.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -64.42 136.15 56.81 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.887 0.851 . . . . 0.0 110.637 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 37' ' ' MET . 12.5 mm -101.86 117.45 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.79 65.57 1.05 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.5 p -73.94 161.79 29.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.269 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -54.14 -52.88 40.78 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -80.64 157.55 25.93 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.527 0.68 . . . . 0.0 110.62 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -76.15 134.43 39.95 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.893 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.09 132.79 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -168.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -135.93 -27.81 1.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -173.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 p -152.69 171.87 17.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.563 0.619 . . . . 0.0 111.251 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -156.32 170.06 23.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.633 0.651 . . . . 0.0 111.157 176.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 26' ' ' THR . 14.5 mtt180 -140.2 147.1 39.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.496 1.918 . . . . 0.0 109.31 159.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -63.58 163.53 11.04 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.624 0.769 . . . . 0.0 110.607 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.09 -36.51 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 117.809 0.277 . . . . 0.0 110.458 159.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 163.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.634 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . 0.293 0.1 OUTLIER 63.19 -52.66 0.2 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 129.372 3.069 . . . . 0.0 116.508 159.19 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.61 -178.07 9.0 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 163.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -172.83 -179.13 2.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -168.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.94 88.59 2.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 159.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pt -108.3 162.47 6.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 169.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 ptm -108.24 167.94 9.66 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.493 1.139 . . . . 0.0 110.118 161.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 82.2 m -153.58 163.22 40.35 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 124.5 1.12 . . . . 0.0 108.496 -158.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -85.58 -21.37 28.54 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -133.58 -175.15 3.73 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 122.811 0.444 . . . . 0.0 111.267 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.1 t -92.13 3.46 55.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.307 1.043 . . . . 0.0 111.811 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -132.98 88.71 36.2 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 126.011 1.725 . . . . 0.0 110.088 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -48.76 -26.77 10.06 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.203 3.268 . . . . 0.0 113.293 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -64.3 -44.32 91.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.46 -0.775 . . . . 0.0 111.495 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.7 p -104.13 13.83 31.65 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.65 135.3 7.48 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 123.966 0.793 . . . . 0.0 112.898 172.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.4 m -63.75 137.78 58.21 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.086 -0.655 . . . . 0.0 109.821 169.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 89.3 m -130.39 157.21 43.22 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 125.372 1.469 . . . . 0.0 107.317 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -85.07 93.43 8.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 123.677 1.704 . . . . 0.0 110.821 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -83.87 50.93 1.92 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.658 1.983 . . . . 0.0 107.122 169.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -119.23 -174.1 2.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.88 1.672 . . . . 0.0 108.255 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.11 143.12 50.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 167.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -146.5 5.69 0.93 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.693 -166.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.411 ' CG ' ' N ' ' A' ' 25' ' ' ASN . 19.8 t-105 -78.07 -163.63 0.45 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -165.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' N ' ' CG ' ' A' ' 24' ' ' TRP . 15.0 t-20 -68.31 61.55 0.09 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.526 2.731 . . . . 0.0 110.411 176.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 t -141.93 149.79 40.61 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 127.477 2.311 . . . . 0.0 105.692 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.2 t -72.56 69.8 0.89 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.433 1.493 . . . . 0.0 111.706 -164.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.3 t -93.42 124.84 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.125 0.97 . . . . 0.0 109.53 -165.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.77 132.39 11.34 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.0 mt -83.71 153.3 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 169.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.13 158.52 29.86 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 68.87 69.38 0.28 Allowed 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 127.343 2.257 . . . . 0.0 115.835 169.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 49.84 19.26 0.42 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.596 1.159 . . . . 0.0 112.304 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.45 110.86 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -146.26 26.42 1.19 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.939 0.895 . . . . 0.0 112.771 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -138.56 121.45 16.58 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.295 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.587 ' H ' HD13 ' A' ' 75' ' ' ILE . 53.1 tpp -83.62 134.7 34.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.3 t -131.05 120.21 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.1 p -104.14 45.37 0.96 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.184 0.993 . . . . 0.0 109.975 -159.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.06 -154.73 35.66 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.58 22.42 0.22 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.56 -56.78 2.31 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.521 0.728 . . . . 0.0 109.339 -174.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t 125.63 -40.33 0.01 OUTLIER 'General case' 0 C--O 1.232 0.171 0 C-N-CA 130.504 3.522 . . . . 0.0 108.422 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.88 34.14 0.39 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.171 1.388 . . . . 0.0 110.598 -166.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.88 -22.67 15.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 168.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm 68.0 157.11 0.13 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 127.044 2.138 . . . . 0.0 112.35 -165.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -53.96 146.19 14.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.564 1.146 . . . . 0.0 111.739 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.43 136.21 10.3 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 59.0 m -122.8 149.76 43.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.01 136.83 21.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.633 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.6 m -89.45 117.38 28.33 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 170.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.1 mt -106.53 137.92 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.028 1.731 . . . . 0.0 107.049 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.451 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 5.0 m-90 -122.14 160.63 24.69 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.54 1.536 . . . . 0.0 112.7 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -91.79 -33.89 14.8 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.494 2.318 . . . . 0.0 111.236 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.41 128.02 9.44 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 124.668 1.128 . . . . 0.0 111.736 -169.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -44.29 121.31 2.5 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.814 2.046 . . . . 0.0 112.087 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.38 -60.56 0.59 Allowed Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 126.574 2.035 . . . . 0.0 109.593 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 30.6 p 168.94 43.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.385 1.874 . . . . 0.0 111.472 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 m -120.41 176.75 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.36 -157.93 28.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -73.59 158.57 34.55 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 126.246 1.818 . . . . 0.0 108.161 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.451 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 2.4 p -159.18 160.68 35.75 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.987 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.0 p -142.67 149.9 39.49 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.1 t -91.17 128.24 36.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -119.95 116.04 24.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.924 1.69 . . . . 0.0 108.491 -177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 11.5 m -98.09 146.73 25.26 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 123.516 0.726 . . . . 0.0 109.77 173.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.2 t -149.41 136.85 11.24 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.405 1.082 . . . . 0.0 111.01 173.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.88 177.75 3.32 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.912 1.741 . . . . 0.0 112.213 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.4 175.24 7.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 37.73 54.1 1.51 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 126.071 1.748 . . . . 0.0 112.265 171.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.24 168.44 25.98 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.923 0.868 . . . . 0.0 108.948 175.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.18 134.34 52.85 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.705 2.002 . . . . 0.0 107.244 172.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.83 118.16 20.38 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -169.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -78.55 122.94 26.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.951 -0.468 . . . . 0.0 110.013 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.587 HD13 ' H ' ' A' ' 37' ' ' MET . 1.9 mp -102.42 104.19 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 169.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.05 69.86 1.26 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 169.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 p -74.01 176.01 6.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.238 1.815 . . . . 0.0 110.58 -162.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.99 -41.59 92.42 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 171.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -93.72 164.18 13.24 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.768 0.827 . . . . 0.0 110.545 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -80.93 133.82 35.61 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.85 129.89 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.086 0.554 . . . . 0.0 110.039 -169.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ttt85 -136.54 -13.2 1.76 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -172.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.84 169.32 16.76 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.454 -0.779 . . . . 0.0 111.708 -173.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -166.9 171.79 10.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.463 0.649 . . . . 0.0 112.46 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . 0.295 0.0 OUTLIER -137.56 135.83 37.04 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 129.281 3.033 . . . . 0.0 105.227 170.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -64.5 159.19 22.09 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 158.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.09 -41.54 3.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 119.351 0.978 . . . . 0.0 111.171 163.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 172.988 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.769 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 64.2 -74.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.677 2.391 . . . . 0.0 110.819 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.33 169.25 1.74 Allowed Glycine 0 N--CA 1.435 -1.399 0 C-N-CA 125.208 1.385 . . . . 0.0 111.748 -159.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -176.15 168.7 2.87 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -170.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -150.01 103.98 3.25 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 pt -153.1 159.54 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 126.335 1.854 . . . . 0.0 107.843 -167.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.7 ptm -106.55 147.2 29.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.946 0.898 . . . . 0.0 110.088 166.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 1.3 m -117.87 162.31 18.32 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 175.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 10.8 pttt -62.86 -37.47 86.97 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 116.347 -2.141 . . . . 0.0 109.936 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -122.15 -171.25 2.21 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 126.831 2.053 . . . . 0.0 109.143 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 50.8 t -78.47 3.23 16.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -118.3 114.52 36.54 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 121.269 -0.894 . . . . 0.0 113.166 -164.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.67 -23.48 56.36 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 120.932 1.088 . . . . 0.0 111.834 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -64.54 -63.11 1.21 Allowed 'General case' 0 C--N 1.341 0.203 0 CA-C-N 119.448 1.022 . . . . 0.0 110.221 -176.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.0 p -118.92 13.76 13.14 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.9 -19.38 78.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 119.266 -0.741 . . . . 0.0 113.456 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.9 m 58.33 93.22 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -160.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 1.2 m -98.04 145.31 26.65 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -91.61 98.88 11.92 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.536 1.16 . . . . 0.0 109.474 172.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -83.38 45.56 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.801 2.04 . . . . 0.0 107.995 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.54 -177.68 6.79 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.373 1.469 . . . . 0.0 110.198 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -63.71 150.36 44.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 163.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -139.86 -15.7 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.029 0.932 . . . . 0.0 111.894 176.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -91.08 112.98 25.11 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 48.72 64.52 1.67 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.709 1.203 . . . . 0.0 110.044 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.21 -178.61 4.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.81 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.3 t -154.41 54.61 0.69 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -94.7 129.98 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 125.395 1.478 . . . . 0.0 109.384 -170.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.15 126.58 7.77 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.783 0.706 . . . . 0.0 112.41 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.4 mm -107.14 166.24 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 130.406 3.482 . . . . 0.0 108.426 -174.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 153.85 175.88 25.62 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 165.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 91.32 79.89 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 129.763 3.225 . . . . 0.0 112.343 174.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 80.61 6.96 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 129.34 3.056 . . . . 0.0 110.819 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 62.1 t -83.99 118.49 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 CA-C-N 118.912 0.778 . . . . 0.0 112.467 -164.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.414 ' CE1' ' HE1' ' A' ' 36' ' ' TRP . 4.4 p80 -146.55 35.53 0.96 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 163.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.414 ' HE1' ' CE1' ' A' ' 35' ' ' HIS . 74.6 m95 -140.67 124.47 17.16 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.148 1.34 . . . . 0.0 112.224 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.567 ' H ' HD13 ' A' ' 75' ' ' ILE . 14.1 tpt -84.89 131.14 34.54 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 161.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.47 85.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -172.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 t -93.95 143.89 25.94 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.26 176.86 37.11 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 124.493 1.044 . . . . 0.0 111.286 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.499 ' O ' ' HB1' ' A' ' 69' ' ' ALA . . . -76.64 -35.85 39.59 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 122.756 -0.261 . . . . 0.0 112.678 -171.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.11 -150.97 0.47 Allowed 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 122.798 0.439 . . . . 0.0 111.666 -168.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 85.94 -54.68 0.07 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 127.677 2.391 . . . . 0.0 105.985 174.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -105.88 151.55 24.4 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 159.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.95 -13.71 57.4 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 123.8 0.714 . . . . 0.0 111.349 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -124.47 164.6 19.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -53.03 144.46 15.12 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.56 153.6 16.9 Favored Glycine 0 C--O 1.239 0.442 0 N-CA-C 107.078 -2.409 . . . . 0.0 107.078 167.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.6 m -126.52 144.23 50.94 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.93 126.68 49.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.0 m -83.59 118.88 24.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 168.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 mt -96.65 150.74 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 -129.08 157.85 40.59 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.984 1.714 . . . . 0.0 111.549 -175.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -82.42 -44.28 16.26 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.09 2.156 . . . . 0.0 111.636 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.81 135.15 21.33 Favored Glycine 0 N--CA 1.449 -0.494 0 O-C-N 120.999 -1.063 . . . . 0.0 111.098 -173.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.1 m -54.48 102.54 0.06 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.587 0.755 . . . . 0.0 109.979 171.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.53 -75.92 0.4 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 24.0 p 158.69 42.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 128.692 2.797 . . . . 0.0 110.397 -174.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.38 176.28 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.33 -167.19 44.81 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 119.615 1.098 . . . . 0.0 110.592 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -73.84 149.57 41.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.497 -1.002 . . . . 0.0 108.874 -170.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.9 161.34 40.94 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.103 -163.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.53 117.05 4.66 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -167.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.5 m -71.55 100.25 2.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.317 0.647 . . . . 0.0 109.51 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.8 tpp -84.04 103.56 13.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.655 1.182 . . . . 0.0 107.836 172.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 50.7 m -84.7 146.45 27.43 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.3 t -155.53 108.31 2.2 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.447 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.2 162.13 14.82 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.844 2.363 . . . . 0.0 113.297 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 41' ' ' GLY . . . -73.53 137.94 44.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 -174.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 58.76 48.56 11.23 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.348 1.859 . . . . 0.0 110.853 -166.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m -124.44 116.81 23.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.314 0.578 . . . . 0.0 109.99 170.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.406 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -74.35 114.11 12.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 158.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.2 m -116.2 123.84 48.78 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.286 1.834 . . . . 0.0 107.922 -172.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -78.24 132.49 37.56 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 118.454 0.57 . . . . 0.0 110.364 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 37' ' ' MET . 1.2 mp -98.35 107.54 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -123.52 144.63 49.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 p -142.35 -161.93 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 175.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -101.39 15.58 57.41 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.073 168.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.7 169.97 17.42 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 119.075 1.437 . . . . 0.0 109.425 -173.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -70.51 133.98 47.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 170.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.61 128.75 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.19 -46.97 0.64 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.559 -158.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -133.06 175.89 8.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 119.758 1.163 . . . . 0.0 110.424 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -160.64 163.86 32.25 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 119.779 1.172 . . . . 0.0 113.34 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.06 127.77 10.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 169.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -66.1 115.87 6.59 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.53 -39.33 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 C-N-CA 124.612 1.165 . . . . 0.0 110.047 -168.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.92 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.487 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.69 63.49 0.85 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.243 1.817 . . . . 0.0 111.897 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' C ' ' HB3' ' A' ' 42' ' ' SER . . . -164.14 161.37 34.33 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 118.847 -0.974 . . . . 0.0 112.742 164.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -119.04 -174.16 2.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 170.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 tt -140.98 117.71 11.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.211 1.404 . . . . 0.0 108.266 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.27 165.95 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 123.783 0.833 . . . . 0.0 110.077 174.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.6 ptm -105.51 142.39 35.34 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.29 1.036 . . . . 0.0 108.541 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.4 m -138.46 158.53 44.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.651 1.181 . . . . 0.0 108.935 -165.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -82.57 -5.88 59.02 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -162.63 -172.44 3.12 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.219 1.408 . . . . 0.0 108.149 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.7 t -86.43 3.57 43.26 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.594 0.757 . . . . 0.0 112.081 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -128.43 105.71 19.35 Favored Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 118.754 -0.641 . . . . 0.0 111.574 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -58.14 -24.89 68.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.513 1.476 . . . . 0.0 111.581 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -63.83 -27.69 69.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.223 -0.923 . . . . 0.0 110.953 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.0 t -138.79 23.23 2.65 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.352 0.661 . . . . 0.0 111.338 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.05 123.7 5.98 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 164.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.14 94.59 4.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 171.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.5 m -92.44 149.77 21.19 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -171.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -96.29 98.9 10.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.798 0.808 . . . . 0.0 111.462 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -83.77 44.83 1.02 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 130.028 3.331 . . . . 0.0 111.304 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -101.28 174.13 6.13 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.748 1.219 . . . . 0.0 110.057 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -65.04 143.82 57.68 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.496 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.27 -27.35 8.71 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.931 1.292 . . . . 0.0 109.913 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -84.52 143.28 29.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.785 1.634 . . . . 0.0 106.812 -177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 44.92 43.57 7.23 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.818 1.647 . . . . 0.0 111.527 171.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.3 t -162.98 149.31 12.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 167.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.4 t -115.97 84.17 2.07 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.581 1.152 . . . . 0.0 111.282 -165.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.5 t -84.8 153.63 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.119 -165.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.02 154.21 31.7 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.448 1.023 . . . . 0.0 111.63 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.4 166.15 8.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 128.103 2.561 . . . . 0.0 105.831 172.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.02 162.22 12.57 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-O 121.439 0.466 . . . . 0.0 113.117 164.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 62.51 81.48 0.2 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.466 2.307 . . . . 0.0 111.185 -175.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 66.24 3.66 2.83 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 125.919 1.687 . . . . 0.0 111.339 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.0 t -102.56 99.31 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -145.99 33.4 1.01 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.168 0.987 . . . . 0.0 111.08 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -144.45 121.84 11.65 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.598 ' H ' HD13 ' A' ' 75' ' ' ILE . 43.0 ttm -85.4 138.77 32.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 158.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 t -134.08 150.31 31.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.6 p -129.06 -173.92 3.12 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.445 0.698 . . . . 0.0 109.343 -170.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.47 -152.91 20.54 Favored Glycine 0 C--O 1.221 -0.672 0 CA-C-O 118.611 -1.105 . . . . 0.0 112.445 161.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 40.0 52.06 3.36 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.655 1.598 . . . . 0.0 113.285 173.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.403 ' HB3' ' C ' ' A' ' 3' ' ' GLY . 6.7 t -143.37 -152.92 0.44 Allowed 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.768 -0.842 . . . . 0.0 112.495 -177.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.2 t -121.98 -39.63 2.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.052 1.741 . . . . 0.0 109.528 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.1 129.84 11.61 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 120.652 -1.28 . . . . 0.0 109.071 175.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.27 78.09 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -173.28 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.012 1.325 . . . . 0.0 112.143 173.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -43.61 143.76 0.92 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.87 0.868 . . . . 0.0 111.601 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -146.86 157.62 27.47 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -171.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.4 m -136.65 154.6 50.6 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.888 0.875 . . . . 0.0 108.869 -172.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.29 141.61 49.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.795 1.238 . . . . 0.0 109.023 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 m -83.61 116.96 22.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 159.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -94.46 145.54 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -126.28 151.61 47.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.71 1.604 . . . . 0.0 109.722 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -58.65 -40.81 84.48 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 124.384 1.074 . . . . 0.0 109.766 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 82' ' ' ARG . . . -163.2 175.85 39.47 Favored Glycine 0 C--O 1.221 -0.71 0 C-N-CA 116.097 -2.954 . . . . 0.0 120.434 175.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.9 m 32.29 80.84 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.875 2.87 . . . . 0.0 116.314 159.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.3 43.53 95.02 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 52.55 69.25 0.71 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.062 1.345 . . . . 0.0 111.902 171.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.12 175.93 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 C-N-CA 126.743 2.017 . . . . 0.0 107.921 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.6 -160.0 53.41 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.6 ttp-105 -76.82 156.6 32.14 Favored 'General case' 0 CA--C 1.5 -0.956 0 O-C-N 121.934 -0.744 . . . . 0.0 109.585 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.42 144.24 34.35 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.864 -172.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 p -139.93 147.24 40.25 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.065 1.346 . . . . 0.0 108.466 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 t -85.57 113.06 21.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.4 tpt -86.14 139.41 31.12 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 165.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 50.8 m -139.06 143.04 38.2 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.2 t -150.77 123.53 4.17 Favored Pre-proline 0 CA--C 1.535 0.365 0 C-N-CA 124.134 0.974 . . . . 0.0 110.026 -170.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -52.99 157.35 8.25 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.943 2.428 . . . . 0.0 110.646 168.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.8 138.57 32.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.034 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 77.04 44.47 0.1 Allowed 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 125.748 1.619 . . . . 0.0 109.192 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -149.9 169.3 21.48 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 164.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.6 t -113.15 139.14 48.99 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.018 1.727 . . . . 0.0 107.751 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 24.7 m -140.96 101.63 4.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -163.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -67.67 130.39 42.87 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.795 -0.566 . . . . 0.0 110.25 176.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.598 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -94.13 106.88 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.302 1.841 . . . . 0.0 106.954 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -166.39 71.02 0.13 Allowed 'General case' 0 N--CA 1.461 0.107 0 O-C-N 121.7 -0.625 . . . . 0.0 109.681 176.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 p -74.4 -160.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.124 0.488 . . . . 0.0 110.471 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.8 -24.66 60.41 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 121.374 -0.829 . . . . 0.0 111.783 168.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -118.26 153.89 33.18 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.525 1.163 . . . . 0.0 109.317 169.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -73.87 141.5 46.07 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 125.806 1.942 . . . . 0.0 107.093 163.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.06 136.21 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 124.137 0.975 . . . . 0.0 109.047 -168.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.412 ' HB3' ' HA2' ' A' ' 55' ' ' GLY . 46.6 ttt180 -106.76 -22.27 12.77 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 116.975 -1.488 . . . . 0.0 112.803 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -137.16 170.7 15.65 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 122.909 2.595 . . . . 0.0 113.316 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -160.11 166.84 29.06 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.069 0.548 . . . . 0.0 109.999 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.11 145.48 28.41 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -71.34 149.91 45.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.085 0.954 . . . . 0.0 112.312 -170.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.6 m -137.42 -7.4 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-N 120.814 1.643 . . . . 0.0 109.299 158.66 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.628 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.85 -38.82 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.992 2.117 . . . . 0.0 108.338 172.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.7 163.79 37.14 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-O 121.803 0.668 . . . . 0.0 112.449 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' H ' ' H ' ' A' ' 41' ' ' GLY . 18.5 p90 -168.38 166.45 12.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.517 HD21 ' SD ' ' A' ' 37' ' ' MET . 1.3 tt -136.22 91.51 2.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.394 1.478 . . . . 0.0 107.248 176.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.07 159.31 11.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.409 1.084 . . . . 0.0 109.568 174.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.469 ' HB2' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -111.72 166.85 10.82 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 126.169 1.788 . . . . 0.0 114.6 166.117 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 18' ' ' CYS . 64.0 m -151.12 160.27 43.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.275 1.83 . . . . 0.0 109.555 -159.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.3 -39.42 78.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.572 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -138.98 -170.16 2.8 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 125.875 1.67 . . . . 0.0 108.056 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 t -76.05 3.59 10.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -107.04 104.32 51.5 Favored Pre-proline 0 CA--C 1.539 0.524 0 O-C-N 121.644 -0.66 . . . . 0.0 112.191 -164.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.39 -23.51 51.04 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.99 1.793 . . . . 0.0 112.27 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.52 -56.28 5.01 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.705 1.202 . . . . 0.0 109.648 -172.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.2 t -132.82 13.85 4.37 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 112.702 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.39 -45.91 58.57 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 168.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 t 76.9 124.63 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.264 1.426 . . . . 0.0 107.848 -164.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 8' ' ' CYS . 83.4 m -136.58 140.12 42.65 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 125.633 1.573 . . . . 0.0 107.882 -164.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . 0.254 7.5 p-10 -82.78 97.51 8.64 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 120.566 1.53 . . . . 0.0 110.363 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -82.74 53.23 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.901 2.08 . . . . 0.0 108.484 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -84.92 156.25 21.31 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 158.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.09 144.12 30.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 165.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -143.15 41.02 1.5 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.469 0.708 . . . . 0.0 109.347 -165.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -124.99 130.44 52.36 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -169.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 t30 51.13 55.71 9.11 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.448 0.699 . . . . 0.0 110.117 -172.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 t -160.39 146.88 15.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.761 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -79.57 71.88 6.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 128.8 2.84 . . . . 0.0 108.097 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.5 t -84.21 139.06 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 O-C-N 121.712 -0.617 . . . . 0.0 109.397 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.59 139.29 24.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 31' ' ' GLY . 45.7 mm -98.19 166.22 2.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 125.315 1.446 . . . . 0.0 107.238 168.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.427 ' N ' HG22 ' A' ' 30' ' ' ILE . . . 96.27 170.07 34.77 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 57.65 100.9 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.865 2.066 . . . . 0.0 112.615 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.42 10.68 4.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.383 1.073 . . . . 0.0 112.566 169.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.469 HG13 ' HB2' ' A' ' 7' ' ' MET . 1.6 t -136.19 113.1 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -146.75 18.12 1.29 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -138.31 114.14 9.9 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.517 ' SD ' HD21 ' A' ' 5' ' ' LEU . 48.1 ttp -85.4 124.75 32.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.43 94.86 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 t -93.97 127.49 39.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -171.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.44 -59.87 5.89 Favored Glycine 0 CA--C 1.501 -0.833 0 CA-C-O 125.938 2.966 . . . . 0.0 110.024 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.498 ' H ' ' H ' ' A' ' 4' ' ' TYR . . . 46.6 25.96 2.38 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 108.408 -3.896 . . . . 0.0 111.658 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.31 155.63 39.37 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 120.754 -1.439 . . . . 0.0 110.952 -172.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.262 0.1 OUTLIER 73.47 -4.18 2.29 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.562 1.145 . . . . 0.0 111.545 -167.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -111.95 122.8 48.78 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 158.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.9 -30.02 56.45 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 166.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? -63.95 136.46 57.36 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.258 0.551 . . . . 0.0 110.283 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -44.07 143.51 1.14 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.064 0.946 . . . . 0.0 110.549 164.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.89 144.0 16.85 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 170.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.7 m -138.85 152.27 47.68 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 119.382 1.591 . . . . 0.0 109.5 -173.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.4 140.5 35.5 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.721 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.2 m -83.86 135.19 34.6 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 168.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 mt -122.82 152.7 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.402 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 27.2 m-90 -139.8 152.99 46.99 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.824 1.25 . . . . 0.0 113.997 -173.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -82.84 -39.8 21.17 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 126.591 1.956 . . . . 0.0 108.898 167.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.77 125.13 36.07 Favored Glycine 0 CA--C 1.522 0.488 0 O-C-N 119.36 -2.087 . . . . 0.0 108.987 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -67.8 107.1 2.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.71 42.21 2.35 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 125.789 1.661 . . . . 0.0 111.971 -169.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 25.6 p 45.4 46.99 10.75 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.448 1.899 . . . . 0.0 114.714 166.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 m -126.27 176.58 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 127.437 2.295 . . . . 0.0 107.843 166.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.46 -157.74 23.26 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 120.841 -1.162 . . . . 0.0 112.332 167.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -70.19 150.73 46.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.402 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 5.8 p -141.75 172.61 12.46 Favored 'General case' 0 N--CA 1.436 -1.158 0 O-C-N 124.023 0.827 . . . . 0.0 111.483 -166.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -144.01 -175.41 4.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 159.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 t -127.96 122.43 32.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 168.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.0 tpt -121.64 118.66 29.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 96.9 m -113.78 146.74 39.47 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.8 t -138.1 121.95 11.58 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 124.432 1.093 . . . . 0.0 108.382 -178.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.32 151.27 9.85 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.111 2.541 . . . . 0.0 112.347 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.02 143.59 47.49 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 54.84 61.63 2.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.003 1.721 . . . . 0.0 109.067 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -154.48 157.41 38.36 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.39 124.44 49.6 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 126.891 2.076 . . . . 0.0 108.957 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 59.4 m -129.36 113.8 15.41 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.667 1.587 . . . . 0.0 108.717 -168.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -71.2 127.24 31.93 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.551 -0.718 . . . . 0.0 110.037 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.509 HD13 ' H ' ' A' ' 37' ' ' MET . 1.6 mp -85.96 111.59 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 123.978 0.911 . . . . 0.0 108.644 174.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -163.71 98.77 0.88 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 162.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.2 p -74.35 -157.53 0.06 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -79.03 -2.04 86.31 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.786 -1.196 . . . . 0.0 112.27 168.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -140.63 174.29 10.66 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 118.91 1.355 . . . . 0.0 108.953 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -79.78 133.65 36.32 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.408 ' HB ' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -95.89 133.3 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -167.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.7 mtt-85 -126.21 -36.31 2.34 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 118.328 -0.844 . . . . 0.0 113.095 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.93 163.21 33.5 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 119.482 1.037 . . . . 0.0 110.971 171.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.417 ' CD1' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -151.16 169.21 22.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.069 0.548 . . . . 0.0 111.258 165.567 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -157.09 126.0 5.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.183 172.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.465 HH21 ' C ' ' A' ' 88' ' ' GLU . 31.3 mtp180 -55.44 141.94 34.64 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.854 0.462 . . . . 0.0 110.763 175.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.4 m -96.95 -43.74 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 123.836 0.71 . . . . 0.0 109.295 163.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.465 ' C ' HH21 ' A' ' 86' ' ' ARG . 1.9 tt0 . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.063 0.945 . . . . 0.0 108.569 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.419 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.77 126.28 0.23 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.167 2.587 . . . . 0.0 104.037 -176.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.668 ' H ' HG22 ' A' ' 43' ' ' THR . . . -74.86 156.91 49.87 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -179.27 174.8 0.99 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.123 0.969 . . . . 0.0 109.791 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 tt -138.75 116.09 11.17 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 162.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.83 158.84 23.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 126.613 1.965 . . . . 0.0 106.134 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -121.62 175.7 6.09 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.579 0.704 . . . . 0.0 110.427 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 93.7 m -153.16 154.58 35.05 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -159.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -77.6 1.95 18.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 115.095 1.516 . . . . 0.0 115.095 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -158.97 -172.79 3.94 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 125.537 1.535 . . . . 0.0 109.416 169.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.98 3.77 32.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.698 0.761 . . . . 0.0 112.504 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -113.27 130.12 23.93 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 124.07 0.948 . . . . 0.0 110.87 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.09 -46.77 7.52 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 119.85 0.982 . . . . 0.0 109.995 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -64.01 -50.66 67.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.704 0.802 . . . . 0.0 111.069 -161.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 t -110.65 14.34 22.36 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.695 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.79 -50.04 15.54 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t 71.11 116.29 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -158.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.9 m -136.13 148.56 48.28 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.069 -158.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -93.71 93.14 7.84 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 123.704 1.716 . . . . 0.0 110.833 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -83.66 58.04 4.39 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 111.359 -2.655 . . . . 0.0 103.929 158.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.26 177.51 4.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 127.444 2.298 . . . . 0.0 106.582 172.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -66.98 143.31 56.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 118.557 -1.257 . . . . 0.0 107.722 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -139.99 -12.24 1.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.835 1.254 . . . . 0.0 109.938 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -86.91 173.18 9.52 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.093 1.357 . . . . 0.0 108.57 -165.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -33.46 76.78 0.0 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 131.235 3.814 . . . . 0.0 113.846 -166.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.1 t -176.21 178.83 1.34 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 128.605 2.762 . . . . 0.0 108.179 168.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.8 t -72.27 127.36 32.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.752 0.821 . . . . 0.0 109.736 -173.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 t -127.4 133.86 67.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.43 161.79 53.01 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 121.829 -0.544 . . . . 0.0 111.865 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.7 mt -135.41 151.97 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.449 1.9 . . . . 0.0 106.065 165.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 156.22 156.72 7.96 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.242 0.474 . . . . 0.0 112.003 163.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 67.48 86.15 0.13 Allowed 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 128.186 2.594 . . . . 0.0 112.517 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 61.35 3.25 0.74 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 128.378 2.671 . . . . 0.0 112.409 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.1 t -86.51 98.76 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -146.04 29.3 1.09 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 173.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 89.4 m95 -144.77 113.67 6.84 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -173.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.459 ' H ' HD13 ' A' ' 75' ' ' ILE . 43.9 ttm -87.59 140.03 29.93 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 168.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.61 95.7 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -174.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 p -93.94 151.7 19.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.994 1.317 . . . . 0.0 114.37 -158.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -124.08 143.73 15.01 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.717 ' HA3' ' CB ' ' A' ' 69' ' ' ALA . . . -141.09 -32.49 0.14 Allowed Glycine 0 CA--C 1.498 -1.004 0 CA-C-O 121.795 0.664 . . . . 0.0 114.696 -158.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.352 27.5 m -35.83 158.67 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 125.014 1.325 . . . . 0.0 111.851 158.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 3' ' ' GLY . 0.4 OUTLIER 47.88 30.57 1.99 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.783 0.802 . . . . 0.0 110.068 -169.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.7 t70 58.8 38.49 24.71 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.978 1.37 . . . . 0.0 111.158 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -45.37 -47.35 11.49 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 125.216 1.389 . . . . 0.0 110.324 159.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 52.96 -173.79 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.388 1.075 . . . . 0.0 110.269 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -52.73 154.2 2.84 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.793 -0.567 . . . . 0.0 110.669 171.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.75 140.87 12.49 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 106.199 -2.761 . . . . 0.0 106.199 168.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.3 m -130.73 158.1 41.02 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 117.574 0.687 . . . . 0.0 109.194 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.41 154.42 40.83 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.137 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.3 m -99.98 131.63 45.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 167.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 mm -114.88 144.64 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -167.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -132.78 151.7 51.94 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.357 0.98 . . . . 0.0 112.67 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -88.87 -33.62 17.27 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.07 1.748 . . . . 0.0 109.42 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.14 141.89 42.08 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 m -63.5 151.68 40.62 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 159.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.19 38.75 90.92 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.887 -174.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 30.1 p 44.85 50.97 8.7 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.287 1.835 . . . . 0.0 114.016 170.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -123.88 176.62 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.019 1.328 . . . . 0.0 108.002 169.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.22 -151.42 21.5 Favored Glycine 0 CA--C 1.52 0.377 0 O-C-N 121.313 -0.867 . . . . 0.0 111.592 172.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -80.2 150.85 29.97 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 p -147.55 174.46 11.71 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.53 0.681 . . . . 0.0 111.411 -164.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.0 t -147.31 -176.18 5.13 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 158.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.89 133.93 42.08 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 166.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.1 ttt -124.24 144.0 50.21 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.289 1.035 . . . . 0.0 108.849 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.4 m -115.88 151.38 35.41 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 37.5 t -142.45 122.41 8.04 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 123.516 0.726 . . . . 0.0 110.157 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -60.07 165.2 10.91 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.237 1.958 . . . . 0.0 110.061 171.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.717 ' CB ' ' HA3' ' A' ' 41' ' ' GLY . . . -74.1 174.88 8.05 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.621 173.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.4 p30 47.15 45.93 16.23 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 124.559 1.144 . . . . 0.0 109.977 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.1 m -143.09 139.46 30.47 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.407 ' SG ' ' CE3' ' A' ' 36' ' ' TRP . 0.1 OUTLIER -101.97 113.85 27.45 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 167.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 120.95 41.21 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.07 2.148 . . . . 0.0 106.525 -168.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -84.75 111.22 19.4 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.803 0.841 . . . . 0.0 109.453 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 37' ' ' MET . 1.7 mp -80.44 93.4 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.18 75.35 0.45 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -6.52 48.86 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -173.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.07 -43.08 1.45 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.47 156.4 29.36 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 117.891 0.845 . . . . 0.0 111.724 175.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -78.93 133.54 36.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 165.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.36 143.74 12.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.193 0.997 . . . . 0.0 108.973 -170.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -126.17 -25.89 3.47 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 171.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.94 165.07 30.91 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.37 179.53 9.05 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.426 1.49 . . . . 0.0 109.883 170.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -148.7 123.75 10.07 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.351 1.86 . . . . 0.0 106.783 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -75.8 139.18 41.63 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.643 1.565 . . . . 0.0 108.546 170.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.1 m -109.6 -35.43 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 117.763 -1.113 . . . . 0.0 113.749 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 CA--C 1.529 0.149 0 CA-C-N 119.671 1.123 . . . . 0.0 110.629 -174.829 . . . . . . . . 0 0 . 1 stop_ save_